DrugA,DrugB,Interaction,Mechanism,risk_level
Lorcaserin,Obeticholic acid,The metabolism of Lorcaserin can be decreased when combined with Obeticholic acid.,decrease,no risk
Lorcaserin,Octinoxate,Lorcaserin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Lorcaserin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lorcaserin is combined with Oliceridine.",increase,risk
Lorcaserin,Olsalazine,Olsalazine may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Omaveloxolone,The serum concentration of Lorcaserin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lorcaserin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Opium,The metabolism of Opium can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Oritavancin,The metabolism of Lorcaserin can be decreased when combined with Oritavancin.,decrease,no risk
Lorcaserin,Orphenadrine,Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lorcaserin,Oseltamivir,Oseltamivir may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Osilodrostat,The metabolism of Lorcaserin can be decreased when combined with Osilodrostat.,decrease,no risk
Lorcaserin,Osimertinib,The serum concentration of Lorcaserin can be decreased when it is combined with Osimertinib.,decrease,no risk
Lorcaserin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Oxacillin,Oxacillin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Oxamniquine,The metabolism of Lorcaserin can be decreased when combined with Oxamniquine.,decrease,no risk
Lorcaserin,Oxaprozin,Oxaprozin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Lorcaserin.,increase,risk
Lorcaserin,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Lorcaserin.,increase,risk
Lorcaserin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Lorcaserin.,increase,risk
Lorcaserin,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Oxtriphylline,The metabolism of Lorcaserin can be decreased when combined with Oxtriphylline.,decrease,no risk
Lorcaserin,Oxybenzone,Oxybenzone may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Lorcaserin.,increase,risk
Lorcaserin,Oxybutynin,The metabolism of Lorcaserin can be decreased when combined with Oxybutynin.,decrease,no risk
Lorcaserin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Oxyquinoline,Lorcaserin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Lorcaserin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Lorcaserin.,increase,risk
Lorcaserin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Quinethazone,Quinethazone may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lorcaserin,Quinidine,The metabolism of Lorcaserin can be decreased when combined with Quinidine.,decrease,no risk
Lorcaserin,Quinine,The metabolism of Lorcaserin can be decreased when combined with Quinine.,decrease,no risk
Lorcaserin,Quinupramine,The risk or severity of CNS depression can be increased when Lorcaserin is combined with Quinupramine.,increase,risk
Lorcaserin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Lorcaserin.,increase,risk
Lorcaserin,Vaborbactam,Lorcaserin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Lorcaserin,Vadadustat,The serum concentration of Lorcaserin can be decreased when it is combined with Vadadustat.,decrease,no risk
Lorcaserin,Valaciclovir,Valaciclovir may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Valdecoxib,Valdecoxib may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Valganciclovir,Valganciclovir may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Lorcaserin is combined with Valproate bismuth.,increase,risk
Lorcaserin,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Lorcaserin.,increase,risk
Lorcaserin,Vancomycin,Lorcaserin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Varenicline,Varenicline may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Lorcaserin.,increase,risk
Lorcaserin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Vemurafenib,The serum concentration of Lorcaserin can be increased when it is combined with Vemurafenib.,increase,no risk
Lorcaserin,Venetoclax,The metabolism of Lorcaserin can be decreased when combined with Venetoclax.,decrease,no risk
Lorcaserin,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Lorcaserin is combined with Venlafaxine.,increase,risk
Lorcaserin,Verapamil,The metabolism of Lorcaserin can be decreased when combined with Verapamil.,decrease,no risk
Lorcaserin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Lorcaserin.,increase,risk
Lorcaserin,Vilanterol,Lorcaserin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Lorcaserin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Viloxazine,The metabolism of Lorcaserin can be decreased when combined with Viloxazine.,decrease,no risk
Lorcaserin,Vinblastine,The metabolism of Lorcaserin can be decreased when combined with Vinblastine.,decrease,no risk
Lorcaserin,Vinorelbine,The metabolism of Lorcaserin can be decreased when combined with Vinorelbine.,decrease,no risk
Lorcaserin,Voriconazole,The metabolism of Lorcaserin can be decreased when combined with Voriconazole.,decrease,no risk
Lorcaserin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Warfarin,Lorcaserin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Lorcaserin.,increase,risk
Lorcaserin,Zanamivir,Zanamivir may decrease the excretion rate of Lorcaserin which could result in a higher serum level.,decrease,no risk
Lorcaserin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Ziconotide,The risk or severity of CNS depression can be increased when Lorcaserin is combined with Ziconotide.,increase,risk
Lorcaserin,Zidovudine,The metabolism of Lorcaserin can be decreased when combined with Zidovudine.,decrease,no risk
Lorcaserin,Zileuton,The metabolism of Lorcaserin can be decreased when combined with Zileuton.,decrease,no risk
Lorcaserin,Zimelidine,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Zimelidine.,increase,risk
Lorcaserin,Ziprasidone,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Ziprasidone.,increase,risk
Lorcaserin,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lorcaserin.,increase,risk
Lorcaserin,Zolpidem,Lorcaserin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Lorcaserin,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Lorcaserin.,increase,risk
Lorcaserin,Zopiclone,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Zopiclone.,increase,risk
Lorcaserin,Zotepine,The risk or severity of adverse effects can be increased when Lorcaserin is combined with Zotepine.,increase,risk
Lorcaserin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Lorcaserin.,decrease,no risk
Lorcaserin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Lorcaserin.,increase,risk
Osanetant,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Osanetant.,increase,risk
Osanetant,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Osanetant is combined with Gabapentin enacarbil.,increase,risk
Osanetant,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Osanetant.,increase,risk
Osanetant,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Osanetant is combined with Ganaxolone.",increase,risk
Osanetant,Gepirone,The risk or severity of CNS depression can be increased when Osanetant is combined with Gepirone.,increase,risk
Osanetant,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Osanetant.,increase,risk
Osanetant,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Osanetant.,increase,risk
Osanetant,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Osanetant.,increase,risk
Osanetant,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Osanetant.,increase,risk
Osanetant,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Osanetant.,increase,risk
Osanetant,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Osanetant.,increase,risk
Osanetant,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Osanetant.,increase,risk
Osanetant,Hydrocodone,Osanetant may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Osanetant,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Osanetant.,increase,risk
Osanetant,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Osanetant.,increase,no risk
Osanetant,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Osanetant.,increase,risk
Osanetant,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Osanetant.,increase,risk
Osanetant,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Osanetant.,increase,risk
Osanetant,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Osanetant is combined with Oliceridine.",increase,risk
Osanetant,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Osanetant.,increase,risk
Osanetant,Opium,The risk or severity of CNS depression can be increased when Osanetant is combined with Opium.,increase,risk
Osanetant,Orphenadrine,Osanetant may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Osanetant,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Osanetant.,increase,risk
Osanetant,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Osanetant.,increase,risk
Osanetant,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Osanetant.,increase,risk
Osanetant,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Osanetant.,increase,risk
Osanetant,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Osanetant.,increase,risk
Osanetant,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Osanetant.,increase,risk
Osanetant,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Osanetant.,increase,risk
Osanetant,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Osanetant.,increase,risk
Osanetant,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Osanetant.,increase,risk
Osanetant,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Osanetant.,decrease,no risk
Osanetant,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Osanetant.,increase,risk
Osanetant,Quinupramine,The risk or severity of CNS depression can be increased when Osanetant is combined with Quinupramine.,increase,risk
Osanetant,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Osanetant.,increase,risk
Osanetant,Valproate bismuth,Osanetant may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Osanetant,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Osanetant.,increase,risk
Osanetant,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Osanetant.,increase,risk
Osanetant,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Osanetant.,increase,risk
Osanetant,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Osanetant.,increase,risk
Osanetant,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Osanetant.,increase,risk
Osanetant,Viloxazine,The risk or severity of CNS depression can be increased when Osanetant is combined with Viloxazine.,increase,risk
Osanetant,Vincristine,Vincristine may increase the neurotoxic activities of Osanetant.,increase,no risk
Osanetant,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Osanetant.,increase,no risk
Osanetant,Viomycin,Osanetant may increase the neurotoxic activities of Viomycin.,increase,no risk
Osanetant,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Osanetant.,increase,risk
Osanetant,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Osanetant.,increase,risk
Osanetant,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Osanetant.,increase,risk
Osanetant,Ziconotide,The risk or severity of CNS depression can be increased when Osanetant is combined with Ziconotide.,increase,risk
Osanetant,Zimelidine,The risk or severity of adverse effects can be increased when Osanetant is combined with Zimelidine.,increase,risk
Osanetant,Ziprasidone,The risk or severity of adverse effects can be increased when Osanetant is combined with Ziprasidone.,increase,risk
Osanetant,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Osanetant.,increase,risk
Osanetant,Zolpidem,Osanetant may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Osanetant,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Osanetant.,increase,risk
Osanetant,Zopiclone,The risk or severity of adverse effects can be increased when Osanetant is combined with Zopiclone.,increase,risk
Osanetant,Zotepine,The risk or severity of CNS depression can be increased when Osanetant is combined with Zotepine.,increase,risk
Osanetant,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Osanetant.,increase,risk
Osanetant,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Osanetant.,increase,risk
Vildagliptin,Gatifloxacin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Vildagliptin,Gefapixant,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Gefapixant.,increase,no risk
Vildagliptin,Gemifloxacin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Vildagliptin,Gliclazide,Vildagliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Vildagliptin,Glimepiride,Vildagliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Vildagliptin,Glipizide,Vildagliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Vildagliptin,Gliquidone,Vildagliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Vildagliptin,Glyburide,Vildagliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Vildagliptin,Glymidine,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Glymidine.,increase,no risk
Vildagliptin,Goserelin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Vildagliptin,Grepafloxacin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Vildagliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Vildagliptin.,increase,risk
Vildagliptin,Haloperidol,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Haloperidol.,decrease,no risk
Vildagliptin,Histrelin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Vildagliptin,Hydrochlorothiazide,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Vildagliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Vildagliptin.,increase,risk
Vildagliptin,Hydroflumethiazide,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Vildagliptin,Hydroxychloroquine,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Vildagliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Vildagliptin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Vildagliptin is combined with Ketotifen.,increase,risk
Vildagliptin,Octreotide,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Vildagliptin,Ofloxacin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Vildagliptin,Olanzapine,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Vildagliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Vildagliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Vildagliptin,Oxprenolol,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Vildagliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Vildagliptin,Quetiapine,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Vildagliptin,Quinapril,The risk or severity of angioedema can be increased when Vildagliptin is combined with Quinapril.,increase,risk
Vildagliptin,Quinethazone,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Vildagliptin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Vildagliptin.,increase,risk
Vildagliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Vildagliptin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Vildagliptin.,increase,risk
Vildagliptin,Udenafil,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Udenafil.,increase,no risk
Vildagliptin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Vildagliptin.,increase,risk
Vildagliptin,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Vildagliptin.,increase,risk
Vildagliptin,Valdecoxib,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Valdecoxib.,increase,no risk
Vildagliptin,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Vildagliptin.,increase,risk
Vildagliptin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Vildagliptin.,increase,risk
Vildagliptin,Vemurafenib,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Vemurafenib.,increase,no risk
Vildagliptin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Vildagliptin.,increase,risk
Vildagliptin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Vildagliptin.,increase,risk
Vildagliptin,Vorinostat,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Vorinostat.,decrease,no risk
Vildagliptin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Vildagliptin.,increase,risk
Vildagliptin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Vildagliptin.,increase,risk
Vildagliptin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Vildagliptin.,increase,risk
Vildagliptin,Ziprasidone,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Vildagliptin,Zofenopril,The risk or severity of angioedema can be increased when Vildagliptin is combined with Zofenopril.,increase,risk
Vildagliptin,Zonisamide,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Zonisamide.,increase,no risk
Voglibose,Gatifloxacin,The therapeutic efficacy of Voglibose can be increased when used in combination with Gatifloxacin.,increase,no risk
Voglibose,Gefapixant,The therapeutic efficacy of Voglibose can be increased when used in combination with Gefapixant.,increase,no risk
Voglibose,Gemifloxacin,The therapeutic efficacy of Voglibose can be increased when used in combination with Gemifloxacin.,increase,no risk
Voglibose,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Voglibose.,increase,risk
Voglibose,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Voglibose.,increase,risk
Voglibose,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Voglibose.,increase,risk
Voglibose,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with Voglibose.,increase,risk
Voglibose,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Voglibose.,increase,risk
Voglibose,Glymidine,The therapeutic efficacy of Voglibose can be increased when used in combination with Glymidine.,increase,no risk
Voglibose,Goserelin,The therapeutic efficacy of Voglibose can be decreased when used in combination with Goserelin.,decrease,no risk
Voglibose,Grepafloxacin,The therapeutic efficacy of Voglibose can be increased when used in combination with Grepafloxacin.,increase,no risk
Voglibose,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Voglibose.,increase,risk
Voglibose,Haloperidol,The therapeutic efficacy of Voglibose can be decreased when used in combination with Haloperidol.,decrease,no risk
Voglibose,Histrelin,The therapeutic efficacy of Voglibose can be decreased when used in combination with Histrelin.,decrease,no risk
Voglibose,Hydrochlorothiazide,The therapeutic efficacy of Voglibose can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Voglibose,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Voglibose.,increase,risk
Voglibose,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Voglibose.,increase,risk
Voglibose,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Voglibose.,increase,risk
Voglibose,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Voglibose.,increase,risk
Voglibose,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Voglibose.,increase,risk
Voglibose,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Voglibose.,increase,risk
Voglibose,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Voglibose.,increase,risk
Voglibose,Hydroflumethiazide,The therapeutic efficacy of Voglibose can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Voglibose,Hydroxychloroquine,The therapeutic efficacy of Voglibose can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Voglibose,Hydroxyprogesterone caproate,The therapeutic efficacy of Voglibose can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Voglibose,Ketotifen,The risk or severity of thrombocytopenia can be increased when Voglibose is combined with Ketotifen.,increase,risk
Voglibose,Octreotide,The therapeutic efficacy of Voglibose can be decreased when used in combination with Octreotide.,decrease,no risk
Voglibose,Ofloxacin,The therapeutic efficacy of Voglibose can be increased when used in combination with Ofloxacin.,increase,no risk
Voglibose,Olanzapine,The therapeutic efficacy of Voglibose can be decreased when used in combination with Olanzapine.,decrease,no risk
Voglibose,Olsalazine,Olsalazine may increase the hypoglycemic activities of Voglibose.,increase,no risk
Voglibose,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Voglibose.,increase,no risk
Voglibose,Oxprenolol,The therapeutic efficacy of Voglibose can be increased when used in combination with Oxprenolol.,increase,no risk
Voglibose,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Voglibose.,increase,no risk
Voglibose,Quetiapine,The therapeutic efficacy of Voglibose can be decreased when used in combination with Quetiapine.,decrease,no risk
Voglibose,Quinethazone,The therapeutic efficacy of Voglibose can be decreased when used in combination with Quinethazone.,decrease,no risk
Voglibose,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Voglibose.,increase,risk
Voglibose,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Voglibose.,decrease,no risk
Voglibose,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Voglibose.,increase,risk
Voglibose,Udenafil,The therapeutic efficacy of Voglibose can be increased when used in combination with Udenafil.,increase,no risk
Voglibose,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Voglibose.,increase,risk
Voglibose,Valdecoxib,The therapeutic efficacy of Voglibose can be increased when used in combination with Valdecoxib.,increase,no risk
Voglibose,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Voglibose.,increase,risk
Voglibose,Vemurafenib,The therapeutic efficacy of Voglibose can be increased when used in combination with Vemurafenib.,increase,no risk
Voglibose,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Voglibose.,increase,risk
Voglibose,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Voglibose.,increase,risk
Voglibose,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Voglibose.,increase,risk
Voglibose,Vorinostat,The therapeutic efficacy of Voglibose can be decreased when used in combination with Vorinostat.,decrease,no risk
Voglibose,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Voglibose.,increase,risk
Voglibose,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Voglibose.,increase,risk
Voglibose,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Voglibose.,increase,risk
Voglibose,Ziprasidone,The therapeutic efficacy of Voglibose can be decreased when used in combination with Ziprasidone.,decrease,no risk
Voglibose,Zonisamide,The therapeutic efficacy of Voglibose can be increased when used in combination with Zonisamide.,increase,no risk
Vatalanib,Voriconazole,The serum concentration of Vatalanib can be increased when it is combined with Voriconazole.,increase,no risk
Elacridar,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Ombitasvir,Elacridar may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Elacridar,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Oxaliplatin,Elacridar may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Elacridar,Ozanimod,Elacridar may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Elacridar,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Quinine,The serum concentration of Quinine can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Velpatasvir,Elacridar may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Elacridar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Vincristine,The excretion of Vincristine can be decreased when combined with Elacridar.,decrease,no risk
Elacridar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Elacridar.,increase,no risk
Elacridar,Voxilaprevir,Elacridar may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Elacridar,Zidovudine,Elacridar may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Dapoxetine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Bimekizumab,The metabolism of Dapoxetine can be increased when combined with Bimekizumab.,increase,no risk
Dapoxetine,Biperiden,The metabolism of Dapoxetine can be decreased when combined with Biperiden.,decrease,no risk
Dapoxetine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Dapoxetine.,increase,no risk
Dapoxetine,Bivalirudin,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Bivalirudin.,increase,risk
Dapoxetine,Boceprevir,The metabolism of Dapoxetine can be decreased when combined with Boceprevir.,decrease,no risk
Dapoxetine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Dapoxetine.,increase,risk
Dapoxetine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Dapoxetine.,increase,risk
Dapoxetine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Dapoxetine.,increase,risk
Dapoxetine,Brexpiprazole,Dapoxetine may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Dapoxetine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dapoxetine.,increase,no risk
Dapoxetine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Dapoxetine.,increase,risk
Dapoxetine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Dapoxetine.,increase,risk
Dapoxetine,Bromocriptine,Dapoxetine may increase the orthostatic hypotensive activities of Bromocriptine.,increase,no risk
Dapoxetine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Dapoxetine.,increase,risk
Dapoxetine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Dapoxetine.,increase,risk
Dapoxetine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Bumadizone.,increase,risk
Dapoxetine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Dapoxetine.,increase,risk
Dapoxetine,Buprenorphine,Dapoxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Dapoxetine,Bupropion,The metabolism of Dapoxetine can be decreased when combined with Bupropion.,decrease,no risk
Dapoxetine,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Dapoxetine.,increase,risk
Dapoxetine,Busulfan,The metabolism of Busulfan can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Dapoxetine.,increase,risk
Dapoxetine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Dapoxetine.,increase,risk
Dapoxetine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Dapoxetine.,increase,risk
Dapoxetine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Dapoxetine.,increase,risk
Dapoxetine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Dapoxetine.,increase,risk
Dapoxetine,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Dapoxetine.,increase,risk
Dapoxetine,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Dapoxetine.,increase,risk
Dapoxetine,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Dapoxetine.,increase,risk
Dapoxetine,Galantamine,The metabolism of Dapoxetine can be decreased when combined with Galantamine.,decrease,no risk
Dapoxetine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Dapoxetine.,increase,risk
Dapoxetine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dapoxetine is combined with Ganaxolone.",increase,risk
Dapoxetine,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Dapoxetine.,increase,risk
Dapoxetine,Gefitinib,The metabolism of Dapoxetine can be decreased when combined with Gefitinib.,decrease,no risk
Dapoxetine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dapoxetine.,increase,no risk
Dapoxetine,Gilteritinib,The therapeutic efficacy of Dapoxetine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Dapoxetine,Givosiran,The serum concentration of Dapoxetine can be increased when it is combined with Givosiran.,increase,no risk
Dapoxetine,Gliclazide,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Gliclazide.,increase,risk
Dapoxetine,Glimepiride,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Glimepiride.,increase,risk
Dapoxetine,Glipizide,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Glipizide.,increase,risk
Dapoxetine,Gliquidone,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Gliquidone.,increase,risk
Dapoxetine,Glofitamab,The serum concentration of Dapoxetine can be increased when it is combined with Glofitamab.,increase,no risk
Dapoxetine,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Dapoxetine.,increase,risk
Dapoxetine,Glyburide,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Glyburide.,increase,risk
Dapoxetine,Glycerol phenylbutyrate,The metabolism of Dapoxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Dapoxetine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Glycol salicylate.,increase,risk
Dapoxetine,Glymidine,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Glymidine.,increase,risk
Dapoxetine,Golimumab,The metabolism of Dapoxetine can be increased when combined with Golimumab.,increase,no risk
Dapoxetine,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Dapoxetine.,increase,risk
Dapoxetine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Dapoxetine.,increase,risk
Dapoxetine,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Dapoxetine.,increase,risk
Dapoxetine,Halofantrine,The metabolism of Dapoxetine can be decreased when combined with Halofantrine.,decrease,no risk
Dapoxetine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dapoxetine.,increase,risk
Dapoxetine,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Dapoxetine.,increase,risk
Dapoxetine,Heparin,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Heparin.,increase,risk
Dapoxetine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Dapoxetine.,increase,risk
Dapoxetine,Hydralazine,Dapoxetine may increase the hypotensive activities of Hydralazine.,increase,no risk
Dapoxetine,Hydrochlorothiazide,The risk or severity of hyponatremia can be increased when Dapoxetine is combined with Hydrochlorothiazide.,increase,risk
Dapoxetine,Hydrocodone,Dapoxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dapoxetine,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Dapoxetine is combined with Hydroflumethiazide.,increase,risk
Dapoxetine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Dapoxetine.,increase,risk
Dapoxetine,Hydroxychloroquine,The metabolism of Dapoxetine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Dapoxetine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dapoxetine.,increase,no risk
Dapoxetine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Dapoxetine.,increase,risk
Dapoxetine,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Dapoxetine.,increase,risk
Dapoxetine,Ketoconazole,The metabolism of Dapoxetine can be decreased when combined with Ketoconazole.,decrease,no risk
Dapoxetine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Ketoprofen.,increase,risk
Dapoxetine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Ketorolac.,increase,risk
Dapoxetine,Octreotide,The risk or severity of hypoglycemia can be increased when Octreotide is combined with Dapoxetine.,increase,risk
Dapoxetine,Olanzapine,Dapoxetine may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Dapoxetine,Olaparib,The metabolism of Olaparib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dapoxetine is combined with Oliceridine.",increase,risk
Dapoxetine,Omaveloxolone,The serum concentration of Dapoxetine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dapoxetine,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Dapoxetine.,increase,risk
Dapoxetine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Dapoxetine.,increase,risk
Dapoxetine,Oritavancin,The metabolism of Dapoxetine can be decreased when combined with Oritavancin.,decrease,no risk
Dapoxetine,Orphenadrine,Dapoxetine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dapoxetine,Osilodrostat,The metabolism of Dapoxetine can be decreased when combined with Osilodrostat.,decrease,no risk
Dapoxetine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Ospemifene,The metabolism of Dapoxetine can be decreased when combined with Ospemifene.,decrease,no risk
Dapoxetine,Oxamniquine,The metabolism of Dapoxetine can be decreased when combined with Oxamniquine.,decrease,no risk
Dapoxetine,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Oxaprozin.,increase,risk
Dapoxetine,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxybutynin,The metabolism of Dapoxetine can be decreased when combined with Oxybutynin.,decrease,no risk
Dapoxetine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Dapoxetine.,increase,risk
Dapoxetine,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Oxyphenbutazone.,increase,risk
Dapoxetine,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Dapoxetine.,increase,risk
Dapoxetine,Quetiapine,Dapoxetine may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Dapoxetine,Quinapril,Dapoxetine may increase the orthostatic hypotensive activities of Quinapril.,increase,no risk
Dapoxetine,Quinethazone,The risk or severity of hyponatremia can be increased when Dapoxetine is combined with Quinethazone.,increase,risk
Dapoxetine,Quinidine,Dapoxetine may increase the orthostatic hypotensive activities of Quinidine.,increase,no risk
Dapoxetine,Quinine,The metabolism of Dapoxetine can be decreased when combined with Quinine.,decrease,no risk
Dapoxetine,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Dapoxetine.,increase,risk
Dapoxetine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Ubidecarenone.,increase,risk
Dapoxetine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dapoxetine.,increase,no risk
Dapoxetine,Udenafil,The risk or severity of orthostatic hypotension can be increased when Dapoxetine is combined with Udenafil.,increase,risk
Dapoxetine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Dapoxetine.,increase,risk
Dapoxetine,Urokinase,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Urokinase.,increase,risk
Dapoxetine,Vadadustat,The serum concentration of Dapoxetine can be increased when it is combined with Vadadustat.,increase,no risk
Dapoxetine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Dapoxetine is combined with Valdecoxib.,increase,risk
Dapoxetine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Dapoxetine is combined with Valproate bismuth.,increase,risk
Dapoxetine,Valproic acid,The risk or severity of adverse effects can be increased when Valproic acid is combined with Dapoxetine.,increase,risk
Dapoxetine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vardenafil,The risk or severity of orthostatic hypotension can be increased when Dapoxetine is combined with Vardenafil.,increase,risk
Dapoxetine,Vasopressin,Dapoxetine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Dapoxetine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Dapoxetine.,increase,risk
Dapoxetine,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Dapoxetine is combined with Venlafaxine.,increase,risk
Dapoxetine,Verapamil,The metabolism of Dapoxetine can be decreased when combined with Verapamil.,decrease,no risk
Dapoxetine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Dapoxetine.,increase,risk
Dapoxetine,Vilazodone,The metabolism of Dapoxetine can be decreased when combined with Vilazodone.,decrease,no risk
Dapoxetine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Dapoxetine is combined with Vildagliptin.,increase,risk
Dapoxetine,Viloxazine,The metabolism of Dapoxetine can be decreased when combined with Viloxazine.,decrease,no risk
Dapoxetine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vincristine,The metabolism of Vincristine can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vindesine,The metabolism of Vindesine can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Vorapaxar,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Vorapaxar.,increase,risk
Dapoxetine,Voriconazole,The metabolism of Dapoxetine can be decreased when combined with Voriconazole.,decrease,no risk
Dapoxetine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Dapoxetine.,increase,risk
Dapoxetine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dapoxetine.,increase,no risk
Dapoxetine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dapoxetine.,increase,no risk
Dapoxetine,Ximelagatran,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Ximelagatran.,increase,risk
Dapoxetine,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Dapoxetine.,increase,risk
Dapoxetine,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Dapoxetine.,increase,risk
Dapoxetine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Ziconotide,The risk or severity of adverse effects can be increased when Ziconotide is combined with Dapoxetine.,increase,risk
Dapoxetine,Zimelidine,The risk or severity of adverse effects can be increased when Zimelidine is combined with Dapoxetine.,increase,risk
Dapoxetine,Ziprasidone,The risk or severity of adverse effects can be increased when Dapoxetine is combined with Ziprasidone.,increase,risk
Dapoxetine,Zofenopril,Dapoxetine may increase the orthostatic hypotensive activities of Zofenopril.,increase,no risk
Dapoxetine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Dapoxetine is combined with Zolmitriptan.,increase,risk
Dapoxetine,Zolpidem,Dapoxetine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dapoxetine,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Dapoxetine.,increase,risk
Dapoxetine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dapoxetine.,decrease,no risk
Dapoxetine,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Dapoxetine.,increase,risk
Dapoxetine,Zuclopenthixol,Dapoxetine may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Dapoxetine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dapoxetine.,increase,risk
Cilansetron,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Cilansetron.,increase,risk
Cilansetron,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cilansetron is combined with Gabapentin enacarbil.,increase,risk
Cilansetron,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cilansetron.,increase,risk
Cilansetron,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cilansetron is combined with Ganaxolone.",increase,risk
Cilansetron,Gepirone,The risk or severity of CNS depression can be increased when Cilansetron is combined with Gepirone.,increase,risk
Cilansetron,Gilteritinib,The therapeutic efficacy of Cilansetron can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cilansetron,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Cilansetron.,increase,risk
Cilansetron,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cilansetron.,increase,risk
Cilansetron,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cilansetron.,increase,risk
Cilansetron,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cilansetron.,increase,risk
Cilansetron,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Cilansetron.,increase,risk
Cilansetron,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cilansetron.,increase,risk
Cilansetron,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cilansetron.,increase,risk
Cilansetron,Hydrocodone,Cilansetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cilansetron,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cilansetron.,increase,risk
Cilansetron,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cilansetron.,increase,no risk
Cilansetron,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Cilansetron.,increase,risk
Cilansetron,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Cilansetron.,increase,risk
Cilansetron,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cilansetron.,increase,risk
Cilansetron,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cilansetron is combined with Oliceridine.",increase,risk
Cilansetron,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Cilansetron.,increase,risk
Cilansetron,Opium,The risk or severity of CNS depression can be increased when Cilansetron is combined with Opium.,increase,risk
Cilansetron,Orphenadrine,Cilansetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cilansetron,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Cilansetron.,increase,risk
Cilansetron,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Cilansetron.,increase,risk
Cilansetron,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Cilansetron.,increase,risk
Cilansetron,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Cilansetron.,increase,risk
Cilansetron,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Cilansetron.,increase,risk
Cilansetron,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Cilansetron.,increase,risk
Cilansetron,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Cilansetron.,increase,risk
Cilansetron,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Cilansetron.,increase,risk
Cilansetron,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Cilansetron.,increase,risk
Cilansetron,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Cilansetron.,increase,risk
Cilansetron,Quinupramine,The risk or severity of CNS depression can be increased when Cilansetron is combined with Quinupramine.,increase,risk
Cilansetron,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Cilansetron.,increase,risk
Cilansetron,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Cilansetron.,increase,risk
Cilansetron,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Cilansetron.,increase,risk
Cilansetron,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Cilansetron.,increase,risk
Cilansetron,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Cilansetron.,increase,risk
Cilansetron,Vilazodone,The risk or severity of CNS depression can be increased when Cilansetron is combined with Vilazodone.,increase,risk
Cilansetron,Viloxazine,The risk or severity of CNS depression can be increased when Cilansetron is combined with Viloxazine.,increase,risk
Cilansetron,Vortioxetine,The risk or severity of CNS depression can be increased when Cilansetron is combined with Vortioxetine.,increase,risk
Cilansetron,Warfarin,The risk or severity of adverse effects can be increased when Cilansetron is combined with Warfarin.,increase,risk
Cilansetron,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Cilansetron.,increase,risk
Cilansetron,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Cilansetron.,increase,risk
Cilansetron,Ziconotide,The risk or severity of CNS depression can be increased when Cilansetron is combined with Ziconotide.,increase,risk
Cilansetron,Zimelidine,The risk or severity of adverse effects can be increased when Cilansetron is combined with Zimelidine.,increase,risk
Cilansetron,Ziprasidone,The risk or severity of adverse effects can be increased when Cilansetron is combined with Ziprasidone.,increase,risk
Cilansetron,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Cilansetron.,increase,risk
Cilansetron,Zolpidem,Cilansetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cilansetron,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Cilansetron.,increase,risk
Cilansetron,Zopiclone,The risk or severity of adverse effects can be increased when Cilansetron is combined with Zopiclone.,increase,risk
Cilansetron,Zotepine,The risk or severity of CNS depression can be increased when Cilansetron is combined with Zotepine.,increase,risk
Cilansetron,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Cilansetron.,increase,risk
Cilansetron,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cilansetron.,increase,risk
Calanolide A,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Calanolide A.,increase,no risk
Calanolide A,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Calanolide A.,increase,no risk
Calanolide A,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Calanolide A.,increase,no risk
Calanolide A,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Calanolide A.,increase,no risk
Calanolide A,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Calanolide A.,increase,no risk
Calanolide A,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Calanolide A.,decrease,no risk
Calanolide A,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Calanolide A.,decrease,no risk
Bifeprunox,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Bifeprunox.,increase,risk
Bifeprunox,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Gabapentin enacarbil.,increase,risk
Bifeprunox,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Bifeprunox.,increase,risk
Bifeprunox,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Bifeprunox is combined with Ganaxolone.",increase,risk
Bifeprunox,Gepirone,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Gepirone.,increase,risk
Bifeprunox,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Bifeprunox.,increase,risk
Bifeprunox,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Bifeprunox.,increase,risk
Bifeprunox,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Bifeprunox.,increase,risk
Bifeprunox,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Bifeprunox.,increase,risk
Bifeprunox,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Bifeprunox.,increase,risk
Bifeprunox,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Bifeprunox.,increase,risk
Bifeprunox,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Bifeprunox.,increase,risk
Bifeprunox,Hydrocodone,Bifeprunox may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Bifeprunox,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Bifeprunox.,increase,risk
Bifeprunox,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Bifeprunox.,increase,no risk
Bifeprunox,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Bifeprunox.,increase,risk
Bifeprunox,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Bifeprunox.,increase,risk
Bifeprunox,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Bifeprunox.,increase,risk
Bifeprunox,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Bifeprunox is combined with Oliceridine.",increase,risk
Bifeprunox,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Bifeprunox.,increase,risk
Bifeprunox,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Bifeprunox.,decrease,no risk
Bifeprunox,Opium,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Opium.,increase,risk
Bifeprunox,Orphenadrine,Bifeprunox may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Bifeprunox,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Bifeprunox.,increase,risk
Bifeprunox,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Bifeprunox.,increase,risk
Bifeprunox,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Bifeprunox.,increase,risk
Bifeprunox,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Bifeprunox.,increase,risk
Bifeprunox,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Bifeprunox.,increase,risk
Bifeprunox,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Bifeprunox.,increase,risk
Bifeprunox,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Bifeprunox.,increase,risk
Bifeprunox,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Bifeprunox.,increase,risk
Bifeprunox,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Bifeprunox.,increase,risk
Bifeprunox,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Bifeprunox.,decrease,no risk
Bifeprunox,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Bifeprunox.,increase,risk
Bifeprunox,Quinupramine,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Quinupramine.,increase,risk
Bifeprunox,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Bifeprunox.,increase,risk
Bifeprunox,Valproate bismuth,Bifeprunox may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Bifeprunox,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Bifeprunox.,increase,risk
Bifeprunox,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Bifeprunox.,increase,risk
Bifeprunox,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Bifeprunox.,increase,risk
Bifeprunox,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Bifeprunox.,increase,risk
Bifeprunox,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Bifeprunox.,increase,risk
Bifeprunox,Viloxazine,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Viloxazine.,increase,risk
Bifeprunox,Vincristine,Vincristine may increase the neurotoxic activities of Bifeprunox.,increase,no risk
Bifeprunox,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Bifeprunox.,increase,no risk
Bifeprunox,Viomycin,Bifeprunox may increase the neurotoxic activities of Viomycin.,increase,no risk
Bifeprunox,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Bifeprunox.,increase,risk
Bifeprunox,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Bifeprunox.,increase,risk
Bifeprunox,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Bifeprunox.,increase,risk
Bifeprunox,Ziconotide,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Ziconotide.,increase,risk
Bifeprunox,Zimelidine,The risk or severity of adverse effects can be increased when Bifeprunox is combined with Zimelidine.,increase,risk
Bifeprunox,Ziprasidone,The risk or severity of adverse effects can be increased when Bifeprunox is combined with Ziprasidone.,increase,risk
Bifeprunox,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Bifeprunox.,increase,risk
Bifeprunox,Zolpidem,Bifeprunox may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Bifeprunox,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Bifeprunox.,increase,risk
Bifeprunox,Zopiclone,The risk or severity of adverse effects can be increased when Bifeprunox is combined with Zopiclone.,increase,risk
Bifeprunox,Zotepine,The risk or severity of CNS depression can be increased when Bifeprunox is combined with Zotepine.,increase,risk
Bifeprunox,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Bifeprunox.,increase,risk
Bifeprunox,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Bifeprunox.,increase,risk
Bicifadine,Galantamine,The metabolism of Bicifadine can be decreased when combined with Galantamine.,decrease,no risk
Bicifadine,Gatifloxacin,The metabolism of Bicifadine can be decreased when combined with Gatifloxacin.,decrease,no risk
Bicifadine,Gefitinib,The metabolism of Bicifadine can be decreased when combined with Gefitinib.,decrease,no risk
Bicifadine,Gemfibrozil,The metabolism of Bicifadine can be decreased when combined with Gemfibrozil.,decrease,no risk
Bicifadine,Gemifloxacin,The metabolism of Bicifadine can be decreased when combined with Gemifloxacin.,decrease,no risk
Bicifadine,Ginkgo biloba,The metabolism of Bicifadine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Bicifadine,Givosiran,The serum concentration of Bicifadine can be increased when it is combined with Givosiran.,increase,no risk
Bicifadine,Glofitamab,The serum concentration of Bicifadine can be increased when it is combined with Glofitamab.,increase,no risk
Bicifadine,Glycerol phenylbutyrate,The metabolism of Bicifadine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bicifadine,Golimumab,The metabolism of Bicifadine can be increased when combined with Golimumab.,increase,no risk
Bicifadine,Grepafloxacin,The metabolism of Bicifadine can be decreased when combined with Grepafloxacin.,decrease,no risk
Bicifadine,Guanabenz,The metabolism of Bicifadine can be decreased when combined with Guanabenz.,decrease,no risk
Bicifadine,Halofantrine,The metabolism of Bicifadine can be decreased when combined with Halofantrine.,decrease,no risk
Bicifadine,Haloperidol,The serum concentration of Bicifadine can be increased when it is combined with Haloperidol.,increase,no risk
Bicifadine,Hydroxychloroquine,The metabolism of Bicifadine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Bicifadine,Hydroxyzine,The metabolism of Bicifadine can be decreased when combined with Hydroxyzine.,decrease,no risk
Bicifadine,Ketoconazole,The metabolism of Bicifadine can be decreased when combined with Ketoconazole.,decrease,no risk
Bicifadine,Obeticholic acid,The metabolism of Bicifadine can be decreased when combined with Obeticholic acid.,decrease,no risk
Bicifadine,Olanzapine,The metabolism of Bicifadine can be decreased when combined with Olanzapine.,decrease,no risk
Bicifadine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Ondansetron,The metabolism of Bicifadine can be decreased when combined with Ondansetron.,decrease,no risk
Bicifadine,Opium,The metabolism of Opium can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Oritavancin,The metabolism of Bicifadine can be decreased when combined with Oritavancin.,decrease,no risk
Bicifadine,Orphenadrine,The metabolism of Bicifadine can be decreased when combined with Orphenadrine.,decrease,no risk
Bicifadine,Osilodrostat,The metabolism of Bicifadine can be decreased when combined with Osilodrostat.,decrease,no risk
Bicifadine,Osimertinib,The serum concentration of Bicifadine can be decreased when it is combined with Osimertinib.,decrease,no risk
Bicifadine,Ospemifene,The metabolism of Bicifadine can be decreased when combined with Ospemifene.,decrease,no risk
Bicifadine,Oxamniquine,The metabolism of Bicifadine can be decreased when combined with Oxamniquine.,decrease,no risk
Bicifadine,Oxprenolol,The metabolism of Bicifadine can be decreased when combined with Oxprenolol.,decrease,no risk
Bicifadine,Oxtriphylline,The metabolism of Bicifadine can be decreased when combined with Oxtriphylline.,decrease,no risk
Bicifadine,Oxybutynin,The metabolism of Bicifadine can be decreased when combined with Oxybutynin.,decrease,no risk
Bicifadine,Oxycodone,The metabolism of Bicifadine can be decreased when combined with Oxycodone.,decrease,no risk
Bicifadine,Oxymorphone,The metabolism of Bicifadine can be decreased when combined with Oxymorphone.,decrease,no risk
Bicifadine,Quetiapine,The metabolism of Bicifadine can be decreased when combined with Quetiapine.,decrease,no risk
Bicifadine,Quinidine,The metabolism of Bicifadine can be decreased when combined with Quinidine.,decrease,no risk
Bicifadine,Quinine,The metabolism of Bicifadine can be decreased when combined with Quinine.,decrease,no risk
Bicifadine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Valproic acid,The metabolism of Bicifadine can be decreased when combined with Valproic acid.,decrease,no risk
Bicifadine,Vemurafenib,The serum concentration of Bicifadine can be increased when it is combined with Vemurafenib.,increase,no risk
Bicifadine,Venlafaxine,The metabolism of Bicifadine can be decreased when combined with Venlafaxine.,decrease,no risk
Bicifadine,Verapamil,The metabolism of Bicifadine can be decreased when combined with Verapamil.,decrease,no risk
Bicifadine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Vilazodone,The metabolism of Bicifadine can be decreased when combined with Vilazodone.,decrease,no risk
Bicifadine,Viloxazine,The metabolism of Bicifadine can be decreased when combined with Viloxazine.,decrease,no risk
Bicifadine,Vinblastine,The metabolism of Bicifadine can be decreased when combined with Vinblastine.,decrease,no risk
Bicifadine,Vinorelbine,The metabolism of Bicifadine can be decreased when combined with Vinorelbine.,decrease,no risk
Bicifadine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Warfarin,The metabolism of Bicifadine can be decreased when combined with Warfarin.,decrease,no risk
Bicifadine,Yohimbine,The metabolism of Bicifadine can be decreased when combined with Yohimbine.,decrease,no risk
Bicifadine,Zileuton,The metabolism of Bicifadine can be decreased when combined with Zileuton.,decrease,no risk
Bicifadine,Zimelidine,The metabolism of Bicifadine can be decreased when combined with Zimelidine.,decrease,no risk
Bicifadine,Zolmitriptan,The metabolism of Bicifadine can be decreased when combined with Zolmitriptan.,decrease,no risk
Bicifadine,Zolpidem,The metabolism of Bicifadine can be decreased when combined with Zolpidem.,decrease,no risk
Bicifadine,Zonisamide,The metabolism of Bicifadine can be decreased when combined with Zonisamide.,decrease,no risk
Bicifadine,Zotepine,The metabolism of Zotepine can be decreased when combined with Bicifadine.,decrease,no risk
Bicifadine,Zuclopenthixol,The metabolism of Bicifadine can be decreased when combined with Zuclopenthixol.,decrease,no risk
Bepotastine,Gabapentin enacarbil,Bepotastine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Bepotastine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Gadodiamide,Gadodiamide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Gadofosveset trisodium,Bepotastine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Bepotastine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Gadoteric acid,Bepotastine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Bepotastine,Gadoteridol,Gadoteridol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Ganciclovir,Ganciclovir may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Gemcitabine,Gemcitabine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Gentamicin,Bepotastine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Bepotastine,Gimeracil,Bepotastine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Bepotastine,Givosiran,Givosiran may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Glipizide,Glipizide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Glycerol phenylbutyrate,Bepotastine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Bepotastine,Golodirsen,Bepotastine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Bepotastine,Goserelin,Goserelin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Guanethidine,Guanethidine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Guanfacine,Guanfacine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Haloperidol,Haloperidol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Hydralazine,Hydralazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bepotastine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bepotastine,Hydromorphone,Hydromorphone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Hydroxyethyl Starch,Bepotastine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Bepotastine,Hyoscyamine,Bepotastine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Bepotastine,Kanamycin,Bepotastine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Bepotastine,Ketamine,Ketamine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Ketazolam,Ketazolam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Ketoprofen,Ketoprofen may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Ketorolac,Ketorolac may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Octinoxate,Bepotastine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Bepotastine,Olsalazine,Olsalazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Opium,Bepotastine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Bepotastine,Oseltamivir,Oseltamivir may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Oxacillin,Oxacillin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Oxaprozin,Oxaprozin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Oxazepam,Oxazepam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Oxybenzone,Oxybenzone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Oxyquinoline,Bepotastine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Bepotastine,Quetiapine,Quetiapine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Quinethazone,Quinethazone may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bepotastine,Quinidine,Bepotastine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Bepotastine,Vaborbactam,Bepotastine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Bepotastine,Valaciclovir,Valaciclovir may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Valbenazine,Bepotastine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Bepotastine,Valdecoxib,Valdecoxib may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Valganciclovir,Valganciclovir may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Vancomycin,Bepotastine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Bepotastine,Varenicline,Varenicline may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Venlafaxine,Venlafaxine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Verapamil,Verapamil may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Vilanterol,Bepotastine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Bepotastine,Viloxazine,Bepotastine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Bepotastine,Vortioxetine,Bepotastine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Bepotastine,Warfarin,Bepotastine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Bepotastine,Zaleplon,Zaleplon may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Zanamivir,Zanamivir may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Bepotastine,Zonisamide,Zonisamide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Becocalcidiol,Vamorolone,The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Vamorolone.,decrease,no risk
Becocalcidiol,Vitamin D,The risk or severity of adverse effects can be increased when Becocalcidiol is combined with Vitamin D.,increase,risk
Phenserine,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Oxprenolol,Phenserine may increase the bradycardic activities of Oxprenolol.,increase,no risk
Phenserine,Oxybuprocaine,Phenserine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Phenserine,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Vamorolone,The therapeutic efficacy of Phenserine can be decreased when used in combination with Vamorolone.,decrease,no risk
Phenserine,Varenicline,The risk or severity of adverse effects can be increased when Phenserine is combined with Varenicline.,increase,risk
Phenserine,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Phenserine.,decrease,no risk
Phenserine,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Phenserine.,decrease,no risk
Vapreotide,Olaparib,The metabolism of Olaparib can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vapreotide is combined with Oxetacaine.,increase,risk
Vapreotide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vapreotide is combined with Oxybuprocaine.,increase,risk
Vapreotide,Quinidine,The metabolism of Quinidine can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vapreotide.,increase,no risk
Vapreotide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vincristine,The metabolism of Vincristine can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vindesine,The metabolism of Vindesine can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Vapreotide.,increase,no risk
Vapreotide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Vapreotide.,increase,no risk
Vapreotide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Vapreotide.,decrease,no risk
Vapreotide,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Vapreotide.,decrease,no risk
Pegaptanib,Gabapentin enacarbil,Pegaptanib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gadodiamide,Gadodiamide may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gadofosveset trisodium,Pegaptanib may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gadoteric acid,Pegaptanib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gadoteridol,Gadoteridol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Ganciclovir,Ganciclovir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gemcitabine,Gemcitabine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gentamicin,Pegaptanib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pegaptanib,Gimeracil,Pegaptanib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pegaptanib,Givosiran,Givosiran may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Glipizide,Glipizide may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Glycerol phenylbutyrate,Pegaptanib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pegaptanib,Golodirsen,Pegaptanib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pegaptanib,Goserelin,Goserelin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Guanethidine,Guanethidine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Guanfacine,Guanfacine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Haloperidol,Haloperidol may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Hydralazine,Hydralazine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pegaptanib,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pegaptanib,Hydromorphone,Hydromorphone may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Hydroxyethyl Starch,Pegaptanib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pegaptanib,Kanamycin,Pegaptanib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pegaptanib,Ketamine,Ketamine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Ketazolam,Ketazolam may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Ketoprofen,Ketoprofen may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Ketorolac,Ketorolac may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Octinoxate,Pegaptanib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pegaptanib,Olsalazine,Olsalazine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Opium,Pegaptanib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oseltamivir,Oseltamivir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oxacillin,Oxacillin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oxaprozin,Oxaprozin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oxazepam,Oxazepam may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oxybenzone,Oxybenzone may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Oxyquinoline,Pegaptanib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pegaptanib,Quetiapine,Quetiapine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Quinethazone,Quinethazone may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pegaptanib,Quinidine,Pegaptanib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pegaptanib,Vaborbactam,Pegaptanib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pegaptanib,Valaciclovir,Valaciclovir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Valbenazine,Pegaptanib may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Pegaptanib,Valdecoxib,Valdecoxib may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Valganciclovir,Valganciclovir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Vancomycin,Pegaptanib may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pegaptanib,Varenicline,Varenicline may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Venlafaxine,Venlafaxine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Verapamil,Verapamil may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Vilanterol,Pegaptanib may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Pegaptanib,Viloxazine,Pegaptanib may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Pegaptanib,Vortioxetine,Pegaptanib may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Pegaptanib,Warfarin,Pegaptanib may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Pegaptanib,Zaleplon,Zaleplon may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Zanamivir,Zanamivir may decrease the excretion rate of Pegaptanib which could result in a higher serum level.,decrease,no risk
Pegaptanib,Zonisamide,Zonisamide may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Milnacipran,Bacitracin,Bacitracin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,decrease,no risk
Milnacipran,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.,increase,no risk
Milnacipran,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Balsalazide.,increase,risk
Milnacipran,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Beclomethasone dipropionate,The metabolism of Milnacipran can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Milnacipran,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Bemiparin,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Bemiparin.,increase,risk
Milnacipran,Bendroflumethiazide,The risk or severity of hyponatremia can be increased when Milnacipran is combined with Bendroflumethiazide.,increase,risk
Milnacipran,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Benorilate.,increase,risk
Milnacipran,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Benoxaprofen.,increase,risk
Milnacipran,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Milnacipran.,increase,risk
Milnacipran,Benserazide,Milnacipran may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Milnacipran,Benzatropine,Benzatropine may decrease the excretion rate of Milnacipran which could result in a higher serum level.,decrease,no risk
Milnacipran,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Milnacipran.,increase,risk
Milnacipran,Benznidazole,Milnacipran may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Milnacipran,Benzocaine,The risk or severity of adverse effects can be increased when Benzocaine is combined with Milnacipran.,increase,risk
Milnacipran,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Milnacipran.,increase,risk
Milnacipran,Benzthiazide,The risk or severity of hyponatremia can be increased when Milnacipran is combined with Benzthiazide.,increase,risk
Milnacipran,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Benzydamine.,increase,risk
Milnacipran,Benzyl alcohol,The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Milnacipran.,increase,risk
Milnacipran,Bepotastine,Bepotastine may decrease the excretion rate of Milnacipran which could result in a higher serum level.,decrease,no risk
Milnacipran,Bepridil,The metabolism of Bepridil can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Berotralstat,The metabolism of Milnacipran can be decreased when combined with Berotralstat.,decrease,no risk
Milnacipran,Betamethasone,The metabolism of Milnacipran can be increased when combined with Betamethasone.,increase,no risk
Milnacipran,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Milnacipran.,increase,no risk
Milnacipran,Bethanidine,Milnacipran may increase the tachycardic activities of Bethanidine.,increase,no risk
Milnacipran,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Milnacipran.,increase,risk
Milnacipran,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Milnacipran is combined with Bexagliflozin.,increase,risk
Milnacipran,Bexarotene,The metabolism of Milnacipran can be increased when combined with Bexarotene.,increase,no risk
Milnacipran,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Bicisate,Milnacipran may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Milnacipran,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Milnacipran.,increase,risk
Milnacipran,Bismuth subgallate,Milnacipran may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Milnacipran,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Milnacipran.,increase,no risk
Milnacipran,Bisoxatin,Milnacipran may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Milnacipran,Bivalirudin,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Bivalirudin.,increase,risk
Milnacipran,Bleomycin,Bleomycin may decrease the excretion rate of Milnacipran which could result in a higher serum level.,decrease,no risk
Milnacipran,Boceprevir,The metabolism of Milnacipran can be decreased when combined with Boceprevir.,decrease,no risk
Milnacipran,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Bosentan,The metabolism of Milnacipran can be increased when combined with Bosentan.,increase,no risk
Milnacipran,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Milnacipran.,increase,risk
Milnacipran,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Milnacipran.,increase,risk
Milnacipran,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Milnacipran.,increase,risk
Milnacipran,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Brigatinib,The metabolism of Milnacipran can be increased when combined with Brigatinib.,increase,no risk
Milnacipran,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.,increase,no risk
Milnacipran,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Milnacipran.,increase,risk
Milnacipran,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Milnacipran.,increase,risk
Milnacipran,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Milnacipran.,increase,risk
Milnacipran,Bromotheophylline,Bromotheophylline may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Milnacipran,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Milnacipran.,increase,risk
Milnacipran,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Milnacipran.,increase,risk
Milnacipran,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Milnacipran.,increase,risk
Milnacipran,Budesonide,The metabolism of Milnacipran can be increased when combined with Budesonide.,increase,no risk
Milnacipran,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Bumadizone.,increase,risk
Milnacipran,Bumetanide,Bumetanide may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Milnacipran,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Milnacipran.,increase,risk
Milnacipran,Buprenorphine,Milnacipran may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Milnacipran,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Milnacipran.,increase,risk
Milnacipran,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Milnacipran.,increase,risk
Milnacipran,Busulfan,The metabolism of Busulfan can be decreased when combined with Milnacipran.,decrease,no risk
Milnacipran,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Milnacipran.,increase,risk
Milnacipran,Butalbital,The metabolism of Milnacipran can be increased when combined with Butalbital.,increase,no risk
Milnacipran,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Milnacipran.,increase,risk
Milnacipran,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Milnacipran.,increase,risk
Milnacipran,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Milnacipran.,increase,risk
Milnacipran,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Milnacipran.,increase,risk
Milnacipran,Butylscopolamine,The risk or severity of Tachycardia can be increased when Milnacipran is combined with Butylscopolamine.,increase,risk
Lucinactant,Bendroflumethiazide,Bendroflumethiazide may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Bepridil,Bepridil may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Beractant,Lucinactant may increase the bradycardic activities of Beractant.,increase,no risk
Lucinactant,Betaxolol,Betaxolol may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Bisoprolol,Bisoprolol may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Bretylium,Bretylium may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Galantamine,Galantamine may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Guanfacine,Guanfacine may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Lucinactant.,increase,no risk
Lucinactant,Oxprenolol,Oxprenolol may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Verapamil,Verapamil may increase the bradycardic activities of Lucinactant.,increase,no risk
Lucinactant,Zonisamide,Zonisamide may increase the bradycardic activities of Lucinactant.,increase,no risk
Ximelagatran,Gemcitabine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Gemcitabine.,increase,risk
Ximelagatran,Gemfibrozil,The metabolism of Ximelagatran can be decreased when combined with Gemfibrozil.,decrease,no risk
Ximelagatran,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ximelagatran is combined with Gemtuzumab ozogamicin.,increase,risk
Ximelagatran,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ximelagatran.,increase,risk
Ximelagatran,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Ximelagatran,Gliclazide,The metabolism of Ximelagatran can be decreased when combined with Gliclazide.,decrease,no risk
Ximelagatran,Glimepiride,The metabolism of Ximelagatran can be decreased when combined with Glimepiride.,decrease,no risk
Ximelagatran,Glipizide,The metabolism of Ximelagatran can be decreased when combined with Glipizide.,decrease,no risk
Ximelagatran,Gliquidone,The metabolism of Ximelagatran can be decreased when combined with Gliquidone.,decrease,no risk
Ximelagatran,Glofitamab,The serum concentration of Ximelagatran can be increased when it is combined with Glofitamab.,increase,no risk
Ximelagatran,Glyburide,The metabolism of Ximelagatran can be decreased when combined with Glyburide.,decrease,no risk
Ximelagatran,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ximelagatran.,increase,risk
Ximelagatran,Golimumab,The metabolism of Ximelagatran can be increased when combined with Golimumab.,increase,no risk
Ximelagatran,Haloperidol,The metabolism of Ximelagatran can be decreased when combined with Haloperidol.,decrease,no risk
Ximelagatran,Halothane,The metabolism of Ximelagatran can be decreased when combined with Halothane.,decrease,no risk
Ximelagatran,Hemin,Hemin may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Ximelagatran,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ximelagatran.,increase,risk
Ximelagatran,Hydrochlorothiazide,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Ximelagatran,Hydroflumethiazide,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Ximelagatran,Hydromorphone,The metabolism of Ximelagatran can be decreased when combined with Hydromorphone.,decrease,no risk
Ximelagatran,Hydroxyprogesterone caproate,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ximelagatran,Hydroxyurea,The risk or severity of bleeding can be increased when Ximelagatran is combined with Hydroxyurea.,increase,risk
Ximelagatran,Ketamine,The metabolism of Ximelagatran can be decreased when combined with Ketamine.,decrease,no risk
Ximelagatran,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ximelagatran.,increase,risk
Ximelagatran,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ximelagatran.,increase,risk
Ximelagatran,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Obeticholic acid.,increase,risk
Ximelagatran,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Ximelagatran is combined with Obinutuzumab.,increase,risk
Ximelagatran,Olanzapine,The metabolism of Ximelagatran can be decreased when combined with Olanzapine.,decrease,no risk
Ximelagatran,Olaparib,The risk or severity of bleeding can be increased when Ximelagatran is combined with Olaparib.,increase,risk
Ximelagatran,Olive oil,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Olive oil.,decrease,no risk
Ximelagatran,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ximelagatran.,decrease,no risk
Ximelagatran,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Ximelagatran.,increase,risk
Ximelagatran,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ximelagatran is combined with Omacetaxine mepesuccinate.,increase,risk
Ximelagatran,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Ximelagatran,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ximelagatran.,increase,risk
Ximelagatran,Omega-3-carboxylic acids,The therapeutic efficacy of Ximelagatran can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ximelagatran,Ondansetron,The metabolism of Ximelagatran can be decreased when combined with Ondansetron.,decrease,no risk
Ximelagatran,Oritavancin,The metabolism of Ximelagatran can be decreased when combined with Oritavancin.,decrease,no risk
Ximelagatran,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ximelagatran.,decrease,no risk
Ximelagatran,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ximelagatran.,increase,risk
Ximelagatran,Oxandrolone,The metabolism of Ximelagatran can be decreased when combined with Oxandrolone.,decrease,no risk
Ximelagatran,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ximelagatran.,increase,risk
Ximelagatran,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ximelagatran.,increase,risk
Ximelagatran,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Ximelagatran,Quinidine,The therapeutic efficacy of Ximelagatran can be increased when used in combination with Quinidine.,increase,no risk
Ximelagatran,Quinine,The therapeutic efficacy of Ximelagatran can be increased when used in combination with Quinine.,increase,no risk
Ximelagatran,Ulipristal,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ulipristal.,decrease,no risk
Ximelagatran,Urokinase,Urokinase may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Ximelagatran,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Ursodeoxycholic acid.,increase,risk
Ximelagatran,Vadadustat,The metabolism of Ximelagatran can be decreased when combined with Vadadustat.,decrease,no risk
Ximelagatran,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ximelagatran.,increase,risk
Ximelagatran,Valproic acid,The metabolism of Ximelagatran can be decreased when combined with Valproic acid.,decrease,no risk
Ximelagatran,Valsartan,The metabolism of Ximelagatran can be decreased when combined with Valsartan.,decrease,no risk
Ximelagatran,Vardenafil,The metabolism of Ximelagatran can be decreased when combined with Vardenafil.,decrease,no risk
Ximelagatran,Vemurafenib,The metabolism of Ximelagatran can be decreased when combined with Vemurafenib.,decrease,no risk
Ximelagatran,Venlafaxine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Venlafaxine.,increase,risk
Ximelagatran,Vinblastine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Vinblastine.,increase,risk
Ximelagatran,Vindesine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Vindesine.,increase,risk
Ximelagatran,Vinorelbine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Vinorelbine.,increase,risk
Ximelagatran,Vitamin E,Vitamin E may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Ximelagatran,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ximelagatran.,decrease,no risk
Ximelagatran,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ximelagatran.,increase,risk
Ximelagatran,Voriconazole,The metabolism of Ximelagatran can be decreased when combined with Voriconazole.,decrease,no risk
Ximelagatran,Vorinostat,The risk or severity of bleeding can be increased when Ximelagatran is combined with Vorinostat.,increase,risk
Ximelagatran,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ximelagatran.,decrease,no risk
Ximelagatran,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ximelagatran.,decrease,no risk
Ximelagatran,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Ximelagatran.,increase,risk
Ximelagatran,Zafirlukast,The metabolism of Ximelagatran can be decreased when combined with Zafirlukast.,decrease,no risk
Ximelagatran,Zidovudine,The risk or severity of bleeding can be increased when Ximelagatran is combined with Zidovudine.,increase,risk
Ximelagatran,Zileuton,The metabolism of Ximelagatran can be decreased when combined with Zileuton.,decrease,no risk
Ximelagatran,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ximelagatran.,increase,risk
Ximelagatran,Zolpidem,The metabolism of Ximelagatran can be decreased when combined with Zolpidem.,decrease,no risk
Ximelagatran,Zopiclone,The metabolism of Ximelagatran can be decreased when combined with Zopiclone.,decrease,no risk
Nesiritide,Obinutuzumab,The risk or severity of adverse effects can be increased when Nesiritide is combined with Obinutuzumab.,increase,risk
Nesiritide,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Nesiritide.,increase,risk
Nesiritide,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Nesiritide.,increase,risk
Nesiritide,Opicapone,The risk or severity of adverse effects can be increased when Nesiritide is combined with Opicapone.,increase,risk
Nesiritide,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Nesiritide.,increase,risk
Nesiritide,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Nesiritide.,increase,risk
Nesiritide,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Nesiritide.,increase,risk
Nesiritide,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Nesiritide.,increase,risk
Nesiritide,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Nesiritide.,increase,risk
Nesiritide,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Nesiritide.,increase,risk
Nesiritide,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Nesiritide.,increase,risk
Nesiritide,Vericiguat,The risk or severity of adverse effects can be increased when Nesiritide is combined with Vericiguat.,increase,risk
Nesiritide,Zofenopril,Nesiritide may increase the hypotensive activities of Zofenopril.,increase,no risk
Thymalfasin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Benzocaine.,increase,risk
Thymalfasin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Benzyl alcohol.,increase,risk
Thymalfasin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Bupivacaine.,increase,risk
Thymalfasin,Butacaine,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Butacaine.,increase,risk
Thymalfasin,Butamben,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Butamben.,increase,risk
Thymalfasin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Oxetacaine.,increase,risk
Thymalfasin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Thymalfasin is combined with Oxybuprocaine.,increase,risk
Galiximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Galiximab is combined with Human varicella-zoster immune globulin.,increase,risk
Galiximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Galiximab is combined with Obiltoxaximab.,increase,risk
Galiximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Galiximab is combined with Obinutuzumab.,increase,risk
Galiximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Galiximab is combined with Ocrelizumab.,increase,risk
Galiximab,Odesivimab,The risk or severity of adverse effects can be increased when Galiximab is combined with Odesivimab.,increase,risk
Galiximab,Ofatumumab,The risk or severity of adverse effects can be increased when Galiximab is combined with Ofatumumab.,increase,risk
Galiximab,Olaratumab,The risk or severity of adverse effects can be increased when Galiximab is combined with Olaratumab.,increase,risk
Galiximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galiximab.,increase,risk
Galiximab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Galiximab is combined with Oxetacaine.,increase,risk
Galiximab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Galiximab is combined with Oxybuprocaine.,increase,risk
Galiximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Galiximab.,increase,no risk
Galiximab,Ublituximab,The risk or severity of adverse effects can be increased when Galiximab is combined with Ublituximab.,increase,risk
Galiximab,Ustekinumab,The risk or severity of adverse effects can be increased when Galiximab is combined with Ustekinumab.,increase,risk
Galiximab,Vedolizumab,The risk or severity of adverse effects can be increased when Galiximab is combined with Vedolizumab.,increase,risk
Ticagrelor,Boceprevir,The metabolism of Ticagrelor can be decreased when combined with Boceprevir.,decrease,no risk
Ticagrelor,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Bosentan,The metabolism of Bosentan can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Budesonide,The metabolism of Ticagrelor can be increased when combined with Budesonide.,increase,no risk
Ticagrelor,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Ticagrelor.,increase,risk
Ticagrelor,Buprenorphine,Buprenorphine can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Bupropion,The metabolism of Bupropion can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Buspirone,The metabolism of Ticagrelor can be decreased when combined with Buspirone.,decrease,no risk
Ticagrelor,Busulfan,The metabolism of Busulfan can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Butorphanol,Butorphanol can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Gefitinib,The metabolism of Ticagrelor can be decreased when combined with Gefitinib.,decrease,no risk
Ticagrelor,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ticagrelor is combined with Gemtuzumab ozogamicin.,increase,risk
Ticagrelor,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ticagrelor.,increase,risk
Ticagrelor,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ticagrelor.,increase,no risk
Ticagrelor,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Glipizide,The metabolism of Glipizide can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Glofitamab,The serum concentration of Ticagrelor can be increased when it is combined with Glofitamab.,increase,no risk
Ticagrelor,Glucosamine,Glucosamine may increase the antiplatelet activities of Ticagrelor.,increase,no risk
Ticagrelor,Glyburide,The metabolism of Ticagrelor can be decreased when combined with Glyburide.,decrease,no risk
Ticagrelor,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ticagrelor.,increase,risk
Ticagrelor,Golimumab,The metabolism of Ticagrelor can be increased when combined with Golimumab.,increase,no risk
Ticagrelor,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Halofantrine,The metabolism of Ticagrelor can be decreased when combined with Halofantrine.,decrease,no risk
Ticagrelor,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Halothane,The metabolism of Halothane can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Hemin,Hemin may increase the anticoagulant activities of Ticagrelor.,increase,no risk
Ticagrelor,Heparin,The risk or severity of bleeding can be increased when Ticagrelor is combined with Heparin.,increase,risk
Ticagrelor,Hydrochlorothiazide,The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Ticagrelor,Hydrocodone,Hydrocodone can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Hydrocortisone,The metabolism of Ticagrelor can be decreased when combined with Hydrocortisone.,decrease,no risk
Ticagrelor,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Hydroflumethiazide,The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Ticagrelor,Hydromorphone,Hydromorphone can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Hydroxyprogesterone caproate,The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ticagrelor,Hydroxyurea,The risk or severity of bleeding can be increased when Ticagrelor is combined with Hydroxyurea.,increase,risk
Ticagrelor,Hydroxyzine,The metabolism of Ticagrelor can be decreased when combined with Hydroxyzine.,decrease,no risk
Ticagrelor,Ketamine,The metabolism of Ketamine can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Ketoconazole,The metabolism of Ticagrelor can be decreased when combined with Ketoconazole.,decrease,no risk
Ticagrelor,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ticagrelor.,increase,risk
Ticagrelor,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ticagrelor.,increase,risk
Ticagrelor,Obeticholic acid,The risk or severity of adverse effects can be increased when Ticagrelor is combined with Obeticholic acid.,increase,risk
Ticagrelor,Obinutuzumab,The risk or severity of adverse effects can be increased when Ticagrelor is combined with Obinutuzumab.,increase,risk
Ticagrelor,Olaparib,The metabolism of Olaparib can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Oliceridine,Oliceridine can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Olive oil,The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Olive oil.,decrease,no risk
Ticagrelor,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Ticagrelor.,increase,risk
Ticagrelor,Olutasidenib,The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Olutasidenib.,decrease,no risk
Ticagrelor,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ticagrelor is combined with Omacetaxine mepesuccinate.,increase,risk
Ticagrelor,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Omaveloxolone,The serum concentration of Ticagrelor can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ticagrelor,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Ticagrelor.,increase,no risk
Ticagrelor,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ticagrelor.,increase,risk
Ticagrelor,Omega-3-carboxylic acids,The therapeutic efficacy of Ticagrelor can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ticagrelor,Ondansetron,The metabolism of Ticagrelor can be decreased when combined with Ondansetron.,decrease,no risk
Ticagrelor,Opium,Opium can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Osilodrostat,The metabolism of Ticagrelor can be decreased when combined with Osilodrostat.,decrease,no risk
Ticagrelor,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ticagrelor.,increase,risk
Ticagrelor,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ticagrelor.,increase,risk
Ticagrelor,Oxcarbazepine,The metabolism of Ticagrelor can be increased when combined with Oxcarbazepine.,increase,no risk
Ticagrelor,Oxybutynin,The metabolism of Ticagrelor can be decreased when combined with Oxybutynin.,decrease,no risk
Ticagrelor,Oxycodone,Oxycodone can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Oxymorphone,Oxymorphone can cause a decrease in the absorption of Ticagrelor resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ticagrelor,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ticagrelor.,increase,risk
Pagoclone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pagoclone.,increase,risk
Pagoclone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pagoclone is combined with Gabapentin enacarbil.,increase,risk
Pagoclone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Pagoclone.,increase,risk
Pagoclone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pagoclone is combined with Ganaxolone.",increase,risk
Pagoclone,Gepirone,The risk or severity of CNS depression can be increased when Pagoclone is combined with Gepirone.,increase,risk
Pagoclone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Pagoclone.,increase,risk
Pagoclone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Pagoclone.,increase,risk
Pagoclone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Pagoclone.,increase,risk
Pagoclone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Pagoclone.,increase,risk
Pagoclone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pagoclone.,increase,risk
Pagoclone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Pagoclone.,increase,risk
Pagoclone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Pagoclone.,increase,risk
Pagoclone,Hydrocodone,Pagoclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pagoclone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Pagoclone.,increase,risk
Pagoclone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pagoclone.,increase,no risk
Pagoclone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Pagoclone.,increase,risk
Pagoclone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Pagoclone.,increase,risk
Pagoclone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Pagoclone.,increase,risk
Pagoclone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pagoclone is combined with Oliceridine.",increase,risk
Pagoclone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pagoclone.,increase,risk
Pagoclone,Opium,The risk or severity of CNS depression can be increased when Pagoclone is combined with Opium.,increase,risk
Pagoclone,Orphenadrine,Pagoclone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pagoclone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pagoclone.,increase,risk
Pagoclone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pagoclone.,increase,risk
Pagoclone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Pagoclone.,increase,risk
Pagoclone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Pagoclone.,increase,risk
Pagoclone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Pagoclone.,increase,risk
Pagoclone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Pagoclone.,increase,risk
Pagoclone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Pagoclone.,increase,risk
Pagoclone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Pagoclone.,increase,risk
Pagoclone,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Pagoclone.,increase,risk
Pagoclone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Pagoclone.,increase,risk
Pagoclone,Quinupramine,The risk or severity of CNS depression can be increased when Pagoclone is combined with Quinupramine.,increase,risk
Pagoclone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Pagoclone.,increase,risk
Pagoclone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Pagoclone.,increase,risk
Pagoclone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Pagoclone.,increase,risk
Pagoclone,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Pagoclone.,increase,risk
Pagoclone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Pagoclone.,increase,risk
Pagoclone,Vilazodone,The risk or severity of CNS depression can be increased when Pagoclone is combined with Vilazodone.,increase,risk
Pagoclone,Viloxazine,The risk or severity of CNS depression can be increased when Pagoclone is combined with Viloxazine.,increase,risk
Pagoclone,Vortioxetine,The risk or severity of CNS depression can be increased when Pagoclone is combined with Vortioxetine.,increase,risk
Pagoclone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Pagoclone.,increase,risk
Pagoclone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Pagoclone.,increase,risk
Pagoclone,Ziconotide,The risk or severity of CNS depression can be increased when Pagoclone is combined with Ziconotide.,increase,risk
Pagoclone,Zimelidine,The risk or severity of adverse effects can be increased when Pagoclone is combined with Zimelidine.,increase,risk
Pagoclone,Ziprasidone,The risk or severity of adverse effects can be increased when Pagoclone is combined with Ziprasidone.,increase,risk
Pagoclone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Pagoclone.,increase,risk
Pagoclone,Zolpidem,Pagoclone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pagoclone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Pagoclone.,increase,risk
Pagoclone,Zopiclone,The risk or severity of adverse effects can be increased when Pagoclone is combined with Zopiclone.,increase,risk
Pagoclone,Zotepine,The risk or severity of CNS depression can be increased when Pagoclone is combined with Zotepine.,increase,risk
Pagoclone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Pagoclone.,increase,risk
Pagoclone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Pagoclone.,increase,risk
Tesmilifene,Galantamine,The metabolism of Tesmilifene can be decreased when combined with Galantamine.,decrease,no risk
Tesmilifene,Gefitinib,The metabolism of Tesmilifene can be decreased when combined with Gefitinib.,decrease,no risk
Tesmilifene,Gemcitabine,The risk or severity of bleeding can be increased when Tesmilifene is combined with Gemcitabine.,increase,risk
Tesmilifene,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Tesmilifene is combined with Gemtuzumab ozogamicin.,increase,risk
Tesmilifene,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Tesmilifene.,increase,no risk
Tesmilifene,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Tesmilifene.,increase,no risk
Tesmilifene,Givosiran,The serum concentration of Tesmilifene can be increased when it is combined with Givosiran.,increase,no risk
Tesmilifene,Glofitamab,The serum concentration of Tesmilifene can be increased when it is combined with Glofitamab.,increase,no risk
Tesmilifene,Glucosamine,Glucosamine may increase the antiplatelet activities of Tesmilifene.,increase,no risk
Tesmilifene,Glycerol phenylbutyrate,The metabolism of Tesmilifene can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Tesmilifene,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Tesmilifene.,increase,risk
Tesmilifene,Golimumab,The metabolism of Tesmilifene can be increased when combined with Golimumab.,increase,no risk
Tesmilifene,Halofantrine,The metabolism of Tesmilifene can be decreased when combined with Halofantrine.,decrease,no risk
Tesmilifene,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tesmilifene.,increase,no risk
Tesmilifene,Heparin,The risk or severity of bleeding can be increased when Tesmilifene is combined with Heparin.,increase,risk
Tesmilifene,Hydroxychloroquine,The metabolism of Tesmilifene can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Tesmilifene,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Hydroxyurea,The risk or severity of bleeding can be increased when Tesmilifene is combined with Hydroxyurea.,increase,risk
Tesmilifene,Hydroxyzine,The metabolism of Tesmilifene can be decreased when combined with Hydroxyzine.,decrease,no risk
Tesmilifene,Ketoconazole,The metabolism of Tesmilifene can be decreased when combined with Ketoconazole.,decrease,no risk
Tesmilifene,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Tesmilifene.,increase,risk
Tesmilifene,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Tesmilifene.,increase,risk
Tesmilifene,Obeticholic acid,The risk or severity of adverse effects can be increased when Tesmilifene is combined with Obeticholic acid.,increase,risk
Tesmilifene,Obinutuzumab,The risk or severity of adverse effects can be increased when Tesmilifene is combined with Obinutuzumab.,increase,risk
Tesmilifene,Olanzapine,The metabolism of Tesmilifene can be decreased when combined with Olanzapine.,decrease,no risk
Tesmilifene,Olaparib,The metabolism of Olaparib can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Tesmilifene.,decrease,no risk
Tesmilifene,Olsalazine,The risk or severity of bleeding can be increased when Tesmilifene is combined with Olsalazine.,increase,risk
Tesmilifene,Omaveloxolone,The serum concentration of Tesmilifene can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tesmilifene,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Tesmilifene.,increase,no risk
Tesmilifene,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tesmilifene.,increase,risk
Tesmilifene,Ondansetron,The metabolism of Tesmilifene can be decreased when combined with Ondansetron.,decrease,no risk
Tesmilifene,Opium,The metabolism of Opium can be decreased when combined with Tesmilifene.,decrease,no risk
Tesmilifene,Oritavancin,The metabolism of Tesmilifene can be decreased when combined with Oritavancin.,decrease,no risk
Tesmilifene,Orphenadrine,The metabolism of Tesmilifene can be decreased when combined with Orphenadrine.,decrease,no risk
Tesmilifene,Osilodrostat,The metabolism of Tesmilifene can be decreased when combined with Osilodrostat.,decrease,no risk
Tesmilifene,Osimertinib,The metabolism of Osimertinib can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Ospemifene,The metabolism of Tesmilifene can be decreased when combined with Ospemifene.,decrease,no risk
Tesmilifene,Oxaliplatin,The risk or severity of bleeding can be increased when Tesmilifene is combined with Oxaliplatin.,increase,risk
Tesmilifene,Oxamniquine,The metabolism of Tesmilifene can be decreased when combined with Oxamniquine.,decrease,no risk
Tesmilifene,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Tesmilifene.,increase,risk
Tesmilifene,Oxprenolol,The metabolism of Tesmilifene can be decreased when combined with Oxprenolol.,decrease,no risk
Tesmilifene,Oxybutynin,The metabolism of Tesmilifene can be decreased when combined with Oxybutynin.,decrease,no risk
Tesmilifene,Oxycodone,The metabolism of Tesmilifene can be decreased when combined with Oxycodone.,decrease,no risk
Tesmilifene,Oxymorphone,The metabolism of Tesmilifene can be decreased when combined with Oxymorphone.,decrease,no risk
Tesmilifene,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Tesmilifene.,increase,risk
Tesmilifene,Quetiapine,The metabolism of Tesmilifene can be decreased when combined with Quetiapine.,decrease,no risk
Tesmilifene,Quinidine,The metabolism of Quinidine can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Quinine,The metabolism of Tesmilifene can be decreased when combined with Quinine.,decrease,no risk
Tesmilifene,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Tesmilifene.,decrease,no risk
Tesmilifene,Urokinase,Tesmilifene may increase the anticoagulant activities of Urokinase.,increase,no risk
Tesmilifene,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Tesmilifene is combined with Ursodeoxycholic acid.,increase,risk
Tesmilifene,Vadadustat,The serum concentration of Tesmilifene can be increased when it is combined with Vadadustat.,increase,no risk
Tesmilifene,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Tesmilifene.,decrease,no risk
Tesmilifene,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Tesmilifene.,increase,risk
Tesmilifene,Vandetanib,The metabolism of Vandetanib can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Tesmilifene.,decrease,no risk
Tesmilifene,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Venetoclax,The metabolism of Venetoclax can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Venlafaxine,The risk or severity of bleeding can be increased when Tesmilifene is combined with Venlafaxine.,increase,risk
Tesmilifene,Verapamil,The metabolism of Tesmilifene can be decreased when combined with Verapamil.,decrease,no risk
Tesmilifene,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Tesmilifene.,decrease,no risk
Tesmilifene,Vilazodone,The metabolism of Tesmilifene can be decreased when combined with Vilazodone.,decrease,no risk
Tesmilifene,Viloxazine,The metabolism of Tesmilifene can be decreased when combined with Viloxazine.,decrease,no risk
Tesmilifene,Vinblastine,The metabolism of Vinblastine can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Vincristine,The metabolism of Vincristine can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Vindesine,The metabolism of Vindesine can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Vinflunine,The metabolism of Vinflunine can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Vitamin E,Vitamin E may increase the antiplatelet activities of Tesmilifene.,increase,no risk
Tesmilifene,Vorapaxar,The risk or severity of bleeding can be increased when Tesmilifene is combined with Vorapaxar.,increase,risk
Tesmilifene,Voriconazole,The metabolism of Tesmilifene can be decreased when combined with Voriconazole.,decrease,no risk
Tesmilifene,Vorinostat,The risk or severity of bleeding can be increased when Tesmilifene is combined with Vorinostat.,increase,risk
Tesmilifene,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Tesmilifene.,increase,risk
Tesmilifene,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Tesmilifene.,increase,no risk
Tesmilifene,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Tesmilifene.,increase,no risk
Tesmilifene,Ximelagatran,The risk or severity of bleeding can be increased when Tesmilifene is combined with Ximelagatran.,increase,risk
Tesmilifene,Yohimbine,The metabolism of Tesmilifene can be decreased when combined with Yohimbine.,decrease,no risk
Tesmilifene,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Zidovudine,The risk or severity of bleeding can be increased when Tesmilifene is combined with Zidovudine.,increase,risk
Tesmilifene,Zimelidine,The metabolism of Tesmilifene can be decreased when combined with Zimelidine.,decrease,no risk
Tesmilifene,Ziprasidone,The metabolism of Tesmilifene can be decreased when combined with Ziprasidone.,decrease,no risk
Tesmilifene,Zolpidem,The metabolism of Zolpidem can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Tesmilifene.,decrease,no risk
Tesmilifene,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Tesmilifene.,increase,no risk
Tesmilifene,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Tesmilifene.,decrease,no risk
Voclosporin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Voclosporin.,increase,risk
Voclosporin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Voclosporin.,increase,risk
Voclosporin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Glofitamab,The serum concentration of Voclosporin can be increased when it is combined with Glofitamab.,increase,no risk
Voclosporin,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Voclosporin.,increase,risk
Voclosporin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Guselkumab,The risk or severity of adverse effects can be increased when Voclosporin is combined with Guselkumab.,increase,risk
Voclosporin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Haloperidol,The metabolism of Voclosporin can be decreased when combined with Haloperidol.,decrease,no risk
Voclosporin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Voclosporin.,increase,risk
Voclosporin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Voclosporin is combined with Hydrocortisone acetate.,increase,risk
Voclosporin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Voclosporin is combined with Hydrocortisone butyrate.,increase,risk
Voclosporin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Voclosporin is combined with Hydrocortisone succinate.,increase,risk
Voclosporin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Voclosporin.,increase,risk
Voclosporin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Voclosporin.,increase,risk
Voclosporin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Ketoconazole,The metabolism of Voclosporin can be decreased when combined with Ketoconazole.,decrease,no risk
Voclosporin,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Voclosporin.,increase,risk
Voclosporin,Ocrelizumab,The risk or severity of adverse effects can be increased when Voclosporin is combined with Ocrelizumab.,increase,risk
Voclosporin,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Voclosporin.,increase,risk
Voclosporin,Olaparib,The risk or severity of adverse effects can be increased when Olaparib is combined with Voclosporin.,increase,risk
Voclosporin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Omaveloxolone,The serum concentration of Voclosporin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Voclosporin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Voclosporin.,increase,risk
Voclosporin,Ozanimod,The risk or severity of adverse effects can be increased when Voclosporin is combined with Ozanimod.,increase,risk
Voclosporin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Quinine,The serum concentration of Voclosporin can be increased when it is combined with Quinine.,increase,no risk
Voclosporin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Voclosporin.,increase,risk
Voclosporin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Umbralisib,The serum concentration of Voclosporin can be increased when it is combined with Umbralisib.,increase,no risk
Voclosporin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Upadacitinib,The risk or severity of adverse effects can be increased when Voclosporin is combined with Upadacitinib.,increase,risk
Voclosporin,Vadadustat,The serum concentration of Voclosporin can be increased when it is combined with Vadadustat.,increase,no risk
Voclosporin,Vandetanib,The serum concentration of Voclosporin can be increased when it is combined with Vandetanib.,increase,no risk
Voclosporin,Vardenafil,The serum concentration of Voclosporin can be increased when it is combined with Vardenafil.,increase,no risk
Voclosporin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Voclosporin.,increase,risk
Voclosporin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Voclosporin.,increase,risk
Voclosporin,Velpatasvir,The serum concentration of Voclosporin can be increased when it is combined with Velpatasvir.,increase,no risk
Voclosporin,Vemurafenib,The serum concentration of Voclosporin can be increased when it is combined with Vemurafenib.,increase,no risk
Voclosporin,Venetoclax,The metabolism of Voclosporin can be decreased when combined with Venetoclax.,decrease,no risk
Voclosporin,Verapamil,The metabolism of Voclosporin can be decreased when combined with Verapamil.,decrease,no risk
Voclosporin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Voclosporin.,decrease,no risk
Voclosporin,Vilanterol,The risk or severity of adverse effects can be increased when Vilanterol is combined with Voclosporin.,increase,risk
Voclosporin,Viloxazine,The metabolism of Voclosporin can be decreased when combined with Viloxazine.,decrease,no risk
Voclosporin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Voclosporin.,increase,risk
Voclosporin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Voclosporin.,increase,risk
Voclosporin,Vorapaxar,The serum concentration of Voclosporin can be increased when it is combined with Vorapaxar.,increase,no risk
Voclosporin,Voriconazole,The metabolism of Voclosporin can be decreased when combined with Voriconazole.,decrease,no risk
Voclosporin,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Voclosporin.,increase,risk
Voclosporin,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Voclosporin.,increase,no risk
Voclosporin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Voclosporin.,increase,risk
Voclosporin,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Voclosporin.,increase,risk
Voclosporin,Zimelidine,The metabolism of Voclosporin can be decreased when combined with Zimelidine.,decrease,no risk
Voclosporin,Ziprasidone,The metabolism of Voclosporin can be decreased when combined with Ziprasidone.,decrease,no risk
Voclosporin,Zonisamide,The serum concentration of Voclosporin can be increased when it is combined with Zonisamide.,increase,no risk
Sitimagene ceradenovec,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Benzocaine.,increase,risk
Sitimagene ceradenovec,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Benzyl alcohol.,increase,risk
Sitimagene ceradenovec,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Bupivacaine.,increase,risk
Sitimagene ceradenovec,Butacaine,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Butacaine.,increase,risk
Sitimagene ceradenovec,Butamben,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Butamben.,increase,risk
Sitimagene ceradenovec,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Oxetacaine.,increase,risk
Sitimagene ceradenovec,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sitimagene ceradenovec is combined with Oxybuprocaine.,increase,risk
Flibanserin,Butaperazine,The risk or severity of CNS depression can be increased when Flibanserin is combined with Butaperazine.,increase,risk
Flibanserin,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Flibanserin.,increase,risk
Flibanserin,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Flibanserin.,increase,risk
Flibanserin,Butriptyline,The risk or severity of CNS depression can be increased when Flibanserin is combined with Butriptyline.,increase,risk
Flibanserin,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Flibanserin.,increase,risk
Flibanserin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Flibanserin is combined with Gabapentin enacarbil.,increase,risk
Flibanserin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Flibanserin.,increase,risk
Flibanserin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Flibanserin is combined with Ganaxolone.",increase,risk
Flibanserin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Gemfibrozil,The serum concentration of Flibanserin can be increased when it is combined with Gemfibrozil.,increase,no risk
Flibanserin,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Flibanserin.,increase,risk
Flibanserin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Flibanserin.,increase,risk
Flibanserin,Gilteritinib,The therapeutic efficacy of Flibanserin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Flibanserin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Glofitamab,The serum concentration of Flibanserin can be increased when it is combined with Glofitamab.,increase,no risk
Flibanserin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Flibanserin.,increase,risk
Flibanserin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Flibanserin.,increase,risk
Flibanserin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Guanabenz,Flibanserin may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Flibanserin,Guanadrel,Flibanserin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Flibanserin,Guanethidine,Flibanserin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Flibanserin,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Flibanserin.,increase,risk
Flibanserin,Guanoxan,Flibanserin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Flibanserin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Flibanserin.,increase,risk
Flibanserin,Haloperidol,The metabolism of Flibanserin can be decreased when combined with Haloperidol.,decrease,no risk
Flibanserin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Flibanserin.,increase,risk
Flibanserin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Flibanserin.,increase,risk
Flibanserin,Hydralazine,Flibanserin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Flibanserin,Hydrochlorothiazide,Flibanserin may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Flibanserin,Hydrocodone,Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Flibanserin,Hydroflumethiazide,Flibanserin may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Flibanserin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Flibanserin.,increase,risk
Flibanserin,Hydroxyprogesterone caproate,The risk or severity of adverse effects can be increased when Hydroxyprogesterone caproate is combined with Flibanserin.,increase,risk
Flibanserin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Flibanserin.,increase,no risk
Flibanserin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Flibanserin.,increase,risk
Flibanserin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Flibanserin.,increase,risk
Flibanserin,Ketoconazole,The metabolism of Flibanserin can be decreased when combined with Ketoconazole.,decrease,no risk
Flibanserin,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Flibanserin.,increase,risk
Flibanserin,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Flibanserin.,increase,risk
Flibanserin,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Flibanserin.,increase,risk
Flibanserin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Flibanserin is combined with Oliceridine.",increase,risk
Flibanserin,Olmesartan,Flibanserin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Flibanserin,Olodaterol,The risk or severity of hypertension can be increased when Flibanserin is combined with Olodaterol.,increase,risk
Flibanserin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Omaveloxolone,The serum concentration of Flibanserin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Flibanserin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Flibanserin.,increase,risk
Flibanserin,Opium,The risk or severity of CNS depression can be increased when Flibanserin is combined with Opium.,increase,risk
Flibanserin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Flibanserin.,increase,risk
Flibanserin,Orphenadrine,Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Flibanserin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Flibanserin.,increase,risk
Flibanserin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Flibanserin.,increase,risk
Flibanserin,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Flibanserin.,increase,risk
Flibanserin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Flibanserin.,increase,risk
Flibanserin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Flibanserin.,increase,risk
Flibanserin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Flibanserin.,increase,risk
Flibanserin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Flibanserin.,increase,risk
Flibanserin,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Flibanserin.,increase,risk
Flibanserin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Flibanserin.,increase,risk
Flibanserin,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Flibanserin.,increase,risk
Flibanserin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Flibanserin.,increase,risk
Flibanserin,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Flibanserin.,increase,risk
Flibanserin,Quinapril,Flibanserin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Flibanserin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Flibanserin.,increase,risk
Flibanserin,Quinupramine,The risk or severity of CNS depression can be increased when Flibanserin is combined with Quinupramine.,increase,risk
Flibanserin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Ulipristal,The risk or severity of adverse effects can be increased when Ulipristal is combined with Flibanserin.,increase,risk
Flibanserin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Flibanserin.,increase,risk
Flibanserin,Vadadustat,The serum concentration of Flibanserin can be increased when it is combined with Vadadustat.,increase,no risk
Flibanserin,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Flibanserin.,increase,risk
Flibanserin,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Flibanserin is combined with Valproate bismuth.,increase,risk
Flibanserin,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Flibanserin.,increase,risk
Flibanserin,Valsartan,Flibanserin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Flibanserin,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Flibanserin.,increase,risk
Flibanserin,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Venetoclax,The metabolism of Flibanserin can be decreased when combined with Venetoclax.,decrease,no risk
Flibanserin,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Flibanserin is combined with Venlafaxine.,increase,risk
Flibanserin,Verapamil,The metabolism of Flibanserin can be decreased when combined with Verapamil.,decrease,no risk
Flibanserin,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Flibanserin.,increase,risk
Flibanserin,Vilanterol,The risk or severity of hypertension can be increased when Flibanserin is combined with Vilanterol.,increase,risk
Flibanserin,Vilazodone,The risk or severity of CNS depression can be increased when Flibanserin is combined with Vilazodone.,increase,risk
Flibanserin,Viloxazine,The metabolism of Flibanserin can be decreased when combined with Viloxazine.,decrease,no risk
Flibanserin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Vincristine,The excretion of Vincristine can be decreased when combined with Flibanserin.,decrease,no risk
Flibanserin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Voriconazole,The metabolism of Flibanserin can be decreased when combined with Voriconazole.,decrease,no risk
Flibanserin,Vortioxetine,The risk or severity of CNS depression can be increased when Flibanserin is combined with Vortioxetine.,increase,risk
Flibanserin,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Flibanserin.,increase,no risk
Flibanserin,Warfarin,The risk or severity of adverse effects can be increased when Flibanserin is combined with Warfarin.,increase,risk
Flibanserin,Xamoterol,The risk or severity of hypertension can be increased when Flibanserin is combined with Xamoterol.,increase,risk
Flibanserin,Xylometazoline,The risk or severity of hypertension can be increased when Flibanserin is combined with Xylometazoline.,increase,risk
Flibanserin,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Flibanserin.,increase,risk
Flibanserin,Zafirlukast,The serum concentration of Flibanserin can be increased when it is combined with Zafirlukast.,increase,no risk
Flibanserin,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Flibanserin.,increase,risk
Flibanserin,Ziconotide,The risk or severity of CNS depression can be increased when Flibanserin is combined with Ziconotide.,increase,risk
Flibanserin,Zimelidine,The metabolism of Flibanserin can be decreased when combined with Zimelidine.,decrease,no risk
Flibanserin,Ziprasidone,The metabolism of Flibanserin can be decreased when combined with Ziprasidone.,decrease,no risk
Flibanserin,Zofenopril,Flibanserin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Flibanserin,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Flibanserin is combined with Zolmitriptan.,increase,risk
Flibanserin,Zolpidem,Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Flibanserin,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Flibanserin.,increase,risk
Flibanserin,Zopiclone,The risk or severity of adverse effects can be increased when Flibanserin is combined with Zopiclone.,increase,risk
Flibanserin,Zotepine,The risk or severity of CNS depression can be increased when Flibanserin is combined with Zotepine.,increase,risk
Flibanserin,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Flibanserin.,increase,risk
Flibanserin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Flibanserin.,increase,risk
Oritavancin,Galantamine,The metabolism of Galantamine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Glipizide,The metabolism of Glipizide can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Glyburide,The metabolism of Glyburide can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Oritavancin.,increase,no risk
Oritavancin,Halothane,The metabolism of Halothane can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Oritavancin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Ketamine,The metabolism of Ketamine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Olaparib,The metabolism of Olaparib can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Oritavancin.,decrease,no risk
Oritavancin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Opium,The metabolism of Opium can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Oxetacaine.,increase,risk
Oritavancin,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Oxybuprocaine.,increase,risk
Oritavancin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Quinidine,The metabolism of Quinidine can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Quinine,The metabolism of Quinine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Oritavancin.,decrease,no risk
Oritavancin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Valsartan,The metabolism of Valsartan can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Oritavancin.,decrease,no risk
Oritavancin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Vincristine,The metabolism of Vincristine can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Vindesine,The metabolism of Vindesine can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Warfarin,The risk or severity of bleeding can be increased when Oritavancin is combined with Warfarin.,increase,risk
Oritavancin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Zileuton,The metabolism of Zileuton can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Oritavancin.,decrease,no risk
Oritavancin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Oritavancin.,increase,no risk
Oritavancin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Oritavancin.,decrease,no risk
G17DT Immunogen,Gemtuzumab ozogamicin,The therapeutic efficacy of G17DT can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
G17DT Immunogen,Glatiramer,The therapeutic efficacy of G17DT can be decreased when used in combination with Glatiramer.,decrease,no risk
G17DT Immunogen,Golimumab,The therapeutic efficacy of G17DT can be decreased when used in combination with Golimumab.,decrease,no risk
G17DT Immunogen,Guselkumab,The therapeutic efficacy of G17DT can be decreased when used in combination with Guselkumab.,decrease,no risk
G17DT Immunogen,Hydrocortisone,The therapeutic efficacy of G17DT can be decreased when used in combination with Hydrocortisone.,decrease,no risk
G17DT Immunogen,Hydrocortisone acetate,The therapeutic efficacy of G17DT can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
G17DT Immunogen,Hydrocortisone butyrate,The therapeutic efficacy of G17DT can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
G17DT Immunogen,Hydrocortisone succinate,The therapeutic efficacy of G17DT can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
G17DT Immunogen,Hydroxychloroquine,The therapeutic efficacy of G17DT can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
G17DT Immunogen,Hydroxyurea,The therapeutic efficacy of G17DT can be decreased when used in combination with Hydroxyurea.,decrease,no risk
G17DT Immunogen,Obinutuzumab,The therapeutic efficacy of G17DT can be decreased when used in combination with Obinutuzumab.,decrease,no risk
G17DT Immunogen,Ocrelizumab,The therapeutic efficacy of G17DT can be decreased when used in combination with Ocrelizumab.,decrease,no risk
G17DT Immunogen,Ofatumumab,The therapeutic efficacy of G17DT can be decreased when used in combination with Ofatumumab.,decrease,no risk
G17DT Immunogen,Olaparib,The therapeutic efficacy of G17DT can be decreased when used in combination with Olaparib.,decrease,no risk
G17DT Immunogen,Oxaliplatin,The therapeutic efficacy of G17DT can be decreased when used in combination with Oxaliplatin.,decrease,no risk
G17DT Immunogen,Ozanimod,The therapeutic efficacy of G17DT can be decreased when used in combination with Ozanimod.,decrease,no risk
G17DT Immunogen,Ublituximab,The therapeutic efficacy of G17DT can be decreased when used in combination with Ublituximab.,decrease,no risk
G17DT Immunogen,Upadacitinib,The therapeutic efficacy of G17DT can be decreased when used in combination with Upadacitinib.,decrease,no risk
G17DT Immunogen,Vedolizumab,The therapeutic efficacy of G17DT can be decreased when used in combination with Vedolizumab.,decrease,no risk
G17DT Immunogen,Vilanterol,The therapeutic efficacy of G17DT can be decreased when used in combination with Vilanterol.,decrease,no risk
G17DT Immunogen,Vinblastine,The therapeutic efficacy of G17DT can be decreased when used in combination with Vinblastine.,decrease,no risk
G17DT Immunogen,Vincristine,The therapeutic efficacy of G17DT can be decreased when used in combination with Vincristine.,decrease,no risk
G17DT Immunogen,Vindesine,The therapeutic efficacy of G17DT can be decreased when used in combination with Vindesine.,decrease,no risk
G17DT Immunogen,Vinorelbine,The therapeutic efficacy of G17DT can be decreased when used in combination with Vinorelbine.,decrease,no risk
G17DT Immunogen,Voclosporin,The therapeutic efficacy of G17DT can be decreased when used in combination with Voclosporin.,decrease,no risk
G17DT Immunogen,Vorinostat,The therapeutic efficacy of G17DT can be decreased when used in combination with Vorinostat.,decrease,no risk
G17DT Immunogen,Zidovudine,The therapeutic efficacy of G17DT can be decreased when used in combination with Zidovudine.,decrease,no risk
Renzapride,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Renzapride.,increase,risk
Renzapride,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Renzapride is combined with Gabapentin enacarbil.,increase,risk
Renzapride,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Renzapride.,increase,risk
Renzapride,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Renzapride is combined with Ganaxolone.",increase,risk
Renzapride,Gepirone,The risk or severity of CNS depression can be increased when Renzapride is combined with Gepirone.,increase,risk
Renzapride,Gilteritinib,The therapeutic efficacy of Renzapride can be decreased when used in combination with Gilteritinib.,decrease,no risk
Renzapride,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Renzapride.,increase,risk
Renzapride,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Renzapride.,increase,risk
Renzapride,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Renzapride.,increase,risk
Renzapride,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Renzapride.,increase,risk
Renzapride,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Renzapride.,increase,risk
Renzapride,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Renzapride.,increase,risk
Renzapride,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Renzapride.,increase,risk
Renzapride,Hydrocodone,Renzapride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Renzapride,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Renzapride.,increase,risk
Renzapride,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Renzapride.,increase,no risk
Renzapride,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Renzapride.,increase,risk
Renzapride,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Renzapride.,increase,risk
Renzapride,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Renzapride.,increase,risk
Renzapride,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Renzapride is combined with Oliceridine.",increase,risk
Renzapride,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Renzapride.,increase,risk
Renzapride,Opium,The risk or severity of CNS depression can be increased when Renzapride is combined with Opium.,increase,risk
Renzapride,Orphenadrine,Renzapride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Renzapride,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Renzapride.,increase,risk
Renzapride,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Renzapride.,increase,risk
Renzapride,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Renzapride.,increase,risk
Renzapride,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Renzapride.,increase,risk
Renzapride,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Renzapride.,increase,risk
Renzapride,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Renzapride.,increase,risk
Renzapride,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Renzapride.,increase,risk
Renzapride,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Renzapride.,increase,risk
Renzapride,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Renzapride.,increase,risk
Renzapride,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Renzapride.,increase,risk
Renzapride,Quinupramine,The risk or severity of CNS depression can be increased when Renzapride is combined with Quinupramine.,increase,risk
Renzapride,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Renzapride.,increase,risk
Renzapride,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Renzapride.,increase,risk
Renzapride,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Renzapride.,increase,risk
Renzapride,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Renzapride.,increase,risk
Renzapride,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Renzapride.,increase,risk
Renzapride,Vilazodone,The risk or severity of CNS depression can be increased when Renzapride is combined with Vilazodone.,increase,risk
Renzapride,Viloxazine,The risk or severity of CNS depression can be increased when Renzapride is combined with Viloxazine.,increase,risk
Renzapride,Vortioxetine,The risk or severity of CNS depression can be increased when Renzapride is combined with Vortioxetine.,increase,risk
Renzapride,Warfarin,The risk or severity of adverse effects can be increased when Renzapride is combined with Warfarin.,increase,risk
Renzapride,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Renzapride.,increase,risk
Renzapride,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Renzapride.,increase,risk
Renzapride,Ziconotide,The risk or severity of CNS depression can be increased when Renzapride is combined with Ziconotide.,increase,risk
Renzapride,Zimelidine,The risk or severity of adverse effects can be increased when Renzapride is combined with Zimelidine.,increase,risk
Renzapride,Ziprasidone,The risk or severity of adverse effects can be increased when Renzapride is combined with Ziprasidone.,increase,risk
Renzapride,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Renzapride.,increase,risk
Renzapride,Zolpidem,Renzapride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Renzapride,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Renzapride.,increase,risk
Renzapride,Zopiclone,The risk or severity of adverse effects can be increased when Renzapride is combined with Zopiclone.,increase,risk
Renzapride,Zotepine,The risk or severity of CNS depression can be increased when Renzapride is combined with Zotepine.,increase,risk
Renzapride,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Renzapride.,increase,risk
Renzapride,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Renzapride.,increase,risk
Ceftobiprole,Gabapentin enacarbil,Ceftobiprole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gadobenic acid,Ceftobiprole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gadodiamide,Ceftobiprole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gadofosveset trisodium,Ceftobiprole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gadopentetic acid,Ceftobiprole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gadoteric acid,Ceftobiprole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gadoteridol,Ceftobiprole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Ganciclovir,Ceftobiprole may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gemcitabine,Ceftobiprole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gemfibrozil,Ceftobiprole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gentamicin,Ceftobiprole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Gimeracil,Ceftobiprole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Givosiran.,increase,risk
Ceftobiprole,Glipizide,Ceftobiprole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Glycerol phenylbutyrate,Ceftobiprole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Golodirsen,Ceftobiprole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Goserelin,Ceftobiprole may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Guanethidine,Ceftobiprole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Guanfacine,Ceftobiprole may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Haloperidol,Ceftobiprole may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceftobiprole.,decrease,no risk
Ceftobiprole,Hydralazine,Ceftobiprole may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Hydromorphone,Ceftobiprole may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Hydroxocobalamin,Ceftobiprole may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Hydroxyethyl Starch,Ceftobiprole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Kanamycin,Ceftobiprole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Ketamine,Ceftobiprole may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Ketazolam,Ceftobiprole may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Octinoxate,Ceftobiprole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceftobiprole is combined with Olsalazine.,increase,risk
Ceftobiprole,Opium,Ceftobiprole may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Oseltamivir,Ceftobiprole may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Oxacillin,Ceftobiprole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Oxazepam,Ceftobiprole may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceftobiprole is combined with Oxetacaine.,increase,risk
Ceftobiprole,Oxybenzone,Ceftobiprole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceftobiprole is combined with Oxybuprocaine.,increase,risk
Ceftobiprole,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Oxyquinoline,Ceftobiprole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Quetiapine,Ceftobiprole may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Quinidine,Ceftobiprole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftobiprole.,decrease,no risk
Ceftobiprole,Vaborbactam,Ceftobiprole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Valbenazine,Ceftobiprole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Ceftobiprole.,increase,risk
Ceftobiprole,Valganciclovir,Ceftobiprole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Vancomycin,Ceftobiprole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Varenicline,Ceftobiprole may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Venlafaxine,Ceftobiprole may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Verapamil,Ceftobiprole may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceftobiprole.,decrease,no risk
Ceftobiprole,Vilanterol,Ceftobiprole may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Viloxazine,Ceftobiprole may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ceftobiprole.,decrease,no risk
Ceftobiprole,Vortioxetine,Ceftobiprole may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Warfarin,Ceftobiprole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ceftobiprole.,decrease,no risk
Ceftobiprole,Zaleplon,Ceftobiprole may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Zanamivir,Ceftobiprole may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ceftobiprole,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftobiprole is combined with Zoledronic acid.,increase,risk
Ceftobiprole,Zonisamide,Ceftobiprole may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Clevidipine,Bacitracin,Bacitracin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Baclofen,Baclofen may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Balsalazide,The risk or severity of hyperkalemia can be increased when Balsalazide is combined with Clevidipine.,increase,risk
Clevidipine,Baricitinib,Clevidipine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Clevidipine,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Bemiparin,The risk or severity of hyperkalemia can be increased when Clevidipine is combined with Bemiparin.,increase,risk
Clevidipine,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Clevidipine.,increase,risk
Clevidipine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Benorilate,The risk or severity of hyperkalemia can be increased when Clevidipine is combined with Benorilate.,increase,risk
Clevidipine,Benoxaprofen,The risk or severity of hyperkalemia can be increased when Benoxaprofen is combined with Clevidipine.,increase,risk
Clevidipine,Benserazide,Clevidipine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Clevidipine,Benzatropine,Benzatropine may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Benznidazole,Clevidipine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Clevidipine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Benzonatate,The serum concentration of Clevidipine can be increased when it is combined with Benzonatate.,increase,no risk
Clevidipine,Benzthiazide,Benzthiazide may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Benzydamine,The risk or severity of hyperkalemia can be increased when Clevidipine is combined with Benzydamine.,increase,risk
Clevidipine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Bepotastine,Bepotastine may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Bepridil,Bepridil may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Beractant,Clevidipine may increase the bradycardic activities of Beractant.,increase,no risk
Clevidipine,Berotralstat,The metabolism of Clevidipine can be decreased when combined with Berotralstat.,decrease,no risk
Clevidipine,Betaine,Betaine may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Bethanidine,Clevidipine may increase the hypotensive activities of Bethanidine.,increase,no risk
Clevidipine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Bexagliflozin.,increase,risk
Clevidipine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Bicisate,Clevidipine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Clevidipine,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Clevidipine.,increase,no risk
Clevidipine,Bimekizumab,The metabolism of Clevidipine can be increased when combined with Bimekizumab.,increase,no risk
Clevidipine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Bioallethrin,Clevidipine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Clevidipine,Biperiden,The metabolism of Clevidipine can be decreased when combined with Biperiden.,decrease,no risk
Clevidipine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Clevidipine.,decrease,no risk
Clevidipine,Bismuth subgallate,Clevidipine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Clevidipine,Bisoprolol,The therapeutic efficacy of Clevidipine can be increased when used in combination with Bisoprolol.,increase,no risk
Clevidipine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Clevidipine.,decrease,no risk
Clevidipine,Bleomycin,Bleomycin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Boceprevir,The serum concentration of Clevidipine can be increased when it is combined with Boceprevir.,increase,no risk
Clevidipine,Bortezomib,The metabolism of Bortezomib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Bosentan,The metabolism of Bosentan can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Bosutinib,The metabolism of Bosutinib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Bretylium,Bretylium may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Brexpiprazole,The risk or severity of hypotension can be increased when Brexpiprazole is combined with Clevidipine.,increase,risk
Clevidipine,Brigatinib,The metabolism of Brigatinib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Bromazepam,Bromazepam may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Bromocriptine,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Bromocriptine.,increase,risk
Clevidipine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Budesonide,Budesonide may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Bumadizone,The risk or severity of hyperkalemia can be increased when Clevidipine is combined with Bumadizone.,increase,risk
Clevidipine,Bumetanide,Bumetanide may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Clevidipine.,increase,risk
Clevidipine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Bupropion,The metabolism of Clevidipine can be decreased when combined with Bupropion.,decrease,no risk
Clevidipine,Buspirone,Buspirone may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Busulfan,The metabolism of Busulfan can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Butabarbital,Butabarbital may increase the hypotensive activities of Clevidipine.,increase,no risk
Clevidipine,Butalbital,Butalbital may increase the hypotensive activities of Clevidipine.,increase,no risk
Clevidipine,Gabapentin enacarbil,Clevidipine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Clevidipine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Gadodiamide,Gadodiamide may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Gadofosveset trisodium,Clevidipine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Clevidipine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Gadoteric acid,Clevidipine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Clevidipine,Gadoteridol,Gadoteridol may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Galantamine,Galantamine may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Ganciclovir,Ganciclovir may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Gefitinib,The metabolism of Clevidipine can be decreased when combined with Gefitinib.,decrease,no risk
Clevidipine,Gemcitabine,Gemcitabine may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Gentamicin,Clevidipine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Clevidipine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Gimeracil,Clevidipine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Clevidipine,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Givosiran,The serum concentration of Clevidipine can be increased when it is combined with Givosiran.,increase,no risk
Clevidipine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Glipizide,The metabolism of Glipizide can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Glofitamab,The serum concentration of Clevidipine can be increased when it is combined with Glofitamab.,increase,no risk
Clevidipine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Clevidipine.,decrease,no risk
Clevidipine,Glyburide,The metabolism of Glyburide can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Clevidipine.,decrease,no risk
Clevidipine,Glycerol phenylbutyrate,The metabolism of Clevidipine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Clevidipine,Glymidine,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Glymidine.,increase,risk
Clevidipine,Golimumab,The metabolism of Clevidipine can be increased when combined with Golimumab.,increase,no risk
Clevidipine,Golodirsen,Clevidipine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Clevidipine,Goserelin,Goserelin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Guanabenz,Clevidipine may increase the hypotensive activities of Guanabenz.,increase,no risk
Clevidipine,Guanadrel,Clevidipine may increase the hypotensive activities of Guanadrel.,increase,no risk
Clevidipine,Guanethidine,Guanethidine may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Clevidipine.,increase,risk
Clevidipine,Guanoxan,Clevidipine may increase the hypotensive activities of Guanoxan.,increase,no risk
Clevidipine,Halofantrine,The metabolism of Clevidipine can be decreased when combined with Halofantrine.,decrease,no risk
Clevidipine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Halothane,The metabolism of Halothane can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Clevidipine.,increase,risk
Clevidipine,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Hydralazine,The risk or severity of adverse effects can be increased when Hydralazine is combined with Clevidipine.,increase,risk
Clevidipine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Clevidipine.,increase,risk
Clevidipine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Hydroxychloroquine,The metabolism of Clevidipine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Clevidipine,Hydroxyethyl Starch,Clevidipine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Clevidipine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Hydroxyzine,The metabolism of Clevidipine can be decreased when combined with Hydroxyzine.,decrease,no risk
Clevidipine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Kanamycin,Clevidipine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Clevidipine,Ketamine,Ketamine may increase the neuromuscular blocking activities of Clevidipine.,increase,no risk
Clevidipine,Ketazolam,Ketazolam may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Ketoconazole,The metabolism of Clevidipine can be decreased when combined with Ketoconazole.,decrease,no risk
Clevidipine,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Clevidipine.,increase,risk
Clevidipine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Obinutuzumab,The risk or severity of adverse effects can be increased when Clevidipine is combined with Obinutuzumab.,increase,risk
Clevidipine,Octinoxate,Clevidipine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Clevidipine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Clevidipine.,increase,no risk
Clevidipine,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Clevidipine.,increase,risk
Clevidipine,Olaparib,The metabolism of Olaparib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Clevidipine.,decrease,no risk
Clevidipine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Clevidipine.,increase,risk
Clevidipine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Olsalazine,Olsalazine may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Omaveloxolone,The serum concentration of Clevidipine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Clevidipine,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Opicapone,The risk or severity of adverse effects can be increased when Clevidipine is combined with Opicapone.,increase,risk
Clevidipine,Opium,Clevidipine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Clevidipine,Oritavancin,The metabolism of Clevidipine can be decreased when combined with Oritavancin.,decrease,no risk
Clevidipine,Orphenadrine,The metabolism of Clevidipine can be decreased when combined with Orphenadrine.,decrease,no risk
Clevidipine,Oseltamivir,Oseltamivir may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Osilodrostat,The metabolism of Clevidipine can be decreased when combined with Osilodrostat.,decrease,no risk
Clevidipine,Osimertinib,The metabolism of Osimertinib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Clevidipine.,increase,no risk
Clevidipine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Oxacillin,Oxacillin may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Oxamniquine,The metabolism of Clevidipine can be decreased when combined with Oxamniquine.,decrease,no risk
Clevidipine,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Clevidipine.,increase,risk
Clevidipine,Oxazepam,Oxazepam may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Oxybenzone,Oxybenzone may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Oxybuprocaine,The serum concentration of Clevidipine can be increased when it is combined with Oxybuprocaine.,increase,no risk
Clevidipine,Oxybutynin,The metabolism of Clevidipine can be decreased when combined with Oxybutynin.,decrease,no risk
Clevidipine,Oxycodone,The metabolism of Clevidipine can be decreased when combined with Oxycodone.,decrease,no risk
Clevidipine,Oxymorphone,The metabolism of Clevidipine can be decreased when combined with Oxymorphone.,decrease,no risk
Clevidipine,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Clevidipine.,increase,risk
Clevidipine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Clevidipine.,decrease,no risk
Clevidipine,Oxyquinoline,Clevidipine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Clevidipine,Quetiapine,The risk or severity of hypotension can be increased when Quetiapine is combined with Clevidipine.,increase,risk
Clevidipine,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Clevidipine.,increase,risk
Clevidipine,Quinethazone,Quinethazone may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clevidipine,Quinidine,Quinidine may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Quinine,The metabolism of Clevidipine can be decreased when combined with Quinine.,decrease,no risk
Clevidipine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Clevidipine.,increase,risk
Clevidipine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Vaborbactam,Clevidipine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Clevidipine,Vadadustat,The serum concentration of Clevidipine can be increased when it is combined with Vadadustat.,increase,no risk
Clevidipine,Valaciclovir,Valaciclovir may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Valbenazine,Clevidipine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Clevidipine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Valganciclovir,Valganciclovir may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Valsartan,The metabolism of Valsartan can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Vancomycin,Clevidipine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Clevidipine,Vandetanib,The metabolism of Vandetanib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Varenicline,Varenicline may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Vecuronium,Clevidipine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Clevidipine,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Venetoclax,The metabolism of Venetoclax can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Venlafaxine,The metabolism of Clevidipine can be decreased when combined with Venlafaxine.,decrease,no risk
Clevidipine,Verapamil,Verapamil may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Vericiguat,The risk or severity of adverse effects can be increased when Clevidipine is combined with Vericiguat.,increase,risk
Clevidipine,Vernakalant,Clevidipine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Clevidipine,Vilanterol,Clevidipine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Clevidipine,Vilazodone,The metabolism of Clevidipine can be decreased when combined with Vilazodone.,decrease,no risk
Clevidipine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Vildagliptin.,increase,risk
Clevidipine,Viloxazine,The metabolism of Clevidipine can be decreased when combined with Viloxazine.,decrease,no risk
Clevidipine,Vinblastine,The metabolism of Vinblastine can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Vincristine,The metabolism of Vincristine can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Vindesine,The metabolism of Vindesine can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Vinflunine,The metabolism of Vinflunine can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Voriconazole,The metabolism of Clevidipine can be decreased when combined with Voriconazole.,decrease,no risk
Clevidipine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Clevidipine.,increase,no risk
Clevidipine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Xylometazoline,Clevidipine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Clevidipine,Yohimbine,The metabolism of Clevidipine can be decreased when combined with Yohimbine.,decrease,no risk
Clevidipine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Zaleplon,Zaleplon may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Zanamivir,Zanamivir may decrease the excretion rate of Clevidipine which could result in a higher serum level.,decrease,no risk
Clevidipine,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Ziconotide,Clevidipine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Clevidipine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Zileuton,The metabolism of Zileuton can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Zimelidine,The metabolism of Clevidipine can be decreased when combined with Zimelidine.,decrease,no risk
Clevidipine,Ziprasidone,The metabolism of Clevidipine can be decreased when combined with Ziprasidone.,decrease,no risk
Clevidipine,Zofenopril,The risk or severity of hyperkalemia can be increased when Clevidipine is combined with Zofenopril.,increase,risk
Clevidipine,Zolpidem,The metabolism of Zolpidem can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Clevidipine.,increase,no risk
Clevidipine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Clevidipine.,decrease,no risk
Clevidipine,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Clevidipine.,increase,no risk
Clevidipine,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Clevidipine.,decrease,no risk
Gabapentin enacarbil,Bromperidol,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Bromperidol.,increase,risk
Gabapentin enacarbil,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Budesonide,Budesonide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Bumadizone,Bumadizone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Bumetanide,Bumetanide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gabapentin enacarbil,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Buprenorphine,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Gabapentin enacarbil,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Butaperazine,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Butaperazine.,increase,risk
Gabapentin enacarbil,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Butriptyline,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Butriptyline.,increase,risk
Gabapentin enacarbil,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gadodiamide,Gadodiamide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gadoteric acid,Gabapentin enacarbil may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gadoteridol,Gadoteridol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gabapentin enacarbil is combined with Ganaxolone.",increase,risk
Gabapentin enacarbil,Ganciclovir,Ganciclovir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gemcitabine,Gemcitabine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gentamicin,Gabapentin enacarbil may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Gepirone,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Gepirone.,increase,risk
Gabapentin enacarbil,Gimeracil,Gabapentin enacarbil may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Givosiran,Givosiran may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Glipizide,Glipizide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Glycerol phenylbutyrate,Gabapentin enacarbil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Golodirsen,Gabapentin enacarbil may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Goserelin,Goserelin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Guanethidine,Guanethidine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Hydralazine,Hydralazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gabapentin enacarbil,Hydrocodone,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Gabapentin enacarbil,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gabapentin enacarbil,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Hydrotalcite,The serum concentration of Gabapentin enacarbil can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Gabapentin enacarbil,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Hydroxyethyl Starch,Gabapentin enacarbil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Gabapentin enacarbil,Kanamycin,Gabapentin enacarbil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Ketoprofen,Ketoprofen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Ketorolac,Ketorolac may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Octinoxate,Gabapentin enacarbil may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Gabapentin enacarbil is combined with Oliceridine.",increase,risk
Gabapentin enacarbil,Olsalazine,Olsalazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Opium,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Opium.,increase,risk
Gabapentin enacarbil,Orphenadrine,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Gabapentin enacarbil,Oseltamivir,Oseltamivir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Oxacillin,Oxacillin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Oxaprozin,Oxaprozin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxybenzone,Oxybenzone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Oxyquinoline,Gabapentin enacarbil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Quinethazone,Quinethazone may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gabapentin enacarbil,Quinidine,Gabapentin enacarbil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Quinupramine,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Quinupramine.,increase,risk
Gabapentin enacarbil,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Vaborbactam,Gabapentin enacarbil may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Valaciclovir,Valaciclovir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Valbenazine,Gabapentin enacarbil may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Valdecoxib,Valdecoxib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Valganciclovir,Valganciclovir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Vancomycin,Gabapentin enacarbil may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Varenicline,Varenicline may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Verapamil,Verapamil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Vilanterol,Gabapentin enacarbil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Viloxazine,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Viloxazine.,increase,risk
Gabapentin enacarbil,Vortioxetine,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Vortioxetine.,increase,risk
Gabapentin enacarbil,Warfarin,Gabapentin enacarbil may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Zanamivir,Zanamivir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gabapentin enacarbil,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Zimelidine,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Zimelidine.,increase,risk
Gabapentin enacarbil,Ziprasidone,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Ziprasidone.,increase,risk
Gabapentin enacarbil,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Zolpidem,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Gabapentin enacarbil,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Zopiclone,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Zopiclone.,increase,risk
Gabapentin enacarbil,Zotepine,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Zotepine.,increase,risk
Gabapentin enacarbil,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Gabapentin enacarbil.,increase,risk
Gabapentin enacarbil,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Gabapentin enacarbil.,increase,risk
Desmoteplase,Gemcitabine,The risk or severity of bleeding can be increased when Desmoteplase is combined with Gemcitabine.,increase,risk
Desmoteplase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Desmoteplase is combined with Gemtuzumab ozogamicin.,increase,risk
Desmoteplase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Desmoteplase.,increase,risk
Desmoteplase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Desmoteplase.,increase,no risk
Desmoteplase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Desmoteplase.,increase,risk
Desmoteplase,Hemin,Hemin may increase the anticoagulant activities of Desmoteplase.,increase,no risk
Desmoteplase,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Desmoteplase.,increase,risk
Desmoteplase,Hydrochlorothiazide,The therapeutic efficacy of Desmoteplase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Desmoteplase,Hydroflumethiazide,The therapeutic efficacy of Desmoteplase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Desmoteplase,Hydroxyprogesterone caproate,The therapeutic efficacy of Desmoteplase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Desmoteplase,Hydroxyurea,The risk or severity of bleeding can be increased when Desmoteplase is combined with Hydroxyurea.,increase,risk
Desmoteplase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Desmoteplase.,increase,risk
Desmoteplase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Desmoteplase.,increase,risk
Desmoteplase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Desmoteplase is combined with Obeticholic acid.,increase,risk
Desmoteplase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Desmoteplase is combined with Obinutuzumab.,increase,risk
Desmoteplase,Olaparib,The risk or severity of bleeding can be increased when Desmoteplase is combined with Olaparib.,increase,risk
Desmoteplase,Olive oil,The therapeutic efficacy of Desmoteplase can be decreased when used in combination with Olive oil.,decrease,no risk
Desmoteplase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Desmoteplase.,increase,risk
Desmoteplase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Desmoteplase is combined with Omacetaxine mepesuccinate.,increase,risk
Desmoteplase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Desmoteplase.,increase,no risk
Desmoteplase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Desmoteplase.,increase,risk
Desmoteplase,Omega-3-carboxylic acids,The therapeutic efficacy of Desmoteplase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Desmoteplase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Desmoteplase.,increase,risk
Desmoteplase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Desmoteplase.,increase,risk
Desmoteplase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Desmoteplase.,increase,risk
Desmoteplase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Desmoteplase.,decrease,no risk
Desmoteplase,Quinidine,The therapeutic efficacy of Desmoteplase can be increased when used in combination with Quinidine.,increase,no risk
Desmoteplase,Quinine,The therapeutic efficacy of Desmoteplase can be increased when used in combination with Quinine.,increase,no risk
Desmoteplase,Ulipristal,The therapeutic efficacy of Desmoteplase can be decreased when used in combination with Ulipristal.,decrease,no risk
Desmoteplase,Urokinase,Urokinase may increase the anticoagulant activities of Desmoteplase.,increase,no risk
Desmoteplase,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Desmoteplase is combined with Ursodeoxycholic acid.,increase,risk
Desmoteplase,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Desmoteplase.,increase,risk
Desmoteplase,Venlafaxine,The risk or severity of bleeding can be increased when Desmoteplase is combined with Venlafaxine.,increase,risk
Desmoteplase,Vinblastine,The risk or severity of bleeding can be increased when Desmoteplase is combined with Vinblastine.,increase,risk
Desmoteplase,Vindesine,The risk or severity of bleeding can be increased when Desmoteplase is combined with Vindesine.,increase,risk
Desmoteplase,Vinorelbine,The risk or severity of bleeding can be increased when Desmoteplase is combined with Vinorelbine.,increase,risk
Desmoteplase,Vitamin E,Vitamin E may increase the anticoagulant activities of Desmoteplase.,increase,no risk
Desmoteplase,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Desmoteplase.,decrease,no risk
Desmoteplase,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Desmoteplase.,increase,risk
Desmoteplase,Vorinostat,The risk or severity of bleeding can be increased when Desmoteplase is combined with Vorinostat.,increase,risk
Desmoteplase,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Desmoteplase.,increase,risk
Desmoteplase,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Desmoteplase.,increase,risk
Desmoteplase,Zidovudine,The risk or severity of bleeding can be increased when Desmoteplase is combined with Zidovudine.,increase,risk
Desmoteplase,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Desmoteplase.,increase,risk
Permethrin,Gabapentin enacarbil,Permethrin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Permethrin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Gadodiamide,Gadodiamide may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Gadofosveset trisodium,Permethrin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Permethrin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Gadoteric acid,Permethrin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Permethrin,Gadoteridol,Gadoteridol may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Ganciclovir,Ganciclovir may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Gemcitabine,Gemcitabine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Gentamicin,Permethrin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Permethrin,Gimeracil,Permethrin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Permethrin,Givosiran,Givosiran may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Glipizide,Glipizide may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Glycerol phenylbutyrate,Permethrin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Permethrin,Golodirsen,Permethrin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Permethrin,Goserelin,Goserelin may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Guanethidine,Guanethidine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Guanfacine,Guanfacine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Haloperidol,Haloperidol may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Hydralazine,Hydralazine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Permethrin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Permethrin,Hydromorphone,Hydromorphone may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Hydroxyethyl Starch,Permethrin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Permethrin,Kanamycin,Permethrin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Permethrin,Ketamine,Ketamine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Ketazolam,Ketazolam may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Ketoprofen,Ketoprofen may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Ketorolac,Ketorolac may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Octinoxate,Permethrin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Permethrin,Olsalazine,Olsalazine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Opium,Permethrin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Permethrin,Oseltamivir,Oseltamivir may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Oxacillin,Oxacillin may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Oxaprozin,Oxaprozin may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Oxazepam,Oxazepam may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Oxybenzone,Oxybenzone may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Oxyquinoline,Permethrin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Permethrin,Quetiapine,Quetiapine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Quinethazone,Quinethazone may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Permethrin,Quinidine,Permethrin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Permethrin,Vaborbactam,Permethrin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Permethrin,Valaciclovir,Valaciclovir may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Valbenazine,Permethrin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Permethrin,Valdecoxib,Valdecoxib may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Valganciclovir,Valganciclovir may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Vancomycin,Permethrin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Permethrin,Varenicline,Varenicline may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Venlafaxine,Venlafaxine may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Verapamil,Verapamil may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Vilanterol,Permethrin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Permethrin,Viloxazine,Permethrin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Permethrin,Vortioxetine,Permethrin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Permethrin,Warfarin,Permethrin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Permethrin,Zaleplon,Zaleplon may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Zanamivir,Zanamivir may decrease the excretion rate of Permethrin which could result in a higher serum level.,decrease,no risk
Permethrin,Zonisamide,Zonisamide may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Defibrotide,Gemcitabine,The risk or severity of bleeding can be increased when Defibrotide is combined with Gemcitabine.,increase,risk
Defibrotide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Defibrotide is combined with Gemtuzumab ozogamicin.,increase,risk
Defibrotide,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Defibrotide.,increase,risk
Defibrotide,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Defibrotide.,increase,no risk
Defibrotide,Glucosamine,Glucosamine may increase the antiplatelet activities of Defibrotide.,increase,no risk
Defibrotide,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Defibrotide.,increase,risk
Defibrotide,Hemin,Hemin may increase the anticoagulant activities of Defibrotide.,increase,no risk
Defibrotide,Heparin,The risk or severity of bleeding can be increased when Defibrotide is combined with Heparin.,increase,risk
Defibrotide,Hydrochlorothiazide,The therapeutic efficacy of Defibrotide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Defibrotide,Hydroflumethiazide,The therapeutic efficacy of Defibrotide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Defibrotide,Hydroxyprogesterone caproate,The therapeutic efficacy of Defibrotide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Defibrotide,Hydroxyurea,The risk or severity of bleeding can be increased when Defibrotide is combined with Hydroxyurea.,increase,risk
Defibrotide,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Defibrotide.,increase,risk
Defibrotide,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Defibrotide.,increase,risk
Defibrotide,Obeticholic acid,The risk or severity of adverse effects can be increased when Defibrotide is combined with Obeticholic acid.,increase,risk
Defibrotide,Obinutuzumab,The risk or severity of adverse effects can be increased when Defibrotide is combined with Obinutuzumab.,increase,risk
Defibrotide,Olaparib,The risk or severity of bleeding can be increased when Defibrotide is combined with Olaparib.,increase,risk
Defibrotide,Olive oil,The therapeutic efficacy of Defibrotide can be decreased when used in combination with Olive oil.,decrease,no risk
Defibrotide,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Defibrotide.,increase,risk
Defibrotide,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Defibrotide is combined with Omacetaxine mepesuccinate.,increase,risk
Defibrotide,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Defibrotide.,increase,no risk
Defibrotide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Defibrotide.,increase,risk
Defibrotide,Omega-3-carboxylic acids,The therapeutic efficacy of Defibrotide can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Defibrotide,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Defibrotide.,increase,risk
Defibrotide,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Defibrotide.,increase,risk
Defibrotide,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Defibrotide.,increase,risk
Defibrotide,Quinestrol,Quinestrol may decrease the anticoagulant activities of Defibrotide.,decrease,no risk
Defibrotide,Quinidine,The therapeutic efficacy of Defibrotide can be increased when used in combination with Quinidine.,increase,no risk
Defibrotide,Quinine,The therapeutic efficacy of Defibrotide can be increased when used in combination with Quinine.,increase,no risk
Defibrotide,Ulipristal,The therapeutic efficacy of Defibrotide can be decreased when used in combination with Ulipristal.,decrease,no risk
Defibrotide,Urokinase,Urokinase may increase the anticoagulant activities of Defibrotide.,increase,no risk
Defibrotide,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Defibrotide is combined with Ursodeoxycholic acid.,increase,risk
Defibrotide,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Defibrotide.,increase,risk
Defibrotide,Venlafaxine,The risk or severity of bleeding can be increased when Defibrotide is combined with Venlafaxine.,increase,risk
Defibrotide,Vinblastine,The risk or severity of bleeding can be increased when Defibrotide is combined with Vinblastine.,increase,risk
Defibrotide,Vindesine,The risk or severity of bleeding can be increased when Defibrotide is combined with Vindesine.,increase,risk
Defibrotide,Vinorelbine,The risk or severity of bleeding can be increased when Defibrotide is combined with Vinorelbine.,increase,risk
Defibrotide,Vitamin E,Vitamin E may increase the antiplatelet activities of Defibrotide.,increase,no risk
Defibrotide,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Defibrotide.,decrease,no risk
Defibrotide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Defibrotide.,increase,risk
Defibrotide,Vorinostat,The risk or severity of bleeding can be increased when Defibrotide is combined with Vorinostat.,increase,risk
Defibrotide,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Defibrotide.,increase,risk
Defibrotide,Warfarin,The risk or severity of bleeding can be increased when Defibrotide is combined with Warfarin.,increase,risk
Defibrotide,Ximelagatran,The risk or severity of bleeding can be increased when Defibrotide is combined with Ximelagatran.,increase,risk
Defibrotide,Zidovudine,The risk or severity of bleeding can be increased when Defibrotide is combined with Zidovudine.,increase,risk
Defibrotide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Defibrotide.,increase,risk
Rifalazil,Vadadustat,The serum concentration of Rifalazil can be increased when it is combined with Vadadustat.,increase,no risk
Rifalazil,Venetoclax,The metabolism of Rifalazil can be decreased when combined with Venetoclax.,decrease,no risk
Rifalazil,Verapamil,The metabolism of Rifalazil can be decreased when combined with Verapamil.,decrease,no risk
Rifalazil,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rifalazil.,decrease,no risk
Rifalazil,Viloxazine,The metabolism of Rifalazil can be decreased when combined with Viloxazine.,decrease,no risk
Rifalazil,Voriconazole,The metabolism of Rifalazil can be decreased when combined with Voriconazole.,decrease,no risk
Rifalazil,Warfarin,The risk or severity of bleeding can be increased when Rifalazil is combined with Warfarin.,increase,risk
Rifalazil,Zimelidine,The metabolism of Rifalazil can be decreased when combined with Zimelidine.,decrease,no risk
Rifalazil,Ziprasidone,The metabolism of Rifalazil can be decreased when combined with Ziprasidone.,decrease,no risk
Ospemifene,Galantamine,The metabolism of Galantamine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Gemfibrozil,The metabolism of Ospemifene can be decreased when combined with Gemfibrozil.,decrease,no risk
Ospemifene,Ginkgo biloba,The metabolism of Ospemifene can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ospemifene,Gliclazide,The metabolism of Ospemifene can be decreased when combined with Gliclazide.,decrease,no risk
Ospemifene,Glimepiride,The metabolism of Ospemifene can be decreased when combined with Glimepiride.,decrease,no risk
Ospemifene,Glipizide,The metabolism of Ospemifene can be decreased when combined with Glipizide.,decrease,no risk
Ospemifene,Gliquidone,The metabolism of Ospemifene can be decreased when combined with Gliquidone.,decrease,no risk
Ospemifene,Glofitamab,The serum concentration of Ospemifene can be increased when it is combined with Glofitamab.,increase,no risk
Ospemifene,Glyburide,The metabolism of Ospemifene can be decreased when combined with Glyburide.,decrease,no risk
Ospemifene,Golimumab,The metabolism of Ospemifene can be increased when combined with Golimumab.,increase,no risk
Ospemifene,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ospemifene.,increase,no risk
Ospemifene,Halothane,The metabolism of Ospemifene can be decreased when combined with Halothane.,decrease,no risk
Ospemifene,Hydrocodone,The metabolism of Ospemifene can be decreased when combined with Hydrocodone.,decrease,no risk
Ospemifene,Hydrocortisone,The metabolism of Ospemifene can be increased when combined with Hydrocortisone.,increase,no risk
Ospemifene,Hydromorphone,The metabolism of Ospemifene can be decreased when combined with Hydromorphone.,decrease,no risk
Ospemifene,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Ketamine,The metabolism of Ospemifene can be decreased when combined with Ketamine.,decrease,no risk
Ospemifene,Ketoconazole,The metabolism of Ospemifene can be decreased when combined with Ketoconazole.,decrease,no risk
Ospemifene,Ketorolac,The metabolism of Ospemifene can be decreased when combined with Ketorolac.,decrease,no risk
Ospemifene,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Omaveloxolone,The serum concentration of Ospemifene can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ospemifene,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Opium,The metabolism of Opium can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Oritavancin,The metabolism of Ospemifene can be decreased when combined with Oritavancin.,decrease,no risk
Ospemifene,Orphenadrine,The metabolism of Ospemifene can be decreased when combined with Orphenadrine.,decrease,no risk
Ospemifene,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Oxandrolone,The metabolism of Ospemifene can be decreased when combined with Oxandrolone.,decrease,no risk
Ospemifene,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Quinestrol,The risk or severity of adverse effects can be increased when Quinestrol is combined with Ospemifene.,increase,risk
Ospemifene,Quinidine,The metabolism of Ospemifene can be decreased when combined with Quinidine.,decrease,no risk
Ospemifene,Quinine,The metabolism of Quinine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Vadadustat,The serum concentration of Ospemifene can be decreased when it is combined with Vadadustat.,decrease,no risk
Ospemifene,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Valdecoxib,The metabolism of Ospemifene can be decreased when combined with Valdecoxib.,decrease,no risk
Ospemifene,Valproic acid,The metabolism of Ospemifene can be decreased when combined with Valproic acid.,decrease,no risk
Ospemifene,Valsartan,The metabolism of Ospemifene can be decreased when combined with Valsartan.,decrease,no risk
Ospemifene,Vardenafil,The metabolism of Ospemifene can be decreased when combined with Vardenafil.,decrease,no risk
Ospemifene,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Vemurafenib,The metabolism of Ospemifene can be decreased when combined with Vemurafenib.,decrease,no risk
Ospemifene,Venetoclax,The metabolism of Ospemifene can be decreased when combined with Venetoclax.,decrease,no risk
Ospemifene,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Verapamil,The metabolism of Ospemifene can be decreased when combined with Verapamil.,decrease,no risk
Ospemifene,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Viloxazine,The metabolism of Ospemifene can be decreased when combined with Viloxazine.,decrease,no risk
Ospemifene,Voriconazole,The metabolism of Ospemifene can be decreased when combined with Voriconazole.,decrease,no risk
Ospemifene,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Warfarin,The metabolism of Ospemifene can be increased when combined with Warfarin.,increase,no risk
Ospemifene,Ximelagatran,The metabolism of Ospemifene can be decreased when combined with Ximelagatran.,decrease,no risk
Ospemifene,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Zafirlukast,The metabolism of Ospemifene can be decreased when combined with Zafirlukast.,decrease,no risk
Ospemifene,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Zidovudine,The metabolism of Ospemifene can be decreased when combined with Zidovudine.,decrease,no risk
Ospemifene,Zileuton,The metabolism of Ospemifene can be decreased when combined with Zileuton.,decrease,no risk
Ospemifene,Zimelidine,The metabolism of Ospemifene can be decreased when combined with Zimelidine.,decrease,no risk
Ospemifene,Ziprasidone,The metabolism of Ospemifene can be decreased when combined with Ziprasidone.,decrease,no risk
Ospemifene,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ospemifene.,decrease,no risk
Ospemifene,Zopiclone,The metabolism of Ospemifene can be decreased when combined with Zopiclone.,decrease,no risk
Ospemifene,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ospemifene.,decrease,no risk
Eribulin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Eribulin.,increase,risk
Eribulin,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Eribulin.,increase,risk
Eribulin,Butacaine,The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Butacaine.,increase,risk
Eribulin,Butamben,The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Butamben.,increase,risk
Eribulin,Butriptyline,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Butriptyline.,increase,risk
Eribulin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Gadobenic acid.,increase,risk
Eribulin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Eribulin.,increase,risk
Eribulin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Eribulin.,increase,risk
Eribulin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Eribulin.,increase,risk
Eribulin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Gemifloxacin.,increase,risk
Eribulin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Eribulin.,increase,risk
Eribulin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Eribulin.,increase,risk
Eribulin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Gilteritinib.,increase,risk
Eribulin,Glasdegib,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Glasdegib.,increase,risk
Eribulin,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Eribulin.,increase,risk
Eribulin,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Eribulin.,increase,risk
Eribulin,Goserelin,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Goserelin.,increase,risk
Eribulin,Granisetron,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Granisetron.,increase,risk
Eribulin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Grepafloxacin.,increase,risk
Eribulin,Guselkumab,The risk or severity of adverse effects can be increased when Eribulin is combined with Guselkumab.,increase,risk
Eribulin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Halofantrine,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Halofantrine.,increase,risk
Eribulin,Haloperidol,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Haloperidol.,increase,risk
Eribulin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Eribulin.,increase,risk
Eribulin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Eribulin.,increase,risk
Eribulin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Eribulin.,increase,risk
Eribulin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Eribulin.,increase,risk
Eribulin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Eribulin is combined with Hydrocortisone acetate.,increase,risk
Eribulin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Eribulin is combined with Hydrocortisone butyrate.,increase,risk
Eribulin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Eribulin is combined with Hydrocortisone succinate.,increase,risk
Eribulin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Eribulin.,increase,risk
Eribulin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Eribulin.,increase,risk
Eribulin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Eribulin.,increase,risk
Eribulin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Hydroxyzine.,increase,risk
Eribulin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Eribulin.,increase,risk
Eribulin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Eribulin.,increase,risk
Eribulin,Obinutuzumab,The risk or severity of adverse effects can be increased when Eribulin is combined with Obinutuzumab.,increase,risk
Eribulin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Eribulin.,increase,no risk
Eribulin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Eribulin.,increase,risk
Eribulin,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Eribulin.,increase,risk
Eribulin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ofloxacin.,increase,risk
Eribulin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Eribulin.,increase,risk
Eribulin,Olaparib,The risk or severity of adverse effects can be increased when Eribulin is combined with Olaparib.,increase,risk
Eribulin,Olodaterol,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Olodaterol.,increase,risk
Eribulin,Ondansetron,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ondansetron.,increase,risk
Eribulin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Eribulin.,increase,risk
Eribulin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Eribulin.,increase,risk
Eribulin,Oxatomide,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Oxatomide.,increase,risk
Eribulin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Oxetacaine.,increase,risk
Eribulin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Eribulin is combined with Oxybuprocaine.,increase,risk
Eribulin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Eribulin.,increase,risk
Eribulin,Ozanimod,The risk or severity of adverse effects can be increased when Eribulin is combined with Ozanimod.,increase,risk
Eribulin,Quetiapine,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quetiapine.,increase,risk
Eribulin,Quinidine,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quinidine.,increase,risk
Eribulin,Quinine,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quinine.,increase,risk
Eribulin,Quizartinib,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quizartinib.,increase,risk
Eribulin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Eribulin.,increase,risk
Eribulin,Upadacitinib,The risk or severity of adverse effects can be increased when Eribulin is combined with Upadacitinib.,increase,risk
Eribulin,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Eribulin.,increase,risk
Eribulin,Valproic acid,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Valproic acid.,increase,risk
Eribulin,Vandetanib,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Vandetanib.,increase,risk
Eribulin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Eribulin.,increase,risk
Eribulin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Eribulin.,increase,risk
Eribulin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Vedolizumab,The risk or severity of adverse effects can be increased when Eribulin is combined with Vedolizumab.,increase,risk
Eribulin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Eribulin.,increase,risk
Eribulin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Eribulin.,increase,risk
Eribulin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Eribulin.,decrease,no risk
Eribulin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Eribulin.,increase,risk
Eribulin,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Eribulin.,increase,risk
Eribulin,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Eribulin.,increase,risk
Eribulin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Eribulin.,increase,risk
Eribulin,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Eribulin.,increase,risk
Eribulin,Voclosporin,The risk or severity of adverse effects can be increased when Eribulin is combined with Voclosporin.,increase,risk
Eribulin,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Eribulin.,increase,risk
Eribulin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Eribulin.,increase,risk
Eribulin,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Eribulin.,increase,risk
Eribulin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Eribulin.,increase,risk
Eribulin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Eribulin.,increase,risk
Eribulin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Eribulin.,increase,risk
Eribulin,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Eribulin.,increase,risk
Eribulin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Ziprasidone.,increase,risk
Eribulin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Eribulin.,increase,risk
Eribulin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Eribulin is combined with Zuclopenthixol.,increase,risk
Iloperidone,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Iloperidone.,increase,risk
Iloperidone,Berotralstat,The metabolism of Iloperidone can be decreased when combined with Berotralstat.,decrease,no risk
Iloperidone,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Betamethasone,The metabolism of Iloperidone can be increased when combined with Betamethasone.,increase,no risk
Iloperidone,Betamethasone phosphate,The metabolism of Iloperidone can be increased when combined with Betamethasone phosphate.,increase,no risk
Iloperidone,Betaxolol,Betaxolol may increase the orthostatic hypotensive activities of Iloperidone.,increase,no risk
Iloperidone,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Bicalutamide,The metabolism of Iloperidone can be decreased when combined with Bicalutamide.,decrease,no risk
Iloperidone,Bifonazole,The metabolism of Iloperidone can be decreased when combined with Bifonazole.,decrease,no risk
Iloperidone,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Iloperidone.,increase,risk
Iloperidone,Bimekizumab,The metabolism of Iloperidone can be increased when combined with Bimekizumab.,increase,no risk
Iloperidone,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Bismuth subcitrate potassium,Iloperidone may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Iloperidone,Bismuth subgallate,Iloperidone may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Iloperidone,Bismuth subnitrate,Iloperidone may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Iloperidone,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Iloperidone.,increase,no risk
Iloperidone,Boceprevir,The metabolism of Iloperidone can be decreased when combined with Boceprevir.,decrease,no risk
Iloperidone,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Iloperidone.,increase,risk
Iloperidone,Bosentan,Iloperidone may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Iloperidone,Bosutinib,The metabolism of Iloperidone can be decreased when combined with Bosutinib.,decrease,no risk
Iloperidone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Iloperidone.,increase,risk
Iloperidone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Iloperidone.,increase,risk
Iloperidone,Brentuximab vedotin,The metabolism of Iloperidone can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Iloperidone,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Iloperidone.,increase,risk
Iloperidone,Brexanolone,The risk or severity of CNS depression can be increased when Iloperidone is combined with Brexanolone.,increase,risk
Iloperidone,Brexpiprazole,"Iloperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Iloperidone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Iloperidone.,increase,no risk
Iloperidone,Brivaracetam,The risk or severity of CNS depression can be increased when Iloperidone is combined with Brivaracetam.,increase,risk
Iloperidone,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Iloperidone.,increase,risk
Iloperidone,Bromocriptine,The metabolism of Iloperidone can be decreased when combined with Bromocriptine.,decrease,no risk
Iloperidone,Bromperidol,The risk or severity of CNS depression can be increased when Iloperidone is combined with Bromperidol.,increase,risk
Iloperidone,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Iloperidone.,increase,risk
Iloperidone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Iloperidone.,increase,risk
Iloperidone,Budesonide,The metabolism of Iloperidone can be increased when combined with Budesonide.,increase,no risk
Iloperidone,Bumadizone,The risk or severity of hypertension can be increased when Iloperidone is combined with Bumadizone.,increase,risk
Iloperidone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Iloperidone.,increase,risk
Iloperidone,Buprenorphine,Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Iloperidone,Bupropion,The metabolism of Iloperidone can be decreased when combined with Bupropion.,decrease,no risk
Iloperidone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Iloperidone.,increase,risk
Iloperidone,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Iloperidone.,increase,risk
Iloperidone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Iloperidone.,increase,risk
Iloperidone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Iloperidone.,increase,risk
Iloperidone,Butaperazine,The risk or severity of CNS depression can be increased when Iloperidone is combined with Butaperazine.,increase,risk
Iloperidone,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Iloperidone.,increase,risk
Iloperidone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Iloperidone.,increase,risk
Iloperidone,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Iloperidone.,increase,risk
Iloperidone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Iloperidone.,increase,risk
Iloperidone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Iloperidone is combined with Gabapentin enacarbil.,increase,risk
Iloperidone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Iloperidone.,increase,risk
Iloperidone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Iloperidone.,increase,risk
Iloperidone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Iloperidone.,increase,risk
Iloperidone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Iloperidone is combined with Ganaxolone.",increase,risk
Iloperidone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Iloperidone.,increase,risk
Iloperidone,Gefitinib,The metabolism of Iloperidone can be decreased when combined with Gefitinib.,decrease,no risk
Iloperidone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Iloperidone.,increase,risk
Iloperidone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Iloperidone.,increase,risk
Iloperidone,Gilteritinib,The therapeutic efficacy of Iloperidone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Iloperidone,Givosiran,The serum concentration of Iloperidone can be increased when it is combined with Givosiran.,increase,no risk
Iloperidone,Glasdegib,The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Glasdegib.,increase,risk
Iloperidone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Glofitamab,The serum concentration of Iloperidone can be increased when it is combined with Glofitamab.,increase,no risk
Iloperidone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Iloperidone.,increase,risk
Iloperidone,Glyburide,The metabolism of Iloperidone can be decreased when combined with Glyburide.,decrease,no risk
Iloperidone,Glycerol phenylbutyrate,The metabolism of Iloperidone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Iloperidone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Golimumab,The metabolism of Iloperidone can be increased when combined with Golimumab.,increase,no risk
Iloperidone,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Iloperidone.,increase,risk
Iloperidone,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Iloperidone.,increase,risk
Iloperidone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Iloperidone.,increase,risk
Iloperidone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Guanadrel,Iloperidone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Iloperidone,Guanethidine,Iloperidone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Iloperidone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Guanoxan,Iloperidone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Iloperidone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Iloperidone.,increase,risk
Iloperidone,Halofantrine,The metabolism of Iloperidone can be decreased when combined with Halofantrine.,decrease,no risk
Iloperidone,Haloperidol,The metabolism of Iloperidone can be decreased when combined with Haloperidol.,decrease,no risk
Iloperidone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Iloperidone.,increase,risk
Iloperidone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Iloperidone.,increase,risk
Iloperidone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Iloperidone.,increase,risk
Iloperidone,Hydralazine,The metabolism of Iloperidone can be decreased when combined with Hydralazine.,decrease,no risk
Iloperidone,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Iloperidone.,increase,risk
Iloperidone,Hydrocodone,Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Iloperidone,Hydrocortisone,The metabolism of Iloperidone can be decreased when combined with Hydrocortisone.,decrease,no risk
Iloperidone,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Hydroflumethiazide,Iloperidone may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Iloperidone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Iloperidone.,increase,risk
Iloperidone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Iloperidone.,increase,risk
Iloperidone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Hydroxyzine.,increase,risk
Iloperidone,Hyoscyamine,Iloperidone may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Iloperidone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Iloperidone.,increase,risk
Iloperidone,Ketazolam,The metabolism of Iloperidone can be decreased when combined with Ketazolam.,decrease,no risk
Iloperidone,Ketoconazole,The metabolism of Iloperidone can be decreased when combined with Ketoconazole.,decrease,no risk
Iloperidone,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Iloperidone.,increase,risk
Iloperidone,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Iloperidone.,increase,risk
Iloperidone,Octreotide,The metabolism of Iloperidone can be decreased when combined with Octreotide.,decrease,no risk
Iloperidone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Iloperidone.,increase,risk
Iloperidone,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.",increase,no risk
Iloperidone,Olaparib,The metabolism of Iloperidone can be decreased when combined with Olaparib.,decrease,no risk
Iloperidone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Iloperidone is combined with Oliceridine.",increase,risk
Iloperidone,Olmesartan,Iloperidone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Iloperidone,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Omaveloxolone,The serum concentration of Iloperidone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Iloperidone,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Iloperidone.,increase,risk
Iloperidone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Opium,The risk or severity of CNS depression can be increased when Iloperidone is combined with Opium.,increase,risk
Iloperidone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Oritavancin,The metabolism of Iloperidone can be decreased when combined with Oritavancin.,decrease,no risk
Iloperidone,Orphenadrine,The metabolism of Iloperidone can be decreased when combined with Orphenadrine.,decrease,no risk
Iloperidone,Osilodrostat,The metabolism of Iloperidone can be decreased when combined with Osilodrostat.,decrease,no risk
Iloperidone,Ospemifene,The metabolism of Iloperidone can be decreased when combined with Ospemifene.,decrease,no risk
Iloperidone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Iloperidone.,increase,risk
Iloperidone,Oxamniquine,The metabolism of Iloperidone can be decreased when combined with Oxamniquine.,decrease,no risk
Iloperidone,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Iloperidone.,increase,risk
Iloperidone,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Iloperidone.,increase,risk
Iloperidone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Iloperidone.,increase,risk
Iloperidone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Iloperidone.,increase,risk
Iloperidone,Oxetacaine,The metabolism of Iloperidone can be decreased when combined with Oxetacaine.,decrease,no risk
Iloperidone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Iloperidone.,increase,risk
Iloperidone,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Iloperidone.,increase,no risk
Iloperidone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Iloperidone.,increase,risk
Iloperidone,Oxybutynin,The metabolism of Iloperidone can be decreased when combined with Oxybutynin.,decrease,no risk
Iloperidone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Iloperidone.,increase,risk
Iloperidone,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Oxymetholone,The metabolism of Iloperidone can be decreased when combined with Oxymetholone.,decrease,no risk
Iloperidone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Iloperidone.,increase,risk
Iloperidone,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Iloperidone.,increase,risk
Iloperidone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Iloperidone.,increase,risk
Iloperidone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Iloperidone.,increase,risk
Iloperidone,Quetiapine,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.",increase,no risk
Iloperidone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Quinapril,Iloperidone may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Iloperidone,Quinidine,The metabolism of Iloperidone can be decreased when combined with Quinidine.,decrease,no risk
Iloperidone,Quinine,The metabolism of Iloperidone can be decreased when combined with Quinine.,decrease,no risk
Iloperidone,Quinupramine,The risk or severity of CNS depression can be increased when Iloperidone is combined with Quinupramine.,increase,risk
Iloperidone,Quinupristin,The metabolism of Iloperidone can be decreased when combined with Quinupristin.,decrease,no risk
Iloperidone,Quizartinib,The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Quizartinib.,increase,risk
Iloperidone,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Iloperidone.,increase,risk
Iloperidone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Iloperidone.,increase,risk
Iloperidone,Vadadustat,The serum concentration of Iloperidone can be increased when it is combined with Vadadustat.,increase,no risk
Iloperidone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Iloperidone.,increase,risk
Iloperidone,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Iloperidone is combined with Valproate bismuth.,increase,risk
Iloperidone,Valproic acid,The metabolism of Iloperidone can be decreased when combined with Valproic acid.,decrease,no risk
Iloperidone,Valsartan,Iloperidone may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Iloperidone,Vandetanib,The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Vandetanib.,increase,risk
Iloperidone,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Iloperidone.,increase,risk
Iloperidone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Iloperidone.,increase,risk
Iloperidone,Vemurafenib,The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Vemurafenib.,increase,risk
Iloperidone,Venetoclax,The metabolism of Iloperidone can be decreased when combined with Venetoclax.,decrease,no risk
Iloperidone,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Iloperidone is combined with Venlafaxine.,increase,risk
Iloperidone,Verapamil,The metabolism of Iloperidone can be decreased when combined with Verapamil.,decrease,no risk
Iloperidone,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Iloperidone.,increase,risk
Iloperidone,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Iloperidone.,increase,risk
Iloperidone,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Iloperidone.,increase,risk
Iloperidone,Vilazodone,The metabolism of Iloperidone can be decreased when combined with Vilazodone.,decrease,no risk
Iloperidone,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Viloxazine,The metabolism of Iloperidone can be decreased when combined with Viloxazine.,decrease,no risk
Iloperidone,Vinblastine,The metabolism of Iloperidone can be decreased when combined with Vinblastine.,decrease,no risk
Iloperidone,Vincristine,The metabolism of Vincristine can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Vinorelbine,The metabolism of Iloperidone can be decreased when combined with Vinorelbine.,decrease,no risk
Iloperidone,Viomycin,Iloperidone may increase the neurotoxic activities of Viomycin.,increase,no risk
Iloperidone,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Iloperidone.,decrease,no risk
Iloperidone,Voriconazole,The metabolism of Iloperidone can be decreased when combined with Voriconazole.,decrease,no risk
Iloperidone,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Iloperidone.,increase,risk
Iloperidone,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Iloperidone.,increase,risk
Iloperidone,Warfarin,The risk or severity of adverse effects can be increased when Iloperidone is combined with Warfarin.,increase,risk
Iloperidone,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Iloperidone.,decrease,no risk
Iloperidone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Iloperidone.,increase,risk
Iloperidone,Zafirlukast,The metabolism of Iloperidone can be decreased when combined with Zafirlukast.,decrease,no risk
Iloperidone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Iloperidone.,increase,risk
Iloperidone,Ziconotide,The risk or severity of CNS depression can be increased when Iloperidone is combined with Ziconotide.,increase,risk
Iloperidone,Zimelidine,The metabolism of Iloperidone can be decreased when combined with Zimelidine.,decrease,no risk
Iloperidone,Ziprasidone,The risk or severity of QTc prolongation can be increased when Iloperidone is combined with Ziprasidone.,increase,risk
Iloperidone,Zofenopril,Iloperidone may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Iloperidone,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Iloperidone.,increase,risk
Iloperidone,Zolpidem,Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Iloperidone,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Iloperidone.,increase,risk
Iloperidone,Zopiclone,The risk or severity of adverse effects can be increased when Iloperidone is combined with Zopiclone.,increase,risk
Iloperidone,Zotepine,The risk or severity of CNS depression can be increased when Iloperidone is combined with Zotepine.,increase,risk
Iloperidone,Zuclopenthixol,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Iloperidone.",increase,no risk
Iloperidone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Iloperidone.,increase,risk
Lofexidine,Bacitracin,Bacitracin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Baclofen,The therapeutic efficacy of Baclofen can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Balsalazide,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Balsalazide.,decrease,no risk
Lofexidine,Baricitinib,Lofexidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Lofexidine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Bedaquiline.,increase,risk
Lofexidine,Belinostat,The metabolism of Lofexidine can be increased when combined with Belinostat.,increase,no risk
Lofexidine,Benazepril,Lofexidine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Lofexidine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Lofexidine.,decrease,no risk
Lofexidine,Bendroflumethiazide,The therapeutic efficacy of Lofexidine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Lofexidine,Benorilate,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Benorilate.,decrease,no risk
Lofexidine,Benoxaprofen,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Lofexidine,Benperidol,The therapeutic efficacy of Benperidol can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Benserazide,Lofexidine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Lofexidine,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Lofexidine.,increase,risk
Lofexidine,Benznidazole,Lofexidine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Lofexidine,Benzocaine,The therapeutic efficacy of Benzocaine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Benzphetamine,The therapeutic efficacy of Benzphetamine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Benzthiazide,The therapeutic efficacy of Lofexidine can be increased when used in combination with Benzthiazide.,increase,no risk
Lofexidine,Benzydamine,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Benzydamine.,decrease,no risk
Lofexidine,Benzyl alcohol,The therapeutic efficacy of Benzyl alcohol can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Benzylpenicilloyl polylysine,Lofexidine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Lofexidine,Bepotastine,Bepotastine may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Bepridil,The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Bepridil.,increase,risk
Lofexidine,Berotralstat,The metabolism of Lofexidine can be decreased when combined with Berotralstat.,decrease,no risk
Lofexidine,Betaxolol,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Betaxolol.,decrease,no risk
Lofexidine,Bethanidine,Bethanidine may decrease the antihypertensive activities of Lofexidine.,decrease,no risk
Lofexidine,Bicisate,Lofexidine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lofexidine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lofexidine.,increase,risk
Lofexidine,Bimatoprost,Bimatoprost may increase the hypotensive activities of Lofexidine.,increase,no risk
Lofexidine,Bimekizumab,The metabolism of Lofexidine can be increased when combined with Bimekizumab.,increase,no risk
Lofexidine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Lofexidine.,decrease,no risk
Lofexidine,Biperiden,The metabolism of Lofexidine can be decreased when combined with Biperiden.,decrease,no risk
Lofexidine,Bismuth subgallate,Lofexidine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lofexidine,Bisoprolol,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Bisoprolol.,decrease,no risk
Lofexidine,Bisoxatin,Lofexidine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lofexidine,Bleomycin,Bleomycin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Bortezomib,The metabolism of Lofexidine can be decreased when combined with Bortezomib.,decrease,no risk
Lofexidine,Bosentan,Lofexidine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Lofexidine,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Botulinum toxin type B,The therapeutic efficacy of Botulinum toxin type B can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Bretylium,Lofexidine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Lofexidine,Brexanolone,The therapeutic efficacy of Brexanolone can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Brexpiprazole,The therapeutic efficacy of Brexpiprazole can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Brimonidine,Brimonidine may increase the antihypertensive activities of Lofexidine.,increase,no risk
Lofexidine,Brivaracetam,The therapeutic efficacy of Brivaracetam can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Bromazepam,The therapeutic efficacy of Bromazepam can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lofexidine,Bromperidol,The therapeutic efficacy of Bromperidol can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Brompheniramine,The therapeutic efficacy of Brompheniramine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Lofexidine.,increase,risk
Lofexidine,Budesonide,Budesonide may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Bumadizone,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Bumadizone.,decrease,no risk
Lofexidine,Bumetanide,Bumetanide may increase the excretion rate of Lofexidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lofexidine,Bupivacaine,The therapeutic efficacy of Bupivacaine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Buprenorphine,Lofexidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Lofexidine,Bupropion,The therapeutic efficacy of Bupropion can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Lofexidine.,increase,risk
Lofexidine,Buspirone,The therapeutic efficacy of Buspirone can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butabarbital,The therapeutic efficacy of Butabarbital can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butalbital,The therapeutic efficacy of Butalbital can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butaperazine,The therapeutic efficacy of Butaperazine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butobarbital,The therapeutic efficacy of Butobarbital can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butorphanol,The therapeutic efficacy of Butorphanol can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butriptyline,The therapeutic efficacy of Butriptyline can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Lofexidine is combined with Butylscopolamine.,increase,risk
Lofexidine,Gabapentin,The therapeutic efficacy of Gabapentin can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Gabapentin enacarbil,The therapeutic efficacy of Gabapentin enacarbil can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Lofexidine.,increase,risk
Lofexidine,Gadodiamide,Gadodiamide may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Gadofosveset trisodium,Lofexidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lofexidine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Gadoteric acid,Lofexidine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lofexidine,Gadoteridol,Gadoteridol may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lofexidine.,increase,risk
Lofexidine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Ganciclovir,Ganciclovir may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Gatifloxacin,The metabolism of Lofexidine can be decreased when combined with Gatifloxacin.,decrease,no risk
Lofexidine,Gefitinib,The metabolism of Lofexidine can be decreased when combined with Gefitinib.,decrease,no risk
Lofexidine,Gemcitabine,Gemcitabine may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Gemfibrozil,The metabolism of Lofexidine can be decreased when combined with Gemfibrozil.,decrease,no risk
Lofexidine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Lofexidine.,increase,risk
Lofexidine,Gentamicin,Lofexidine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lofexidine,Gepirone,The therapeutic efficacy of Gepirone can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Gilteritinib,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Lofexidine,Gimeracil,Lofexidine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lofexidine,Givosiran,The serum concentration of Lofexidine can be increased when it is combined with Givosiran.,increase,no risk
Lofexidine,Glasdegib,The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Glasdegib.,increase,risk
Lofexidine,Glipizide,Glipizide may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Glofitamab,The serum concentration of Lofexidine can be increased when it is combined with Glofitamab.,increase,no risk
Lofexidine,Glutethimide,The therapeutic efficacy of Glutethimide can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Glycerol phenylbutyrate,The metabolism of Lofexidine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Lofexidine,Glycol salicylate,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Lofexidine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Lofexidine.,increase,risk
Lofexidine,Golimumab,The metabolism of Lofexidine can be increased when combined with Golimumab.,increase,no risk
Lofexidine,Golodirsen,Lofexidine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Lofexidine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lofexidine.,increase,risk
Lofexidine,Granisetron,The therapeutic efficacy of Granisetron can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Grepafloxacin.,increase,risk
Lofexidine,Guanabenz,The metabolism of Lofexidine can be decreased when combined with Guanabenz.,decrease,no risk
Lofexidine,Guanadrel,Lofexidine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Lofexidine,Guanethidine,Lofexidine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Lofexidine,Guanfacine,The therapeutic efficacy of Guanfacine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Guanidine,The excretion of Guanidine can be decreased when combined with Lofexidine.,decrease,no risk
Lofexidine,Guanoxan,Lofexidine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Lofexidine,Halazepam,The therapeutic efficacy of Halazepam can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Halofantrine,The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Halofantrine.,increase,risk
Lofexidine,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Halothane,The therapeutic efficacy of Halothane can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Hexafluronium,The therapeutic efficacy of Hexafluronium can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Hexocyclium,The risk or severity of Tachycardia can be increased when Lofexidine is combined with Hexocyclium.,increase,risk
Lofexidine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lofexidine.,increase,risk
Lofexidine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Lofexidine.,increase,risk
Lofexidine,Hydralazine,Lofexidine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Lofexidine,Hydrochlorothiazide,The therapeutic efficacy of Lofexidine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Lofexidine,Hydrocodone,Lofexidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lofexidine,Hydroflumethiazide,The therapeutic efficacy of Lofexidine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Lofexidine,Hydromorphone,The therapeutic efficacy of Hydromorphone can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Lofexidine which could result in a higher serum level.,decrease,no risk
Lofexidine,Hydroxychloroquine,The metabolism of Lofexidine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Lofexidine,Hydroxyethyl Starch,Lofexidine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Lofexidine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Hydroxyzine.,increase,risk
Lofexidine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lofexidine.,increase,risk
Lofexidine,Kanamycin,Lofexidine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Lofexidine,Ketamine,The therapeutic efficacy of Ketamine can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Ketazolam,The therapeutic efficacy of Ketazolam can be increased when used in combination with Lofexidine.,increase,no risk
Lofexidine,Ketoconazole,The metabolism of Lofexidine can be decreased when combined with Ketoconazole.,decrease,no risk
Lofexidine,Ketoprofen,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Lofexidine,Ketorolac,The therapeutic efficacy of Lofexidine can be decreased when used in combination with Ketorolac.,decrease,no risk
Pexelizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Obiltoxaximab.,increase,risk
Pexelizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Obinutuzumab.,increase,risk
Pexelizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Ocrelizumab.,increase,risk
Pexelizumab,Odesivimab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Odesivimab.,increase,risk
Pexelizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Ofatumumab.,increase,risk
Pexelizumab,Olaratumab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Olaratumab.,increase,risk
Pexelizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pexelizumab.,increase,risk
Pexelizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Pexelizumab.,increase,no risk
Pexelizumab,Ublituximab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Ublituximab.,increase,risk
Pexelizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Ustekinumab.,increase,risk
Pexelizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Pexelizumab is combined with Vedolizumab.,increase,risk
Ranpirnase,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Benzocaine.,increase,risk
Ranpirnase,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Benzyl alcohol.,increase,risk
Ranpirnase,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Bupivacaine.,increase,risk
Ranpirnase,Butacaine,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Butacaine.,increase,risk
Ranpirnase,Butamben,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Butamben.,increase,risk
Ranpirnase,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Oxetacaine.,increase,risk
Ranpirnase,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ranpirnase is combined with Oxybuprocaine.,increase,risk
Pirfenidone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Pirfenidone.",decrease,no risk
Pirfenidone,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Pirfenidone.,increase,risk
Pirfenidone,Bosentan,The metabolism of Pirfenidone can be increased when combined with Bosentan.,increase,no risk
Pirfenidone,Bosutinib,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Bosutinib.,increase,risk
Pirfenidone,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Brentuximab vedotin.,increase,risk
Pirfenidone,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Brodalumab,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Brodalumab.,increase,risk
Pirfenidone,Bromazepam,The metabolism of Pirfenidone can be decreased when combined with Bromazepam.,decrease,no risk
Pirfenidone,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Pirfenidone.,increase,risk
Pirfenidone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Bupivacaine.,increase,risk
Pirfenidone,Buprenorphine,The metabolism of Pirfenidone can be decreased when combined with Buprenorphine.,decrease,no risk
Pirfenidone,Bupropion,The metabolism of Pirfenidone can be decreased when combined with Bupropion.,decrease,no risk
Pirfenidone,Buspirone,The metabolism of Pirfenidone can be decreased when combined with Buspirone.,decrease,no risk
Pirfenidone,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Pirfenidone.,increase,risk
Pirfenidone,Butacaine,The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Butacaine.,increase,risk
Pirfenidone,Butamben,The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Butamben.,increase,risk
Pirfenidone,Galantamine,The metabolism of Pirfenidone can be decreased when combined with Galantamine.,decrease,no risk
Pirfenidone,Gatifloxacin,The metabolism of Pirfenidone can be decreased when combined with Gatifloxacin.,decrease,no risk
Pirfenidone,Gefitinib,The metabolism of Pirfenidone can be decreased when combined with Gefitinib.,decrease,no risk
Pirfenidone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pirfenidone.,increase,risk
Pirfenidone,Gemfibrozil,The metabolism of Pirfenidone can be decreased when combined with Gemfibrozil.,decrease,no risk
Pirfenidone,Gemifloxacin,The metabolism of Pirfenidone can be decreased when combined with Gemifloxacin.,decrease,no risk
Pirfenidone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pirfenidone.,increase,risk
Pirfenidone,Ginkgo biloba,The metabolism of Pirfenidone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Pirfenidone,Givosiran,The serum concentration of Pirfenidone can be increased when it is combined with Givosiran.,increase,no risk
Pirfenidone,Glatiramer,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Glatiramer.,increase,risk
Pirfenidone,Gliclazide,The metabolism of Pirfenidone can be decreased when combined with Gliclazide.,decrease,no risk
Pirfenidone,Glimepiride,The metabolism of Pirfenidone can be decreased when combined with Glimepiride.,decrease,no risk
Pirfenidone,Glipizide,The metabolism of Pirfenidone can be decreased when combined with Glipizide.,decrease,no risk
Pirfenidone,Gliquidone,The metabolism of Pirfenidone can be decreased when combined with Gliquidone.,decrease,no risk
Pirfenidone,Glofitamab,The serum concentration of Pirfenidone can be increased when it is combined with Glofitamab.,increase,no risk
Pirfenidone,Glyburide,The metabolism of Pirfenidone can be decreased when combined with Glyburide.,decrease,no risk
Pirfenidone,Glycerin,The metabolism of Pirfenidone can be increased when combined with Glycerin.,increase,no risk
Pirfenidone,Glycerol phenylbutyrate,The metabolism of Pirfenidone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Pirfenidone,Golimumab,The metabolism of Pirfenidone can be increased when combined with Golimumab.,increase,no risk
Pirfenidone,Grepafloxacin,The metabolism of Pirfenidone can be decreased when combined with Grepafloxacin.,decrease,no risk
Pirfenidone,Guanabenz,The metabolism of Pirfenidone can be decreased when combined with Guanabenz.,decrease,no risk
Pirfenidone,Guselkumab,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Guselkumab.,increase,risk
Pirfenidone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Halofantrine,The metabolism of Pirfenidone can be decreased when combined with Halofantrine.,decrease,no risk
Pirfenidone,Haloperidol,The serum concentration of Pirfenidone can be increased when it is combined with Haloperidol.,increase,no risk
Pirfenidone,Halothane,The metabolism of Pirfenidone can be decreased when combined with Halothane.,decrease,no risk
Pirfenidone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Pirfenidone.,increase,risk
Pirfenidone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Hydrocortisone acetate.,increase,risk
Pirfenidone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Hydrocortisone butyrate.,increase,risk
Pirfenidone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Hydrocortisone succinate.,increase,risk
Pirfenidone,Hydromorphone,The metabolism of Pirfenidone can be decreased when combined with Hydromorphone.,decrease,no risk
Pirfenidone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Pirfenidone.,increase,risk
Pirfenidone,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Pirfenidone.,increase,risk
Pirfenidone,Hydroxyzine,The metabolism of Pirfenidone can be decreased when combined with Hydroxyzine.,decrease,no risk
Pirfenidone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Ketamine,The metabolism of Pirfenidone can be decreased when combined with Ketamine.,decrease,no risk
Pirfenidone,Ketoconazole,The metabolism of Pirfenidone can be decreased when combined with Ketoconazole.,decrease,no risk
Pirfenidone,Ketorolac,The metabolism of Pirfenidone can be decreased when combined with Ketorolac.,decrease,no risk
Pirfenidone,Obeticholic acid,The metabolism of Pirfenidone can be decreased when combined with Obeticholic acid.,decrease,no risk
Pirfenidone,Obinutuzumab,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Obinutuzumab.,increase,risk
Pirfenidone,Ocrelizumab,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Ocrelizumab.,increase,risk
Pirfenidone,Ofatumumab,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Ofatumumab.,increase,risk
Pirfenidone,Olanzapine,The metabolism of Pirfenidone can be decreased when combined with Olanzapine.,decrease,no risk
Pirfenidone,Olaparib,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Olaparib.,increase,risk
Pirfenidone,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Omeprazole,The metabolism of Pirfenidone can be decreased when combined with Omeprazole.,decrease,no risk
Pirfenidone,Ondansetron,The metabolism of Pirfenidone can be decreased when combined with Ondansetron.,decrease,no risk
Pirfenidone,Opium,The metabolism of Opium can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Oritavancin,The metabolism of Pirfenidone can be decreased when combined with Oritavancin.,decrease,no risk
Pirfenidone,Orphenadrine,The metabolism of Pirfenidone can be decreased when combined with Orphenadrine.,decrease,no risk
Pirfenidone,Osilodrostat,The metabolism of Pirfenidone can be decreased when combined with Osilodrostat.,decrease,no risk
Pirfenidone,Osimertinib,The serum concentration of Pirfenidone can be decreased when it is combined with Osimertinib.,decrease,no risk
Pirfenidone,Ospemifene,The metabolism of Pirfenidone can be decreased when combined with Ospemifene.,decrease,no risk
Pirfenidone,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Pirfenidone.,increase,risk
Pirfenidone,Oxamniquine,The metabolism of Pirfenidone can be decreased when combined with Oxamniquine.,decrease,no risk
Pirfenidone,Oxandrolone,The metabolism of Pirfenidone can be decreased when combined with Oxandrolone.,decrease,no risk
Pirfenidone,Oxcarbazepine,The metabolism of Pirfenidone can be decreased when combined with Oxcarbazepine.,decrease,no risk
Pirfenidone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Oxetacaine.,increase,risk
Pirfenidone,Oxprenolol,The metabolism of Pirfenidone can be decreased when combined with Oxprenolol.,decrease,no risk
Pirfenidone,Oxtriphylline,The metabolism of Pirfenidone can be decreased when combined with Oxtriphylline.,decrease,no risk
Pirfenidone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pirfenidone is combined with Oxybuprocaine.,increase,risk
Pirfenidone,Oxybutynin,The metabolism of Pirfenidone can be decreased when combined with Oxybutynin.,decrease,no risk
Pirfenidone,Oxycodone,The metabolism of Pirfenidone can be decreased when combined with Oxycodone.,decrease,no risk
Pirfenidone,Oxymorphone,The metabolism of Pirfenidone can be decreased when combined with Oxymorphone.,decrease,no risk
Pirfenidone,Ozanimod,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Ozanimod.,increase,risk
Pirfenidone,Quetiapine,The metabolism of Pirfenidone can be decreased when combined with Quetiapine.,decrease,no risk
Pirfenidone,Quinidine,The metabolism of Pirfenidone can be decreased when combined with Quinidine.,decrease,no risk
Pirfenidone,Quinine,The metabolism of Pirfenidone can be decreased when combined with Quinine.,decrease,no risk
Pirfenidone,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Pirfenidone.,increase,risk
Pirfenidone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Upadacitinib,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Upadacitinib.,increase,risk
Pirfenidone,Vadadustat,The metabolism of Pirfenidone can be decreased when combined with Vadadustat.,decrease,no risk
Pirfenidone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Valdecoxib,The metabolism of Pirfenidone can be decreased when combined with Valdecoxib.,decrease,no risk
Pirfenidone,Valproic acid,The metabolism of Pirfenidone can be decreased when combined with Valproic acid.,decrease,no risk
Pirfenidone,Valsartan,The metabolism of Pirfenidone can be decreased when combined with Valsartan.,decrease,no risk
Pirfenidone,Vardenafil,The metabolism of Pirfenidone can be decreased when combined with Vardenafil.,decrease,no risk
Pirfenidone,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Pirfenidone.,increase,risk
Pirfenidone,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Vayarin,The metabolism of Pirfenidone can be decreased when combined with Vayarin.,decrease,no risk
Pirfenidone,Vedolizumab,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Vedolizumab.,increase,risk
Pirfenidone,Vemurafenib,The serum concentration of Pirfenidone can be increased when it is combined with Vemurafenib.,increase,no risk
Pirfenidone,Venlafaxine,The metabolism of Pirfenidone can be decreased when combined with Venlafaxine.,decrease,no risk
Pirfenidone,Verapamil,The metabolism of Pirfenidone can be decreased when combined with Verapamil.,decrease,no risk
Pirfenidone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pirfenidone.,decrease,no risk
Pirfenidone,Vilanterol,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Vilanterol.,increase,risk
Pirfenidone,Vilazodone,The metabolism of Pirfenidone can be decreased when combined with Vilazodone.,decrease,no risk
Pirfenidone,Viloxazine,The metabolism of Pirfenidone can be decreased when combined with Viloxazine.,decrease,no risk
Pirfenidone,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Pirfenidone.,increase,risk
Pirfenidone,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Pirfenidone.,increase,risk
Pirfenidone,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Pirfenidone.,increase,risk
Pirfenidone,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pirfenidone.,increase,risk
Pirfenidone,Voclosporin,The risk or severity of adverse effects can be increased when Pirfenidone is combined with Voclosporin.,increase,risk
Pirfenidone,Vonoprazan,The metabolism of Pirfenidone can be decreased when combined with Vonoprazan.,decrease,no risk
Pirfenidone,Voriconazole,The metabolism of Pirfenidone can be decreased when combined with Voriconazole.,decrease,no risk
Pirfenidone,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Pirfenidone.,increase,risk
Pirfenidone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Warfarin,The metabolism of Pirfenidone can be decreased when combined with Warfarin.,decrease,no risk
Pirfenidone,Ximelagatran,The metabolism of Pirfenidone can be decreased when combined with Ximelagatran.,decrease,no risk
Pirfenidone,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Pirfenidone.,increase,risk
Pirfenidone,Yohimbine,The metabolism of Pirfenidone can be decreased when combined with Yohimbine.,decrease,no risk
Pirfenidone,Zafirlukast,The metabolism of Pirfenidone can be decreased when combined with Zafirlukast.,decrease,no risk
Pirfenidone,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Pirfenidone.,increase,risk
Pirfenidone,Zileuton,The metabolism of Pirfenidone can be decreased when combined with Zileuton.,decrease,no risk
Pirfenidone,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Zolpidem,The metabolism of Pirfenidone can be decreased when combined with Zolpidem.,decrease,no risk
Pirfenidone,Zonisamide,The metabolism of Pirfenidone can be decreased when combined with Zonisamide.,decrease,no risk
Pirfenidone,Zopiclone,The metabolism of Pirfenidone can be decreased when combined with Zopiclone.,decrease,no risk
Pirfenidone,Zotepine,The metabolism of Zotepine can be decreased when combined with Pirfenidone.,decrease,no risk
Pirfenidone,Zucapsaicin,The metabolism of Pirfenidone can be decreased when combined with Zucapsaicin.,decrease,no risk
Pirfenidone,Zuclopenthixol,The metabolism of Pirfenidone can be decreased when combined with Zuclopenthixol.,decrease,no risk
Ramoplanin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Ramoplanin.,decrease,no risk
Ramoplanin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Benzocaine.,increase,risk
Ramoplanin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Benzyl alcohol.,increase,risk
Ramoplanin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Bupivacaine.,increase,risk
Ramoplanin,Butacaine,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Butacaine.,increase,risk
Ramoplanin,Butamben,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Butamben.,increase,risk
Ramoplanin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Oxetacaine.,increase,risk
Ramoplanin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ramoplanin is combined with Oxybuprocaine.,increase,risk
Ramoplanin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ramoplanin.,decrease,no risk
Ramoplanin,Warfarin,The risk or severity of bleeding can be increased when Ramoplanin is combined with Warfarin.,increase,risk
Ezogabine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Benzyl alcohol.,increase,risk
Ezogabine,Bepotastine,Bepotastine may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Bepridil,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Bepridil.,increase,risk
Ezogabine,Berotralstat,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Berotralstat.,increase,risk
Ezogabine,Bicisate,Ezogabine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ezogabine,Bilastine,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Bilastine.,increase,risk
Ezogabine,Bismuth subgallate,Ezogabine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ezogabine,Bisoprolol,Bisoprolol may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Bisoxatin,Ezogabine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ezogabine,Bleomycin,Bleomycin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Borage oil,The therapeutic efficacy of Ezogabine can be decreased when used in combination with Borage oil.,decrease,no risk
Ezogabine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Ezogabine.,increase,risk
Ezogabine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Ezogabine.,increase,risk
Ezogabine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Ezogabine.,increase,risk
Ezogabine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Ezogabine.,increase,risk
Ezogabine,Brexanolone,The risk or severity of CNS depression can be increased when Ezogabine is combined with Brexanolone.,increase,risk
Ezogabine,Brexpiprazole,The risk or severity of CNS depression can be increased when Ezogabine is combined with Brexpiprazole.,increase,risk
Ezogabine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Ezogabine.,increase,no risk
Ezogabine,Brivaracetam,The risk or severity of CNS depression can be increased when Ezogabine is combined with Brivaracetam.,increase,risk
Ezogabine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Ezogabine.,increase,risk
Ezogabine,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Ezogabine.,increase,risk
Ezogabine,Bromotheophylline,Ezogabine may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezogabine,Bromperidol,The risk or severity of CNS depression can be increased when Ezogabine is combined with Bromperidol.,increase,risk
Ezogabine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Ezogabine.,increase,risk
Ezogabine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ezogabine.,increase,risk
Ezogabine,Budesonide,Budesonide may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Bumadizone,Bumadizone may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Bumetanide,Bumetanide may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezogabine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Bupivacaine.,increase,risk
Ezogabine,Buprenorphine,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Ezogabine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Ezogabine.,increase,risk
Ezogabine,Buserelin,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Buserelin.,increase,risk
Ezogabine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Ezogabine.,increase,risk
Ezogabine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Ezogabine.,increase,risk
Ezogabine,Butacaine,The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Butacaine.,increase,risk
Ezogabine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Ezogabine.,increase,risk
Ezogabine,Butamben,The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Butamben.,increase,risk
Ezogabine,Butaperazine,The risk or severity of CNS depression can be increased when Ezogabine is combined with Butaperazine.,increase,risk
Ezogabine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Ezogabine.,increase,risk
Ezogabine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Ezogabine.,increase,risk
Ezogabine,Butriptyline,The risk or severity of CNS depression can be increased when Ezogabine is combined with Butriptyline.,increase,risk
Ezogabine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ezogabine.,increase,risk
Ezogabine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ezogabine is combined with Gabapentin enacarbil.,increase,risk
Ezogabine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Gadobenic acid.,increase,risk
Ezogabine,Gadodiamide,Gadodiamide may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Gadofosveset trisodium,Ezogabine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ezogabine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Gadoteric acid,Ezogabine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ezogabine,Gadoteridol,Gadoteridol may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Ezogabine.,increase,risk
Ezogabine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ezogabine.,increase,risk
Ezogabine,Gamolenic acid,The therapeutic efficacy of Ezogabine can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Ezogabine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ezogabine is combined with Ganaxolone.",increase,risk
Ezogabine,Ganciclovir,The therapeutic efficacy of Ezogabine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ezogabine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Ezogabine.,increase,risk
Ezogabine,Gemcitabine,Gemcitabine may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Gemfibrozil,The metabolism of Ezogabine can be decreased when combined with Gemfibrozil.,decrease,no risk
Ezogabine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Gemifloxacin.,increase,risk
Ezogabine,Gentamicin,Ezogabine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ezogabine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Ezogabine.,increase,risk
Ezogabine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Ezogabine.,increase,no risk
Ezogabine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Gilteritinib.,increase,risk
Ezogabine,Gimeracil,Ezogabine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ezogabine,Givosiran,Givosiran may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Glasdegib,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Glasdegib.,increase,risk
Ezogabine,Glecaprevir,The metabolism of Ezogabine can be decreased when combined with Glecaprevir.,decrease,no risk
Ezogabine,Glipizide,Glipizide may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Ezogabine.,increase,risk
Ezogabine,Glycerol phenylbutyrate,Ezogabine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ezogabine,Golodirsen,Ezogabine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ezogabine,Goserelin,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Goserelin.,increase,risk
Ezogabine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ezogabine.,increase,risk
Ezogabine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Grepafloxacin.,increase,risk
Ezogabine,Guanethidine,Guanethidine may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ezogabine.,increase,risk
Ezogabine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ezogabine.,increase,risk
Ezogabine,Halofantrine,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Halofantrine.,increase,risk
Ezogabine,Haloperidol,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Haloperidol.,increase,risk
Ezogabine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ezogabine.,increase,risk
Ezogabine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ezogabine.,increase,risk
Ezogabine,Histrelin,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Histrelin.,increase,risk
Ezogabine,Hydralazine,Hydralazine may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezogabine,Hydrocodone,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ezogabine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezogabine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ezogabine.,increase,risk
Ezogabine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Hydroxychloroquine,The therapeutic efficacy of Ezogabine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Ezogabine,Hydroxyethyl Starch,Ezogabine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ezogabine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Ezogabine.,increase,no risk
Ezogabine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Hydroxyzine.,increase,risk
Ezogabine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Ezogabine.,increase,risk
Ezogabine,Kanamycin,Ezogabine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ezogabine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Ezogabine.,increase,risk
Ezogabine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Ezogabine.,increase,risk
Ezogabine,Ketoconazole,The metabolism of Ezogabine can be decreased when combined with Ketoconazole.,decrease,no risk
Ezogabine,Ketoprofen,Ketoprofen may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Ketorolac,Ketorolac may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Octinoxate,Ezogabine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ezogabine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Ezogabine.,increase,risk
Ezogabine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Ofloxacin.,increase,risk
Ezogabine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Ezogabine.,increase,risk
Ezogabine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ezogabine is combined with Oliceridine.",increase,risk
Ezogabine,Olodaterol,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Olodaterol.,increase,risk
Ezogabine,Olsalazine,Olsalazine may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Ombitasvir,The metabolism of Ezogabine can be decreased when combined with Ombitasvir.,decrease,no risk
Ezogabine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ezogabine.,increase,risk
Ezogabine,Opium,The risk or severity of CNS depression can be increased when Ezogabine is combined with Opium.,increase,risk
Ezogabine,Orlistat,Orlistat can cause a decrease in the absorption of Ezogabine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ezogabine,Orphenadrine,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ezogabine,Oseltamivir,Oseltamivir may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Oxacillin,Oxacillin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Ezogabine.,increase,risk
Ezogabine,Oxaprozin,Oxaprozin may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Oxatomide,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Oxatomide.,increase,risk
Ezogabine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ezogabine.,increase,risk
Ezogabine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ezogabine.,increase,risk
Ezogabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Oxetacaine.,increase,risk
Ezogabine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Ezogabine.,increase,risk
Ezogabine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Ezogabine.,increase,risk
Ezogabine,Oxtriphylline,Ezogabine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezogabine,Oxybenzone,Oxybenzone may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ezogabine is combined with Oxybuprocaine.,increase,risk
Ezogabine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ezogabine.,increase,risk
Ezogabine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Ezogabine.,increase,risk
Ezogabine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Oxyquinoline,Ezogabine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ezogabine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Ezogabine.,increase,risk
Ezogabine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Ezogabine.,increase,risk
Ezogabine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Ezogabine.,increase,risk
Ezogabine,Quinethazone,Quinethazone may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ezogabine,Quinidine,Ezogabine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ezogabine,Quinine,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Quinine.,increase,risk
Ezogabine,Quinupramine,The risk or severity of CNS depression can be increased when Ezogabine is combined with Quinupramine.,increase,risk
Ezogabine,Quizartinib,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Quizartinib.,increase,risk
Ezogabine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Ezogabine.,increase,no risk
Ezogabine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Ezogabine.,increase,risk
Ezogabine,Vaborbactam,Ezogabine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ezogabine,Valaciclovir,Valaciclovir may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Valbenazine,Ezogabine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ezogabine,Valdecoxib,Valdecoxib may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Valganciclovir,The therapeutic efficacy of Ezogabine can be decreased when used in combination with Valganciclovir.,decrease,no risk
Ezogabine,Valproic acid,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Valproic acid.,increase,risk
Ezogabine,Vancomycin,Ezogabine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ezogabine,Vandetanib,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Vandetanib.,increase,risk
Ezogabine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Ezogabine.,increase,risk
Ezogabine,Varenicline,Varenicline may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Ezogabine.,increase,risk
Ezogabine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ezogabine.,increase,risk
Ezogabine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ezogabine.,increase,risk
Ezogabine,Verapamil,Verapamil may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Vernakalant,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Vernakalant.,increase,risk
Ezogabine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Ezogabine.,increase,risk
Ezogabine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Ezogabine.,increase,risk
Ezogabine,Vilazodone,The risk or severity of CNS depression can be increased when Ezogabine is combined with Vilazodone.,increase,risk
Ezogabine,Viloxazine,The risk or severity of CNS depression can be increased when Ezogabine is combined with Viloxazine.,increase,risk
Ezogabine,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Ezogabine.,increase,risk
Ezogabine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Ezogabine.,increase,risk
Ezogabine,Vortioxetine,The risk or severity of CNS depression can be increased when Ezogabine is combined with Vortioxetine.,increase,risk
Ezogabine,Warfarin,Ezogabine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ezogabine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Ezogabine.,increase,risk
Ezogabine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ezogabine.,increase,risk
Ezogabine,Zanamivir,Zanamivir may decrease the excretion rate of Ezogabine which could result in a higher serum level.,decrease,no risk
Ezogabine,Ziconotide,The risk or severity of CNS depression can be increased when Ezogabine is combined with Ziconotide.,increase,risk
Ezogabine,Zidovudine,The metabolism of Ezogabine can be increased when combined with Zidovudine.,increase,no risk
Ezogabine,Zimelidine,The risk or severity of adverse effects can be increased when Ezogabine is combined with Zimelidine.,increase,risk
Ezogabine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Ziprasidone.,increase,risk
Ezogabine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ezogabine.,increase,risk
Ezogabine,Zolpidem,Ezogabine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ezogabine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ezogabine.,increase,risk
Ezogabine,Zopiclone,The risk or severity of adverse effects can be increased when Ezogabine is combined with Zopiclone.,increase,risk
Ezogabine,Zotepine,The risk or severity of CNS depression can be increased when Ezogabine is combined with Zotepine.,increase,risk
Ezogabine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Zuclopenthixol.,increase,risk
Ezogabine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ezogabine.,increase,risk
Afelimomab,Bepridil,The metabolism of Bepridil can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Besilesomab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Besilesomab.,increase,risk
Afelimomab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Afelimomab.,increase,risk
Afelimomab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Afelimomab.,increase,risk
Afelimomab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Bezlotoxumab.,increase,risk
Afelimomab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bimekizumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Bimekizumab.,increase,risk
Afelimomab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Afelimomab.,increase,risk
Afelimomab,Blinatumomab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Blinatumomab.,increase,risk
Afelimomab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Afelimomab.",decrease,no risk
Afelimomab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bosentan,The metabolism of Bosentan can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Brodalumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Brodalumab.,increase,risk
Afelimomab,Brolucizumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Brolucizumab.,increase,risk
Afelimomab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Afelimomab.,increase,risk
Afelimomab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Bupropion,The metabolism of Bupropion can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Burosumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Burosumab.,increase,risk
Afelimomab,Buspirone,The metabolism of Buspirone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Busulfan,The metabolism of Busulfan can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Galantamine,The metabolism of Galantamine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Galcanezumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Galcanezumab.,increase,risk
Afelimomab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Afelimomab.,increase,risk
Afelimomab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Afelimomab.,increase,risk
Afelimomab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Glatiramer,The risk or severity of adverse effects can be increased when Afelimomab is combined with Glatiramer.,increase,risk
Afelimomab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Glipizide,The metabolism of Glipizide can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Glofitamab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Glofitamab.,increase,risk
Afelimomab,Glyburide,The metabolism of Glyburide can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Golimumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Golimumab.,increase,risk
Afelimomab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Guselkumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Guselkumab.,increase,risk
Afelimomab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Halothane,The metabolism of Halothane can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Afelimomab is combined with Hepatitis B immune globulin.,increase,risk
Afelimomab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Afelimomab.,increase,risk
Afelimomab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Afelimomab is combined with Human cytomegalovirus immune globulin.,increase,risk
Afelimomab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Afelimomab.,increase,risk
Afelimomab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Afelimomab is combined with Human Rho(D) immune globulin.,increase,risk
Afelimomab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Afelimomab is combined with Human varicella-zoster immune globulin.,increase,risk
Afelimomab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Afelimomab is combined with Hydrocortisone succinate.,increase,risk
Afelimomab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Afelimomab.,increase,risk
Afelimomab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Ketamine,The metabolism of Ketamine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Obiltoxaximab.,increase,risk
Afelimomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Obinutuzumab.,increase,risk
Afelimomab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Afelimomab.,increase,no risk
Afelimomab,Odesivimab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Odesivimab.,increase,risk
Afelimomab,Ofatumumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Ofatumumab.,increase,risk
Afelimomab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Olaparib,The metabolism of Olaparib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Olaratumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Olaratumab.,increase,risk
Afelimomab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Afelimomab.,increase,risk
Afelimomab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Opium,The metabolism of Opium can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Afelimomab.,increase,risk
Afelimomab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ozanimod,The risk or severity of adverse effects can be increased when Afelimomab is combined with Ozanimod.,increase,risk
Afelimomab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Afelimomab.,increase,no risk
Afelimomab,Quinidine,The metabolism of Quinidine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Quinine,The metabolism of Quinine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Afelimomab.,increase,risk
Afelimomab,Udenafil,The metabolism of Udenafil can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Upadacitinib,The risk or severity of adverse effects can be increased when Afelimomab is combined with Upadacitinib.,increase,risk
Afelimomab,Ustekinumab,The risk or severity of adverse effects can be increased when Afelimomab is combined with Ustekinumab.,increase,risk
Afelimomab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Valsartan,The metabolism of Valsartan can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Afelimomab.,increase,risk
Afelimomab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Vedolizumab,The risk or severity of infection can be increased when Afelimomab is combined with Vedolizumab.,increase,risk
Afelimomab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Verapamil,The metabolism of Verapamil can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Afelimomab.,decrease,no risk
Afelimomab,Vilanterol,The risk or severity of adverse effects can be increased when Afelimomab is combined with Vilanterol.,increase,risk
Afelimomab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vincristine,The metabolism of Vincristine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vindesine,The metabolism of Vindesine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Voclosporin,The risk or severity of adverse effects can be increased when Afelimomab is combined with Voclosporin.,increase,risk
Afelimomab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Afelimomab.,increase,risk
Afelimomab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Warfarin,The metabolism of Warfarin can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Afelimomab.,increase,risk
Afelimomab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zileuton,The metabolism of Zileuton can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zotepine,The metabolism of Zotepine can be increased when combined with Afelimomab.,increase,no risk
Afelimomab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Afelimomab.,increase,no risk
Azimilide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Azimilide.,increase,risk
Azimilide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Azimilide.,increase,risk
Azimilide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Azimilide.,increase,risk
Azimilide,Gefitinib,The metabolism of Azimilide can be decreased when combined with Gefitinib.,decrease,no risk
Azimilide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Azimilide.,increase,risk
Azimilide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Azimilide.,increase,risk
Azimilide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Gilteritinib.,increase,risk
Azimilide,Glasdegib,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Glasdegib.,increase,risk
Azimilide,Glofitamab,The serum concentration of Azimilide can be increased when it is combined with Glofitamab.,increase,no risk
Azimilide,Glyburide,The metabolism of Azimilide can be decreased when combined with Glyburide.,decrease,no risk
Azimilide,Golimumab,The metabolism of Azimilide can be increased when combined with Golimumab.,increase,no risk
Azimilide,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Azimilide.,increase,risk
Azimilide,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Azimilide.,increase,risk
Azimilide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Grepafloxacin.,increase,risk
Azimilide,Halofantrine,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Halofantrine.,increase,risk
Azimilide,Haloperidol,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Haloperidol.,increase,risk
Azimilide,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Azimilide.,increase,risk
Azimilide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Azimilide.,increase,risk
Azimilide,Hydrocortisone,The metabolism of Azimilide can be decreased when combined with Hydrocortisone.,decrease,no risk
Azimilide,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Azimilide.,decrease,no risk
Azimilide,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Azimilide.,decrease,no risk
Azimilide,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Azimilide.,decrease,no risk
Azimilide,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Azimilide.,decrease,no risk
Azimilide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Azimilide.,increase,risk
Azimilide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Azimilide.,decrease,no risk
Azimilide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Hydroxyzine.,increase,risk
Azimilide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Azimilide.,increase,no risk
Azimilide,Ketoconazole,The metabolism of Azimilide can be decreased when combined with Ketoconazole.,decrease,no risk
Azimilide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Azimilide.,increase,risk
Azimilide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Azimilide.,increase,risk
Azimilide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Azimilide.,increase,risk
Azimilide,Olaparib,The metabolism of Olaparib can be decreased when combined with Azimilide.,decrease,no risk
Azimilide,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Azimilide.,increase,risk
Azimilide,Omaveloxolone,The serum concentration of Azimilide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Azimilide,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Azimilide.,increase,risk
Azimilide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Azimilide.,increase,risk
Azimilide,Osilodrostat,The metabolism of Azimilide can be decreased when combined with Osilodrostat.,decrease,no risk
Azimilide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Azimilide.,increase,risk
Azimilide,Oxatomide,The risk or severity of QTc prolongation can be increased when Azimilide is combined with Oxatomide.,increase,risk
Azimilide,Oxcarbazepine,The metabolism of Azimilide can be increased when combined with Oxcarbazepine.,increase,no risk
Azimilide,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Azimilide.,increase,no risk
Azimilide,Oxybutynin,The metabolism of Azimilide can be decreased when combined with Oxybutynin.,decrease,no risk
Azimilide,Oxycodone,The metabolism of Azimilide can be decreased when combined with Oxycodone.,decrease,no risk
Azimilide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Azimilide.,increase,risk
Epratuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Epratuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Obiltoxaximab.,increase,risk
Epratuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Obinutuzumab.,increase,risk
Epratuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Ocrelizumab.,increase,risk
Epratuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Odesivimab.,increase,risk
Epratuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Ofatumumab.,increase,risk
Epratuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Olaratumab.,increase,risk
Epratuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Epratuzumab.,increase,risk
Epratuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Epratuzumab is combined with Oxetacaine.,increase,risk
Epratuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Epratuzumab is combined with Oxybuprocaine.,increase,risk
Epratuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Epratuzumab.,increase,no risk
Epratuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Ublituximab.,increase,risk
Epratuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Ustekinumab.,increase,risk
Epratuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Epratuzumab is combined with Vedolizumab.,increase,risk
Tipifarnib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Benzocaine.,increase,risk
Tipifarnib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Benzyl alcohol.,increase,risk
Tipifarnib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Bupivacaine.,increase,risk
Tipifarnib,Butacaine,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Butacaine.,increase,risk
Tipifarnib,Butamben,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Butamben.,increase,risk
Tipifarnib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Oxetacaine.,increase,risk
Tipifarnib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tipifarnib is combined with Oxybuprocaine.,increase,risk
Troxacitabine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Benzocaine.,increase,risk
Troxacitabine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Benzyl alcohol.,increase,risk
Troxacitabine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Bupivacaine.,increase,risk
Troxacitabine,Butacaine,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Butacaine.,increase,risk
Troxacitabine,Butamben,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Butamben.,increase,risk
Troxacitabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Oxetacaine.,increase,risk
Troxacitabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Troxacitabine is combined with Oxybuprocaine.,increase,risk
Bectumomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Obiltoxaximab.,increase,risk
Bectumomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Obinutuzumab.,increase,risk
Bectumomab,Ocrelizumab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Ocrelizumab.,increase,risk
Bectumomab,Odesivimab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Odesivimab.,increase,risk
Bectumomab,Ofatumumab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Ofatumumab.,increase,risk
Bectumomab,Olaratumab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Olaratumab.,increase,risk
Bectumomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bectumomab.,increase,risk
Bectumomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Bectumomab.,increase,no risk
Bectumomab,Ublituximab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Ublituximab.,increase,risk
Bectumomab,Ustekinumab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Ustekinumab.,increase,risk
Bectumomab,Vedolizumab,The risk or severity of adverse effects can be increased when Bectumomab is combined with Vedolizumab.,increase,risk
Oregovomab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Oregovomab is combined with Human varicella-zoster immune globulin.,increase,risk
Oregovomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Obiltoxaximab.,increase,risk
Oregovomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Obinutuzumab.,increase,risk
Oregovomab,Ocrelizumab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Ocrelizumab.,increase,risk
Oregovomab,Odesivimab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Odesivimab.,increase,risk
Oregovomab,Ofatumumab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Ofatumumab.,increase,risk
Oregovomab,Olaratumab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Olaratumab.,increase,risk
Oregovomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Oregovomab.,increase,risk
Oregovomab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Oregovomab is combined with Oxetacaine.,increase,risk
Oregovomab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oregovomab is combined with Oxybuprocaine.,increase,risk
Oregovomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Oregovomab.,increase,no risk
Oregovomab,Ublituximab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Ublituximab.,increase,risk
Oregovomab,Ustekinumab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Ustekinumab.,increase,risk
Oregovomab,Vedolizumab,The risk or severity of adverse effects can be increased when Oregovomab is combined with Vedolizumab.,increase,risk
Banoxantrone,Glofitamab,The serum concentration of Banoxantrone can be increased when it is combined with Glofitamab.,increase,no risk
Banoxantrone,Golimumab,The metabolism of Banoxantrone can be increased when combined with Golimumab.,increase,no risk
Banoxantrone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Banoxantrone.,increase,no risk
Banoxantrone,Halothane,The metabolism of Banoxantrone can be decreased when combined with Halothane.,decrease,no risk
Banoxantrone,Hydrocodone,The metabolism of Banoxantrone can be decreased when combined with Hydrocodone.,decrease,no risk
Banoxantrone,Hydrocortisone,The metabolism of Banoxantrone can be increased when combined with Hydrocortisone.,increase,no risk
Banoxantrone,Ketamine,The metabolism of Banoxantrone can be decreased when combined with Ketamine.,decrease,no risk
Banoxantrone,Ketoconazole,The metabolism of Banoxantrone can be decreased when combined with Ketoconazole.,decrease,no risk
Banoxantrone,Omaveloxolone,The serum concentration of Banoxantrone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Banoxantrone,Orphenadrine,The metabolism of Banoxantrone can be decreased when combined with Orphenadrine.,decrease,no risk
Banoxantrone,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Banoxantrone.,decrease,no risk
Banoxantrone,Ospemifene,The metabolism of Banoxantrone can be decreased when combined with Ospemifene.,decrease,no risk
Banoxantrone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Banoxantrone is combined with Oxetacaine.,increase,risk
Banoxantrone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Banoxantrone is combined with Oxybuprocaine.,increase,risk
Banoxantrone,Vadadustat,The serum concentration of Banoxantrone can be decreased when it is combined with Vadadustat.,decrease,no risk
Banoxantrone,Valproic acid,The metabolism of Banoxantrone can be decreased when combined with Valproic acid.,decrease,no risk
Banoxantrone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Banoxantrone.,decrease,no risk
Banoxantrone,Venetoclax,The metabolism of Banoxantrone can be decreased when combined with Venetoclax.,decrease,no risk
Banoxantrone,Verapamil,The metabolism of Banoxantrone can be decreased when combined with Verapamil.,decrease,no risk
Banoxantrone,Viloxazine,The metabolism of Banoxantrone can be decreased when combined with Viloxazine.,decrease,no risk
Banoxantrone,Voriconazole,The metabolism of Banoxantrone can be decreased when combined with Voriconazole.,decrease,no risk
Banoxantrone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Banoxantrone.,decrease,no risk
Banoxantrone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Banoxantrone.,decrease,no risk
Banoxantrone,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Banoxantrone.,decrease,no risk
Banoxantrone,Zimelidine,The metabolism of Banoxantrone can be decreased when combined with Zimelidine.,decrease,no risk
Banoxantrone,Ziprasidone,The metabolism of Banoxantrone can be decreased when combined with Ziprasidone.,decrease,no risk
Plitidepsin,Valproic acid,The metabolism of Plitidepsin can be decreased when combined with Valproic acid.,decrease,no risk
Plitidepsin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Plitidepsin.,decrease,no risk
Plitidepsin,Zidovudine,The metabolism of Plitidepsin can be decreased when combined with Zidovudine.,decrease,no risk
IGN311,Obiltoxaximab,The risk or severity of adverse effects can be increased when IGN311 is combined with Obiltoxaximab.,increase,risk
IGN311,Obinutuzumab,The risk or severity of adverse effects can be increased when IGN311 is combined with Obinutuzumab.,increase,risk
IGN311,Ocrelizumab,The risk or severity of adverse effects can be increased when IGN311 is combined with Ocrelizumab.,increase,risk
IGN311,Odesivimab,The risk or severity of adverse effects can be increased when IGN311 is combined with Odesivimab.,increase,risk
IGN311,Ofatumumab,The risk or severity of adverse effects can be increased when IGN311 is combined with Ofatumumab.,increase,risk
IGN311,Olaratumab,The risk or severity of adverse effects can be increased when IGN311 is combined with Olaratumab.,increase,risk
IGN311,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with IGN311.,increase,risk
IGN311,Quinestrol,Quinestrol may increase the thrombogenic activities of IGN311.,increase,no risk
IGN311,Ublituximab,The risk or severity of adverse effects can be increased when IGN311 is combined with Ublituximab.,increase,risk
IGN311,Ustekinumab,The risk or severity of adverse effects can be increased when IGN311 is combined with Ustekinumab.,increase,risk
IGN311,Vedolizumab,The risk or severity of adverse effects can be increased when IGN311 is combined with Vedolizumab.,increase,risk
Satraplatin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Benzocaine.,increase,risk
Satraplatin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Benzyl alcohol.,increase,risk
Satraplatin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Bupivacaine.,increase,risk
Satraplatin,Butacaine,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Butacaine.,increase,risk
Satraplatin,Butamben,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Butamben.,increase,risk
Satraplatin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Oxetacaine.,increase,risk
Satraplatin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Satraplatin is combined with Oxybuprocaine.,increase,risk
Adecatumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Obiltoxaximab.,increase,risk
Adecatumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Obinutuzumab.,increase,risk
Adecatumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Ocrelizumab.,increase,risk
Adecatumumab,Odesivimab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Odesivimab.,increase,risk
Adecatumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Ofatumumab.,increase,risk
Adecatumumab,Olaratumab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Olaratumab.,increase,risk
Adecatumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adecatumumab.,increase,risk
Adecatumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Adecatumumab.,increase,no risk
Adecatumumab,Ublituximab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Ublituximab.,increase,risk
Adecatumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Ustekinumab.,increase,risk
Adecatumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Adecatumumab is combined with Vedolizumab.,increase,risk
Tesevatinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Benzocaine.,increase,risk
Tesevatinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Benzyl alcohol.,increase,risk
Tesevatinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Bupivacaine.,increase,risk
Tesevatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Butacaine.,increase,risk
Tesevatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Butamben.,increase,risk
Tesevatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Oxetacaine.,increase,risk
Tesevatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tesevatinib is combined with Oxybuprocaine.,increase,risk
Tesevatinib,Voriconazole,The serum concentration of Tesevatinib can be increased when it is combined with Voriconazole.,increase,no risk
Belinostat,Butamben,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Butamben.,increase,risk
Belinostat,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Belinostat.,increase,risk
Belinostat,Gemfibrozil,The metabolism of Belinostat can be decreased when combined with Gemfibrozil.,decrease,no risk
Belinostat,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belinostat.,increase,risk
Belinostat,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Belinostat.,increase,no risk
Belinostat,Glasdegib,The serum concentration of Belinostat can be increased when it is combined with Glasdegib.,increase,no risk
Belinostat,Glatiramer,The risk or severity of adverse effects can be increased when Belinostat is combined with Glatiramer.,increase,risk
Belinostat,Glecaprevir,The metabolism of Belinostat can be decreased when combined with Glecaprevir.,decrease,no risk
Belinostat,Golimumab,The risk or severity of adverse effects can be increased when Belinostat is combined with Golimumab.,increase,risk
Belinostat,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Belinostat.,increase,no risk
Belinostat,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Belinostat.,increase,no risk
Belinostat,Guanabenz,The metabolism of Guanabenz can be increased when combined with Belinostat.,increase,no risk
Belinostat,Guselkumab,The risk or severity of adverse effects can be increased when Belinostat is combined with Guselkumab.,increase,risk
Belinostat,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Belinostat.,decrease,no risk
Belinostat,Haloperidol,The metabolism of Haloperidol can be increased when combined with Belinostat.,increase,no risk
Belinostat,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Belinostat.,increase,risk
Belinostat,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Belinostat.,decrease,no risk
Belinostat,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Belinostat.,decrease,no risk
Belinostat,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Belinostat.,increase,risk
Belinostat,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Belinostat.,increase,risk
Belinostat,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Belinostat is combined with Hydrocortisone acetate.,increase,risk
Belinostat,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Belinostat is combined with Hydrocortisone butyrate.,increase,risk
Belinostat,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Belinostat is combined with Hydrocortisone succinate.,increase,risk
Belinostat,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Belinostat.,increase,risk
Belinostat,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Belinostat.,increase,risk
Belinostat,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Belinostat.,increase,risk
Belinostat,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Belinostat.,decrease,no risk
Belinostat,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Belinostat.,decrease,no risk
Belinostat,Ketoconazole,The metabolism of Belinostat can be decreased when combined with Ketoconazole.,decrease,no risk
Belinostat,Obinutuzumab,The risk or severity of adverse effects can be increased when Belinostat is combined with Obinutuzumab.,increase,risk
Belinostat,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Belinostat.,increase,no risk
Belinostat,Ofatumumab,The risk or severity of adverse effects can be increased when Belinostat is combined with Ofatumumab.,increase,risk
Belinostat,Olanzapine,The metabolism of Olanzapine can be increased when combined with Belinostat.,increase,no risk
Belinostat,Olaparib,The risk or severity of adverse effects can be increased when Belinostat is combined with Olaparib.,increase,risk
Belinostat,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Belinostat.,increase,no risk
Belinostat,Ombitasvir,The metabolism of Belinostat can be decreased when combined with Ombitasvir.,decrease,no risk
Belinostat,Ondansetron,The metabolism of Ondansetron can be increased when combined with Belinostat.,increase,no risk
Belinostat,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Belinostat.,increase,no risk
Belinostat,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Belinostat.,increase,risk
Belinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Oxetacaine.,increase,risk
Belinostat,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Belinostat.,increase,no risk
Belinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Belinostat is combined with Oxybuprocaine.,increase,risk
Belinostat,Ozanimod,The risk or severity of adverse effects can be increased when Belinostat is combined with Ozanimod.,increase,risk
Belinostat,Quinidine,The serum concentration of Belinostat can be increased when it is combined with Quinidine.,increase,no risk
Belinostat,Quinine,The serum concentration of Belinostat can be increased when it is combined with Quinine.,increase,no risk
Belinostat,Quizartinib,The metabolism of Belinostat can be decreased when combined with Quizartinib.,decrease,no risk
Ataluren,Valsartan,The excretion of Valsartan can be decreased when combined with Ataluren.,decrease,no risk
Ataluren,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Ataluren.,decrease,no risk
Ataluren,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Ataluren.,decrease,no risk
Ataluren,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Ataluren.,increase,no risk
Ataluren,Zidovudine,The excretion of Zidovudine can be decreased when combined with Ataluren.,decrease,no risk
Migalastat,Gabapentin enacarbil,Migalastat may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Migalastat,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Gadodiamide,Gadodiamide may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Gadofosveset trisodium,Migalastat may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Migalastat,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Gadoteric acid,Migalastat may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Migalastat,Gadoteridol,Gadoteridol may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Ganciclovir,Ganciclovir may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Gemcitabine,Gemcitabine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Gemfibrozil,The metabolism of Migalastat can be decreased when combined with Gemfibrozil.,decrease,no risk
Migalastat,Gentamicin,Migalastat may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Migalastat,Gimeracil,Migalastat may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Migalastat,Givosiran,Givosiran may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Glecaprevir,The metabolism of Migalastat can be decreased when combined with Glecaprevir.,decrease,no risk
Migalastat,Glipizide,Glipizide may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Glycerol phenylbutyrate,Migalastat may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Migalastat,Golodirsen,Migalastat may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Migalastat,Goserelin,Goserelin may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Guanethidine,Guanethidine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Guanfacine,Guanfacine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Haloperidol,Haloperidol may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Hydralazine,Hydralazine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Migalastat,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Migalastat,Hydromorphone,Hydromorphone may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Hydroxyethyl Starch,Migalastat may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Migalastat,Kanamycin,Migalastat may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Migalastat,Ketamine,Ketamine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Ketazolam,Ketazolam may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Ketoconazole,The metabolism of Migalastat can be decreased when combined with Ketoconazole.,decrease,no risk
Migalastat,Ketoprofen,Ketoprofen may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Ketorolac,Ketorolac may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Octinoxate,Migalastat may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Migalastat,Olsalazine,Olsalazine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Ombitasvir,The metabolism of Migalastat can be decreased when combined with Ombitasvir.,decrease,no risk
Migalastat,Opium,Migalastat may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Migalastat,Oseltamivir,Oseltamivir may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Oxacillin,Oxacillin may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Oxaprozin,Oxaprozin may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Oxazepam,Oxazepam may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Oxybenzone,Oxybenzone may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Oxyquinoline,Migalastat may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Migalastat,Quetiapine,Quetiapine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Quinethazone,Quinethazone may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Migalastat,Quinidine,Migalastat may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Migalastat,Quizartinib,The metabolism of Migalastat can be decreased when combined with Quizartinib.,decrease,no risk
Migalastat,Vaborbactam,Migalastat may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Migalastat,Valaciclovir,Valaciclovir may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Valbenazine,Migalastat may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Migalastat,Valdecoxib,Valdecoxib may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Valganciclovir,Valganciclovir may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Valproic acid,The metabolism of Migalastat can be decreased when combined with Valproic acid.,decrease,no risk
Migalastat,Vancomycin,Migalastat may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Migalastat,Varenicline,Varenicline may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Venlafaxine,Venlafaxine may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Verapamil,Verapamil may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Vilanterol,Migalastat may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Migalastat,Viloxazine,Migalastat may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Migalastat,Vortioxetine,Migalastat may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Migalastat,Warfarin,Migalastat may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Migalastat,Zaleplon,Zaleplon may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Zanamivir,Zanamivir may decrease the excretion rate of Migalastat which could result in a higher serum level.,decrease,no risk
Migalastat,Zidovudine,The metabolism of Migalastat can be increased when combined with Zidovudine.,increase,no risk
Migalastat,Zonisamide,Zonisamide may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amonafide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Benzocaine.,increase,risk
Amonafide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Benzyl alcohol.,increase,risk
Amonafide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Bupivacaine.,increase,risk
Amonafide,Butacaine,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Butacaine.,increase,risk
Amonafide,Butamben,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Butamben.,increase,risk
Amonafide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Oxetacaine.,increase,risk
Amonafide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Amonafide is combined with Oxybuprocaine.,increase,risk
Foretinib,Voriconazole,The serum concentration of Foretinib can be increased when it is combined with Voriconazole.,increase,no risk
Arbaclofen Placarbil,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Arbaclofen Placarbil is combined with Ganaxolone.",increase,risk
Arbaclofen Placarbil,Gepirone,The risk or severity of CNS depression can be increased when Arbaclofen Placarbil is combined with Gepirone.,increase,risk
Arbaclofen Placarbil,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Hydrocodone,Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Arbaclofen Placarbil,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Arbaclofen Placarbil.,increase,no risk
Arbaclofen Placarbil,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Arbaclofen Placarbil is combined with Oliceridine.",increase,risk
Arbaclofen Placarbil,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Opium,The risk or severity of CNS depression can be increased when Arbaclofen Placarbil is combined with Opium.,increase,risk
Arbaclofen Placarbil,Orphenadrine,Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Arbaclofen Placarbil,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Quinupramine,The risk or severity of CNS depression can be increased when Arbaclofen Placarbil is combined with Quinupramine.,increase,risk
Arbaclofen Placarbil,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Viloxazine,The risk or severity of CNS depression can be increased when Arbaclofen Placarbil is combined with Viloxazine.,increase,risk
Arbaclofen Placarbil,Vortioxetine,The risk or severity of CNS depression can be increased when Arbaclofen Placarbil is combined with Vortioxetine.,increase,risk
Arbaclofen Placarbil,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Zimelidine,The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Zimelidine.,increase,risk
Arbaclofen Placarbil,Ziprasidone,The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Ziprasidone.,increase,risk
Arbaclofen Placarbil,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Zolpidem,Arbaclofen Placarbil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Arbaclofen Placarbil,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Zopiclone,The risk or severity of adverse effects can be increased when Arbaclofen Placarbil is combined with Zopiclone.,increase,risk
Arbaclofen Placarbil,Zotepine,The risk or severity of CNS depression can be increased when Arbaclofen Placarbil is combined with Zotepine.,increase,risk
Arbaclofen Placarbil,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Arbaclofen Placarbil.,increase,risk
Arbaclofen Placarbil,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Arbaclofen Placarbil.,increase,risk
Ularitide,Gabapentin enacarbil,Ularitide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gadobenic acid,Ularitide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gadodiamide,Ularitide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gadofosveset trisodium,Ularitide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gadopentetic acid,Ularitide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gadoteric acid,Ularitide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gadoteridol,Ularitide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Ganciclovir,Ularitide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gemcitabine,Ularitide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gemfibrozil,Ularitide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gimeracil,Ularitide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Glipizide,Ularitide may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Gluconic Acid,The risk or severity of dehydration can be increased when Ularitide is combined with Gluconic Acid.,increase,risk
Ularitide,Glycerin,The risk or severity of dehydration can be increased when Ularitide is combined with Glycerin.,increase,risk
Ularitide,Glycerol phenylbutyrate,Ularitide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Golodirsen,Ularitide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Goserelin,Ularitide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Guanethidine,Ularitide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Guanfacine,Ularitide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Haloperidol,Ularitide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Hydralazine,Ularitide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Hydrocodone,The therapeutic efficacy of Ularitide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Ularitide,Hydromorphone,Ularitide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Hydroxocobalamin,Ularitide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Hydroxyethyl Starch,Ularitide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Ketamine,Ularitide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Ketazolam,Ularitide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Ketoprofen,Ularitide may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Octinoxate,Ularitide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oliceridine,The therapeutic efficacy of Ularitide can be decreased when used in combination with Oliceridine.,decrease,no risk
Ularitide,Opium,Ularitide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oseltamivir,Ularitide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oxacillin,Ularitide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oxaprozin,Ularitide may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oxazepam,Ularitide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oxybenzone,Ularitide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Oxycodone,The therapeutic efficacy of Ularitide can be decreased when used in combination with Oxycodone.,decrease,no risk
Ularitide,Oxymorphone,The therapeutic efficacy of Ularitide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Ularitide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Ularitide is combined with Oxyphenisatin acetate.,increase,risk
Ularitide,Oxyquinoline,Ularitide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Quetiapine,Ularitide may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Quinidine,Ularitide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Vaborbactam,Ularitide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Valaciclovir,Ularitide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Valbenazine,Ularitide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Valganciclovir,Ularitide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Vancomycin,Ularitide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Varenicline,Ularitide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Venlafaxine,Ularitide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Verapamil,Ularitide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Vilanterol,Ularitide may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Viloxazine,Ularitide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Vortioxetine,Ularitide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Warfarin,Ularitide may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Zaleplon,Ularitide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Zanamivir,Ularitide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ularitide,Ziconotide,The risk or severity of CNS depression can be increased when Ularitide is combined with Ziconotide.,increase,risk
Ularitide,Zonisamide,Ularitide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indacaterol,Bromotheophylline,The risk or severity of adverse effects can be increased when Bromotheophylline is combined with Indacaterol.,increase,risk
Indacaterol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Indacaterol.,increase,risk
Indacaterol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Indacaterol.,increase,risk
Indacaterol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Indacaterol.,increase,risk
Indacaterol,Bumadizone,The risk or severity of hypertension can be increased when Indacaterol is combined with Bumadizone.,increase,risk
Indacaterol,Bumetanide,The risk or severity of hypokalemia can be increased when Indacaterol is combined with Bumetanide.,increase,risk
Indacaterol,Buserelin,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Buserelin.,increase,risk
Indacaterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Indacaterol.,increase,risk
Indacaterol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Indacaterol.,increase,risk
Indacaterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Indacaterol is combined with Butylscopolamine.,increase,risk
Indacaterol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gadobenic acid.,increase,risk
Indacaterol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Indacaterol.,increase,risk
Indacaterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Indacaterol.,increase,risk
Indacaterol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Indacaterol.,increase,risk
Indacaterol,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Indacaterol.,increase,no risk
Indacaterol,Gemfibrozil,The metabolism of Indacaterol can be decreased when combined with Gemfibrozil.,decrease,no risk
Indacaterol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Gemifloxacin.,increase,risk
Indacaterol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Indacaterol.,increase,risk
Indacaterol,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Indacaterol.,increase,no risk
Indacaterol,Glasdegib,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Glasdegib.,increase,risk
Indacaterol,Glecaprevir,The serum concentration of Indacaterol can be increased when it is combined with Glecaprevir.,increase,no risk
Indacaterol,Glofitamab,The serum concentration of Indacaterol can be increased when it is combined with Glofitamab.,increase,no risk
Indacaterol,Goserelin,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Goserelin.,increase,risk
Indacaterol,Granisetron,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Granisetron.,increase,risk
Indacaterol,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Indacaterol.,increase,no risk
Indacaterol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Grepafloxacin.,increase,risk
Indacaterol,Guanabenz,Indacaterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Indacaterol,Guanadrel,Indacaterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Indacaterol,Guanethidine,Indacaterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Indacaterol,Guanfacine,Indacaterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Indacaterol,Guanoxan,Indacaterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Indacaterol,Halofantrine,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Halofantrine.,increase,risk
Indacaterol,Haloperidol,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Haloperidol.,increase,risk
Indacaterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Indacaterol.,increase,risk
Indacaterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Indacaterol is combined with Hexocyclium.,increase,risk
Indacaterol,Histrelin,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Histrelin.,increase,risk
Indacaterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Indacaterol.,increase,risk
Indacaterol,Hydralazine,Indacaterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Indacaterol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Indacaterol is combined with Hydrochlorothiazide.,increase,risk
Indacaterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Indacaterol.,increase,risk
Indacaterol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Indacaterol.,increase,risk
Indacaterol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Indacaterol.,increase,risk
Indacaterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Indacaterol.,increase,risk
Indacaterol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Indacaterol.,increase,risk
Indacaterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Indacaterol is combined with Hydroflumethiazide.,increase,risk
Indacaterol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Indacaterol.,increase,risk
Indacaterol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Hydroxyzine.,increase,risk
Indacaterol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Indacaterol.,increase,risk
Indacaterol,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Indacaterol.,increase,risk
Indacaterol,Ketoconazole,The metabolism of Indacaterol can be decreased when combined with Ketoconazole.,decrease,no risk
Indacaterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Indacaterol.,increase,risk
Indacaterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Indacaterol.,increase,risk
Dutogliptin,Gatifloxacin,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Dutogliptin,Gefapixant,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Gefapixant.,increase,no risk
Dutogliptin,Gemifloxacin,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Dutogliptin,Gliclazide,Dutogliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Dutogliptin,Glimepiride,Dutogliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Dutogliptin,Glipizide,Dutogliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Dutogliptin,Gliquidone,Dutogliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Dutogliptin,Glyburide,Dutogliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Dutogliptin,Glymidine,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Glymidine.,increase,no risk
Dutogliptin,Goserelin,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Dutogliptin,Grepafloxacin,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Dutogliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Dutogliptin.,increase,risk
Dutogliptin,Haloperidol,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Haloperidol.,decrease,no risk
Dutogliptin,Histrelin,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Dutogliptin,Hydrochlorothiazide,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Dutogliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Dutogliptin.,increase,risk
Dutogliptin,Hydroflumethiazide,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Dutogliptin,Hydroxychloroquine,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Dutogliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dutogliptin,Octreotide,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Dutogliptin,Ofloxacin,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Dutogliptin,Olanzapine,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Dutogliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Dutogliptin.,increase,no risk
Dutogliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Dutogliptin.,increase,no risk
Dutogliptin,Oxprenolol,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Dutogliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Dutogliptin.,increase,no risk
Dutogliptin,Quetiapine,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Dutogliptin,Quinapril,The risk or severity of angioedema can be increased when Dutogliptin is combined with Quinapril.,increase,risk
Dutogliptin,Quinethazone,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Dutogliptin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Dutogliptin.,increase,risk
Dutogliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Dutogliptin.,decrease,no risk
Dutogliptin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Dutogliptin.,increase,risk
Dutogliptin,Udenafil,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Udenafil.,increase,no risk
Dutogliptin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Dutogliptin.,increase,risk
Dutogliptin,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Dutogliptin.,increase,risk
Dutogliptin,Valdecoxib,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Valdecoxib.,increase,no risk
Dutogliptin,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Dutogliptin.,increase,risk
Dutogliptin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Dutogliptin.,increase,risk
Dutogliptin,Vemurafenib,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Vemurafenib.,increase,no risk
Dutogliptin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Dutogliptin.,increase,risk
Dutogliptin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Dutogliptin.,increase,risk
Dutogliptin,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Dutogliptin.,increase,risk
Dutogliptin,Vorinostat,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Vorinostat.,decrease,no risk
Dutogliptin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Dutogliptin.,increase,risk
Dutogliptin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Dutogliptin.,increase,risk
Dutogliptin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Dutogliptin.,increase,risk
Dutogliptin,Ziprasidone,The therapeutic efficacy of Dutogliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Dutogliptin,Zofenopril,The risk or severity of angioedema can be increased when Dutogliptin is combined with Zofenopril.,increase,risk
Dutogliptin,Zonisamide,The therapeutic efficacy of Dutogliptin can be increased when used in combination with Zonisamide.,increase,no risk
Ibudilast,Gemcitabine,The risk or severity of bleeding can be increased when Ibudilast is combined with Gemcitabine.,increase,risk
Ibudilast,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ibudilast is combined with Gemtuzumab ozogamicin.,increase,risk
Ibudilast,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Ibudilast.,increase,no risk
Ibudilast,Glucosamine,Glucosamine may increase the antiplatelet activities of Ibudilast.,increase,no risk
Ibudilast,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Ibudilast.,increase,risk
Ibudilast,Guanabenz,Ibudilast may increase the antihypertensive activities of Guanabenz.,increase,no risk
Ibudilast,Guanadrel,Ibudilast may increase the antihypertensive activities of Guanadrel.,increase,no risk
Ibudilast,Guanethidine,Ibudilast may increase the antihypertensive activities of Guanethidine.,increase,no risk
Ibudilast,Guanfacine,Ibudilast may increase the antihypertensive activities of Guanfacine.,increase,no risk
Ibudilast,Guanoxan,Ibudilast may increase the antihypertensive activities of Guanoxan.,increase,no risk
Ibudilast,Halothane,The risk or severity of hypotension can be increased when Ibudilast is combined with Halothane.,increase,risk
Ibudilast,Heparin,The risk or severity of bleeding can be increased when Ibudilast is combined with Heparin.,increase,risk
Ibudilast,Hydralazine,Ibudilast may increase the antihypertensive activities of Hydralazine.,increase,no risk
Ibudilast,Hydrochlorothiazide,Ibudilast may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Ibudilast,Hydroflumethiazide,Ibudilast may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Ibudilast,Hydroxyurea,The risk or severity of bleeding can be increased when Ibudilast is combined with Hydroxyurea.,increase,risk
Ibudilast,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Ibudilast.,increase,risk
Ibudilast,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Ibudilast.,increase,risk
Ibudilast,Obeticholic acid,The risk or severity of adverse effects can be increased when Ibudilast is combined with Obeticholic acid.,increase,risk
Ibudilast,Obinutuzumab,The risk or severity of adverse effects can be increased when Ibudilast is combined with Obinutuzumab.,increase,risk
Ibudilast,Olanzapine,The risk or severity of hypotension and syncope can be increased when Ibudilast is combined with Olanzapine.,increase,risk
Ibudilast,Olaparib,The risk or severity of bleeding can be increased when Ibudilast is combined with Olaparib.,increase,risk
Ibudilast,Olmesartan,Ibudilast may increase the antihypertensive activities of Olmesartan.,increase,no risk
Ibudilast,Olsalazine,The risk or severity of bleeding can be increased when Ibudilast is combined with Olsalazine.,increase,risk
Ibudilast,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Ibudilast.,increase,no risk
Ibudilast,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ibudilast.,increase,risk
Ibudilast,Opicapone,The risk or severity of hypotension can be increased when Ibudilast is combined with Opicapone.,increase,risk
Ibudilast,Oxaliplatin,The risk or severity of bleeding can be increased when Ibudilast is combined with Oxaliplatin.,increase,risk
Ibudilast,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Ibudilast.,increase,risk
Ibudilast,Oxprenolol,Ibudilast may increase the antihypertensive activities of Oxprenolol.,increase,no risk
Ibudilast,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Ibudilast.,increase,risk
Ibudilast,Quetiapine,The risk or severity of hypotension and syncope can be increased when Ibudilast is combined with Quetiapine.,increase,risk
Ibudilast,Quinapril,Ibudilast may increase the antihypertensive activities of Quinapril.,increase,no risk
Ibudilast,Quinidine,The risk or severity of hypotension and syncope can be increased when Ibudilast is combined with Quinidine.,increase,risk
Ibudilast,Udenafil,The risk or severity of adverse effects can be increased when Ibudilast is combined with Udenafil.,increase,risk
Ibudilast,Urokinase,Ibudilast may increase the anticoagulant activities of Urokinase.,increase,no risk
Ibudilast,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Ibudilast is combined with Ursodeoxycholic acid.,increase,risk
Ibudilast,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Ibudilast.,increase,risk
Ibudilast,Valsartan,Ibudilast may increase the antihypertensive activities of Valsartan.,increase,no risk
Ibudilast,Vardenafil,The risk or severity of adverse effects can be increased when Vardenafil is combined with Ibudilast.,increase,risk
Ibudilast,Venlafaxine,The risk or severity of bleeding can be increased when Ibudilast is combined with Venlafaxine.,increase,risk
Ibudilast,Verapamil,The risk or severity of hypotension can be increased when Ibudilast is combined with Verapamil.,increase,risk
Ibudilast,Vericiguat,The risk or severity of hypotension can be increased when Ibudilast is combined with Vericiguat.,increase,risk
Ibudilast,Vinblastine,The risk or severity of bleeding can be increased when Ibudilast is combined with Vinblastine.,increase,risk
Ibudilast,Vindesine,The risk or severity of bleeding can be increased when Ibudilast is combined with Vindesine.,increase,risk
Ibudilast,Vinorelbine,The risk or severity of bleeding can be increased when Ibudilast is combined with Vinorelbine.,increase,risk
Ibudilast,Vitamin E,Vitamin E may increase the antiplatelet activities of Ibudilast.,increase,no risk
Ibudilast,Vorapaxar,The risk or severity of bleeding can be increased when Ibudilast is combined with Vorapaxar.,increase,risk
Ibudilast,Vorinostat,The risk or severity of bleeding can be increased when Ibudilast is combined with Vorinostat.,increase,risk
Ibudilast,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Ibudilast.,increase,risk
Ibudilast,Warfarin,The risk or severity of bleeding can be increased when Ibudilast is combined with Warfarin.,increase,risk
Ibudilast,Ximelagatran,The risk or severity of bleeding can be increased when Ibudilast is combined with Ximelagatran.,increase,risk
Ibudilast,Zidovudine,The risk or severity of bleeding can be increased when Ibudilast is combined with Zidovudine.,increase,risk
Ibudilast,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ibudilast.,increase,risk
Ibudilast,Ziprasidone,The risk or severity of hypotension and syncope can be increased when Ibudilast is combined with Ziprasidone.,increase,risk
Ibudilast,Zofenopril,Ibudilast may increase the antihypertensive activities of Zofenopril.,increase,no risk
Ibudilast,Zuclopenthixol,The risk or severity of hypotension and syncope can be increased when Ibudilast is combined with Zuclopenthixol.,increase,risk
SLV319,Gabapentin,The risk or severity of adverse effects can be increased when SLV319 is combined with Gabapentin.,increase,risk
SLV319,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when SLV319 is combined with Gabapentin enacarbil.,increase,risk
SLV319,Gallamine triethiodide,The risk or severity of adverse effects can be increased when SLV319 is combined with Gallamine triethiodide.,increase,risk
SLV319,Ganaxolone,The risk or severity of adverse effects can be increased when SLV319 is combined with Ganaxolone.,increase,risk
SLV319,Gepirone,The risk or severity of adverse effects can be increased when SLV319 is combined with Gepirone.,increase,risk
SLV319,Glutethimide,The risk or severity of adverse effects can be increased when SLV319 is combined with Glutethimide.,increase,risk
SLV319,Glycopyrronium,The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with SLV319.,increase,risk
SLV319,Granisetron,The risk or severity of adverse effects can be increased when SLV319 is combined with Granisetron.,increase,risk
SLV319,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with SLV319.,increase,risk
SLV319,Guanfacine,The risk or severity of adverse effects can be increased when SLV319 is combined with Guanfacine.,increase,risk
SLV319,Halazepam,The risk or severity of adverse effects can be increased when SLV319 is combined with Halazepam.,increase,risk
SLV319,Haloperidol,The risk or severity of adverse effects can be increased when SLV319 is combined with Haloperidol.,increase,risk
SLV319,Halothane,The risk or severity of adverse effects can be increased when SLV319 is combined with Halothane.,increase,risk
SLV319,Hexafluronium,The risk or severity of adverse effects can be increased when SLV319 is combined with Hexafluronium.,increase,risk
SLV319,Hexocyclium,The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with SLV319.,increase,risk
SLV319,Homatropine methylbromide,The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with SLV319.,increase,risk
SLV319,Hydrocodone,The risk or severity of adverse effects can be increased when SLV319 is combined with Hydrocodone.,increase,risk
SLV319,Hydromorphone,The risk or severity of adverse effects can be increased when SLV319 is combined with Hydromorphone.,increase,risk
SLV319,Hydroxyzine,The risk or severity of adverse effects can be increased when SLV319 is combined with Hydroxyzine.,increase,risk
SLV319,Hyoscyamine,The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with SLV319.,increase,risk
SLV319,Ketamine,The risk or severity of adverse effects can be increased when SLV319 is combined with Ketamine.,increase,risk
SLV319,Ketazolam,The risk or severity of adverse effects can be increased when SLV319 is combined with Ketazolam.,increase,risk
SLV319,Olanzapine,The risk or severity of adverse effects can be increased when SLV319 is combined with Olanzapine.,increase,risk
SLV319,Oliceridine,The risk or severity of adverse effects can be increased when SLV319 is combined with Oliceridine.,increase,risk
SLV319,Olodaterol,The risk or severity of Tachycardia can be increased when SLV319 is combined with Olodaterol.,increase,risk
SLV319,Ondansetron,The risk or severity of adverse effects can be increased when SLV319 is combined with Ondansetron.,increase,risk
SLV319,Opium,The risk or severity of adverse effects can be increased when SLV319 is combined with Opium.,increase,risk
SLV319,Orciprenaline,The risk or severity of Tachycardia can be increased when SLV319 is combined with Orciprenaline.,increase,risk
SLV319,Orphenadrine,The risk or severity of adverse effects can be increased when SLV319 is combined with Orphenadrine.,increase,risk
SLV319,Oxazepam,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxazepam.,increase,risk
SLV319,Oxcarbazepine,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxcarbazepine.,increase,risk
SLV319,Oxitriptan,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxitriptan.,increase,risk
SLV319,Oxprenolol,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxprenolol.,increase,risk
SLV319,Oxybuprocaine,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxybuprocaine.,increase,risk
SLV319,Oxybutynin,The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with SLV319.,increase,risk
SLV319,Oxycodone,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxycodone.,increase,risk
SLV319,Oxymetazoline,The risk or severity of Tachycardia can be increased when SLV319 is combined with Oxymetazoline.,increase,risk
SLV319,Oxymorphone,The risk or severity of adverse effects can be increased when SLV319 is combined with Oxymorphone.,increase,risk
SLV319,Oxyphencyclimine,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with SLV319.,increase,risk
SLV319,Oxyphenonium,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with SLV319.,increase,risk
SLV319,Quazepam,The risk or severity of adverse effects can be increased when SLV319 is combined with Quazepam.,increase,risk
SLV319,Quetiapine,The risk or severity of adverse effects can be increased when SLV319 is combined with Quetiapine.,increase,risk
SLV319,Quinidine,The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with SLV319.,increase,risk
SLV319,Quinine,The risk or severity of adverse effects can be increased when SLV319 is combined with Quinine.,increase,risk
SLV319,Quinupramine,The risk or severity of adverse effects can be increased when SLV319 is combined with Quinupramine.,increase,risk
SLV319,Umeclidinium,The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with SLV319.,increase,risk
SLV319,Urethane,The risk or severity of adverse effects can be increased when SLV319 is combined with Urethane.,increase,risk
SLV319,Valproic acid,The risk or severity of adverse effects can be increased when SLV319 is combined with Valproic acid.,increase,risk
SLV319,Vecuronium,The risk or severity of adverse effects can be increased when SLV319 is combined with Vecuronium.,increase,risk
SLV319,Venlafaxine,The risk or severity of adverse effects can be increased when SLV319 is combined with Venlafaxine.,increase,risk
SLV319,Vigabatrin,The risk or severity of adverse effects can be increased when SLV319 is combined with Vigabatrin.,increase,risk
SLV319,Vilanterol,The risk or severity of Tachycardia can be increased when SLV319 is combined with Vilanterol.,increase,risk
SLV319,Vilazodone,The risk or severity of adverse effects can be increased when SLV319 is combined with Vilazodone.,increase,risk
SLV319,Viloxazine,The risk or severity of adverse effects can be increased when SLV319 is combined with Viloxazine.,increase,risk
SLV319,Vortioxetine,The risk or severity of adverse effects can be increased when SLV319 is combined with Vortioxetine.,increase,risk
SLV319,Xamoterol,The risk or severity of Tachycardia can be increased when SLV319 is combined with Xamoterol.,increase,risk
SLV319,Xylometazoline,The risk or severity of Tachycardia can be increased when SLV319 is combined with Xylometazoline.,increase,risk
SLV319,Yohimbine,The risk or severity of adverse effects can be increased when SLV319 is combined with Yohimbine.,increase,risk
SLV319,Zaleplon,The risk or severity of adverse effects can be increased when SLV319 is combined with Zaleplon.,increase,risk
SLV319,Ziconotide,The risk or severity of adverse effects can be increased when SLV319 is combined with Ziconotide.,increase,risk
SLV319,Zimelidine,The risk or severity of adverse effects can be increased when SLV319 is combined with Zimelidine.,increase,risk
SLV319,Ziprasidone,The risk or severity of adverse effects can be increased when SLV319 is combined with Ziprasidone.,increase,risk
SLV319,Zolmitriptan,The risk or severity of adverse effects can be increased when SLV319 is combined with Zolmitriptan.,increase,risk
SLV319,Zolpidem,The risk or severity of adverse effects can be increased when SLV319 is combined with Zolpidem.,increase,risk
SLV319,Zonisamide,The risk or severity of adverse effects can be increased when SLV319 is combined with Zonisamide.,increase,risk
SLV319,Zopiclone,The risk or severity of adverse effects can be increased when SLV319 is combined with Zopiclone.,increase,risk
SLV319,Zotepine,The risk or severity of adverse effects can be increased when SLV319 is combined with Zotepine.,increase,risk
SLV319,Zuclopenthixol,The risk or severity of adverse effects can be increased when SLV319 is combined with Zuclopenthixol.,increase,risk
SLV319,Zuranolone,The risk or severity of adverse effects can be increased when SLV319 is combined with Zuranolone.,increase,risk
Rilpivirine,Bexarotene,The serum concentration of Rilpivirine can be decreased when it is combined with Bexarotene.,decrease,no risk
Rilpivirine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Bilastine,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Bilastine.,increase,risk
Rilpivirine,Bimekizumab,The metabolism of Rilpivirine can be increased when combined with Bimekizumab.,increase,no risk
Rilpivirine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rilpivirine,Boceprevir,The metabolism of Rilpivirine can be decreased when combined with Boceprevir.,decrease,no risk
Rilpivirine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Bosentan,The serum concentration of Rilpivirine can be decreased when it is combined with Bosentan.,decrease,no risk
Rilpivirine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Rilpivirine.,increase,risk
Rilpivirine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Brigatinib,The serum concentration of Rilpivirine can be decreased when it is combined with Brigatinib.,decrease,no risk
Rilpivirine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Brompheniramine,The metabolism of Brompheniramine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Rilpivirine.,increase,risk
Rilpivirine,Budesonide,The serum concentration of Rilpivirine can be decreased when it is combined with Budesonide.,decrease,no risk
Rilpivirine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Rilpivirine.,increase,risk
Rilpivirine,Buspirone,The metabolism of Buspirone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Busulfan,The metabolism of Busulfan can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Butalbital,The serum concentration of Rilpivirine can be decreased when it is combined with Butalbital.,decrease,no risk
Rilpivirine,Butriptyline,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Butriptyline.,increase,risk
Rilpivirine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Gadobenic acid.,increase,risk
Rilpivirine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Galantamine,The metabolism of Galantamine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Rilpivirine.,increase,risk
Rilpivirine,Gefitinib,Rilpivirine may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Rilpivirine,Gemfibrozil,The metabolism of Rilpivirine can be decreased when combined with Gemfibrozil.,decrease,no risk
Rilpivirine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Gemifloxacin.,increase,risk
Rilpivirine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Gilteritinib.,increase,risk
Rilpivirine,Glasdegib,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Glasdegib.,increase,risk
Rilpivirine,Glecaprevir,The serum concentration of Rilpivirine can be increased when it is combined with Glecaprevir.,increase,no risk
Rilpivirine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Glipizide,The metabolism of Glipizide can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Glofitamab,The serum concentration of Rilpivirine can be increased when it is combined with Glofitamab.,increase,no risk
Rilpivirine,Glyburide,Rilpivirine may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Rilpivirine,Glycerol phenylbutyrate,The serum concentration of Rilpivirine can be decreased when it is combined with Glycerol phenylbutyrate.,decrease,no risk
Rilpivirine,Golimumab,The metabolism of Rilpivirine can be increased when combined with Golimumab.,increase,no risk
Rilpivirine,Goserelin,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Goserelin.,increase,risk
Rilpivirine,Granisetron,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Granisetron.,increase,risk
Rilpivirine,Grapefruit,The serum concentration of Rilpivirine can be increased when it is combined with Grapefruit.,increase,no risk
Rilpivirine,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Grepafloxacin.,increase,risk
Rilpivirine,Griseofulvin,The serum concentration of Rilpivirine can be decreased when it is combined with Griseofulvin.,decrease,no risk
Rilpivirine,Halofantrine,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Halofantrine.,increase,risk
Rilpivirine,Haloperidol,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Haloperidol.,increase,risk
Rilpivirine,Halothane,The metabolism of Halothane can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Rilpivirine.,increase,risk
Rilpivirine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Rilpivirine.,decrease,no risk
Rilpivirine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Rilpivirine.,increase,risk
Rilpivirine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Hydrocortamate,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortamate.,decrease,no risk
Rilpivirine,Hydrocortisone,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Rilpivirine,Hydrocortisone acetate,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortisone acetate.,decrease,no risk
Rilpivirine,Hydrocortisone butyrate,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortisone butyrate.,decrease,no risk
Rilpivirine,Hydrocortisone probutate,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortisone probutate.,decrease,no risk
Rilpivirine,Hydrocortisone succinate,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortisone succinate.,decrease,no risk
Rilpivirine,Hydrocortisone valerate,The serum concentration of Rilpivirine can be decreased when it is combined with Hydrocortisone valerate.,decrease,no risk
Rilpivirine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rilpivirine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Hydroxyzine.,increase,risk
Rilpivirine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Rilpivirine.,increase,risk
Rilpivirine,Ketamine,The serum concentration of Rilpivirine can be decreased when it is combined with Ketamine.,decrease,no risk
Rilpivirine,Ketoconazole,The serum concentration of Ketoconazole can be decreased when it is combined with Rilpivirine.,decrease,no risk
Rilpivirine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Rilpivirine.,increase,risk
Rilpivirine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Ofloxacin.,increase,risk
Rilpivirine,Olanzapine,Olanzapine can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rilpivirine,Olaparib,The metabolism of Olaparib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Olutasidenib,The serum concentration of Rilpivirine can be decreased when it is combined with Olutasidenib.,decrease,no risk
Rilpivirine,Omaveloxolone,The serum concentration of Rilpivirine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Rilpivirine,Ombitasvir,Rilpivirine may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Rilpivirine,Omeprazole,Omeprazole can cause a decrease in the absorption of Rilpivirine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rilpivirine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Opium,The metabolism of Opium can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Oritavancin,The serum concentration of Rilpivirine can be decreased when it is combined with Oritavancin.,decrease,no risk
Rilpivirine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Rilpivirine.,increase,risk
Rilpivirine,Osilodrostat,The serum concentration of Rilpivirine can be increased when it is combined with Osilodrostat.,increase,no risk
Rilpivirine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Ouabain,The excretion of Ouabain can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Rilpivirine.,increase,risk
Rilpivirine,Oxatomide,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Oxatomide.,increase,risk
Rilpivirine,Oxcarbazepine,The serum concentration of Rilpivirine can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Rilpivirine,Oxiconazole,The serum concentration of Rilpivirine can be decreased when it is combined with Oxiconazole.,decrease,no risk
Rilpivirine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Rilpivirine.,increase,risk
Rilpivirine,Ozanimod,Rilpivirine may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Rilpivirine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Quinidine,The serum concentration of Rilpivirine can be increased when it is combined with Quinidine.,increase,no risk
Rilpivirine,Quinine,The serum concentration of Rilpivirine can be decreased when it is combined with Quinine.,decrease,no risk
Rilpivirine,Quizartinib,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Quizartinib.,increase,risk
Rilpivirine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vadadustat,The serum concentration of Rilpivirine can be increased when it is combined with Vadadustat.,increase,no risk
Rilpivirine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Valsartan,The metabolism of Valsartan can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Rilpivirine.,decrease,no risk
Rilpivirine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Rilpivirine.,increase,risk
Rilpivirine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Verapamil,The serum concentration of Rilpivirine can be increased when it is combined with Verapamil.,increase,no risk
Rilpivirine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rilpivirine.,decrease,no risk
Rilpivirine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Rilpivirine.,increase,risk
Rilpivirine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Viloxazine,The serum concentration of Rilpivirine can be increased when it is combined with Viloxazine.,increase,no risk
Rilpivirine,Vinblastine,The serum concentration of Rilpivirine can be decreased when it is combined with Vinblastine.,decrease,no risk
Rilpivirine,Vincristine,The metabolism of Vincristine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vindesine,The metabolism of Vindesine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Vonoprazan,The absorption of Rilpivirine can be decreased when combined with Vonoprazan.,decrease,no risk
Rilpivirine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Voriconazole,The metabolism of Rilpivirine can be decreased when combined with Voriconazole.,decrease,no risk
Rilpivirine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Rilpivirine.,increase,risk
Rilpivirine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Voxilaprevir,Rilpivirine may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Rilpivirine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Rilpivirine.,decrease,no risk
Rilpivirine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Zafirlukast,The serum concentration of Rilpivirine can be increased when it is combined with Zafirlukast.,increase,no risk
Rilpivirine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Rilpivirine.,increase,no risk
Rilpivirine,Zileuton,The metabolism of Zileuton can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Zimelidine,The metabolism of Rilpivirine can be decreased when combined with Zimelidine.,decrease,no risk
Rilpivirine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Ziprasidone.,increase,risk
Rilpivirine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Zonisamide,The metabolism of Rilpivirine can be decreased when combined with Zonisamide.,decrease,no risk
Rilpivirine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Rilpivirine.,decrease,no risk
Rilpivirine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Zuclopenthixol.,increase,risk
Abaloparatide,Obinutuzumab,The risk or severity of adverse effects can be increased when Abaloparatide is combined with Obinutuzumab.,increase,risk
Abaloparatide,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Abaloparatide.,increase,risk
Abaloparatide,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Abaloparatide.,increase,risk
Abaloparatide,Opicapone,The risk or severity of adverse effects can be increased when Abaloparatide is combined with Opicapone.,increase,risk
Abaloparatide,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Abaloparatide.,increase,risk
Abaloparatide,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Abaloparatide.,increase,risk
Abaloparatide,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Abaloparatide.,increase,risk
Abaloparatide,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Abaloparatide.,increase,risk
Abaloparatide,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Abaloparatide.,increase,risk
Abaloparatide,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Abaloparatide.,increase,risk
Abaloparatide,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Abaloparatide.,increase,risk
Abaloparatide,Vericiguat,The risk or severity of adverse effects can be increased when Abaloparatide is combined with Vericiguat.,increase,risk
Abaloparatide,Zofenopril,Abaloparatide may increase the hypotensive activities of Zofenopril.,increase,no risk
Ganaxolone,Gabapentin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gabapentin is combined with Ganaxolone.",increase,risk
Ganaxolone,Gabapentin enacarbil,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gabapentin enacarbil is combined with Ganaxolone.",increase,risk
Ganaxolone,Gallamine triethiodide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gallamine triethiodide is combined with Ganaxolone.",increase,risk
Ganaxolone,Gamolenic acid,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Ganaxolone,Ganciclovir,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Ganciclovir.,decrease,no risk
Ganaxolone,Gepirone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gepirone is combined with Ganaxolone.",increase,risk
Ganaxolone,Gestrinone,The metabolism of Gestrinone can be increased when combined with Ganaxolone.,increase,no risk
Ganaxolone,Glutethimide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Glutethimide is combined with Ganaxolone.",increase,risk
Ganaxolone,Granisetron,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Granisetron is combined with Ganaxolone.",increase,risk
Ganaxolone,Guanfacine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Guanfacine is combined with Ganaxolone.",increase,risk
Ganaxolone,Halazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Halazepam is combined with Ganaxolone.",increase,risk
Ganaxolone,Halofantrine,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Halofantrine.,decrease,no risk
Ganaxolone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ganaxolone.,increase,risk
Ganaxolone,Halothane,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Halothane is combined with Ganaxolone.",increase,risk
Ganaxolone,Hexafluronium,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Hexafluronium is combined with Ganaxolone.",increase,risk
Ganaxolone,Hydrocodone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ganaxolone,Hydromorphone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Hydromorphone is combined with Ganaxolone.",increase,risk
Ganaxolone,Hydroxychloroquine,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Ganaxolone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Ganaxolone.,increase,no risk
Ganaxolone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ganaxolone.,increase,no risk
Ganaxolone,Ketamine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ketamine is combined with Ganaxolone.",increase,risk
Ganaxolone,Ketazolam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ketazolam is combined with Ganaxolone.",increase,risk
Ganaxolone,Olanzapine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Olanzapine is combined with Ganaxolone.",increase,risk
Ganaxolone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ganaxolone is combined with Oliceridine.",increase,risk
Ganaxolone,Ondansetron,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ondansetron is combined with Ganaxolone.",increase,risk
Ganaxolone,Opium,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Opium is combined with Ganaxolone.",increase,risk
Ganaxolone,Orlistat,Orlistat can cause a decrease in the absorption of Ganaxolone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ganaxolone,Orphenadrine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Orphenadrine is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxazepam is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxcarbazepine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxcarbazepine is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Oxetacaine.,increase,risk
Ganaxolone,Oxitriptan,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxitriptan is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxprenolol,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxprenolol is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxtriphylline,Ganaxolone may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ganaxolone,Oxybuprocaine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxybuprocaine is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxycodone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxycodone is combined with Ganaxolone.",increase,risk
Ganaxolone,Oxymorphone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Oxymorphone is combined with Ganaxolone.",increase,risk
Ganaxolone,Quazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Quazepam is combined with Ganaxolone.",increase,risk
Ganaxolone,Quetiapine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Quetiapine is combined with Ganaxolone.",increase,risk
Ganaxolone,Quinidine,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Quinidine.,decrease,no risk
Ganaxolone,Quinine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Quinine is combined with Ganaxolone.",increase,risk
Ganaxolone,Quinupramine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Quinupramine is combined with Ganaxolone.",increase,risk
Ganaxolone,Ulipristal,The metabolism of Ulipristal can be increased when combined with Ganaxolone.,increase,no risk
Ganaxolone,Urethane,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Urethane is combined with Ganaxolone.",increase,risk
Ganaxolone,Valganciclovir,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Valganciclovir.,decrease,no risk
Ganaxolone,Valproic acid,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Valproic acid is combined with Ganaxolone.",increase,risk
Ganaxolone,Vecuronium,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vecuronium is combined with Ganaxolone.",increase,risk
Ganaxolone,Venlafaxine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Venlafaxine is combined with Ganaxolone.",increase,risk
Ganaxolone,Vigabatrin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vigabatrin is combined with Ganaxolone.",increase,risk
Ganaxolone,Vilazodone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vilazodone is combined with Ganaxolone.",increase,risk
Ganaxolone,Viloxazine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Viloxazine is combined with Ganaxolone.",increase,risk
Ganaxolone,Vortioxetine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vortioxetine is combined with Ganaxolone.",increase,risk
Ganaxolone,Yohimbine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Yohimbine is combined with Ganaxolone.",increase,risk
Ganaxolone,Zaleplon,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zaleplon is combined with Ganaxolone.",increase,risk
Ganaxolone,Ziconotide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ziconotide is combined with Ganaxolone.",increase,risk
Ganaxolone,Zimelidine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zimelidine is combined with Ganaxolone.",increase,risk
Ganaxolone,Ziprasidone,The risk or severity of adverse effects can be increased when Ganaxolone is combined with Ziprasidone.,increase,risk
Ganaxolone,Zolmitriptan,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zolmitriptan is combined with Ganaxolone.",increase,risk
Ganaxolone,Zolpidem,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ganaxolone,Zonisamide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zonisamide is combined with Ganaxolone.",increase,risk
Ganaxolone,Zopiclone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zopiclone is combined with Ganaxolone.",increase,risk
Ganaxolone,Zotepine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zotepine is combined with Ganaxolone.",increase,risk
Ganaxolone,Zuclopenthixol,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zuclopenthixol is combined with Ganaxolone.",increase,risk
Ganaxolone,Zuranolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Zuranolone is combined with Ganaxolone.",increase,risk
Tetrathiomolybdate,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Benzocaine.,increase,risk
Tetrathiomolybdate,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Benzyl alcohol.,increase,risk
Tetrathiomolybdate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Bupivacaine.,increase,risk
Tetrathiomolybdate,Butacaine,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Butacaine.,increase,risk
Tetrathiomolybdate,Butamben,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Butamben.,increase,risk
Tetrathiomolybdate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Oxetacaine.,increase,risk
Tetrathiomolybdate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tetrathiomolybdate is combined with Oxybuprocaine.,increase,risk
Enzalutamide,Baclofen,Baclofen may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Balsalazide,Balsalazide may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Baricitinib,The serum concentration of Baricitinib can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Beclomethasone dipropionate,The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bedaquiline,The serum concentration of Bedaquiline can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Belumosudil,The serum concentration of Belumosudil can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Belzutifan,The serum concentration of Belzutifan can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Benorilate,Benorilate may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Benserazide,Enzalutamide may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Benzatropine,Benzatropine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Benznidazole,Enzalutamide may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Enzalutamide,Benzocaine,The serum concentration of Benzocaine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Benzphetamine,The serum concentration of Benzphetamine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Benzthiazide,Benzthiazide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Benzydamine,Benzydamine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Enzalutamide is combined with Benzyl alcohol.,increase,risk
Enzalutamide,Bepotastine,Bepotastine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Bepridil,The serum concentration of Bepridil can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Berotralstat,The metabolism of Enzalutamide can be decreased when combined with Berotralstat.,decrease,no risk
Enzalutamide,Betamethasone,The serum concentration of Betamethasone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Betamethasone phosphate,The serum concentration of Betamethasone phosphate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bexarotene,The serum concentration of Bexarotene can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bezafibrate,The serum concentration of Bezafibrate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bicalutamide,The serum concentration of Bicalutamide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bicisate,Enzalutamide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Enzalutamide,Bictegravir,The serum concentration of Bictegravir can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bifonazole,The serum concentration of Enzalutamide can be increased when it is combined with Bifonazole.,increase,no risk
Enzalutamide,Bimekizumab,The metabolism of Enzalutamide can be increased when combined with Bimekizumab.,increase,no risk
Enzalutamide,Binimetinib,The metabolism of Binimetinib can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Bioallethrin,The serum concentration of Bioallethrin can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bismuth subgallate,Enzalutamide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Enzalutamide,Bisoprolol,The serum concentration of Bisoprolol can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bisoxatin,Enzalutamide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Enzalutamide,Bleomycin,Bleomycin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Boceprevir,The serum concentration of Boceprevir can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bortezomib,The metabolism of Bortezomib can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Bosentan,The serum concentration of Bosentan can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bosutinib,The serum concentration of Bosutinib can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Brigatinib,The serum concentration of Brigatinib can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Brinzolamide,The serum concentration of Brinzolamide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Brivaracetam,The serum concentration of Brivaracetam can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bromazepam,Bromazepam may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Bromocriptine,The serum concentration of Bromocriptine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Budesonide,The serum concentration of Budesonide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bumadizone,Bumadizone may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Bumetanide,Bumetanide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Bupivacaine,The serum concentration of Bupivacaine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Buprenorphine,The serum concentration of Buprenorphine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Bupropion,The serum concentration of Bupropion can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Buspirone,The serum concentration of Buspirone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Busulfan,The serum concentration of Busulfan can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Butabarbital,Butabarbital may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Enzalutamide is combined with Butacaine.,increase,risk
Enzalutamide,Butamben,The risk or severity of methemoglobinemia can be increased when Enzalutamide is combined with Butamben.,increase,risk
Enzalutamide,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gadodiamide,Gadodiamide may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gadoteric acid,Enzalutamide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gadoteridol,Gadoteridol may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Galantamine,The serum concentration of Galantamine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Gallium Ga-68 gozetotide,Enzalutamide may increase effectiveness of Gallium Ga-68 gozetotide as a diagnostic agent.,increase,no risk
Enzalutamide,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Ganciclovir,Ganciclovir may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gefitinib,The metabolism of Gefitinib can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Gemcitabine,Gemcitabine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gemfibrozil,The serum concentration of Enzalutamide can be decreased when it is combined with Gemfibrozil.,decrease,no risk
Enzalutamide,Gentamicin,Enzalutamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Enzalutamide,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Gilteritinib,The serum concentration of Gilteritinib can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Gimeracil,Enzalutamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Enzalutamide,Ginkgo biloba,The metabolism of Enzalutamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Enzalutamide,Givosiran,Givosiran may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Gliclazide,The serum concentration of Gliclazide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Glimepiride,The serum concentration of Glimepiride can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Glipizide,The serum concentration of Glipizide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Gliquidone,The serum concentration of Gliquidone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Glofitamab,The serum concentration of Enzalutamide can be increased when it is combined with Glofitamab.,increase,no risk
Enzalutamide,Glyburide,The serum concentration of Glyburide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Glycerol phenylbutyrate,Enzalutamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Enzalutamide,Golimumab,The metabolism of Enzalutamide can be increased when combined with Golimumab.,increase,no risk
Enzalutamide,Golodirsen,Enzalutamide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Enzalutamide,Goserelin,Goserelin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Granisetron,The serum concentration of Granisetron can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Grazoprevir,The serum concentration of Grazoprevir can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Grepafloxacin,The serum concentration of Grepafloxacin can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Guanethidine,Guanethidine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Guanfacine,The metabolism of Guanfacine can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Halcinonide,The serum concentration of Halcinonide can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Halofantrine,The serum concentration of Halofantrine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Enzalutamide.,increase,no risk
Enzalutamide,Halothane,The serum concentration of Halothane can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydralazine,The serum concentration of Enzalutamide can be increased when it is combined with Hydralazine.,increase,no risk
Enzalutamide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Hydrocortisone,The serum concentration of Hydrocortisone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Hydromorphone,The serum concentration of Hydromorphone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydroxyethyl Starch,Enzalutamide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Enzalutamide,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Hydroxyzine,The serum concentration of Hydroxyzine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Kanamycin,Enzalutamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Enzalutamide,Ketamine,The serum concentration of Ketamine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Ketazolam,The serum concentration of Ketazolam can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Ketoconazole,The serum concentration of Ketoconazole can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Enzalutamide.,increase,risk
Enzalutamide,Ketorolac,The serum concentration of Ketorolac can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Octinoxate,Enzalutamide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Enzalutamide,Octreotide,The serum concentration of Enzalutamide can be increased when it is combined with Octreotide.,increase,no risk
Enzalutamide,Olanzapine,The metabolism of Enzalutamide can be decreased when combined with Olanzapine.,decrease,no risk
Enzalutamide,Olaparib,The metabolism of Olaparib can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Olodaterol,The serum concentration of Olodaterol can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Olsalazine,Olsalazine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Enzalutamide.,decrease,no risk
Enzalutamide,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Enzalutamide.,decrease,no risk
Enzalutamide,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Enzalutamide.,decrease,no risk
Enzalutamide,Omeprazole,The serum concentration of Omeprazole can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Ondansetron,The serum concentration of Ondansetron can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Opium,The serum concentration of Opium can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Oritavancin,The metabolism of Enzalutamide can be decreased when combined with Oritavancin.,decrease,no risk
Enzalutamide,Orphenadrine,The serum concentration of Orphenadrine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Oseltamivir,Oseltamivir may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Osimertinib,The metabolism of Osimertinib can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Ospemifene,The serum concentration of Ospemifene can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Oxacillin,Oxacillin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Oxandrolone,The metabolism of Enzalutamide can be decreased when combined with Oxandrolone.,decrease,no risk
Enzalutamide,Oxaprozin,Oxaprozin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Oxazepam,Oxazepam may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Oxcarbazepine,The metabolism of Enzalutamide can be increased when combined with Oxcarbazepine.,increase,no risk
Enzalutamide,Oxetacaine,The serum concentration of Enzalutamide can be increased when it is combined with Oxetacaine.,increase,no risk
Enzalutamide,Oxybenzone,Oxybenzone may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Enzalutamide is combined with Oxybuprocaine.,increase,risk
Enzalutamide,Oxybutynin,The serum concentration of Oxybutynin can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Oxycodone,The serum concentration of Oxycodone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Oxymetholone,The serum concentration of Enzalutamide can be increased when it is combined with Oxymetholone.,increase,no risk
Enzalutamide,Oxymorphone,The serum concentration of Oxymorphone can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Enzalutamide which could result in a higher serum level.,decrease,no risk
Enzalutamide,Oxyquinoline,Enzalutamide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Enzalutamide,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Enzalutamide.,decrease,no risk
Enzalutamide,Quazepam,The serum concentration of Quazepam can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Quetiapine,The metabolism of Quetiapine can be increased when combined with Enzalutamide.,increase,no risk
Enzalutamide,Quinethazone,Quinethazone may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Enzalutamide,Quinidine,The serum concentration of Quinidine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Quinine,The serum concentration of Quinine can be decreased when it is combined with Enzalutamide.,decrease,no risk
Enzalutamide,Quinupristin,The serum concentration of Enzalutamide can be increased when it is combined with Quinupristin.,increase,no risk
Enzalutamide,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Enzalutamide.,decrease,no risk
Cimicoxib,Bismuth subgallate,Cimicoxib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Cimicoxib,Bisoprolol,Cimicoxib may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Cimicoxib,Bisoxatin,Cimicoxib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Bivalirudin.,increase,risk
Cimicoxib,Bleomycin,Cimicoxib may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Brexpiprazole,The risk or severity of hypertension can be increased when Cimicoxib is combined with Brexpiprazole.,increase,risk
Cimicoxib,Brivaracetam,Cimicoxib may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Cimicoxib,Bromazepam,Cimicoxib may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Cimicoxib,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Cimicoxib.,increase,risk
Cimicoxib,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Cimicoxib.,increase,risk
Cimicoxib,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Cimicoxib.,increase,risk
Cimicoxib,Bufexamac,The risk or severity of adverse effects can be increased when Cimicoxib is combined with Bufexamac.,increase,risk
Cimicoxib,Bumadizone,The risk or severity of adverse effects can be increased when Cimicoxib is combined with Bumadizone.,increase,risk
Cimicoxib,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Bupropion,Cimicoxib may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Cimicoxib,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Cimicoxib.,increase,risk
Cimicoxib,Butabarbital,Cimicoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Cimicoxib,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Cimicoxib.,increase,risk
Cimicoxib,Gabapentin enacarbil,Cimicoxib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gadobenic acid,Cimicoxib may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gadodiamide,Cimicoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gadofosveset trisodium,Cimicoxib may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gadopentetic acid,Cimicoxib may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gadoteric acid,Cimicoxib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gadoteridol,Cimicoxib may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cimicoxib,Ganciclovir,Cimicoxib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gatifloxacin,Cimicoxib may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Cimicoxib,Gemcitabine,Cimicoxib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gemfibrozil,Cimicoxib may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gemifloxacin,Cimicoxib may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Cimicoxib,Gentamicin,Cimicoxib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Gimeracil,Cimicoxib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cimicoxib,Givosiran,The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Givosiran.,increase,risk
Cimicoxib,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Cimicoxib.,decrease,no risk
Cimicoxib,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Cimicoxib.,decrease,no risk
Cimicoxib,Glipizide,The protein binding of Glipizide can be decreased when combined with Cimicoxib.,decrease,no risk
Cimicoxib,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Cimicoxib.,decrease,no risk
Cimicoxib,Glyburide,The protein binding of Glyburide can be decreased when combined with Cimicoxib.,decrease,no risk
Cimicoxib,Glycerol phenylbutyrate,Cimicoxib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cimicoxib,Glycol salicylate,The risk or severity of adverse effects can be increased when Cimicoxib is combined with Glycol salicylate.,increase,risk
Cimicoxib,Golodirsen,Cimicoxib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cimicoxib,Goserelin,Cimicoxib may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Grepafloxacin,Cimicoxib may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Cimicoxib,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Cimicoxib.,increase,no risk
Cimicoxib,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Cimicoxib.,increase,risk
Cimicoxib,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Heparin.,increase,risk
Cimicoxib,Hydralazine,Cimicoxib may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Cimicoxib,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Cimicoxib.,increase,risk
Cimicoxib,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Cimicoxib.,increase,risk
Cimicoxib,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Cimicoxib.,increase,risk
Cimicoxib,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Cimicoxib.,increase,risk
Cimicoxib,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Cimicoxib.,increase,risk
Cimicoxib,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Hydromorphone,Cimicoxib may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cimicoxib,Hydroxocobalamin,Cimicoxib may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Hydroxyethyl Starch,Cimicoxib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cimicoxib,Kanamycin,Cimicoxib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Ketamine,Cimicoxib may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cimicoxib,Ketazolam,Cimicoxib may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cimicoxib,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Cimicoxib.,increase,risk
Cimicoxib,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Cimicoxib.,increase,risk
Cimicoxib,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Cimicoxib.,increase,risk
Cimicoxib,Octinoxate,Cimicoxib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cimicoxib,Ofloxacin,Cimicoxib may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Cimicoxib,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Cimicoxib.",increase,risk
Cimicoxib,Olodaterol,The risk or severity of hypertension can be increased when Cimicoxib is combined with Olodaterol.,increase,risk
Cimicoxib,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cimicoxib is combined with Olsalazine.,increase,risk
Cimicoxib,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Cimicoxib is combined with Omacetaxine mepesuccinate.,increase,risk
Cimicoxib,Opium,Cimicoxib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cimicoxib,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Cimicoxib.,increase,risk
Cimicoxib,Oseltamivir,Cimicoxib may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cimicoxib,Oxacillin,Cimicoxib may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cimicoxib.,increase,risk
Cimicoxib,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Cimicoxib.,increase,risk
Cimicoxib,Oxazepam,Cimicoxib may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cimicoxib,Oxprenolol,Cimicoxib may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Cimicoxib,Oxybenzone,Cimicoxib may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cimicoxib,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Cimicoxib.,increase,risk
Cimicoxib,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Cimicoxib.,increase,risk
Cimicoxib,Oxyquinoline,Cimicoxib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cimicoxib,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Cimicoxib.,increase,risk
Cimicoxib,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Cimicoxib is combined with Quinapril.",increase,risk
Cimicoxib,Quinestrol,Cimicoxib may increase the thrombogenic activities of Quinestrol.,increase,no risk
Cimicoxib,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Quinidine,Cimicoxib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cimicoxib,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Cimicoxib.,increase,risk
Cimicoxib,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Cimicoxib.,decrease,no risk
Cimicoxib,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Urokinase.,increase,risk
Cimicoxib,Vaborbactam,Cimicoxib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cimicoxib,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Cimicoxib.,increase,risk
Cimicoxib,Valbenazine,Cimicoxib may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cimicoxib,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Cimicoxib.,increase,risk
Cimicoxib,Valganciclovir,Cimicoxib may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cimicoxib,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Cimicoxib.,decrease,no risk
Cimicoxib,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Cimicoxib.",increase,risk
Cimicoxib,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Cimicoxib.,increase,risk
Cimicoxib,Vancomycin,Cimicoxib may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cimicoxib,Varenicline,Cimicoxib may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cimicoxib,Venlafaxine,Cimicoxib may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cimicoxib,Verapamil,Cimicoxib may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cimicoxib,Vilanterol,The risk or severity of hypertension can be increased when Cimicoxib is combined with Vilanterol.,increase,risk
Cimicoxib,Vilazodone,The risk or severity of hypertension can be increased when Cimicoxib is combined with Vilazodone.,increase,risk
Cimicoxib,Viloxazine,Cimicoxib may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cimicoxib,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Vorapaxar.,increase,risk
Cimicoxib,Voriconazole,The serum concentration of Cimicoxib can be increased when it is combined with Voriconazole.,increase,no risk
Cimicoxib,Vortioxetine,The risk or severity of hypertension can be increased when Cimicoxib is combined with Vortioxetine.,increase,risk
Labetuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Labetuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Obiltoxaximab.,increase,risk
Labetuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Obinutuzumab.,increase,risk
Labetuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Ocrelizumab.,increase,risk
Labetuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Odesivimab.,increase,risk
Labetuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Ofatumumab.,increase,risk
Labetuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Olaratumab.,increase,risk
Labetuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab.,increase,risk
Labetuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Labetuzumab is combined with Oxetacaine.,increase,risk
Labetuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Labetuzumab is combined with Oxybuprocaine.,increase,risk
Labetuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Labetuzumab.,increase,no risk
Labetuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Ublituximab.,increase,risk
Labetuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Ustekinumab.,increase,risk
Labetuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Labetuzumab is combined with Vedolizumab.,increase,risk
Ancrod,Gemcitabine,The risk or severity of bleeding can be increased when Ancrod is combined with Gemcitabine.,increase,risk
Ancrod,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ancrod is combined with Gemtuzumab ozogamicin.,increase,risk
Ancrod,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ancrod.,increase,risk
Ancrod,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ancrod.,increase,no risk
Ancrod,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ancrod.,increase,risk
Ancrod,Hemin,Hemin may increase the anticoagulant activities of Ancrod.,increase,no risk
Ancrod,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ancrod.,increase,risk
Ancrod,Hydrochlorothiazide,The therapeutic efficacy of Ancrod can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Ancrod,Hydroflumethiazide,The therapeutic efficacy of Ancrod can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Ancrod,Hydroxyprogesterone caproate,The therapeutic efficacy of Ancrod can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ancrod,Hydroxyurea,The risk or severity of bleeding can be increased when Ancrod is combined with Hydroxyurea.,increase,risk
Ancrod,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ancrod.,increase,risk
Ancrod,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ancrod.,increase,risk
Ancrod,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Ancrod is combined with Obeticholic acid.,increase,risk
Ancrod,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Ancrod is combined with Obinutuzumab.,increase,risk
Ancrod,Olaparib,The risk or severity of bleeding can be increased when Ancrod is combined with Olaparib.,increase,risk
Ancrod,Olive oil,The therapeutic efficacy of Ancrod can be decreased when used in combination with Olive oil.,decrease,no risk
Ancrod,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Ancrod.,increase,risk
Ancrod,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ancrod is combined with Omacetaxine mepesuccinate.,increase,risk
Ancrod,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Ancrod.,increase,no risk
Ancrod,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ancrod.,increase,risk
Ancrod,Omega-3-carboxylic acids,The therapeutic efficacy of Ancrod can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ancrod,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ancrod.,increase,risk
Ancrod,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ancrod.,increase,risk
Ancrod,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ancrod.,increase,risk
Ancrod,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ancrod.,decrease,no risk
Ancrod,Quinidine,The therapeutic efficacy of Ancrod can be increased when used in combination with Quinidine.,increase,no risk
Ancrod,Quinine,The therapeutic efficacy of Ancrod can be increased when used in combination with Quinine.,increase,no risk
Ancrod,Ulipristal,The therapeutic efficacy of Ancrod can be decreased when used in combination with Ulipristal.,decrease,no risk
Ancrod,Urokinase,Urokinase may increase the anticoagulant activities of Ancrod.,increase,no risk
Ancrod,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Ancrod is combined with Ursodeoxycholic acid.,increase,risk
Ancrod,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ancrod.,increase,risk
Ancrod,Venlafaxine,The risk or severity of bleeding can be increased when Ancrod is combined with Venlafaxine.,increase,risk
Ancrod,Vinblastine,The risk or severity of bleeding can be increased when Ancrod is combined with Vinblastine.,increase,risk
Ancrod,Vindesine,The risk or severity of bleeding can be increased when Ancrod is combined with Vindesine.,increase,risk
Ancrod,Vinorelbine,The risk or severity of bleeding can be increased when Ancrod is combined with Vinorelbine.,increase,risk
Ancrod,Vitamin E,Vitamin E may increase the anticoagulant activities of Ancrod.,increase,no risk
Ancrod,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ancrod.,decrease,no risk
Ancrod,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ancrod.,increase,risk
Ancrod,Vorinostat,The risk or severity of bleeding can be increased when Ancrod is combined with Vorinostat.,increase,risk
Ancrod,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Ancrod.,increase,risk
Ancrod,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ancrod.,increase,risk
Ancrod,Zidovudine,The risk or severity of bleeding can be increased when Ancrod is combined with Zidovudine.,increase,risk
Ancrod,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ancrod.,increase,risk
Matuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Obiltoxaximab.,increase,risk
Matuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Obinutuzumab.,increase,risk
Matuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Ocrelizumab.,increase,risk
Matuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Odesivimab.,increase,risk
Matuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Ofatumumab.,increase,risk
Matuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Olaratumab.,increase,risk
Matuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Matuzumab.,increase,risk
Matuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Matuzumab.,increase,no risk
Matuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Ublituximab.,increase,risk
Matuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Ustekinumab.,increase,risk
Matuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Matuzumab is combined with Vedolizumab.,increase,risk
Rupintrivir,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rupintrivir.,decrease,no risk
Rupintrivir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Rupintrivir.,decrease,no risk
Pleconaril,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pleconaril.,decrease,no risk
Pleconaril,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Pleconaril.,decrease,no risk
16-Bromoepiandrosterone,Beclomethasone dipropionate,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Beclomethasone dipropionate.,increase,risk
16-Bromoepiandrosterone,Betamethasone,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Betamethasone.,increase,risk
16-Bromoepiandrosterone,Betamethasone phosphate,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Betamethasone phosphate.,increase,risk
16-Bromoepiandrosterone,Budesonide,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Budesonide.,increase,risk
16-Bromoepiandrosterone,Hydrocortisone,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Hydrocortisone.,increase,risk
16-Bromoepiandrosterone,Hydrocortisone acetate,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Hydrocortisone acetate.,increase,risk
16-Bromoepiandrosterone,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Hydrocortisone butyrate.,increase,risk
16-Bromoepiandrosterone,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Hydrocortisone cypionate.,increase,risk
16-Bromoepiandrosterone,Hydrocortisone succinate,The risk or severity of edema formation can be increased when 16-Bromoepiandrosterone is combined with Hydrocortisone succinate.,increase,risk
Trabectedin,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Trabectedin.,increase,risk
Trabectedin,Belumosudil,The risk or severity of adverse effects can be increased when Trabectedin is combined with Belumosudil.,increase,risk
Trabectedin,Belzutifan,The serum concentration of Trabectedin can be decreased when it is combined with Belzutifan.,decrease,no risk
Trabectedin,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Trabectedin.,increase,risk
Trabectedin,Bendamustine,The risk or severity of adverse effects can be increased when Trabectedin is combined with Bendamustine.,increase,risk
Trabectedin,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Trabectedin.,increase,risk
Trabectedin,Benzatropine,The metabolism of Trabectedin can be decreased when combined with Benzatropine.,decrease,no risk
Trabectedin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Benzocaine.,increase,risk
Trabectedin,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Trabectedin.,increase,risk
Trabectedin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Benzyl alcohol.,increase,risk
Trabectedin,Bepridil,The metabolism of Trabectedin can be decreased when combined with Bepridil.,decrease,no risk
Trabectedin,Berotralstat,The serum concentration of Trabectedin can be increased when it is combined with Berotralstat.,increase,no risk
Trabectedin,Betamethasone,The metabolism of Trabectedin can be increased when combined with Betamethasone.,increase,no risk
Trabectedin,Betamethasone phosphate,The metabolism of Trabectedin can be increased when combined with Betamethasone phosphate.,increase,no risk
Trabectedin,Betaxolol,The metabolism of Trabectedin can be decreased when combined with Betaxolol.,decrease,no risk
Trabectedin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Trabectedin.,increase,risk
Trabectedin,Bexarotene,The metabolism of Trabectedin can be increased when combined with Bexarotene.,increase,no risk
Trabectedin,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bezafibrate is combined with Trabectedin.",increase,risk
Trabectedin,Bicalutamide,The metabolism of Trabectedin can be decreased when combined with Bicalutamide.,decrease,no risk
Trabectedin,Bifonazole,The metabolism of Trabectedin can be decreased when combined with Bifonazole.,decrease,no risk
Trabectedin,Bimekizumab,The metabolism of Trabectedin can be increased when combined with Bimekizumab.,increase,no risk
Trabectedin,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Trabectedin.,decrease,no risk
Trabectedin,Biperiden,The metabolism of Trabectedin can be decreased when combined with Biperiden.,decrease,no risk
Trabectedin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trabectedin.,increase,risk
Trabectedin,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Trabectedin.,increase,risk
Trabectedin,Blinatumomab,The risk or severity of adverse effects can be increased when Trabectedin is combined with Blinatumomab.,increase,risk
Trabectedin,Boceprevir,The metabolism of Trabectedin can be decreased when combined with Boceprevir.,decrease,no risk
Trabectedin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Trabectedin.",decrease,no risk
Trabectedin,Bortezomib,The metabolism of Trabectedin can be decreased when combined with Bortezomib.,decrease,no risk
Trabectedin,Bosentan,The metabolism of Trabectedin can be increased when combined with Bosentan.,increase,no risk
Trabectedin,Bosutinib,The metabolism of Trabectedin can be decreased when combined with Bosutinib.,decrease,no risk
Trabectedin,Brentuximab vedotin,The serum concentration of Trabectedin can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Trabectedin,Brexpiprazole,The metabolism of Trabectedin can be decreased when combined with Brexpiprazole.,decrease,no risk
Trabectedin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Trabectedin.,decrease,no risk
Trabectedin,Brodalumab,The risk or severity of adverse effects can be increased when Trabectedin is combined with Brodalumab.,increase,risk
Trabectedin,Bromazepam,The metabolism of Trabectedin can be decreased when combined with Bromazepam.,decrease,no risk
Trabectedin,Budesonide,The metabolism of Trabectedin can be increased when combined with Budesonide.,increase,no risk
Trabectedin,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Bumetanide is combined with Trabectedin.",increase,risk
Trabectedin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Bupivacaine.,increase,risk
Trabectedin,Buprenorphine,The metabolism of Trabectedin can be decreased when combined with Buprenorphine.,decrease,no risk
Trabectedin,Bupropion,The metabolism of Trabectedin can be decreased when combined with Bupropion.,decrease,no risk
Trabectedin,Buspirone,The metabolism of Trabectedin can be decreased when combined with Buspirone.,decrease,no risk
Trabectedin,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Trabectedin.,increase,risk
Trabectedin,Butacaine,The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Butacaine.,increase,risk
Trabectedin,Butalbital,The metabolism of Trabectedin can be increased when combined with Butalbital.,increase,no risk
Trabectedin,Butamben,The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Butamben.,increase,risk
Trabectedin,Galantamine,The metabolism of Trabectedin can be decreased when combined with Galantamine.,decrease,no risk
Trabectedin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Trabectedin.",increase,risk
Trabectedin,Gefitinib,The metabolism of Trabectedin can be decreased when combined with Gefitinib.,decrease,no risk
Trabectedin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Trabectedin.,increase,risk
Trabectedin,Gemfibrozil,The metabolism of Trabectedin can be decreased when combined with Gemfibrozil.,decrease,no risk
Trabectedin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Trabectedin.,increase,risk
Trabectedin,Gilteritinib,The metabolism of Trabectedin can be decreased when combined with Gilteritinib.,decrease,no risk
Trabectedin,Ginkgo biloba,The metabolism of Trabectedin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Trabectedin,Givosiran,The serum concentration of Trabectedin can be increased when it is combined with Givosiran.,increase,no risk
Trabectedin,Glatiramer,The risk or severity of adverse effects can be increased when Trabectedin is combined with Glatiramer.,increase,risk
Trabectedin,Glecaprevir,The metabolism of Trabectedin can be decreased when combined with Glecaprevir.,decrease,no risk
Trabectedin,Gliclazide,The metabolism of Trabectedin can be decreased when combined with Gliclazide.,decrease,no risk
Trabectedin,Glimepiride,The metabolism of Trabectedin can be decreased when combined with Glimepiride.,decrease,no risk
Trabectedin,Glipizide,The metabolism of Trabectedin can be decreased when combined with Glipizide.,decrease,no risk
Trabectedin,Gliquidone,The metabolism of Trabectedin can be decreased when combined with Gliquidone.,decrease,no risk
Trabectedin,Glofitamab,The serum concentration of Trabectedin can be increased when it is combined with Glofitamab.,increase,no risk
Trabectedin,Glyburide,The metabolism of Trabectedin can be decreased when combined with Glyburide.,decrease,no risk
Trabectedin,Glycerin,The metabolism of Trabectedin can be increased when combined with Glycerin.,increase,no risk
Trabectedin,Glycerol phenylbutyrate,The metabolism of Trabectedin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Trabectedin,Golimumab,The metabolism of Trabectedin can be increased when combined with Golimumab.,increase,no risk
Trabectedin,Grapefruit,The serum concentration of Trabectedin can be increased when it is combined with Grapefruit.,increase,no risk
Trabectedin,Griseofulvin,The metabolism of Trabectedin can be increased when combined with Griseofulvin.,increase,no risk
Trabectedin,Guselkumab,The risk or severity of adverse effects can be increased when Trabectedin is combined with Guselkumab.,increase,risk
Trabectedin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Trabectedin.,decrease,no risk
Trabectedin,Halofantrine,The metabolism of Trabectedin can be decreased when combined with Halofantrine.,decrease,no risk
Trabectedin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Trabectedin.,increase,no risk
Trabectedin,Halothane,The metabolism of Trabectedin can be decreased when combined with Halothane.,decrease,no risk
Trabectedin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Trabectedin.,increase,risk
Trabectedin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Trabectedin.,decrease,no risk
Trabectedin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Trabectedin.,decrease,no risk
Trabectedin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Trabectedin.,increase,risk
Trabectedin,Hydralazine,The serum concentration of Trabectedin can be increased when it is combined with Hydralazine.,increase,no risk
Trabectedin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Trabectedin.,increase,risk
Trabectedin,Hydrocodone,The metabolism of Trabectedin can be decreased when combined with Hydrocodone.,decrease,no risk
Trabectedin,Hydrocortamate,The metabolism of Trabectedin can be increased when combined with Hydrocortamate.,increase,no risk
Trabectedin,Hydrocortisone,The metabolism of Trabectedin can be increased when combined with Hydrocortisone.,increase,no risk
Trabectedin,Hydrocortisone acetate,The metabolism of Trabectedin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Trabectedin,Hydrocortisone butyrate,The metabolism of Trabectedin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Trabectedin,Hydrocortisone succinate,The metabolism of Trabectedin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Trabectedin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Trabectedin.,increase,risk
Trabectedin,Hydromorphone,The metabolism of Trabectedin can be decreased when combined with Hydromorphone.,decrease,no risk
Trabectedin,Hydroxychloroquine,The metabolism of Trabectedin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Trabectedin,Hydroxyprogesterone caproate,The metabolism of Trabectedin can be increased when combined with Hydroxyprogesterone caproate.,increase,no risk
Trabectedin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Trabectedin.,increase,risk
Trabectedin,Hydroxyzine,The metabolism of Trabectedin can be decreased when combined with Hydroxyzine.,decrease,no risk
Trabectedin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Trabectedin.,decrease,no risk
Trabectedin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Trabectedin.,decrease,no risk
Trabectedin,Ketamine,The metabolism of Trabectedin can be decreased when combined with Ketamine.,decrease,no risk
Trabectedin,Ketazolam,The serum concentration of Trabectedin can be increased when it is combined with Ketazolam.,increase,no risk
Trabectedin,Ketoconazole,The metabolism of Trabectedin can be decreased when combined with Ketoconazole.,decrease,no risk
Trabectedin,Ketorolac,The metabolism of Trabectedin can be decreased when combined with Ketorolac.,decrease,no risk
Trabectedin,Obinutuzumab,The risk or severity of adverse effects can be increased when Trabectedin is combined with Obinutuzumab.,increase,risk
Trabectedin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Trabectedin.,increase,no risk
Trabectedin,Octreotide,The serum concentration of Trabectedin can be increased when it is combined with Octreotide.,increase,no risk
Trabectedin,Ofatumumab,The risk or severity of adverse effects can be increased when Trabectedin is combined with Ofatumumab.,increase,risk
Trabectedin,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Trabectedin.",increase,risk
Trabectedin,Olanzapine,The metabolism of Trabectedin can be decreased when combined with Olanzapine.,decrease,no risk
Trabectedin,Olaparib,The metabolism of Trabectedin can be decreased when combined with Olaparib.,decrease,no risk
Trabectedin,Oliceridine,The metabolism of Trabectedin can be decreased when combined with Oliceridine.,decrease,no risk
Trabectedin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Trabectedin.,decrease,no risk
Trabectedin,Olutasidenib,The metabolism of Trabectedin can be increased when combined with Olutasidenib.,increase,no risk
Trabectedin,Omaveloxolone,The serum concentration of Trabectedin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Trabectedin,Omeprazole,The metabolism of Trabectedin can be decreased when combined with Omeprazole.,decrease,no risk
Trabectedin,Ondansetron,The metabolism of Trabectedin can be decreased when combined with Ondansetron.,decrease,no risk
Trabectedin,Opium,The metabolism of Trabectedin can be decreased when combined with Opium.,decrease,no risk
Trabectedin,Oritavancin,The metabolism of Trabectedin can be increased when combined with Oritavancin.,increase,no risk
Trabectedin,Orphenadrine,The metabolism of Trabectedin can be decreased when combined with Orphenadrine.,decrease,no risk
Trabectedin,Osilodrostat,The serum concentration of Trabectedin can be increased when it is combined with Osilodrostat.,increase,no risk
Trabectedin,Osimertinib,The metabolism of Trabectedin can be decreased when combined with Osimertinib.,decrease,no risk
Trabectedin,Ospemifene,The metabolism of Trabectedin can be decreased when combined with Ospemifene.,decrease,no risk
Trabectedin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Trabectedin.,increase,risk
Trabectedin,Oxamniquine,The metabolism of Trabectedin can be decreased when combined with Oxamniquine.,decrease,no risk
Trabectedin,Oxandrolone,The metabolism of Trabectedin can be decreased when combined with Oxandrolone.,decrease,no risk
Trabectedin,Oxcarbazepine,The metabolism of Trabectedin can be increased when combined with Oxcarbazepine.,increase,no risk
Trabectedin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trabectedin is combined with Oxetacaine.,increase,risk
Fontolizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Obiltoxaximab.,increase,risk
Fontolizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Obinutuzumab.,increase,risk
Fontolizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Ocrelizumab.,increase,risk
Fontolizumab,Odesivimab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Odesivimab.,increase,risk
Fontolizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Ofatumumab.,increase,risk
Fontolizumab,Olaratumab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Olaratumab.,increase,risk
Fontolizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fontolizumab.,increase,risk
Fontolizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Fontolizumab.,increase,no risk
Fontolizumab,Ublituximab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Ublituximab.,increase,risk
Fontolizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Ustekinumab.,increase,risk
Fontolizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Fontolizumab is combined with Vedolizumab.,increase,risk
NN344,Gatifloxacin,The therapeutic efficacy of NN344 can be increased when used in combination with Gatifloxacin.,increase,no risk
NN344,Gefapixant,The risk or severity of hypoglycemia can be increased when Gefapixant is combined with NN344.,increase,risk
NN344,Gemfibrozil,The risk or severity of hypoglycemia can be increased when Gemfibrozil is combined with NN344.,increase,risk
NN344,Gemifloxacin,The therapeutic efficacy of NN344 can be increased when used in combination with Gemifloxacin.,increase,no risk
NN344,Gestrinone,The therapeutic efficacy of NN344 can be decreased when used in combination with Gestrinone.,decrease,no risk
NN344,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with NN344.,increase,risk
NN344,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with NN344.,increase,risk
NN344,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with NN344.,increase,risk
NN344,Gliquidone,The risk or severity of hypoglycemia can be increased when Gliquidone is combined with NN344.,increase,risk
NN344,Glucagon,The therapeutic efficacy of NN344 can be decreased when used in combination with Glucagon.,decrease,no risk
NN344,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with NN344.,increase,risk
NN344,Glymidine,The risk or severity of hypoglycemia can be increased when Glymidine is combined with NN344.,increase,risk
NN344,Goserelin,The therapeutic efficacy of NN344 can be decreased when used in combination with Goserelin.,decrease,no risk
NN344,Grepafloxacin,The therapeutic efficacy of NN344 can be increased when used in combination with Grepafloxacin.,increase,no risk
NN344,Guanabenz,The metabolism of Guanabenz can be increased when combined with NN344.,increase,no risk
NN344,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with NN344.,increase,risk
NN344,Haloperidol,The therapeutic efficacy of NN344 can be decreased when used in combination with Haloperidol.,decrease,no risk
NN344,Histrelin,The therapeutic efficacy of NN344 can be decreased when used in combination with Histrelin.,decrease,no risk
NN344,Hydrochlorothiazide,The risk or severity of hypoglycemia can be increased when Hydrochlorothiazide is combined with NN344.,increase,risk
NN344,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with NN344.,increase,risk
NN344,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with NN344.,increase,risk
NN344,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with NN344.,increase,risk
NN344,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with NN344.,increase,risk
NN344,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with NN344.,increase,risk
NN344,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with NN344.,increase,risk
NN344,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with NN344.,increase,risk
NN344,Hydroflumethiazide,The risk or severity of hypoglycemia can be increased when Hydroflumethiazide is combined with NN344.,increase,risk
NN344,Hydroxychloroquine,The therapeutic efficacy of NN344 can be increased when used in combination with Hydroxychloroquine.,increase,no risk
NN344,Hydroxyprogesterone caproate,The therapeutic efficacy of NN344 can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
NN344,Octreotide,The therapeutic efficacy of NN344 can be decreased when used in combination with Octreotide.,decrease,no risk
NN344,Ofloxacin,The therapeutic efficacy of NN344 can be increased when used in combination with Ofloxacin.,increase,no risk
NN344,Olanzapine,The therapeutic efficacy of NN344 can be decreased when used in combination with Olanzapine.,decrease,no risk
NN344,Olsalazine,The risk or severity of hypoglycemia can be increased when Olsalazine is combined with NN344.,increase,risk
NN344,Ondansetron,The metabolism of Ondansetron can be increased when combined with NN344.,increase,no risk
NN344,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of NN344.,increase,no risk
NN344,Oxprenolol,The therapeutic efficacy of NN344 can be increased when used in combination with Oxprenolol.,increase,no risk
NN344,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with NN344.,increase,no risk
NN344,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of NN344.,increase,no risk
NN344,Quetiapine,The therapeutic efficacy of NN344 can be decreased when used in combination with Quetiapine.,decrease,no risk
NN344,Quinapril,The risk or severity of hypoglycemia can be increased when Quinapril is combined with NN344.,increase,risk
NN344,Quinestrol,The therapeutic efficacy of NN344 can be decreased when used in combination with Quinestrol.,decrease,no risk
NN344,Quinethazone,The risk or severity of hypoglycemia can be increased when Quinethazone is combined with NN344.,increase,risk
NN344,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with NN344.,increase,risk
NN344,Quinupramine,Quinupramine may decrease the hypoglycemic activities of NN344.,decrease,no risk
NN344,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with NN344.,increase,risk
NN344,Udenafil,The risk or severity of hypoglycemia can be increased when Udenafil is combined with NN344.,increase,risk
NN344,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with NN344.,increase,risk
NN344,Valdecoxib,The risk or severity of hypoglycemia can be increased when Valdecoxib is combined with NN344.,increase,risk
NN344,Valsartan,The risk or severity of hypoglycemia can be increased when Valsartan is combined with NN344.,increase,risk
NN344,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with NN344.,increase,risk
NN344,Vemurafenib,The risk or severity of hypoglycemia can be increased when Vemurafenib is combined with NN344.,increase,risk
NN344,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with NN344.,increase,risk
NN344,Verapamil,The metabolism of Verapamil can be increased when combined with NN344.,increase,no risk
NN344,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with NN344.,increase,risk
NN344,Vorinostat,The therapeutic efficacy of NN344 can be decreased when used in combination with Vorinostat.,decrease,no risk
NN344,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with NN344.,increase,no risk
NN344,Warfarin,The metabolism of Warfarin can be increased when combined with NN344.,increase,no risk
NN344,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with NN344.,increase,risk
NN344,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with NN344.,increase,risk
NN344,Zileuton,The metabolism of Zileuton can be increased when combined with NN344.,increase,no risk
NN344,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with NN344.,increase,risk
NN344,Ziprasidone,The therapeutic efficacy of NN344 can be decreased when used in combination with Ziprasidone.,decrease,no risk
NN344,Zofenopril,The risk or severity of hypoglycemia can be increased when Zofenopril is combined with NN344.,increase,risk
NN344,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with NN344.,increase,no risk
NN344,Zolpidem,The metabolism of Zolpidem can be increased when combined with NN344.,increase,no risk
NN344,Zonisamide,The risk or severity of hypoglycemia can be increased when Zonisamide is combined with NN344.,increase,risk
Elsamitrucin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Benzocaine.,increase,risk
Elsamitrucin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Benzyl alcohol.,increase,risk
Elsamitrucin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Bupivacaine.,increase,risk
Elsamitrucin,Butacaine,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Butacaine.,increase,risk
Elsamitrucin,Butamben,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Butamben.,increase,risk
Elsamitrucin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Oxetacaine.,increase,risk
Elsamitrucin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Elsamitrucin is combined with Oxybuprocaine.,increase,risk
Bavituximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Bavituximab is combined with Human varicella-zoster immune globulin.,increase,risk
Bavituximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Obiltoxaximab.,increase,risk
Bavituximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Obinutuzumab.,increase,risk
Bavituximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Ocrelizumab.,increase,risk
Bavituximab,Odesivimab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Odesivimab.,increase,risk
Bavituximab,Ofatumumab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Ofatumumab.,increase,risk
Bavituximab,Olaratumab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Olaratumab.,increase,risk
Bavituximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bavituximab.,increase,risk
Bavituximab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bavituximab is combined with Oxetacaine.,increase,risk
Bavituximab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bavituximab is combined with Oxybuprocaine.,increase,risk
Bavituximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Bavituximab.,increase,no risk
Bavituximab,Ublituximab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Ublituximab.,increase,risk
Bavituximab,Ustekinumab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Ustekinumab.,increase,risk
Bavituximab,Vedolizumab,The risk or severity of adverse effects can be increased when Bavituximab is combined with Vedolizumab.,increase,risk
Lobeline,Betaine,The risk or severity of adverse effects can be increased when Betaine is combined with Lobeline.,increase,risk
Lobeline,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Lobeline.,increase,risk
Lobeline,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Lobeline.,increase,risk
Lobeline,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Lobeline.,increase,risk
Lobeline,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Lobeline.,increase,risk
Lobeline,Gentamicin,The therapeutic efficacy of Lobeline can be decreased when used in combination with Gentamicin.,decrease,no risk
Lobeline,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Lobeline.,increase,risk
Lobeline,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Lobeline.,increase,risk
Lobeline,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Lobeline.,increase,risk
Lobeline,Kanamycin,The therapeutic efficacy of Lobeline can be decreased when used in combination with Kanamycin.,decrease,no risk
Lobeline,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Lobeline.,increase,risk
Lobeline,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Lobeline.,increase,risk
CR002,Obiltoxaximab,The risk or severity of adverse effects can be increased when CR002 is combined with Obiltoxaximab.,increase,risk
CR002,Obinutuzumab,The risk or severity of adverse effects can be increased when CR002 is combined with Obinutuzumab.,increase,risk
CR002,Ocrelizumab,The risk or severity of adverse effects can be increased when CR002 is combined with Ocrelizumab.,increase,risk
CR002,Odesivimab,The risk or severity of adverse effects can be increased when CR002 is combined with Odesivimab.,increase,risk
CR002,Ofatumumab,The risk or severity of adverse effects can be increased when CR002 is combined with Ofatumumab.,increase,risk
CR002,Olaratumab,The risk or severity of adverse effects can be increased when CR002 is combined with Olaratumab.,increase,risk
CR002,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with CR002.,increase,risk
CR002,Quinestrol,Quinestrol may increase the thrombogenic activities of CR002.,increase,no risk
CR002,Ublituximab,The risk or severity of adverse effects can be increased when CR002 is combined with Ublituximab.,increase,risk
CR002,Ustekinumab,The risk or severity of adverse effects can be increased when CR002 is combined with Ustekinumab.,increase,risk
CR002,Vedolizumab,The risk or severity of adverse effects can be increased when CR002 is combined with Vedolizumab.,increase,risk
OXI-4503,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of OXI-4503 resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
PEV3A,Gemtuzumab ozogamicin,The therapeutic efficacy of PEV3A can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
PEV3A,Glatiramer,The therapeutic efficacy of PEV3A can be decreased when used in combination with Glatiramer.,decrease,no risk
PEV3A,Golimumab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Golimumab.,decrease,no risk
PEV3A,Guselkumab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Guselkumab.,decrease,no risk
PEV3A,Hydrocortisone,The therapeutic efficacy of PEV3A can be decreased when used in combination with Hydrocortisone.,decrease,no risk
PEV3A,Hydrocortisone acetate,The therapeutic efficacy of PEV3A can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
PEV3A,Hydrocortisone butyrate,The therapeutic efficacy of PEV3A can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
PEV3A,Hydrocortisone succinate,The therapeutic efficacy of PEV3A can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
PEV3A,Hydroxychloroquine,The therapeutic efficacy of PEV3A can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
PEV3A,Hydroxyurea,The therapeutic efficacy of PEV3A can be decreased when used in combination with Hydroxyurea.,decrease,no risk
PEV3A,Obinutuzumab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Obinutuzumab.,decrease,no risk
PEV3A,Ocrelizumab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Ocrelizumab.,decrease,no risk
PEV3A,Ofatumumab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Ofatumumab.,decrease,no risk
PEV3A,Olaparib,The therapeutic efficacy of PEV3A can be decreased when used in combination with Olaparib.,decrease,no risk
PEV3A,Oxaliplatin,The therapeutic efficacy of PEV3A can be decreased when used in combination with Oxaliplatin.,decrease,no risk
PEV3A,Ozanimod,The therapeutic efficacy of PEV3A can be decreased when used in combination with Ozanimod.,decrease,no risk
PEV3A,Ublituximab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Ublituximab.,decrease,no risk
PEV3A,Upadacitinib,The therapeutic efficacy of PEV3A can be decreased when used in combination with Upadacitinib.,decrease,no risk
PEV3A,Vedolizumab,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vedolizumab.,decrease,no risk
PEV3A,Vilanterol,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vilanterol.,decrease,no risk
PEV3A,Vinblastine,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vinblastine.,decrease,no risk
PEV3A,Vincristine,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vincristine.,decrease,no risk
PEV3A,Vindesine,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vindesine.,decrease,no risk
PEV3A,Vinorelbine,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vinorelbine.,decrease,no risk
PEV3A,Voclosporin,The therapeutic efficacy of PEV3A can be decreased when used in combination with Voclosporin.,decrease,no risk
PEV3A,Vorinostat,The therapeutic efficacy of PEV3A can be decreased when used in combination with Vorinostat.,decrease,no risk
PEV3A,Zidovudine,The therapeutic efficacy of PEV3A can be decreased when used in combination with Zidovudine.,decrease,no risk
NGX267,Betaine,The risk or severity of adverse effects can be increased when Betaine is combined with NGX267.,increase,risk
NGX267,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with NGX267.,increase,risk
NGX267,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with NGX267.,increase,risk
NGX267,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with NGX267.,increase,risk
NGX267,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with NGX267.,increase,risk
NGX267,Gentamicin,The therapeutic efficacy of NGX267 can be decreased when used in combination with Gentamicin.,decrease,no risk
NGX267,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with NGX267.,increase,risk
NGX267,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with NGX267.,increase,risk
NGX267,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with NGX267.,increase,risk
NGX267,Kanamycin,The therapeutic efficacy of NGX267 can be decreased when used in combination with Kanamycin.,decrease,no risk
NGX267,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with NGX267.,increase,risk
NGX267,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with NGX267.,increase,risk
Cabozantinib,Gemfibrozil,The metabolism of Cabozantinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Cabozantinib,Ginkgo biloba,The metabolism of Cabozantinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Cabozantinib,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Gliclazide,The metabolism of Cabozantinib can be decreased when combined with Gliclazide.,decrease,no risk
Cabozantinib,Glimepiride,The metabolism of Cabozantinib can be decreased when combined with Glimepiride.,decrease,no risk
Cabozantinib,Glipizide,The metabolism of Cabozantinib can be decreased when combined with Glipizide.,decrease,no risk
Cabozantinib,Gliquidone,The metabolism of Cabozantinib can be decreased when combined with Gliquidone.,decrease,no risk
Cabozantinib,Glofitamab,The serum concentration of Cabozantinib can be increased when it is combined with Glofitamab.,increase,no risk
Cabozantinib,Glyburide,The metabolism of Cabozantinib can be decreased when combined with Glyburide.,decrease,no risk
Cabozantinib,Golimumab,The metabolism of Cabozantinib can be increased when combined with Golimumab.,increase,no risk
Cabozantinib,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cabozantinib.,increase,no risk
Cabozantinib,Halothane,The metabolism of Cabozantinib can be decreased when combined with Halothane.,decrease,no risk
Cabozantinib,Hydrocortisone,The metabolism of Cabozantinib can be increased when combined with Hydrocortisone.,increase,no risk
Cabozantinib,Hydromorphone,The metabolism of Cabozantinib can be decreased when combined with Hydromorphone.,decrease,no risk
Cabozantinib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Ketamine,The metabolism of Ketamine can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Ketoconazole,The metabolism of Cabozantinib can be decreased when combined with Ketoconazole.,decrease,no risk
Cabozantinib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Olanzapine,The metabolism of Cabozantinib can be decreased when combined with Olanzapine.,decrease,no risk
Cabozantinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Omaveloxolone,The serum concentration of Cabozantinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cabozantinib,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Ondansetron,The metabolism of Cabozantinib can be decreased when combined with Ondansetron.,decrease,no risk
Cabozantinib,Oritavancin,The metabolism of Cabozantinib can be decreased when combined with Oritavancin.,decrease,no risk
Cabozantinib,Ospemifene,The metabolism of Cabozantinib can be decreased when combined with Ospemifene.,decrease,no risk
Cabozantinib,Oxandrolone,The metabolism of Cabozantinib can be decreased when combined with Oxandrolone.,decrease,no risk
Cabozantinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cabozantinib is combined with Oxetacaine.,increase,risk
Cabozantinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cabozantinib is combined with Oxybuprocaine.,increase,risk
Cabozantinib,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Quinidine,The metabolism of Cabozantinib can be decreased when combined with Quinidine.,decrease,no risk
Cabozantinib,Quinine,The metabolism of Quinine can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Vadadustat,The serum concentration of Cabozantinib can be increased when it is combined with Vadadustat.,increase,no risk
Cabozantinib,Valdecoxib,The metabolism of Cabozantinib can be decreased when combined with Valdecoxib.,decrease,no risk
Cabozantinib,Valproic acid,The metabolism of Cabozantinib can be decreased when combined with Valproic acid.,decrease,no risk
Cabozantinib,Valsartan,The metabolism of Cabozantinib can be decreased when combined with Valsartan.,decrease,no risk
Cabozantinib,Vardenafil,The metabolism of Cabozantinib can be decreased when combined with Vardenafil.,decrease,no risk
Cabozantinib,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Vemurafenib,The metabolism of Cabozantinib can be decreased when combined with Vemurafenib.,decrease,no risk
Cabozantinib,Venetoclax,The metabolism of Cabozantinib can be decreased when combined with Venetoclax.,decrease,no risk
Cabozantinib,Verapamil,The metabolism of Cabozantinib can be decreased when combined with Verapamil.,decrease,no risk
Cabozantinib,Viloxazine,The metabolism of Cabozantinib can be decreased when combined with Viloxazine.,decrease,no risk
Cabozantinib,Voriconazole,The metabolism of Cabozantinib can be decreased when combined with Voriconazole.,decrease,no risk
Cabozantinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Warfarin,The metabolism of Cabozantinib can be increased when combined with Warfarin.,increase,no risk
Cabozantinib,Ximelagatran,The metabolism of Cabozantinib can be decreased when combined with Ximelagatran.,decrease,no risk
Cabozantinib,Zafirlukast,The metabolism of Cabozantinib can be decreased when combined with Zafirlukast.,decrease,no risk
Cabozantinib,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Cabozantinib.,decrease,no risk
Cabozantinib,Zileuton,The metabolism of Cabozantinib can be decreased when combined with Zileuton.,decrease,no risk
Cabozantinib,Zimelidine,The metabolism of Cabozantinib can be decreased when combined with Zimelidine.,decrease,no risk
Cabozantinib,Ziprasidone,The metabolism of Cabozantinib can be decreased when combined with Ziprasidone.,decrease,no risk
Cabozantinib,Zolpidem,The metabolism of Cabozantinib can be decreased when combined with Zolpidem.,decrease,no risk
Cabozantinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Cabozantinib.,decrease,no risk
Pretomanid,Gadoxetic acid,The serum concentration of Gadoxetic acid can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Ginkgo biloba,The metabolism of Pretomanid can be decreased when combined with Ginkgo biloba.,decrease,no risk
Pretomanid,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Glofitamab,The serum concentration of Pretomanid can be increased when it is combined with Glofitamab.,increase,no risk
Pretomanid,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Glycerol phenylbutyrate,The metabolism of Pretomanid can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Pretomanid,Golimumab,The metabolism of Pretomanid can be increased when combined with Golimumab.,increase,no risk
Pretomanid,Grapefruit,The metabolism of Pretomanid can be decreased when combined with Grapefruit.,decrease,no risk
Pretomanid,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Griseofulvin,The metabolism of Pretomanid can be increased when combined with Griseofulvin.,increase,no risk
Pretomanid,Haloperidol,The serum concentration of Pretomanid can be increased when it is combined with Haloperidol.,increase,no risk
Pretomanid,Hydralazine,The metabolism of Pretomanid can be decreased when combined with Hydralazine.,decrease,no risk
Pretomanid,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Hydrocortamate,The metabolism of Pretomanid can be increased when combined with Hydrocortamate.,increase,no risk
Pretomanid,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Hydrocortisone acetate,The metabolism of Pretomanid can be increased when combined with Hydrocortisone acetate.,increase,no risk
Pretomanid,Hydrocortisone butyrate,The metabolism of Pretomanid can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Pretomanid,Hydrocortisone succinate,The metabolism of Pretomanid can be increased when combined with Hydrocortisone succinate.,increase,no risk
Pretomanid,Ketazolam,The metabolism of Pretomanid can be decreased when combined with Ketazolam.,decrease,no risk
Pretomanid,Ketoconazole,The metabolism of Pretomanid can be decreased when combined with Ketoconazole.,decrease,no risk
Pretomanid,Octreotide,The metabolism of Pretomanid can be decreased when combined with Octreotide.,decrease,no risk
Pretomanid,Olaparib,The metabolism of Olaparib can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Olutasidenib,The metabolism of Pretomanid can be increased when combined with Olutasidenib.,increase,no risk
Pretomanid,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Omaveloxolone,The serum concentration of Pretomanid can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Pretomanid,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Oritavancin,The metabolism of Pretomanid can be increased when combined with Oritavancin.,increase,no risk
Pretomanid,Orphenadrine,The metabolism of Pretomanid can be decreased when combined with Orphenadrine.,decrease,no risk
Pretomanid,Oseltamivir,The serum concentration of Oseltamivir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Osilodrostat,The metabolism of Pretomanid can be decreased when combined with Osilodrostat.,decrease,no risk
Pretomanid,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Oxcarbazepine,The metabolism of Pretomanid can be increased when combined with Oxcarbazepine.,increase,no risk
Pretomanid,Oxybutynin,The metabolism of Pretomanid can be decreased when combined with Oxybutynin.,decrease,no risk
Pretomanid,Oxytetracycline,The serum concentration of Oxytetracycline can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Ozanimod,The serum concentration of Ozanimod can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Quinapril,The serum concentration of Quinapril can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Quinine,The serum concentration of Quinine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Quinupristin,The metabolism of Pretomanid can be decreased when combined with Quinupristin.,decrease,no risk
Pretomanid,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Valaciclovir,The serum concentration of Valaciclovir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Valsartan,The serum concentration of Valsartan can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Venetoclax,The serum concentration of Pretomanid can be increased when it is combined with Venetoclax.,increase,no risk
Pretomanid,Verapamil,The serum concentration of Pretomanid can be increased when it is combined with Verapamil.,increase,no risk
Pretomanid,Viloxazine,The metabolism of Pretomanid can be decreased when combined with Viloxazine.,decrease,no risk
Pretomanid,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vindesine,The metabolism of Vindesine can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Vitamin E,The metabolism of Pretomanid can be increased when combined with Vitamin E.,increase,no risk
Pretomanid,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Voriconazole,The serum concentration of Pretomanid can be increased when it is combined with Voriconazole.,increase,no risk
Pretomanid,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Warfarin,The metabolism of Warfarin can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Zafirlukast,The metabolism of Pretomanid can be decreased when combined with Zafirlukast.,decrease,no risk
Pretomanid,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Pretomanid.,decrease,no risk
Pretomanid,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Pretomanid.,increase,no risk
Pretomanid,Zimelidine,The serum concentration of Pretomanid can be increased when it is combined with Zimelidine.,increase,no risk
Pretomanid,Ziprasidone,The serum concentration of Pretomanid can be increased when it is combined with Ziprasidone.,increase,no risk
Pretomanid,Zuclopenthixol,The metabolism of Pretomanid can be decreased when combined with Zuclopenthixol.,decrease,no risk
Albiglutide,Gatifloxacin,The therapeutic efficacy of Albiglutide can be increased when used in combination with Gatifloxacin.,increase,no risk
Albiglutide,Gefapixant,The therapeutic efficacy of Albiglutide can be increased when used in combination with Gefapixant.,increase,no risk
Albiglutide,Gemifloxacin,The therapeutic efficacy of Albiglutide can be increased when used in combination with Gemifloxacin.,increase,no risk
Albiglutide,Gliclazide,Albiglutide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Albiglutide,Glimepiride,Albiglutide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Albiglutide,Glipizide,Albiglutide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Albiglutide,Gliquidone,Albiglutide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Albiglutide,Glyburide,Albiglutide may increase the hypoglycemic activities of Glyburide.,increase,no risk
Albiglutide,Glymidine,The therapeutic efficacy of Albiglutide can be increased when used in combination with Glymidine.,increase,no risk
Albiglutide,Goserelin,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Goserelin.,decrease,no risk
Albiglutide,Grepafloxacin,The therapeutic efficacy of Albiglutide can be increased when used in combination with Grepafloxacin.,increase,no risk
Albiglutide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Albiglutide.,increase,risk
Albiglutide,Haloperidol,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Haloperidol.,decrease,no risk
Albiglutide,Histrelin,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Histrelin.,decrease,no risk
Albiglutide,Hydrochlorothiazide,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Albiglutide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Albiglutide.,increase,risk
Albiglutide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Albiglutide.,increase,risk
Albiglutide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Albiglutide.,increase,risk
Albiglutide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Albiglutide.,increase,risk
Albiglutide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Albiglutide.,increase,risk
Albiglutide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Albiglutide.,increase,risk
Albiglutide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Albiglutide.,increase,risk
Albiglutide,Hydroflumethiazide,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Albiglutide,Hydroxychloroquine,The therapeutic efficacy of Albiglutide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Albiglutide,Hydroxyprogesterone caproate,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Albiglutide,Octreotide,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Octreotide.,decrease,no risk
Albiglutide,Ofloxacin,The therapeutic efficacy of Albiglutide can be increased when used in combination with Ofloxacin.,increase,no risk
Albiglutide,Olanzapine,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Olanzapine.,decrease,no risk
Albiglutide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Albiglutide.,increase,no risk
Albiglutide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Albiglutide.,increase,no risk
Albiglutide,Oxprenolol,The therapeutic efficacy of Albiglutide can be increased when used in combination with Oxprenolol.,increase,no risk
Albiglutide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Albiglutide.,increase,no risk
Albiglutide,Quetiapine,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Quetiapine.,decrease,no risk
Albiglutide,Quinethazone,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Quinethazone.,decrease,no risk
Albiglutide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Albiglutide.,increase,risk
Albiglutide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Albiglutide.,decrease,no risk
Albiglutide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Albiglutide.,increase,risk
Albiglutide,Udenafil,The therapeutic efficacy of Albiglutide can be increased when used in combination with Udenafil.,increase,no risk
Albiglutide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Albiglutide.,increase,risk
Albiglutide,Valdecoxib,The therapeutic efficacy of Albiglutide can be increased when used in combination with Valdecoxib.,increase,no risk
Albiglutide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Albiglutide.,increase,risk
Albiglutide,Vemurafenib,The therapeutic efficacy of Albiglutide can be increased when used in combination with Vemurafenib.,increase,no risk
Albiglutide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Albiglutide.,increase,risk
Albiglutide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Albiglutide.,increase,risk
Albiglutide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Vildagliptin is combined with Albiglutide.,increase,risk
Albiglutide,Vorinostat,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Vorinostat.,decrease,no risk
Albiglutide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Albiglutide.,increase,risk
Albiglutide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Albiglutide.,increase,risk
Albiglutide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Albiglutide.,increase,risk
Albiglutide,Ziprasidone,The therapeutic efficacy of Albiglutide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Albiglutide,Zonisamide,The therapeutic efficacy of Albiglutide can be increased when used in combination with Zonisamide.,increase,no risk
Vintafolide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Benzocaine.,increase,risk
Vintafolide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Benzyl alcohol.,increase,risk
Vintafolide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Bupivacaine.,increase,risk
Vintafolide,Butacaine,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Butacaine.,increase,risk
Vintafolide,Butamben,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Butamben.,increase,risk
Vintafolide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Oxetacaine.,increase,risk
Vintafolide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vintafolide is combined with Oxybuprocaine.,increase,risk
Vintafolide,Voriconazole,The metabolism of Vintafolide can be decreased when combined with Voriconazole.,decrease,no risk
Brincidofovir,Valsartan,The serum concentration of Brincidofovir can be increased when it is combined with Valsartan.,increase,no risk
Brincidofovir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Brincidofovir.,decrease,no risk
Brincidofovir,Velpatasvir,The serum concentration of Brincidofovir can be increased when it is combined with Velpatasvir.,increase,no risk
Brincidofovir,Venetoclax,The serum concentration of Brincidofovir can be increased when it is combined with Venetoclax.,increase,no risk
Brincidofovir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Brincidofovir.,decrease,no risk
Brincidofovir,Vinblastine,The serum concentration of Brincidofovir can be increased when it is combined with Vinblastine.,increase,no risk
Brincidofovir,Vincristine,The serum concentration of Brincidofovir can be increased when it is combined with Vincristine.,increase,no risk
Brincidofovir,Voxilaprevir,The serum concentration of Brincidofovir can be increased when it is combined with Voxilaprevir.,increase,no risk
Brincidofovir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Brincidofovir.,decrease,no risk
Sparsentan,Gefitinib,Sparsentan may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Sparsentan,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Glasdegib,Sparsentan may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Sparsentan,Glecaprevir,Sparsentan may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Sparsentan,Gliclazide,The serum concentration of Gliclazide can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Glimepiride,The serum concentration of Glimepiride can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Glipizide,The serum concentration of Glipizide can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Gliquidone,The serum concentration of Gliquidone can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Glofitamab,The serum concentration of Sparsentan can be increased when it is combined with Glofitamab.,increase,no risk
Sparsentan,Glyburide,The serum concentration of Glyburide can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Glycol salicylate,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Sparsentan.,increase,risk
Sparsentan,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Halothane,The serum concentration of Halothane can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Sparsentan.,increase,risk
Sparsentan,Hydrochlorothiazide,Hydrochlorothiazide may increase the hypotensive and Electrolyte Disturbance activities of Sparsentan.,increase,no risk
Sparsentan,Hydrocodone,The serum concentration of Hydrocodone can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Hydroflumethiazide,Hydroflumethiazide may increase the hypotensive and Electrolyte Disturbance activities of Sparsentan.,increase,no risk
Sparsentan,Hydromorphone,The serum concentration of Hydromorphone can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Hydrotalcite,The therapeutic efficacy of Sparsentan can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Sparsentan,Ketamine,The serum concentration of Ketamine can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Ketoconazole,The serum concentration of Sparsentan can be increased when it is combined with Ketoconazole.,increase,no risk
Sparsentan,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sparsentan.,increase,risk
Sparsentan,Ketorolac,The therapeutic efficacy of Sparsentan can be decreased when used in combination with Ketorolac.,decrease,no risk
Sparsentan,Olanzapine,The therapeutic efficacy of Sparsentan can be decreased when used in combination with Olanzapine.,decrease,no risk
Sparsentan,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Sparsentan.,increase,risk
Sparsentan,Olodaterol,The serum concentration of Olodaterol can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Omaveloxolone,The serum concentration of Sparsentan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sparsentan,Ombitasvir,Sparsentan may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Sparsentan,Omeprazole,The therapeutic efficacy of Sparsentan can be decreased when used in combination with Omeprazole.,decrease,no risk
Sparsentan,Ondansetron,The serum concentration of Ondansetron can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Ospemifene,The serum concentration of Ospemifene can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Oxaliplatin,Sparsentan may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Sparsentan,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Sparsentan.,increase,risk
Sparsentan,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Sparsentan.,increase,risk
Sparsentan,Ozanimod,Sparsentan may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Sparsentan,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Sparsentan.",increase,risk
Sparsentan,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Quinine,The serum concentration of Quinine can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Vadadustat,The serum concentration of Sparsentan can be increased when it is combined with Vadadustat.,increase,no risk
Sparsentan,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Sparsentan.,increase,risk
Sparsentan,Valproic acid,The serum concentration of Valproic acid can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Sparsentan.,increase,risk
Sparsentan,Vardenafil,The serum concentration of Vardenafil can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Velpatasvir,The serum concentration of Velpatasvir can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Verapamil,The metabolism of Sparsentan can be decreased when combined with Verapamil.,decrease,no risk
Sparsentan,Vilazodone,The serum concentration of Vilazodone can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Viloxazine,The metabolism of Sparsentan can be decreased when combined with Viloxazine.,decrease,no risk
Sparsentan,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Vincristine,The excretion of Vincristine can be decreased when combined with Sparsentan.,decrease,no risk
Sparsentan,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Sparsentan.,increase,no risk
Sparsentan,Voriconazole,The serum concentration of Sparsentan can be increased when it is combined with Voriconazole.,increase,no risk
Sparsentan,Vortioxetine,The serum concentration of Vortioxetine can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Voxilaprevir,Sparsentan may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Sparsentan,Warfarin,The serum concentration of Warfarin can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Ximelagatran,The serum concentration of Ximelagatran can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Sparsentan.,increase,no risk
Sparsentan,Zidovudine,The serum concentration of Zidovudine can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Zileuton,The serum concentration of Zileuton can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Zimelidine,The metabolism of Sparsentan can be decreased when combined with Zimelidine.,decrease,no risk
Sparsentan,Ziprasidone,The metabolism of Sparsentan can be decreased when combined with Ziprasidone.,decrease,no risk
Sparsentan,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Sparsentan.",increase,risk
Sparsentan,Zolpidem,The serum concentration of Zolpidem can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Zonisamide,The serum concentration of Zonisamide can be decreased when it is combined with Sparsentan.,decrease,no risk
Sparsentan,Zopiclone,The serum concentration of Zopiclone can be decreased when it is combined with Sparsentan.,decrease,no risk
Rozrolimupab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Obiltoxaximab.,increase,risk
Rozrolimupab,Obinutuzumab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Obinutuzumab.,increase,risk
Rozrolimupab,Ocrelizumab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Ocrelizumab.,increase,risk
Rozrolimupab,Odesivimab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Odesivimab.,increase,risk
Rozrolimupab,Ofatumumab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Ofatumumab.,increase,risk
Rozrolimupab,Olaratumab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Olaratumab.,increase,risk
Rozrolimupab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozrolimupab.,increase,risk
Rozrolimupab,Quinestrol,Quinestrol may increase the thrombogenic activities of Rozrolimupab.,increase,no risk
Rozrolimupab,Ublituximab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Ublituximab.,increase,risk
Rozrolimupab,Ustekinumab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Ustekinumab.,increase,risk
Rozrolimupab,Vedolizumab,The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Vedolizumab.,increase,risk
HE3286,Viloxazine,The metabolism of HE3286 can be decreased when combined with Viloxazine.,decrease,no risk
HE3286,Voriconazole,The metabolism of HE3286 can be decreased when combined with Voriconazole.,decrease,no risk
HE3286,Zimelidine,The metabolism of HE3286 can be decreased when combined with Zimelidine.,decrease,no risk
HE3286,Ziprasidone,The metabolism of HE3286 can be decreased when combined with Ziprasidone.,decrease,no risk
Quizartinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Quizartinib.,increase,risk
Quizartinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Quizartinib.,increase,risk
Quizartinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Quizartinib.,increase,risk
Quizartinib,Gefitinib,The metabolism of Quizartinib can be decreased when combined with Gefitinib.,decrease,no risk
Quizartinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quizartinib.,increase,risk
Quizartinib,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Quizartinib.,increase,risk
Quizartinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Quizartinib.,increase,risk
Quizartinib,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Glipizide,The metabolism of Glipizide can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Glofitamab,The serum concentration of Quizartinib can be increased when it is combined with Glofitamab.,increase,no risk
Quizartinib,Glyburide,The metabolism of Quizartinib can be decreased when combined with Glyburide.,decrease,no risk
Quizartinib,Golimumab,The metabolism of Quizartinib can be increased when combined with Golimumab.,increase,no risk
Quizartinib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quizartinib.,increase,risk
Quizartinib,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quizartinib.,increase,risk
Quizartinib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quizartinib.,increase,risk
Quizartinib,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Quizartinib.,increase,risk
Quizartinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quizartinib.,increase,risk
Quizartinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Quizartinib.,increase,risk
Quizartinib,Hydrocortisone,The metabolism of Quizartinib can be decreased when combined with Hydrocortisone.,decrease,no risk
Quizartinib,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Quizartinib.,increase,risk
Quizartinib,Hydroxyprogesterone caproate,The metabolism of Quizartinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Quizartinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Quizartinib.,increase,risk
Quizartinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Quizartinib.,increase,risk
Quizartinib,Ketoconazole,The serum concentration of Quizartinib can be increased when it is combined with Ketoconazole.,increase,no risk
Quizartinib,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Quizartinib.,increase,risk
Quizartinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quizartinib.,increase,risk
Quizartinib,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Quizartinib.,increase,risk
Quizartinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Quizartinib.,decrease,no risk
Quizartinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Quizartinib.,increase,risk
Quizartinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Omaveloxolone,The serum concentration of Quizartinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Quizartinib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Quizartinib.,increase,risk
Quizartinib,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Quizartinib.,increase,risk
Quizartinib,Osilodrostat,The metabolism of Quizartinib can be decreased when combined with Osilodrostat.,decrease,no risk
Quizartinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Quizartinib.,increase,no risk
Quizartinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quizartinib.,increase,risk
Quizartinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Quizartinib.,increase,risk
Quizartinib,Oxcarbazepine,The metabolism of Quizartinib can be increased when combined with Oxcarbazepine.,increase,no risk
Quizartinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Oxetacaine.,increase,risk
Quizartinib,Oxprenolol,The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Quizartinib.,increase,risk
Quizartinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Oxybuprocaine.,increase,risk
Quizartinib,Oxybutynin,The metabolism of Quizartinib can be decreased when combined with Oxybutynin.,decrease,no risk
Quizartinib,Oxycodone,The metabolism of Quizartinib can be decreased when combined with Oxycodone.,decrease,no risk
Quizartinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quizartinib.,increase,risk
Pracinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Pracinostat.,increase,risk
Pracinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Pracinostat.,increase,risk
Pracinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Pracinostat.,increase,risk
Pracinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Pracinostat.,increase,risk
Pracinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Pracinostat.,increase,risk
Pracinostat,Gilteritinib,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Gilteritinib.,increase,risk
Pracinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Glasdegib.,increase,risk
Pracinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pracinostat.,increase,risk
Pracinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Pracinostat.,increase,risk
Pracinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Grepafloxacin.,increase,risk
Pracinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Halofantrine.,increase,risk
Pracinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Haloperidol.,increase,risk
Pracinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Pracinostat.,increase,risk
Pracinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Pracinostat.,increase,risk
Pracinostat,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pracinostat.,increase,risk
Pracinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Hydroxyzine.,increase,risk
Pracinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pracinostat.,increase,risk
Pracinostat,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Pracinostat.,increase,risk
Pracinostat,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Pracinostat.,increase,risk
Pracinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Pracinostat.,increase,risk
Pracinostat,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Pracinostat.,increase,risk
Pracinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Pracinostat.,increase,risk
Pracinostat,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Pracinostat.,increase,risk
Pracinostat,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Pracinostat.,increase,risk
Pracinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Pracinostat.,increase,risk
Pracinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Oxatomide.,increase,risk
Pracinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pracinostat is combined with Oxetacaine.,increase,risk
Pracinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pracinostat is combined with Oxybuprocaine.,increase,risk
Pracinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Pracinostat.,increase,risk
Pracinostat,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Pracinostat.,increase,risk
Pracinostat,Quinidine,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Quinidine.,increase,risk
Pracinostat,Quinine,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Quinine.,increase,risk
Pracinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Quizartinib.,increase,risk
Pracinostat,Valproic acid,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Valproic acid.,increase,risk
Pracinostat,Vandetanib,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Vandetanib.,increase,risk
Pracinostat,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Pracinostat.,increase,risk
Pracinostat,Vemurafenib,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Vemurafenib.,increase,risk
Pracinostat,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pracinostat.,increase,risk
Pracinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Pracinostat.,increase,risk
Pracinostat,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Pracinostat.,increase,risk
Pracinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Pracinostat is combined with Vorinostat.,increase,risk
Pracinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Ziprasidone.,increase,risk
Pracinostat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Pracinostat.,increase,risk
Pracinostat,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Zuclopenthixol.,increase,risk
APD791,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with APD791.,increase,risk
APD791,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when APD791 is combined with Gabapentin enacarbil.,increase,risk
APD791,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with APD791.,increase,risk
APD791,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when APD791 is combined with Ganaxolone.",increase,risk
APD791,Gepirone,The risk or severity of CNS depression can be increased when APD791 is combined with Gepirone.,increase,risk
APD791,Gilteritinib,The therapeutic efficacy of APD791 can be decreased when used in combination with Gilteritinib.,decrease,no risk
APD791,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with APD791.,increase,risk
APD791,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with APD791.,increase,risk
APD791,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with APD791.,increase,risk
APD791,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with APD791.,increase,risk
APD791,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with APD791.,increase,risk
APD791,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with APD791.,increase,risk
APD791,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with APD791.,increase,risk
APD791,Hydrocodone,APD791 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
APD791,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with APD791.,increase,risk
APD791,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of APD791.,increase,no risk
APD791,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with APD791.,increase,risk
APD791,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with APD791.,increase,risk
APD791,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with APD791.,increase,risk
APD791,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when APD791 is combined with Oliceridine.",increase,risk
APD791,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with APD791.,increase,risk
APD791,Opium,The risk or severity of CNS depression can be increased when APD791 is combined with Opium.,increase,risk
APD791,Orphenadrine,APD791 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
APD791,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with APD791.,increase,risk
APD791,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with APD791.,increase,risk
APD791,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with APD791.,increase,risk
APD791,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with APD791.,increase,risk
APD791,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with APD791.,increase,risk
APD791,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with APD791.,increase,risk
APD791,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with APD791.,increase,risk
APD791,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with APD791.,increase,risk
APD791,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with APD791.,increase,risk
APD791,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with APD791.,increase,risk
APD791,Quinupramine,The risk or severity of CNS depression can be increased when APD791 is combined with Quinupramine.,increase,risk
APD791,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with APD791.,increase,risk
APD791,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with APD791.,increase,risk
APD791,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with APD791.,increase,risk
APD791,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with APD791.,increase,risk
APD791,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with APD791.,increase,risk
APD791,Vilazodone,The risk or severity of CNS depression can be increased when APD791 is combined with Vilazodone.,increase,risk
APD791,Viloxazine,The risk or severity of CNS depression can be increased when APD791 is combined with Viloxazine.,increase,risk
APD791,Vortioxetine,The risk or severity of CNS depression can be increased when APD791 is combined with Vortioxetine.,increase,risk
APD791,Warfarin,The risk or severity of adverse effects can be increased when APD791 is combined with Warfarin.,increase,risk
APD791,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with APD791.,increase,risk
APD791,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with APD791.,increase,risk
APD791,Ziconotide,The risk or severity of CNS depression can be increased when APD791 is combined with Ziconotide.,increase,risk
APD791,Zimelidine,The risk or severity of adverse effects can be increased when APD791 is combined with Zimelidine.,increase,risk
APD791,Ziprasidone,The risk or severity of adverse effects can be increased when APD791 is combined with Ziprasidone.,increase,risk
APD791,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with APD791.,increase,risk
APD791,Zolpidem,APD791 may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
APD791,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with APD791.,increase,risk
APD791,Zopiclone,The risk or severity of adverse effects can be increased when APD791 is combined with Zopiclone.,increase,risk
APD791,Zotepine,The risk or severity of CNS depression can be increased when APD791 is combined with Zotepine.,increase,risk
APD791,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with APD791.,increase,risk
APD791,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with APD791.,increase,risk
Beraprost,Gemcitabine,The risk or severity of bleeding can be increased when Beraprost is combined with Gemcitabine.,increase,risk
Beraprost,Gemfibrozil,The metabolism of Beraprost can be decreased when combined with Gemfibrozil.,decrease,no risk
Beraprost,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Beraprost is combined with Gemtuzumab ozogamicin.,increase,risk
Beraprost,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Beraprost.,increase,risk
Beraprost,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Beraprost.,increase,no risk
Beraprost,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Beraprost.,decrease,no risk
Beraprost,Glucosamine,Glucosamine may increase the antiplatelet activities of Beraprost.,increase,no risk
Beraprost,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Beraprost.,increase,risk
Beraprost,Golimumab,The metabolism of Beraprost can be increased when combined with Golimumab.,increase,no risk
Beraprost,Halofantrine,The metabolism of Beraprost can be decreased when combined with Halofantrine.,decrease,no risk
Beraprost,Hemin,Hemin may increase the anticoagulant activities of Beraprost.,increase,no risk
Beraprost,Heparin,The risk or severity of bleeding can be increased when Beraprost is combined with Heparin.,increase,risk
Beraprost,Hydrochlorothiazide,The therapeutic efficacy of Beraprost can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Beraprost,Hydrocortisone,The metabolism of Beraprost can be increased when combined with Hydrocortisone.,increase,no risk
Beraprost,Hydroflumethiazide,The therapeutic efficacy of Beraprost can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Beraprost,Hydroxychloroquine,The metabolism of Beraprost can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Beraprost,Hydroxyprogesterone caproate,The therapeutic efficacy of Beraprost can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Beraprost,Hydroxyurea,The risk or severity of bleeding can be increased when Beraprost is combined with Hydroxyurea.,increase,risk
Beraprost,Ketamine,The metabolism of Beraprost can be decreased when combined with Ketamine.,decrease,no risk
Beraprost,Ketoconazole,The metabolism of Beraprost can be decreased when combined with Ketoconazole.,decrease,no risk
Beraprost,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Beraprost.,increase,risk
Beraprost,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Beraprost.,increase,risk
Beraprost,Obeticholic acid,The risk or severity of adverse effects can be increased when Beraprost is combined with Obeticholic acid.,increase,risk
Beraprost,Obinutuzumab,The risk or severity of adverse effects can be increased when Beraprost is combined with Obinutuzumab.,increase,risk
Beraprost,Olaparib,The risk or severity of bleeding can be increased when Beraprost is combined with Olaparib.,increase,risk
Beraprost,Olive oil,The therapeutic efficacy of Beraprost can be decreased when used in combination with Olive oil.,decrease,no risk
Beraprost,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Beraprost.,decrease,no risk
Beraprost,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Beraprost.,increase,risk
Beraprost,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Beraprost is combined with Omacetaxine mepesuccinate.,increase,risk
Beraprost,Omaveloxolone,The serum concentration of Beraprost can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Beraprost,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Beraprost.,decrease,no risk
Beraprost,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Beraprost.,increase,no risk
Beraprost,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Beraprost.,increase,risk
Beraprost,Omega-3-carboxylic acids,The therapeutic efficacy of Beraprost can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Beraprost,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Beraprost.,increase,risk
Beraprost,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Beraprost.,increase,risk
Beraprost,Oxybutynin,The metabolism of Beraprost can be decreased when combined with Oxybutynin.,decrease,no risk
Beraprost,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Beraprost.,increase,risk
Beraprost,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Beraprost.,decrease,no risk
Beraprost,Quinestrol,Quinestrol may decrease the anticoagulant activities of Beraprost.,decrease,no risk
Beraprost,Quinidine,The therapeutic efficacy of Beraprost can be increased when used in combination with Quinidine.,increase,no risk
Beraprost,Quinine,The therapeutic efficacy of Beraprost can be increased when used in combination with Quinine.,increase,no risk
Beraprost,Ulipristal,The therapeutic efficacy of Beraprost can be decreased when used in combination with Ulipristal.,decrease,no risk
Beraprost,Urokinase,Urokinase may increase the anticoagulant activities of Beraprost.,increase,no risk
Beraprost,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Beraprost is combined with Ursodeoxycholic acid.,increase,risk
Beraprost,Vadadustat,The serum concentration of Beraprost can be increased when it is combined with Vadadustat.,increase,no risk
Beraprost,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Beraprost.,increase,risk
Beraprost,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Beraprost.,decrease,no risk
Beraprost,Vemurafenib,The metabolism of Beraprost can be decreased when combined with Vemurafenib.,decrease,no risk
Beraprost,Venlafaxine,The risk or severity of bleeding can be increased when Beraprost is combined with Venlafaxine.,increase,risk
Beraprost,Vinblastine,The risk or severity of bleeding can be increased when Beraprost is combined with Vinblastine.,increase,risk
Beraprost,Vindesine,The risk or severity of bleeding can be increased when Beraprost is combined with Vindesine.,increase,risk
Beraprost,Vinorelbine,The risk or severity of bleeding can be increased when Beraprost is combined with Vinorelbine.,increase,risk
Beraprost,Vitamin E,Vitamin E may increase the antiplatelet activities of Beraprost.,increase,no risk
Beraprost,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Beraprost.,decrease,no risk
Beraprost,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Beraprost.,increase,risk
Beraprost,Vorinostat,The risk or severity of bleeding can be increased when Beraprost is combined with Vorinostat.,increase,risk
Beraprost,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Beraprost.,increase,risk
Beraprost,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Beraprost.,decrease,no risk
Beraprost,Warfarin,The risk or severity of bleeding can be increased when Beraprost is combined with Warfarin.,increase,risk
Beraprost,Ximelagatran,The risk or severity of bleeding can be increased when Beraprost is combined with Ximelagatran.,increase,risk
Beraprost,Zidovudine,The metabolism of Beraprost can be decreased when combined with Zidovudine.,decrease,no risk
Beraprost,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Beraprost.,increase,risk
Beraprost,Zopiclone,The metabolism of Beraprost can be decreased when combined with Zopiclone.,decrease,no risk
Tetrodotoxin,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Bromperidol,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Bromperidol.,increase,risk
Tetrodotoxin,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Buprenorphine,Tetrodotoxin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Tetrodotoxin,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Butacaine,The risk or severity of methemoglobinemia can be increased when Tetrodotoxin is combined with Butacaine.,increase,risk
Tetrodotoxin,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Butamben,The risk or severity of methemoglobinemia can be increased when Tetrodotoxin is combined with Butamben.,increase,risk
Tetrodotoxin,Butaperazine,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Butaperazine.,increase,risk
Tetrodotoxin,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Butriptyline,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Butriptyline.,increase,risk
Tetrodotoxin,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Gabapentin enacarbil.,increase,risk
Tetrodotoxin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tetrodotoxin is combined with Ganaxolone.",increase,risk
Tetrodotoxin,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gepirone,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Gepirone.,increase,risk
Tetrodotoxin,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Tetrodotoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Tetrodotoxin,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Tetrodotoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Tetrodotoxin,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Tetrodotoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Tetrodotoxin,Hydrocodone,Tetrodotoxin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tetrodotoxin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tetrodotoxin.,increase,no risk
Tetrodotoxin,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tetrodotoxin is combined with Oliceridine.",increase,risk
Tetrodotoxin,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Opium,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Opium.,increase,risk
Tetrodotoxin,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Orphenadrine,Tetrodotoxin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tetrodotoxin,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tetrodotoxin is combined with Oxetacaine.,increase,risk
Tetrodotoxin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Quinupramine,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Quinupramine.,increase,risk
Tetrodotoxin,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vilazodone,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Vilazodone.,increase,risk
Tetrodotoxin,Viloxazine,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Viloxazine.,increase,risk
Tetrodotoxin,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Vortioxetine,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Vortioxetine.,increase,risk
Tetrodotoxin,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Ziconotide,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Ziconotide.,increase,risk
Tetrodotoxin,Zimelidine,The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Zimelidine.,increase,risk
Tetrodotoxin,Ziprasidone,The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Ziprasidone.,increase,risk
Tetrodotoxin,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Zolpidem,Tetrodotoxin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tetrodotoxin,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Zopiclone,The risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Zopiclone.,increase,risk
Tetrodotoxin,Zotepine,The risk or severity of CNS depression can be increased when Tetrodotoxin is combined with Zotepine.,increase,risk
Tetrodotoxin,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Tetrodotoxin.,increase,risk
Tetrodotoxin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tetrodotoxin.,increase,risk
Vemurafenib,Betamethasone phosphate,The metabolism of Vemurafenib can be increased when combined with Betamethasone phosphate.,increase,no risk
Vemurafenib,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Bexarotene,The metabolism of Vemurafenib can be increased when combined with Bexarotene.,increase,no risk
Vemurafenib,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Bifonazole,The metabolism of Vemurafenib can be decreased when combined with Bifonazole.,decrease,no risk
Vemurafenib,Bilastine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Bilastine.,increase,risk
Vemurafenib,Bimekizumab,The metabolism of Vemurafenib can be increased when combined with Bimekizumab.,increase,no risk
Vemurafenib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Boceprevir,The metabolism of Vemurafenib can be decreased when combined with Boceprevir.,decrease,no risk
Vemurafenib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Bosentan,The metabolism of Vemurafenib can be increased when combined with Bosentan.,increase,no risk
Vemurafenib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Bretylium,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Bretylium.,increase,risk
Vemurafenib,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Brigatinib,The metabolism of Brigatinib can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Bromazepam,The serum concentration of Bromazepam can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Brompheniramine.,increase,risk
Vemurafenib,Buclizine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Buclizine.,increase,risk
Vemurafenib,Budesonide,The metabolism of Vemurafenib can be increased when combined with Budesonide.,increase,no risk
Vemurafenib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Bupivacaine.,increase,risk
Vemurafenib,Buprenorphine,The metabolism of Vemurafenib can be decreased when combined with Buprenorphine.,decrease,no risk
Vemurafenib,Bupropion,The metabolism of Bupropion can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Vemurafenib.,increase,risk
Vemurafenib,Buspirone,The metabolism of Buspirone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Busulfan,The metabolism of Busulfan can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Butacaine,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Butacaine.,increase,risk
Vemurafenib,Butalbital,The metabolism of Vemurafenib can be increased when combined with Butalbital.,increase,no risk
Vemurafenib,Butamben,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Butamben.,increase,risk
Vemurafenib,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Vemurafenib.,increase,risk
Vemurafenib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Vemurafenib.,increase,risk
Vemurafenib,Galantamine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Galantamine.,increase,risk
Vemurafenib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Gatifloxacin.,increase,risk
Vemurafenib,Gefitinib,Gefitinib may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Vemurafenib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Vemurafenib.,increase,risk
Vemurafenib,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Vemurafenib.,increase,risk
Vemurafenib,Gestrinone,The metabolism of Gestrinone can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Ginkgo biloba,The metabolism of Vemurafenib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vemurafenib,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Glofitamab,The serum concentration of Vemurafenib can be increased when it is combined with Glofitamab.,increase,no risk
Vemurafenib,Glyburide,The metabolism of Vemurafenib can be decreased when combined with Glyburide.,decrease,no risk
Vemurafenib,Glycerol phenylbutyrate,The metabolism of Vemurafenib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Vemurafenib,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Golimumab,The metabolism of Vemurafenib can be increased when combined with Golimumab.,increase,no risk
Vemurafenib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vemurafenib.,increase,risk
Vemurafenib,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Vemurafenib.,increase,risk
Vemurafenib,Grapefruit,The serum concentration of Vemurafenib can be increased when it is combined with Grapefruit.,increase,no risk
Vemurafenib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Griseofulvin,The metabolism of Vemurafenib can be increased when combined with Griseofulvin.,increase,no risk
Vemurafenib,Guanabenz,The serum concentration of Guanabenz can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Halofantrine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Halofantrine.,increase,risk
Vemurafenib,Haloperidol,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Haloperidol.,increase,risk
Vemurafenib,Halothane,The metabolism of Halothane can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Vemurafenib.,increase,risk
Vemurafenib,Hydralazine,The serum concentration of Vemurafenib can be increased when it is combined with Hydralazine.,increase,no risk
Vemurafenib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hydrochlorothiazide.,increase,risk
Vemurafenib,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Hydrocortamate,The metabolism of Vemurafenib can be increased when combined with Hydrocortamate.,increase,no risk
Vemurafenib,Hydrocortisone,The metabolism of Vemurafenib can be increased when combined with Hydrocortisone.,increase,no risk
Vemurafenib,Hydrocortisone acetate,The metabolism of Vemurafenib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Vemurafenib,Hydrocortisone butyrate,The metabolism of Vemurafenib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Vemurafenib,Hydrocortisone succinate,The metabolism of Vemurafenib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Vemurafenib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hydroxychloroquine.,increase,risk
Vemurafenib,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hydroxyzine.,increase,risk
Vemurafenib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hyoscyamine.,increase,risk
Vemurafenib,Ketamine,The metabolism of Ketamine can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Ketazolam,The serum concentration of Vemurafenib can be increased when it is combined with Ketazolam.,increase,no risk
Vemurafenib,Ketoconazole,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ketoconazole.,increase,risk
Vemurafenib,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Vemurafenib.,increase,risk
Vemurafenib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Octreotide,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Octreotide.,increase,risk
Vemurafenib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Vemurafenib.,increase,risk
Vemurafenib,Olanzapine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Olanzapine.,increase,risk
Vemurafenib,Olaparib,The metabolism of Olaparib can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Vemurafenib.,decrease,no risk
Vemurafenib,Olodaterol,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Olodaterol.,increase,risk
Vemurafenib,Olutasidenib,The metabolism of Vemurafenib can be increased when combined with Olutasidenib.,increase,no risk
Vemurafenib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Omaveloxolone,The serum concentration of Vemurafenib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vemurafenib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Opium,The metabolism of Opium can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Oritavancin,The metabolism of Vemurafenib can be increased when combined with Oritavancin.,increase,no risk
Vemurafenib,Orphenadrine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Orphenadrine.,increase,risk
Vemurafenib,Osilodrostat,The metabolism of Vemurafenib can be decreased when combined with Osilodrostat.,decrease,no risk
Vemurafenib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Oteseconazole,The serum concentration of Vemurafenib can be increased when it is combined with Oteseconazole.,increase,no risk
Vemurafenib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Vemurafenib.,increase,risk
Vemurafenib,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Vemurafenib.,increase,risk
Vemurafenib,Oxcarbazepine,The metabolism of Vemurafenib can be increased when combined with Oxcarbazepine.,increase,no risk
Vemurafenib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Oxetacaine.,increase,risk
Vemurafenib,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Oxybuprocaine.,increase,risk
Vemurafenib,Oxybutynin,The serum concentration of Vemurafenib can be increased when it is combined with Oxybutynin.,increase,no risk
Vemurafenib,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Oxytocin,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Oxytocin.,increase,risk
Vemurafenib,Ozanimod,Vemurafenib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Vemurafenib,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Vemurafenib.,increase,risk
Vemurafenib,Quinidine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quinidine.,increase,risk
Vemurafenib,Quinine,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quinine.,increase,risk
Vemurafenib,Quinupristin,The metabolism of Vemurafenib can be decreased when combined with Quinupristin.,decrease,no risk
Vemurafenib,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Ulipristal,The metabolism of Ulipristal can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Umbralisib,The serum concentration of Vemurafenib can be increased when it is combined with Umbralisib.,increase,no risk
Vemurafenib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Vadadustat,The serum concentration of Vemurafenib can be increased when it is combined with Vadadustat.,increase,no risk
Vemurafenib,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Valproic acid,The serum concentration of Vemurafenib can be increased when it is combined with Valproic acid.,increase,no risk
Vemurafenib,Valsartan,The metabolism of Valsartan can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Vandetanib,The serum concentration of Vemurafenib can be increased when it is combined with Vandetanib.,increase,no risk
Vemurafenib,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Venlafaxine,Venlafaxine may increase the excretion rate of Vemurafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vemurafenib,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Vernakalant,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Vernakalant.,increase,risk
Vemurafenib,Verteporfin,Vemurafenib may increase the photosensitizing activities of Verteporfin.,increase,no risk
Vemurafenib,Vilanterol,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Vilanterol.,increase,risk
Vemurafenib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Vemurafenib.,increase,no risk
Vemurafenib,Viloxazine,The metabolism of Vemurafenib can be decreased when combined with Viloxazine.,decrease,no risk
Vemurafenib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Vindesine,The metabolism of Vindesine can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Vismodegib,Vismodegib may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Vemurafenib,Vitamin E,The metabolism of Vemurafenib can be increased when combined with Vitamin E.,increase,no risk
Vemurafenib,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Vorapaxar,The serum concentration of Vemurafenib can be increased when it is combined with Vorapaxar.,increase,no risk
Vemurafenib,Voriconazole,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Voriconazole.,increase,risk
Vemurafenib,Vorinostat,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Vorinostat.,increase,risk
Vemurafenib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Voxelotor,The serum concentration of Vemurafenib can be increased when it is combined with Voxelotor.,increase,no risk
Vemurafenib,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Zafirlukast,The serum concentration of Vemurafenib can be increased when it is combined with Zafirlukast.,increase,no risk
Vemurafenib,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Vemurafenib.,increase,no risk
Vemurafenib,Zidovudine,Vemurafenib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Vemurafenib,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Zimelidine,The metabolism of Vemurafenib can be decreased when combined with Zimelidine.,decrease,no risk
Vemurafenib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Ziprasidone.,increase,risk
Vemurafenib,Zolmitriptan,The serum concentration of Zolmitriptan can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Zonisamide,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Zonisamide.,increase,risk
Vemurafenib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Vemurafenib.,decrease,no risk
Vemurafenib,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Vemurafenib.,increase,no risk
Vemurafenib,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Vemurafenib.,increase,risk
Vemurafenib,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Vemurafenib.,decrease,no risk
Cobimetinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Cobimetinib.,decrease,no risk
Cobimetinib,Gemcitabine,The serum concentration of Cobimetinib can be increased when it is combined with Gemcitabine.,increase,no risk
Cobimetinib,Gilteritinib,The metabolism of Cobimetinib can be decreased when combined with Gilteritinib.,decrease,no risk
Cobimetinib,Ginkgo biloba,The metabolism of Cobimetinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Cobimetinib,Glasdegib,The serum concentration of Cobimetinib can be increased when it is combined with Glasdegib.,increase,no risk
Cobimetinib,Glecaprevir,The serum concentration of Cobimetinib can be increased when it is combined with Glecaprevir.,increase,no risk
Cobimetinib,Glofitamab,The serum concentration of Cobimetinib can be increased when it is combined with Glofitamab.,increase,no risk
Cobimetinib,Glyburide,The metabolism of Cobimetinib can be decreased when combined with Glyburide.,decrease,no risk
Cobimetinib,Glycerol phenylbutyrate,The metabolism of Cobimetinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Cobimetinib,Golimumab,The metabolism of Cobimetinib can be increased when combined with Golimumab.,increase,no risk
Cobimetinib,Grapefruit,The serum concentration of Cobimetinib can be increased when it is combined with Grapefruit.,increase,no risk
Cobimetinib,Grazoprevir,The serum concentration of Cobimetinib can be increased when it is combined with Grazoprevir.,increase,no risk
Cobimetinib,Griseofulvin,The metabolism of Cobimetinib can be increased when combined with Griseofulvin.,increase,no risk
Cobimetinib,Haloperidol,The metabolism of Cobimetinib can be decreased when combined with Haloperidol.,decrease,no risk
Cobimetinib,Hydralazine,The serum concentration of Cobimetinib can be increased when it is combined with Hydralazine.,increase,no risk
Cobimetinib,Hydrocortamate,The metabolism of Cobimetinib can be increased when combined with Hydrocortamate.,increase,no risk
Cobimetinib,Hydrocortisone,The metabolism of Cobimetinib can be increased when combined with Hydrocortisone.,increase,no risk
Cobimetinib,Hydrocortisone acetate,The metabolism of Cobimetinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Cobimetinib,Hydrocortisone butyrate,The metabolism of Cobimetinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Cobimetinib,Hydrocortisone succinate,The metabolism of Cobimetinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Cobimetinib,Ketazolam,The serum concentration of Cobimetinib can be increased when it is combined with Ketazolam.,increase,no risk
Cobimetinib,Ketoconazole,The serum concentration of Cobimetinib can be increased when it is combined with Ketoconazole.,increase,no risk
Silver sulfadiazine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Benzocaine.,increase,risk
Silver sulfadiazine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Benzyl alcohol.,increase,risk
Silver sulfadiazine,Benzylpenicillin,Silver sulfadiazine may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Silver sulfadiazine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Bupivacaine.,increase,risk
Silver sulfadiazine,Butacaine,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Butacaine.,increase,risk
Silver sulfadiazine,Butamben,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Butamben.,increase,risk
Silver sulfadiazine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Oxetacaine.,increase,risk
Silver sulfadiazine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Silver sulfadiazine is combined with Oxybuprocaine.,increase,risk
Silver sulfadiazine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Silver sulfadiazine.,decrease,no risk
Methsuximide,Bepridil,Bepridil may increase the arrhythmogenic activities of Methsuximide.,increase,no risk
Methsuximide,Beractant,Methsuximide may increase the bradycardic activities of Beractant.,increase,no risk
Methsuximide,Berotralstat,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Berotralstat.,increase,risk
Methsuximide,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Methsuximide.,increase,no risk
Methsuximide,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Bexagliflozin.,increase,risk
Methsuximide,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Methsuximide.,increase,no risk
Methsuximide,Bilastine,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Bilastine.,increase,risk
Methsuximide,Bimekizumab,The metabolism of Methsuximide can be increased when combined with Bimekizumab.,increase,no risk
Methsuximide,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Methsuximide.,decrease,no risk
Methsuximide,Bioallethrin,Methsuximide may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Methsuximide,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Methsuximide.,decrease,no risk
Methsuximide,Bisoprolol,The therapeutic efficacy of Methsuximide can be increased when used in combination with Bisoprolol.,increase,no risk
Methsuximide,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Methsuximide.,decrease,no risk
Methsuximide,Boceprevir,The serum concentration of Methsuximide can be increased when it is combined with Boceprevir.,increase,no risk
Methsuximide,Borage oil,The therapeutic efficacy of Methsuximide can be decreased when used in combination with Borage oil.,decrease,no risk
Methsuximide,Bortezomib,The metabolism of Methsuximide can be decreased when combined with Bortezomib.,decrease,no risk
Methsuximide,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Methsuximide.,increase,risk
Methsuximide,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Methsuximide.,increase,risk
Methsuximide,Bretylium,Bretylium may increase the arrhythmogenic activities of Methsuximide.,increase,no risk
Methsuximide,Brexanolone,The risk or severity of CNS depression can be increased when Methsuximide is combined with Brexanolone.,increase,risk
Methsuximide,Brexpiprazole,The risk or severity of CNS depression can be increased when Methsuximide is combined with Brexpiprazole.,increase,risk
Methsuximide,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Methsuximide.,increase,no risk
Methsuximide,Brivaracetam,The risk or severity of CNS depression can be increased when Methsuximide is combined with Brivaracetam.,increase,risk
Methsuximide,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Methsuximide.,increase,risk
Methsuximide,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Methsuximide.,increase,risk
Methsuximide,Bromotheophylline,Methsuximide may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methsuximide,Bromperidol,The risk or severity of CNS depression can be increased when Methsuximide is combined with Bromperidol.,increase,risk
Methsuximide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Methsuximide.,increase,risk
Methsuximide,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Methsuximide.,increase,risk
Methsuximide,Bumadizone,The risk or severity of hyperkalemia can be increased when Methsuximide is combined with Bumadizone.,increase,risk
Methsuximide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Methsuximide is combined with Bupivacaine.,increase,risk
Methsuximide,Buprenorphine,Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Methsuximide,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Methsuximide.,increase,risk
Methsuximide,Buserelin,The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Buserelin.,increase,risk
Methsuximide,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Methsuximide.,increase,risk
Methsuximide,Butabarbital,The metabolism of Methsuximide can be increased when combined with Butabarbital.,increase,no risk
Methsuximide,Butacaine,The risk or severity of methemoglobinemia can be increased when Methsuximide is combined with Butacaine.,increase,risk
Methsuximide,Butalbital,The metabolism of Methsuximide can be increased when combined with Butalbital.,increase,no risk
Methsuximide,Butamben,The risk or severity of methemoglobinemia can be increased when Methsuximide is combined with Butamben.,increase,risk
Methsuximide,Butaperazine,The risk or severity of CNS depression can be increased when Methsuximide is combined with Butaperazine.,increase,risk
Methsuximide,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Methsuximide.,increase,risk
Methsuximide,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Methsuximide.,increase,risk
Methsuximide,Butriptyline,The risk or severity of CNS depression can be increased when Methsuximide is combined with Butriptyline.,increase,risk
Fibrinolysin,Olive oil,The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Olive oil.,decrease,no risk
Fibrinolysin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Fibrinolysin.,increase,risk
Fibrinolysin,Venlafaxine,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Venlafaxine.,increase,risk
Interferon alfa,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Interferon alfa.,increase,risk
Interferon alfa,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Interferon alfa.,increase,risk
Interferon alfa,Glatiramer,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Glatiramer.,increase,risk
Interferon alfa,Golimumab,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Golimumab.,increase,risk
Interferon alfa,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Guselkumab,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Guselkumab.,increase,risk
Interferon alfa,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa.,increase,risk
Interferon alfa,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa.,increase,risk
Interferon alfa,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa.,increase,risk
Interferon alfa,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Hydrocortisone acetate.,increase,risk
Interferon alfa,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Hydrocortisone butyrate.,increase,risk
Interferon alfa,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Hydrocortisone succinate.,increase,risk
Interferon alfa,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa.,increase,risk
Interferon alfa,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Interferon alfa.,increase,risk
Interferon alfa,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Interferon alfa.,increase,risk
Interferon alfa,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Obinutuzumab,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Obinutuzumab.,increase,risk
Interferon alfa,Ocrelizumab,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Ocrelizumab.,increase,risk
Interferon alfa,Ofatumumab,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Ofatumumab.,increase,risk
Interferon alfa,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Olaparib,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Olaparib.,increase,risk
Interferon alfa,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Interferon alfa.,increase,risk
Interferon alfa,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Ozanimod,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Ozanimod.,increase,risk
Interferon alfa,Quinine,The metabolism of Quinine can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Interferon alfa.,increase,risk
Interferon alfa,Upadacitinib,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Upadacitinib.,increase,risk
Interferon alfa,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa.,increase,risk
Interferon alfa,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Interferon alfa.,increase,risk
Interferon alfa,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Vedolizumab,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Vedolizumab.,increase,risk
Interferon alfa,Verapamil,The metabolism of Verapamil can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Interferon alfa.,decrease,no risk
Interferon alfa,Vilanterol,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Vilanterol.,increase,risk
Interferon alfa,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Interferon alfa.,increase,risk
Interferon alfa,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Interferon alfa.,increase,risk
Interferon alfa,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Interferon alfa.,increase,risk
Interferon alfa,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Interferon alfa.,increase,risk
Interferon alfa,Voclosporin,The risk or severity of adverse effects can be increased when Interferon alfa is combined with Voclosporin.,increase,risk
Interferon alfa,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa.,increase,risk
Interferon alfa,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Interferon alfa.,increase,risk
Interferon alfa,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Warfarin,The metabolism of Warfarin can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa.,increase,risk
Interferon alfa,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Interferon alfa.,increase,risk
Interferon alfa,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Interferon alfa.,increase,risk
Interferon alfa,Zileuton,The metabolism of Zileuton can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Interferon alfa.,decrease,no risk
Interferon alfa,Zotepine,The metabolism of Zotepine can be decreased when combined with Interferon alfa.,decrease,no risk
Glatiramer,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Glatiramer.,increase,risk
Glatiramer,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Glatiramer.,increase,risk
Glatiramer,Golimumab,The risk or severity of adverse effects can be increased when Glatiramer is combined with Golimumab.,increase,risk
Glatiramer,Guselkumab,The risk or severity of adverse effects can be increased when Glatiramer is combined with Guselkumab.,increase,risk
Glatiramer,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Glatiramer.,increase,risk
Glatiramer,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Glatiramer is combined with Hydrocortisone acetate.,increase,risk
Glatiramer,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Glatiramer is combined with Hydrocortisone butyrate.,increase,risk
Glatiramer,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Glatiramer is combined with Hydrocortisone succinate.,increase,risk
Glatiramer,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Glatiramer.,increase,risk
Glatiramer,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Glatiramer.,increase,risk
Glatiramer,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Obinutuzumab,The risk or severity of adverse effects can be increased when Glatiramer is combined with Obinutuzumab.,increase,risk
Glatiramer,Ocrelizumab,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ocrelizumab.,increase,risk
Glatiramer,Ofatumumab,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ofatumumab.,increase,risk
Glatiramer,Olaparib,The risk or severity of adverse effects can be increased when Glatiramer is combined with Olaparib.,increase,risk
Glatiramer,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Glatiramer.,increase,risk
Glatiramer,Ozanimod,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ozanimod.,increase,risk
Glatiramer,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Glatiramer.,increase,risk
Glatiramer,Upadacitinib,The risk or severity of adverse effects can be increased when Glatiramer is combined with Upadacitinib.,increase,risk
Glatiramer,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Glatiramer.,increase,risk
Glatiramer,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Vedolizumab,The risk or severity of adverse effects can be increased when Glatiramer is combined with Vedolizumab.,increase,risk
Glatiramer,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Glatiramer.,decrease,no risk
Glatiramer,Vilanterol,The risk or severity of adverse effects can be increased when Glatiramer is combined with Vilanterol.,increase,risk
Glatiramer,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Glatiramer.,increase,risk
Glatiramer,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Glatiramer.,increase,risk
Glatiramer,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Glatiramer.,increase,risk
Glatiramer,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Glatiramer.,increase,risk
Glatiramer,Voclosporin,The risk or severity of adverse effects can be increased when Glatiramer is combined with Voclosporin.,increase,risk
Glatiramer,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Glatiramer.,increase,risk
Glatiramer,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Glatiramer.,increase,risk
Glatiramer,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Glatiramer.,increase,risk
Ecabet,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Benzocaine.,increase,risk
Ecabet,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Benzyl alcohol.,increase,risk
Ecabet,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Bupivacaine.,increase,risk
Ecabet,Butacaine,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Butacaine.,increase,risk
Ecabet,Butamben,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Butamben.,increase,risk
Ecabet,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Oxetacaine.,increase,risk
Ecabet,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ecabet is combined with Oxybuprocaine.,increase,risk
Activated charcoal,Olanzapine,The serum concentration of Olanzapine can be decreased when it is combined with Activated charcoal.,decrease,no risk
Rotigotine,Bromperidol,Bromperidol may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Brompheniramine,Brompheniramine may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Bumadizone,The risk or severity of hypertension can be increased when Rotigotine is combined with Bumadizone.,increase,risk
Rotigotine,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Rotigotine.,increase,risk
Rotigotine,Bupivacaine,Bupivacaine may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Buprenorphine,Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Rotigotine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Rotigotine.,increase,risk
Rotigotine,Buspirone,Buspirone may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Butabarbital,Butabarbital may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Butalbital,Butalbital may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Butaperazine,Butaperazine may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Butobarbital,Butobarbital may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Butorphanol,Butorphanol may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Butriptyline,Butriptyline may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Gabapentin,Gabapentin may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Gabapentin enacarbil,Gabapentin enacarbil may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Galantamine,The metabolism of Galantamine can be decreased when combined with Rotigotine.,decrease,no risk
Rotigotine,Gallamine triethiodide,Gallamine triethiodide may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Rotigotine is combined with Ganaxolone.",increase,risk
Rotigotine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Rotigotine.,decrease,no risk
Rotigotine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Rotigotine.,increase,risk
Rotigotine,Gilteritinib,The therapeutic efficacy of Rotigotine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Rotigotine,Givosiran,The serum concentration of Rotigotine can be increased when it is combined with Givosiran.,increase,no risk
Rotigotine,Glofitamab,The serum concentration of Rotigotine can be increased when it is combined with Glofitamab.,increase,no risk
Rotigotine,Glutethimide,Glutethimide may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Glycerol phenylbutyrate,The metabolism of Rotigotine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Rotigotine,Golimumab,The metabolism of Rotigotine can be increased when combined with Golimumab.,increase,no risk
Rotigotine,Granisetron,Granisetron may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Guanabenz,Rotigotine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Rotigotine,Guanadrel,Rotigotine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Rotigotine,Guanethidine,Rotigotine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Rotigotine,Guanfacine,Guanfacine may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Guanoxan,Rotigotine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Rotigotine,Halazepam,Halazepam may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Halofantrine,The metabolism of Rotigotine can be decreased when combined with Halofantrine.,decrease,no risk
Rotigotine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Rotigotine.,increase,risk
Rotigotine,Halothane,Halothane may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Hexafluronium,Hexafluronium may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Hydralazine,Rotigotine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Rotigotine,Hydrochlorothiazide,Rotigotine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Rotigotine,Hydrocodone,Rotigotine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Rotigotine,Hydroflumethiazide,Rotigotine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Rotigotine,Hydromorphone,Hydromorphone may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Hydroxychloroquine,The metabolism of Rotigotine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Rotigotine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rotigotine.,increase,no risk
Rotigotine,Ketamine,Ketamine may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Ketazolam,Ketazolam may increase the sedative activities of Rotigotine.,increase,no risk
Rotigotine,Ketoconazole,The metabolism of Rotigotine can be decreased when combined with Ketoconazole.,decrease,no risk
Rotigotine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Rotigotine.,increase,risk
Rotigotine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Rotigotine.,increase,risk
Hepatitis B immune globulin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Obiltoxaximab.,increase,risk
Hepatitis B immune globulin,Obinutuzumab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Obinutuzumab.,increase,risk
Hepatitis B immune globulin,Ocrelizumab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ocrelizumab.,increase,risk
Hepatitis B immune globulin,Odesivimab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Odesivimab.,increase,risk
Hepatitis B immune globulin,Ofatumumab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ofatumumab.,increase,risk
Hepatitis B immune globulin,Olaratumab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Olaratumab.,increase,risk
Hepatitis B immune globulin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Hepatitis B immune globulin.,increase,risk
Hepatitis B immune globulin,Quinestrol,Quinestrol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Hepatitis B immune globulin,Ublituximab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ublituximab.,increase,risk
Hepatitis B immune globulin,Ustekinumab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ustekinumab.,increase,risk
Hepatitis B immune globulin,Vedolizumab,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Vedolizumab.,increase,risk
Fospropofol,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Fospropofol.,increase,risk
Fospropofol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Fospropofol is combined with Gabapentin enacarbil.,increase,risk
Fospropofol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Fospropofol.,increase,risk
Fospropofol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Fospropofol is combined with Ganaxolone.",increase,risk
Fospropofol,Gepirone,The risk or severity of CNS depression can be increased when Fospropofol is combined with Gepirone.,increase,risk
Fospropofol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Fospropofol.,increase,risk
Fospropofol,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Fospropofol.,increase,risk
Fospropofol,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Fospropofol.,increase,risk
Fospropofol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Fospropofol.,increase,risk
Fospropofol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Fospropofol.,increase,risk
Fospropofol,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Fospropofol.,increase,risk
Fospropofol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Fospropofol.,increase,risk
Fospropofol,Hydrocodone,Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Fospropofol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Fospropofol.,increase,risk
Fospropofol,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Fospropofol.,increase,risk
Fospropofol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fospropofol.,increase,no risk
Fospropofol,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Fospropofol.,increase,risk
Fospropofol,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Fospropofol.,increase,risk
Fospropofol,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Fospropofol.,increase,risk
Fospropofol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Fospropofol is combined with Oliceridine.",increase,risk
Fospropofol,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Fospropofol.,increase,risk
Fospropofol,Opium,The risk or severity of CNS depression can be increased when Fospropofol is combined with Opium.,increase,risk
Fospropofol,Orphenadrine,Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Fospropofol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Fospropofol.,increase,risk
Fospropofol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Fospropofol.,increase,risk
Fospropofol,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Fospropofol.,increase,risk
Fospropofol,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Fospropofol.,increase,risk
Fospropofol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Fospropofol.,increase,risk
Fospropofol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Fospropofol.,increase,risk
Fospropofol,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Fospropofol.,increase,risk
Fospropofol,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Fospropofol.,increase,risk
Fospropofol,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Fospropofol.,increase,risk
Fospropofol,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Fospropofol.,increase,risk
Fospropofol,Quinupramine,The risk or severity of CNS depression can be increased when Fospropofol is combined with Quinupramine.,increase,risk
Fospropofol,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Fospropofol.,increase,risk
Fospropofol,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Fospropofol.,increase,risk
Fospropofol,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Fospropofol.,increase,risk
Fospropofol,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Fospropofol.,increase,risk
Fospropofol,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Fospropofol.,increase,risk
Fospropofol,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Fospropofol.,increase,risk
Fospropofol,Viloxazine,The risk or severity of CNS depression can be increased when Fospropofol is combined with Viloxazine.,increase,risk
Fospropofol,Vortioxetine,The risk or severity of CNS depression can be increased when Fospropofol is combined with Vortioxetine.,increase,risk
Fospropofol,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Fospropofol.,increase,risk
Fospropofol,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Fospropofol.,increase,risk
Fospropofol,Ziconotide,The risk or severity of CNS depression can be increased when Fospropofol is combined with Ziconotide.,increase,risk
Fospropofol,Zimelidine,The risk or severity of adverse effects can be increased when Fospropofol is combined with Zimelidine.,increase,risk
Fospropofol,Ziprasidone,The risk or severity of adverse effects can be increased when Fospropofol is combined with Ziprasidone.,increase,risk
Fospropofol,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Fospropofol.,increase,risk
Fospropofol,Zolpidem,Fospropofol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Fospropofol,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Fospropofol.,increase,risk
Fospropofol,Zopiclone,The risk or severity of adverse effects can be increased when Fospropofol is combined with Zopiclone.,increase,risk
Fospropofol,Zotepine,The risk or severity of CNS depression can be increased when Fospropofol is combined with Zotepine.,increase,risk
Fospropofol,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Fospropofol.,increase,risk
Fospropofol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Fospropofol.,increase,risk
Anecortave acetate,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Anecortave acetate is combined with Zoledronic acid.,increase,risk
Vandetanib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Vandetanib.,increase,risk
Vandetanib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vandetanib.,increase,risk
Vandetanib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Vandetanib.,increase,risk
Vandetanib,Gefitinib,Vandetanib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Vandetanib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Vandetanib.,increase,risk
Vandetanib,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Vandetanib.,increase,risk
Vandetanib,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Vandetanib.,increase,risk
Vandetanib,Ginkgo biloba,The metabolism of Vandetanib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vandetanib,Glasdegib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Glasdegib.,increase,risk
Vandetanib,Glecaprevir,The metabolism of Vandetanib can be decreased when combined with Glecaprevir.,decrease,no risk
Vandetanib,Glofitamab,The serum concentration of Vandetanib can be increased when it is combined with Glofitamab.,increase,no risk
Vandetanib,Glyburide,The metabolism of Vandetanib can be decreased when combined with Glyburide.,decrease,no risk
Vandetanib,Glycerol phenylbutyrate,The metabolism of Vandetanib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Vandetanib,Golimumab,The metabolism of Vandetanib can be increased when combined with Golimumab.,increase,no risk
Vandetanib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Vandetanib.,increase,risk
Vandetanib,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Vandetanib.,increase,risk
Vandetanib,Grapefruit,The serum concentration of Vandetanib can be increased when it is combined with Grapefruit.,increase,no risk
Vandetanib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Vandetanib.,increase,risk
Vandetanib,Griseofulvin,The metabolism of Vandetanib can be increased when combined with Griseofulvin.,increase,no risk
Vandetanib,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Vandetanib.,increase,risk
Vandetanib,Haloperidol,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Haloperidol.,increase,risk
Vandetanib,Histamine,The serum concentration of Histamine can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Vandetanib.,increase,risk
Vandetanib,Hydralazine,The serum concentration of Vandetanib can be increased when it is combined with Hydralazine.,increase,no risk
Vandetanib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Vandetanib.,increase,risk
Vandetanib,Hydrocortamate,The metabolism of Vandetanib can be increased when combined with Hydrocortamate.,increase,no risk
Vandetanib,Hydrocortisone,The metabolism of Vandetanib can be increased when combined with Hydrocortisone.,increase,no risk
Vandetanib,Hydrocortisone acetate,The metabolism of Vandetanib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Vandetanib,Hydrocortisone butyrate,The metabolism of Vandetanib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Vandetanib,Hydrocortisone succinate,The metabolism of Vandetanib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Vandetanib,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Vandetanib.,increase,risk
Vandetanib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Hydroxyzine.,increase,risk
Vandetanib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Vandetanib.,increase,risk
Vandetanib,Ketazolam,The serum concentration of Vandetanib can be increased when it is combined with Ketazolam.,increase,no risk
Vandetanib,Ketoconazole,The metabolism of Vandetanib can be decreased when combined with Ketoconazole.,decrease,no risk
Vandetanib,Octreotide,The serum concentration of Vandetanib can be increased when it is combined with Octreotide.,increase,no risk
Vandetanib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Vandetanib.,increase,risk
Vandetanib,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Vandetanib.,increase,risk
Vandetanib,Olaparib,The metabolism of Vandetanib can be decreased when combined with Olaparib.,decrease,no risk
Vandetanib,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Vandetanib.,increase,risk
Vandetanib,Olutasidenib,The metabolism of Vandetanib can be increased when combined with Olutasidenib.,increase,no risk
Vandetanib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Omaveloxolone,The serum concentration of Vandetanib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vandetanib,Ombitasvir,Vandetanib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Vandetanib,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Vandetanib.,increase,risk
Vandetanib,Oritavancin,The metabolism of Vandetanib can be increased when combined with Oritavancin.,increase,no risk
Vandetanib,Orphenadrine,The metabolism of Vandetanib can be decreased when combined with Orphenadrine.,decrease,no risk
Vandetanib,Osilodrostat,The metabolism of Vandetanib can be decreased when combined with Osilodrostat.,decrease,no risk
Vandetanib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Vandetanib.,increase,risk
Vandetanib,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Vandetanib.,increase,risk
Vandetanib,Oxcarbazepine,The metabolism of Vandetanib can be increased when combined with Oxcarbazepine.,increase,no risk
Vandetanib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Oxetacaine.,increase,risk
Vandetanib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Oxybuprocaine.,increase,risk
Vandetanib,Oxybutynin,The serum concentration of Vandetanib can be increased when it is combined with Oxybutynin.,increase,no risk
Vandetanib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vandetanib.,increase,risk
Vandetanib,Ozanimod,Vandetanib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Vandetanib,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Vandetanib.,increase,risk
Vandetanib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Quinine,The metabolism of Vandetanib can be increased when combined with Quinine.,increase,no risk
Vandetanib,Quinupristin,The metabolism of Vandetanib can be decreased when combined with Quinupristin.,decrease,no risk
Vandetanib,Quizartinib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Quizartinib.,increase,risk
Vandetanib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Vadadustat,The serum concentration of Vandetanib can be increased when it is combined with Vadadustat.,increase,no risk
Vandetanib,Valproic acid,The serum concentration of Vandetanib can be increased when it is combined with Valproic acid.,increase,no risk
Vandetanib,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vandetanib.,increase,risk
Vandetanib,Varenicline,The excretion of Varenicline can be decreased when combined with Vandetanib.,decrease,no risk
Vandetanib,Velpatasvir,Vandetanib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Vandetanib,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Verapamil,The metabolism of Vandetanib can be decreased when combined with Verapamil.,decrease,no risk
Vandetanib,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vandetanib.,increase,risk
Vandetanib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Vandetanib.,increase,risk
Vandetanib,Viloxazine,The metabolism of Vandetanib can be decreased when combined with Viloxazine.,decrease,no risk
Vandetanib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Vincristine,The excretion of Vincristine can be decreased when combined with Vandetanib.,decrease,no risk
Vandetanib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Vitamin E,The metabolism of Vandetanib can be increased when combined with Vitamin E.,increase,no risk
Vandetanib,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Vandetanib.,increase,no risk
Vandetanib,Vorapaxar,The metabolism of Vandetanib can be decreased when combined with Vorapaxar.,decrease,no risk
Vandetanib,Voriconazole,The serum concentration of Vandetanib can be increased when it is combined with Voriconazole.,increase,no risk
Vandetanib,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Vandetanib.,increase,risk
Vandetanib,Voxelotor,The serum concentration of Vandetanib can be increased when it is combined with Voxelotor.,increase,no risk
Vandetanib,Voxilaprevir,Vandetanib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Vandetanib,Warfarin,The metabolism of Vandetanib can be increased when combined with Warfarin.,increase,no risk
Vandetanib,Zafirlukast,The serum concentration of Vandetanib can be increased when it is combined with Zafirlukast.,increase,no risk
Vandetanib,Zidovudine,Vandetanib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Vandetanib,Zimelidine,The metabolism of Vandetanib can be decreased when combined with Zimelidine.,decrease,no risk
Vandetanib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Ziprasidone.,increase,risk
Vandetanib,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Vandetanib.,increase,risk
Vandetanib,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Vandetanib.,increase,risk
Eldecalcitol,Vamorolone,The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Eldecalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Eldecalcitol is combined with Vitamin D.,increase,risk
Motexafin lutetium,Verteporfin,Motexafin lutetium may increase the photosensitizing activities of Verteporfin.,increase,no risk
Girentuximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Obiltoxaximab.,increase,risk
Girentuximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Obinutuzumab.,increase,risk
Girentuximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Ocrelizumab.,increase,risk
Girentuximab,Odesivimab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Odesivimab.,increase,risk
Girentuximab,Ofatumumab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Ofatumumab.,increase,risk
Girentuximab,Olaratumab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Olaratumab.,increase,risk
Girentuximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Girentuximab.,increase,risk
Girentuximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Girentuximab.,increase,no risk
Girentuximab,Ublituximab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Ublituximab.,increase,risk
Girentuximab,Ustekinumab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Ustekinumab.,increase,risk
Girentuximab,Vedolizumab,The risk or severity of adverse effects can be increased when Girentuximab is combined with Vedolizumab.,increase,risk
Pimavanserin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Pimavanserin.,increase,risk
Pimavanserin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Pimavanserin.,increase,risk
Pimavanserin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Pimavanserin.,increase,risk
Pimavanserin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Pimavanserin.,increase,risk
Pimavanserin,Gilteritinib,The therapeutic efficacy of Pimavanserin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Pimavanserin,Ginkgo biloba,The metabolism of Pimavanserin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Pimavanserin,Glasdegib,The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Pimavanserin.,increase,risk
Pimavanserin,Glecaprevir,The metabolism of Pimavanserin can be decreased when combined with Glecaprevir.,decrease,no risk
Pimavanserin,Glofitamab,The serum concentration of Pimavanserin can be increased when it is combined with Glofitamab.,increase,no risk
Pimavanserin,Glyburide,The metabolism of Pimavanserin can be decreased when combined with Glyburide.,decrease,no risk
Pimavanserin,Glycerol phenylbutyrate,The metabolism of Pimavanserin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Pimavanserin,Golimumab,The metabolism of Pimavanserin can be increased when combined with Golimumab.,increase,no risk
Pimavanserin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Pimavanserin.,increase,risk
Pimavanserin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Pimavanserin.,increase,risk
Pimavanserin,Grapefruit,The metabolism of Pimavanserin can be decreased when combined with Grapefruit.,decrease,no risk
Pimavanserin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Pimavanserin.,increase,risk
Pimavanserin,Griseofulvin,The metabolism of Pimavanserin can be increased when combined with Griseofulvin.,increase,no risk
Pimavanserin,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Pimavanserin.,increase,risk
Pimavanserin,Haloperidol,The metabolism of Pimavanserin can be increased when combined with Haloperidol.,increase,no risk
Pimavanserin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Pimavanserin.,increase,risk
Pimavanserin,Hydralazine,The metabolism of Pimavanserin can be decreased when combined with Hydralazine.,decrease,no risk
Pimavanserin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Pimavanserin.,increase,risk
Pimavanserin,Hydrocortamate,The metabolism of Pimavanserin can be increased when combined with Hydrocortamate.,increase,no risk
Pimavanserin,Hydrocortisone,The metabolism of Pimavanserin can be increased when combined with Hydrocortisone.,increase,no risk
Pimavanserin,Hydrocortisone acetate,The metabolism of Pimavanserin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Pimavanserin,Hydrocortisone butyrate,The metabolism of Pimavanserin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Pimavanserin,Hydrocortisone succinate,The metabolism of Pimavanserin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Pimavanserin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pimavanserin.,increase,risk
Pimavanserin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Pimavanserin.,increase,risk
Pimavanserin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pimavanserin.,increase,risk
Pimavanserin,Ketazolam,The metabolism of Pimavanserin can be decreased when combined with Ketazolam.,decrease,no risk
Pimavanserin,Ketoconazole,The metabolism of Pimavanserin can be decreased when combined with Ketoconazole.,decrease,no risk
Pimavanserin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Pimavanserin.,increase,risk
Pimavanserin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Pimavanserin.,increase,risk
Pimavanserin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Pimavanserin.,increase,risk
Pimavanserin,Olaparib,The metabolism of Olaparib can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Pimavanserin.,increase,risk
Pimavanserin,Olutasidenib,The metabolism of Pimavanserin can be increased when combined with Olutasidenib.,increase,no risk
Pimavanserin,Omaveloxolone,The serum concentration of Pimavanserin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Pimavanserin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Pimavanserin.,increase,risk
Pimavanserin,Oritavancin,The metabolism of Pimavanserin can be increased when combined with Oritavancin.,increase,no risk
Pimavanserin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Pimavanserin.,increase,risk
Pimavanserin,Osilodrostat,The metabolism of Pimavanserin can be decreased when combined with Osilodrostat.,decrease,no risk
Pimavanserin,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Pimavanserin.,increase,risk
Pimavanserin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Pimavanserin.,increase,risk
Pimavanserin,Oxcarbazepine,The metabolism of Pimavanserin can be increased when combined with Oxcarbazepine.,increase,no risk
Pimavanserin,Oxprenolol,The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Pimavanserin.,increase,risk
Pimavanserin,Oxybutynin,The metabolism of Pimavanserin can be decreased when combined with Oxybutynin.,decrease,no risk
Pimavanserin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Pimavanserin.,increase,risk
Pimavanserin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Pimavanserin.,increase,risk
Pimavanserin,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Pimavanserin.,increase,risk
Pimavanserin,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Pimavanserin.,increase,risk
Pimavanserin,Quinupramine,Pimavanserin may increase the neurotoxic activities of Quinupramine.,increase,no risk
Pimavanserin,Quinupristin,The metabolism of Pimavanserin can be decreased when combined with Quinupristin.,decrease,no risk
Pimavanserin,Vadadustat,The serum concentration of Pimavanserin can be increased when it is combined with Vadadustat.,increase,no risk
Pimavanserin,Valproate bismuth,Pimavanserin may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Pimavanserin,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Pimavanserin.,increase,risk
Pimavanserin,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Pimavanserin.,increase,risk
Pimavanserin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Pimavanserin.,increase,risk
Pimavanserin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pimavanserin.,increase,risk
Pimavanserin,Venetoclax,The metabolism of Pimavanserin can be increased when combined with Venetoclax.,increase,no risk
Pimavanserin,Verapamil,The metabolism of Pimavanserin can be increased when combined with Verapamil.,increase,no risk
Pimavanserin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pimavanserin.,increase,risk
Pimavanserin,Vilanterol,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Pimavanserin.,increase,risk
Pimavanserin,Viloxazine,The metabolism of Pimavanserin can be decreased when combined with Viloxazine.,decrease,no risk
Pimavanserin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Vincristine,The metabolism of Vincristine can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Vindesine,The metabolism of Vindesine can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Viomycin,Pimavanserin may increase the neurotoxic activities of Viomycin.,increase,no risk
Pimavanserin,Vitamin E,The metabolism of Pimavanserin can be increased when combined with Vitamin E.,increase,no risk
Pimavanserin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Voriconazole,The metabolism of Pimavanserin can be increased when combined with Voriconazole.,increase,no risk
Pimavanserin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Pimavanserin.,increase,risk
Pimavanserin,Warfarin,The metabolism of Warfarin can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Zafirlukast,The metabolism of Pimavanserin can be decreased when combined with Zafirlukast.,decrease,no risk
Pimavanserin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Pimavanserin.,decrease,no risk
Pimavanserin,Zimelidine,The metabolism of Pimavanserin can be increased when combined with Zimelidine.,increase,no risk
Pimavanserin,Ziprasidone,The metabolism of Pimavanserin can be increased when combined with Ziprasidone.,increase,no risk
Pimavanserin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Pimavanserin.,increase,risk
Pimavanserin,Zotepine,Pimavanserin may increase the neurotoxic activities of Zotepine.,increase,no risk
Pimavanserin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Pimavanserin.,increase,risk
Capsaicin,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Capsaicin.,increase,risk
Capsaicin,Betamethasone,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Betamethasone.,decrease,no risk
Capsaicin,Betamethasone phosphate,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Capsaicin,Betaxolol,Capsaicin may increase the bradycardic activities of Betaxolol.,increase,no risk
Capsaicin,Bethanechol,The risk or severity of adverse effects can be increased when Capsaicin is combined with Bethanechol.,increase,risk
Capsaicin,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Capsaicin.,increase,risk
Capsaicin,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Capsaicin.,increase,risk
Capsaicin,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Capsaicin.,increase,risk
Capsaicin,Bimekizumab,The metabolism of Capsaicin can be increased when combined with Bimekizumab.,increase,no risk
Capsaicin,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Capsaicin.,increase,risk
Capsaicin,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Bisoprolol,Capsaicin may increase the bradycardic activities of Bisoprolol.,increase,no risk
Capsaicin,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Capsaicin.,increase,risk
Capsaicin,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Capsaicin.,increase,risk
Capsaicin,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Capsaicin.,increase,risk
Capsaicin,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Capsaicin.,increase,risk
Capsaicin,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Capsaicin.,increase,risk
Capsaicin,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Capsaicin.,increase,risk
Capsaicin,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Capsaicin.,increase,risk
Capsaicin,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Capsaicin.,increase,risk
Capsaicin,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Capsaicin.,increase,risk
Capsaicin,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Capsaicin.,increase,risk
Capsaicin,Bromazepam,The metabolism of Bromazepam can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Brompheniramine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Buclizine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Budesonide,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Budesonide.,decrease,no risk
Capsaicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Capsaicin.,increase,risk
Capsaicin,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Capsaicin.,increase,risk
Capsaicin,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Capsaicin.,increase,risk
Capsaicin,Butabarbital,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Capsaicin is combined with Butacaine.,increase,risk
Capsaicin,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Capsaicin.,increase,risk
Capsaicin,Butamben,The risk or severity of methemoglobinemia can be increased when Capsaicin is combined with Butamben.,increase,risk
Capsaicin,Butobarbital,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Capsaicin.,increase,risk
Capsaicin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Ganaxolone,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Capsaicin.,increase,risk
Capsaicin,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Capsaicin.,increase,risk
Capsaicin,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Capsaicin.,increase,risk
Capsaicin,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Capsaicin.,increase,risk
Capsaicin,Gemfibrozil,The metabolism of Capsaicin can be decreased when combined with Gemfibrozil.,decrease,no risk
Capsaicin,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Capsaicin.,increase,risk
Capsaicin,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Capsaicin.,increase,risk
Capsaicin,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Capsaicin.,increase,risk
Capsaicin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Capsaicin.,increase,no risk
Capsaicin,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Capsaicin.,increase,risk
Capsaicin,Givosiran,The serum concentration of Capsaicin can be increased when it is combined with Givosiran.,increase,no risk
Capsaicin,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Capsaicin.,increase,risk
Capsaicin,Glofitamab,The serum concentration of Capsaicin can be increased when it is combined with Glofitamab.,increase,no risk
Capsaicin,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Golimumab,The metabolism of Capsaicin can be increased when combined with Golimumab.,increase,no risk
Capsaicin,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Capsaicin.,increase,risk
Capsaicin,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Capsaicin.,increase,risk
Capsaicin,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Capsaicin.,increase,risk
Capsaicin,Guanabenz,The metabolism of Guanabenz can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Capsaicin.,increase,risk
Capsaicin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Capsaicin.,increase,no risk
Capsaicin,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Capsaicin.,increase,risk
Capsaicin,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Hydrocortisone,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Capsaicin,Hydrocortisone acetate,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Capsaicin,Hydrocortisone butyrate,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Capsaicin,Hydrocortisone cypionate,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Capsaicin,Hydrocortisone succinate,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Capsaicin,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Capsaicin.,increase,risk
Capsaicin,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Capsaicin.,increase,risk
Capsaicin,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Capsaicin.,increase,risk
Capsaicin,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Capsaicin.,increase,risk
Capsaicin,Ketoconazole,The metabolism of Capsaicin can be decreased when combined with Ketoconazole.,decrease,no risk
Capsaicin,Obeticholic acid,The metabolism of Capsaicin can be decreased when combined with Obeticholic acid.,decrease,no risk
Capsaicin,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Capsaicin.,increase,risk
Capsaicin,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Capsaicin.,increase,risk
Capsaicin,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Capsaicin.,increase,risk
Capsaicin,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Capsaicin.,increase,risk
Capsaicin,Olanzapine,The metabolism of Olanzapine can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Capsaicin.,increase,risk
Capsaicin,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Capsaicin.,increase,risk
Capsaicin,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Capsaicin.,increase,risk
Capsaicin,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Capsaicin.,increase,risk
Capsaicin,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Capsaicin.,increase,risk
Capsaicin,Ondansetron,The metabolism of Ondansetron can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Capsaicin.,increase,risk
Capsaicin,Orphenadrine,The metabolism of Capsaicin can be decreased when combined with Orphenadrine.,decrease,no risk
Capsaicin,Osilodrostat,The metabolism of Capsaicin can be decreased when combined with Osilodrostat.,decrease,no risk
Capsaicin,Osimertinib,The serum concentration of Capsaicin can be decreased when it is combined with Osimertinib.,decrease,no risk
Capsaicin,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Capsaicin.,increase,risk
Capsaicin,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Capsaicin.,increase,risk
Capsaicin,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Capsaicin.,increase,risk
Capsaicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Capsaicin is combined with Oxetacaine.,increase,risk
Capsaicin,Oxprenolol,Capsaicin may increase the bradycardic activities of Oxprenolol.,increase,no risk
Capsaicin,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Capsaicin.,increase,risk
Capsaicin,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Capsaicin.,increase,risk
Capsaicin,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Capsaicin.,increase,risk
Capsaicin,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Capsaicin.,increase,risk
Capsaicin,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Capsaicin.,increase,risk
Capsaicin,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Capsaicin.,increase,risk
Capsaicin,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Capsaicin.,increase,risk
Capsaicin,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Capsaicin.,increase,risk
Capsaicin,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Capsaicin.,increase,risk
Capsaicin,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Capsaicin.,increase,risk
Capsaicin,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Capsaicin.,increase,risk
Capsaicin,Vamorolone,The therapeutic efficacy of Capsaicin can be decreased when used in combination with Vamorolone.,decrease,no risk
Capsaicin,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Capsaicin.,increase,risk
Capsaicin,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Capsaicin.,increase,risk
Capsaicin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Capsaicin.,decrease,no risk
Capsaicin,Varenicline,The risk or severity of adverse effects can be increased when Capsaicin is combined with Varenicline.,increase,risk
Capsaicin,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Capsaicin.,decrease,no risk
Capsaicin,Vemurafenib,The serum concentration of Capsaicin can be increased when it is combined with Vemurafenib.,increase,no risk
Capsaicin,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Capsaicin.,increase,risk
Capsaicin,Verapamil,The metabolism of Verapamil can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Capsaicin.,increase,risk
Capsaicin,Viloxazine,The metabolism of Capsaicin can be decreased when combined with Viloxazine.,decrease,no risk
Capsaicin,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Capsaicin.,increase,risk
Capsaicin,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Capsaicin.,increase,risk
Capsaicin,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Capsaicin.,increase,risk
Capsaicin,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Capsaicin.,increase,risk
Capsaicin,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Capsaicin.,increase,risk
Capsaicin,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Capsaicin.,increase,risk
Capsaicin,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Capsaicin.,increase,risk
Capsaicin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Capsaicin.,decrease,no risk
Capsaicin,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Capsaicin.,increase,risk
Capsaicin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Capsaicin.,increase,no risk
Capsaicin,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Capsaicin.,increase,no risk
Capsaicin,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Capsaicin.,increase,risk
Capsaicin,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Capsaicin.,increase,risk
Capsaicin,Zileuton,The metabolism of Zileuton can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Capsaicin.,decrease,no risk
Capsaicin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Capsaicin.,decrease,no risk
Capsaicin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Capsaicin.,increase,no risk
Capsaicin,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Capsaicin.,increase,risk
Capsaicin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Capsaicin.,decrease,no risk
Capsaicin,Zotepine,The metabolism of Zotepine can be increased when combined with Capsaicin.,increase,no risk
Zalutumumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Human varicella-zoster immune globulin is combined with Zalutumumab.,increase,risk
Zalutumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Zalutumumab.,increase,risk
Zalutumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Zalutumumab.,increase,risk
Zalutumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Zalutumumab.,increase,risk
Zalutumumab,Odesivimab,The risk or severity of adverse effects can be increased when Zalutumumab is combined with Odesivimab.,increase,risk
Zalutumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Zalutumumab.,increase,risk
Zalutumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Zalutumumab.,increase,risk
Zalutumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zalutumumab.,increase,risk
Zalutumumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Zalutumumab is combined with Oxetacaine.,increase,risk
Zalutumumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Zalutumumab is combined with Oxybuprocaine.,increase,risk
Zalutumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Zalutumumab.,increase,no risk
Zalutumumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Zalutumumab.,increase,risk
Zalutumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Zalutumumab.,increase,risk
Zalutumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Zalutumumab.,increase,risk
INGN 225,Gemtuzumab ozogamicin,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
INGN 225,Glatiramer,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Glatiramer.,decrease,no risk
INGN 225,Golimumab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Golimumab.,decrease,no risk
INGN 225,Guselkumab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Guselkumab.,decrease,no risk
INGN 225,Hydrocortisone,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Hydrocortisone.,decrease,no risk
INGN 225,Hydrocortisone acetate,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
INGN 225,Hydrocortisone butyrate,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
INGN 225,Hydrocortisone succinate,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
INGN 225,Hydroxychloroquine,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
INGN 225,Hydroxyurea,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Hydroxyurea.,decrease,no risk
INGN 225,Obinutuzumab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Obinutuzumab.,decrease,no risk
INGN 225,Ocrelizumab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Ocrelizumab.,decrease,no risk
INGN 225,Ofatumumab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Ofatumumab.,decrease,no risk
INGN 225,Olaparib,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Olaparib.,decrease,no risk
INGN 225,Oxaliplatin,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Oxaliplatin.,decrease,no risk
INGN 225,Ozanimod,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Ozanimod.,decrease,no risk
INGN 225,Ublituximab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Ublituximab.,decrease,no risk
INGN 225,Upadacitinib,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Upadacitinib.,decrease,no risk
INGN 225,Vedolizumab,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vedolizumab.,decrease,no risk
INGN 225,Vilanterol,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vilanterol.,decrease,no risk
INGN 225,Vinblastine,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vinblastine.,decrease,no risk
INGN 225,Vincristine,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vincristine.,decrease,no risk
INGN 225,Vindesine,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vindesine.,decrease,no risk
INGN 225,Vinorelbine,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vinorelbine.,decrease,no risk
INGN 225,Voclosporin,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Voclosporin.,decrease,no risk
INGN 225,Vorinostat,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Vorinostat.,decrease,no risk
INGN 225,Zidovudine,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Zidovudine.,decrease,no risk
Romiplostim,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vinblastine.,increase,risk
Romiplostim,Vincristine,The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vincristine.,increase,risk
Romiplostim,Vindesine,The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vindesine.,increase,risk
Romiplostim,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vinflunine.,increase,risk
Romiplostim,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Romiplostim is combined with Vinorelbine.,increase,risk
Obiltoxaximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Obinutuzumab.,increase,risk
Obiltoxaximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ocrelizumab.,increase,risk
Obiltoxaximab,Odesivimab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Odesivimab.,increase,risk
Obiltoxaximab,Ofatumumab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ofatumumab.,increase,risk
Obiltoxaximab,Olaratumab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Olaratumab.,increase,risk
Obiltoxaximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obiltoxaximab.,increase,risk
Obiltoxaximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Obiltoxaximab,Ublituximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ublituximab.,increase,risk
Obiltoxaximab,Ustekinumab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ustekinumab.,increase,risk
Obiltoxaximab,Vedolizumab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Vedolizumab.,increase,risk
Human C1-esterase inhibitor,Gestrinone,The risk or severity of thromboembolism can be increased when Gestrinone is combined with Human C1-esterase inhibitor.,increase,risk
Human C1-esterase inhibitor,Hydroxyprogesterone caproate,The risk or severity of thromboembolism can be increased when Hydroxyprogesterone caproate is combined with Human C1-esterase inhibitor.,increase,risk
Azficel-T,Urokinase,The risk or severity of adverse effects can be increased when Urokinase is combined with Azficel-T.,increase,risk
Azficel-T,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Azficel-T.,increase,risk
Azficel-T,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Azficel-T.,increase,risk
Azficel-T,Warfarin,The risk or severity of adverse effects can be increased when Warfarin is combined with Azficel-T.,increase,risk
Azficel-T,Ximelagatran,The risk or severity of adverse effects can be increased when Ximelagatran is combined with Azficel-T.,increase,risk
Dexlansoprazole,Gefitinib,Dexlansoprazole can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dexlansoprazole,Gemfibrozil,The metabolism of Dexlansoprazole can be decreased when combined with Gemfibrozil.,decrease,no risk
Dexlansoprazole,Gliclazide,The metabolism of Dexlansoprazole can be decreased when combined with Gliclazide.,decrease,no risk
Dexlansoprazole,Glofitamab,The serum concentration of Dexlansoprazole can be increased when it is combined with Glofitamab.,increase,no risk
Dexlansoprazole,Glyburide,The metabolism of Dexlansoprazole can be decreased when combined with Glyburide.,decrease,no risk
Dexlansoprazole,Golimumab,The metabolism of Dexlansoprazole can be increased when combined with Golimumab.,increase,no risk
Dexlansoprazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dexlansoprazole.,increase,no risk
Dexlansoprazole,Ketoconazole,Dexlansoprazole can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dexlansoprazole,Octreotide,Dexlansoprazole can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dexlansoprazole,Olanzapine,The metabolism of Dexlansoprazole can be decreased when combined with Olanzapine.,decrease,no risk
Dexlansoprazole,Omaveloxolone,The serum concentration of Dexlansoprazole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dexlansoprazole,Omeprazole,The metabolism of Dexlansoprazole can be decreased when combined with Omeprazole.,decrease,no risk
Dexlansoprazole,Oritavancin,The metabolism of Dexlansoprazole can be decreased when combined with Oritavancin.,decrease,no risk
Dexlansoprazole,Osilodrostat,The metabolism of Dexlansoprazole can be decreased when combined with Osilodrostat.,decrease,no risk
Dexlansoprazole,Oxcarbazepine,The metabolism of Dexlansoprazole can be decreased when combined with Oxcarbazepine.,decrease,no risk
Dexlansoprazole,Quinine,The metabolism of Dexlansoprazole can be decreased when combined with Quinine.,decrease,no risk
Dexlansoprazole,Vadadustat,The serum concentration of Dexlansoprazole can be increased when it is combined with Vadadustat.,increase,no risk
Dexlansoprazole,Valproic acid,The metabolism of Dexlansoprazole can be decreased when combined with Valproic acid.,decrease,no risk
Dexlansoprazole,Venetoclax,The metabolism of Dexlansoprazole can be decreased when combined with Venetoclax.,decrease,no risk
Dexlansoprazole,Verapamil,The metabolism of Dexlansoprazole can be decreased when combined with Verapamil.,decrease,no risk
Dexlansoprazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Dexlansoprazole.,decrease,no risk
Dexlansoprazole,Viloxazine,The metabolism of Dexlansoprazole can be decreased when combined with Viloxazine.,decrease,no risk
Dexlansoprazole,Vonoprazan,The metabolism of Dexlansoprazole can be decreased when combined with Vonoprazan.,decrease,no risk
Dexlansoprazole,Voriconazole,The metabolism of Dexlansoprazole can be decreased when combined with Voriconazole.,decrease,no risk
Dexlansoprazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dexlansoprazole.,decrease,no risk
Dexlansoprazole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Dexlansoprazole.,decrease,no risk
Dexlansoprazole,Warfarin,The risk or severity of bleeding can be increased when Dexlansoprazole is combined with Warfarin.,increase,risk
Dexlansoprazole,Zafirlukast,The metabolism of Dexlansoprazole can be decreased when combined with Zafirlukast.,decrease,no risk
Dexlansoprazole,Zimelidine,The metabolism of Dexlansoprazole can be decreased when combined with Zimelidine.,decrease,no risk
Dexlansoprazole,Ziprasidone,The metabolism of Dexlansoprazole can be decreased when combined with Ziprasidone.,decrease,no risk
Dexlansoprazole,Zolpidem,The metabolism of Dexlansoprazole can be decreased when combined with Zolpidem.,decrease,no risk
Dexlansoprazole,Zonisamide,The metabolism of Dexlansoprazole can be decreased when combined with Zonisamide.,decrease,no risk
Raltegravir,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Raltegravir.",increase,risk
Raltegravir,Ombitasvir,The metabolism of Raltegravir can be decreased when combined with Ombitasvir.,decrease,no risk
Raltegravir,Omeprazole,Omeprazole can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Raltegravir,Quizartinib,The metabolism of Raltegravir can be decreased when combined with Quizartinib.,decrease,no risk
Raltegravir,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Raltegravir is combined with Ubidecarenone.",increase,risk
Raltegravir,Valproic acid,The metabolism of Raltegravir can be decreased when combined with Valproic acid.,decrease,no risk
Raltegravir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Raltegravir.,decrease,no risk
Raltegravir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Raltegravir.,decrease,no risk
Raltegravir,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Raltegravir.",increase,risk
Raltegravir,Vonoprazan,Vonoprazan can cause an increase in the absorption of Raltegravir resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Raltegravir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Raltegravir.,decrease,no risk
Raltegravir,Zidovudine,The metabolism of Raltegravir can be increased when combined with Zidovudine.,increase,no risk
Raltegravir,Zinc,Zinc can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Raltegravir,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Raltegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Phleum pratense pollen,Benazepril,The risk or severity of adverse effects can be increased when Benazepril is combined with Phleum pratense pollen.,increase,risk
Phleum pratense pollen,Betaxolol,The risk of a hypersensitivity reaction to Phleum pratense pollen is increased when it is combined with Betaxolol.,increase,risk
Phleum pratense pollen,Bisoprolol,The risk of a hypersensitivity reaction to Phleum pratense pollen is increased when it is combined with Bisoprolol.,increase,risk
Phleum pratense pollen,Oxprenolol,The risk of a hypersensitivity reaction to Phleum pratense pollen is increased when it is combined with Oxprenolol.,increase,risk
Phleum pratense pollen,Quinapril,The risk or severity of adverse effects can be increased when Quinapril is combined with Phleum pratense pollen.,increase,risk
Phleum pratense pollen,Zofenopril,The risk or severity of adverse effects can be increased when Zofenopril is combined with Phleum pratense pollen.,increase,risk
Azilsartan medoxomil,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Glycol salicylate.",increase,risk
Azilsartan medoxomil,Guanabenz,Guanabenz may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Guanadrel,Guanadrel may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Guanethidine,Guanethidine may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Guanfacine,Guanfacine may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Guanoxan,Azilsartan medoxomil may increase the hypotensive activities of Guanoxan.,increase,no risk
Azilsartan medoxomil,Halothane,Halothane may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Hydralazine,Hydralazine may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Hydrochlorothiazide,The therapeutic efficacy of Azilsartan medoxomil can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Azilsartan medoxomil,Hydroflumethiazide,The therapeutic efficacy of Azilsartan medoxomil can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Azilsartan medoxomil,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Ketoprofen.",increase,risk
Azilsartan medoxomil,Ketorolac,The therapeutic efficacy of Azilsartan medoxomil can be decreased when used in combination with Ketorolac.,decrease,no risk
Azilsartan medoxomil,Obinutuzumab,Azilsartan medoxomil may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Azilsartan medoxomil,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Azilsartan medoxomil.",increase,risk
Azilsartan medoxomil,Olodaterol,Olodaterol may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Opicapone,The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Opicapone.,increase,risk
Azilsartan medoxomil,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Oxaprozin.",increase,risk
Azilsartan medoxomil,Oxprenolol,Oxprenolol may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Oxymetazoline,The therapeutic efficacy of Azilsartan medoxomil can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Azilsartan medoxomil,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Oxyphenbutazone.",increase,risk
Azilsartan medoxomil,Quetiapine,Quetiapine may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Azilsartan medoxomil.",increase,risk
Azilsartan medoxomil,Quinidine,Quinidine may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Quinine,Quinine may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Quinupramine,Quinupramine may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Udenafil,Udenafil may increase the antihypertensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Unoprostone,Unoprostone may increase the hypotensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Valdecoxib.",increase,risk
Azilsartan medoxomil,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Azilsartan medoxomil.",increase,risk
Azilsartan medoxomil,Vardenafil,Vardenafil may increase the antihypertensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Vericiguat,The risk or severity of adverse effects can be increased when Azilsartan medoxomil is combined with Vericiguat.,increase,risk
Azilsartan medoxomil,Vilanterol,Vilanterol may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Vilazodone,Vilazodone may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Xamoterol,Xamoterol may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Yohimbine,Yohimbine may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Azilsartan medoxomil.,increase,no risk
Azilsartan medoxomil,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Azilsartan medoxomil.",increase,risk
Azilsartan medoxomil,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Azilsartan medoxomil,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Azilsartan medoxomil.,increase,risk
Azilsartan medoxomil,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Azilsartan medoxomil.,decrease,no risk
Tasimelteon,Benorilate,Benorilate may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Benperidol,The risk or severity of CNS depression can be increased when Tasimelteon is combined with Benperidol.,increase,risk
Tasimelteon,Benserazide,Tasimelteon may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Tasimelteon,Benzatropine,Benzatropine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Benznidazole,Tasimelteon may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Tasimelteon,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Tasimelteon.,increase,risk
Tasimelteon,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Tasimelteon.,increase,risk
Tasimelteon,Benzthiazide,Benzthiazide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tasimelteon,Benzydamine,Benzydamine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Benzyl alcohol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Tasimelteon.,increase,risk
Tasimelteon,Bepotastine,Bepotastine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Berotralstat,The metabolism of Tasimelteon can be decreased when combined with Berotralstat.,decrease,no risk
Tasimelteon,Betamethasone,The metabolism of Tasimelteon can be increased when combined with Betamethasone.,increase,no risk
Tasimelteon,Betamethasone phosphate,The metabolism of Tasimelteon can be increased when combined with Betamethasone phosphate.,increase,no risk
Tasimelteon,Betaxolol,The metabolism of Tasimelteon can be decreased when combined with Betaxolol.,decrease,no risk
Tasimelteon,Bexarotene,The metabolism of Tasimelteon can be increased when combined with Bexarotene.,increase,no risk
Tasimelteon,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Bicisate,Tasimelteon may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tasimelteon,Bifonazole,The metabolism of Tasimelteon can be decreased when combined with Bifonazole.,decrease,no risk
Tasimelteon,Bimekizumab,The metabolism of Tasimelteon can be increased when combined with Bimekizumab.,increase,no risk
Tasimelteon,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Bismuth subgallate,Tasimelteon may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tasimelteon,Bisoprolol,Bisoprolol may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Bisoxatin,Tasimelteon may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tasimelteon,Bleomycin,Bleomycin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Boceprevir,The metabolism of Tasimelteon can be decreased when combined with Boceprevir.,decrease,no risk
Tasimelteon,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Bosentan,The metabolism of Tasimelteon can be increased when combined with Bosentan.,increase,no risk
Tasimelteon,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Tasimelteon.,increase,risk
Tasimelteon,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Tasimelteon.,increase,risk
Tasimelteon,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Brexanolone,The risk or severity of CNS depression can be increased when Tasimelteon is combined with Brexanolone.,increase,risk
Tasimelteon,Brexpiprazole,The risk or severity of CNS depression can be increased when Tasimelteon is combined with Brexpiprazole.,increase,risk
Tasimelteon,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.,increase,no risk
Tasimelteon,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Tasimelteon.,increase,risk
Tasimelteon,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Tasimelteon.,increase,risk
Tasimelteon,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Tasimelteon.,increase,risk
Tasimelteon,Bromotheophylline,Bromotheophylline may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tasimelteon,Bromperidol,The risk or severity of CNS depression can be increased when Tasimelteon is combined with Bromperidol.,increase,risk
Tasimelteon,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Tasimelteon.,increase,risk
Tasimelteon,Budesonide,The metabolism of Tasimelteon can be increased when combined with Budesonide.,increase,no risk
Tasimelteon,Bumadizone,Bumadizone may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Bumetanide,Bumetanide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tasimelteon,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Tasimelteon.,increase,risk
Tasimelteon,Buprenorphine,Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Tasimelteon,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Tasimelteon.,increase,risk
Tasimelteon,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Tasimelteon.,increase,risk
Tasimelteon,Busulfan,The metabolism of Busulfan can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Tasimelteon.,increase,risk
Tasimelteon,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Tasimelteon.,increase,risk
Tasimelteon,Butaperazine,The risk or severity of CNS depression can be increased when Tasimelteon is combined with Butaperazine.,increase,risk
Tasimelteon,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Tasimelteon.,increase,risk
Tasimelteon,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Tasimelteon.,increase,risk
Tasimelteon,Butriptyline,The risk or severity of CNS depression can be increased when Butriptyline is combined with Tasimelteon.,increase,risk
Tasimelteon,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Tasimelteon.,increase,risk
Tasimelteon,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Tasimelteon.,increase,risk
Tasimelteon,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gadodiamide,Gadodiamide may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gadoteric acid,Tasimelteon may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gadoteridol,Gadoteridol may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tasimelteon.,increase,risk
Tasimelteon,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tasimelteon is combined with Ganaxolone.",increase,risk
Tasimelteon,Ganciclovir,Ganciclovir may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gatifloxacin,The metabolism of Tasimelteon can be decreased when combined with Gatifloxacin.,decrease,no risk
Tasimelteon,Gemcitabine,Gemcitabine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gemfibrozil,The metabolism of Tasimelteon can be decreased when combined with Gemfibrozil.,decrease,no risk
Tasimelteon,Gemifloxacin,The metabolism of Tasimelteon can be decreased when combined with Gemifloxacin.,decrease,no risk
Tasimelteon,Gentamicin,Tasimelteon may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tasimelteon,Gepirone,The risk or severity of CNS depression can be increased when Tasimelteon is combined with Gepirone.,increase,risk
Tasimelteon,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Tasimelteon.,decrease,no risk
Tasimelteon,Gimeracil,Tasimelteon may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tasimelteon,Ginkgo biloba,The metabolism of Tasimelteon can be decreased when combined with Ginkgo biloba.,decrease,no risk
Tasimelteon,Givosiran,The serum concentration of Tasimelteon can be increased when it is combined with Givosiran.,increase,no risk
Tasimelteon,Glecaprevir,The metabolism of Tasimelteon can be decreased when combined with Glecaprevir.,decrease,no risk
Tasimelteon,Glipizide,Glipizide may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Glofitamab,The serum concentration of Tasimelteon can be increased when it is combined with Glofitamab.,increase,no risk
Tasimelteon,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tasimelteon.,increase,risk
Tasimelteon,Glyburide,The metabolism of Tasimelteon can be decreased when combined with Glyburide.,decrease,no risk
Tasimelteon,Glycerol phenylbutyrate,The metabolism of Tasimelteon can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Tasimelteon,Golimumab,The metabolism of Tasimelteon can be increased when combined with Golimumab.,increase,no risk
Tasimelteon,Golodirsen,Tasimelteon may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tasimelteon,Goserelin,Goserelin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tasimelteon.,increase,risk
Tasimelteon,Grapefruit,The metabolism of Tasimelteon can be decreased when combined with Grapefruit.,decrease,no risk
Tasimelteon,Grepafloxacin,The metabolism of Tasimelteon can be decreased when combined with Grepafloxacin.,decrease,no risk
Tasimelteon,Griseofulvin,The metabolism of Tasimelteon can be increased when combined with Griseofulvin.,increase,no risk
Tasimelteon,Guanabenz,The metabolism of Tasimelteon can be decreased when combined with Guanabenz.,decrease,no risk
Tasimelteon,Guanethidine,Guanethidine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tasimelteon.,increase,risk
Tasimelteon,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tasimelteon.,increase,risk
Tasimelteon,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tasimelteon.,increase,risk
Tasimelteon,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tasimelteon.,increase,risk
Tasimelteon,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tasimelteon.,increase,risk
Tasimelteon,Hydralazine,The metabolism of Tasimelteon can be decreased when combined with Hydralazine.,decrease,no risk
Tasimelteon,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tasimelteon,Hydrocodone,Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tasimelteon,Hydrocortamate,The metabolism of Tasimelteon can be increased when combined with Hydrocortamate.,increase,no risk
Tasimelteon,Hydrocortisone,The metabolism of Tasimelteon can be increased when combined with Hydrocortisone.,increase,no risk
Tasimelteon,Hydrocortisone acetate,The metabolism of Tasimelteon can be increased when combined with Hydrocortisone acetate.,increase,no risk
Tasimelteon,Hydrocortisone butyrate,The metabolism of Tasimelteon can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Tasimelteon,Hydrocortisone succinate,The metabolism of Tasimelteon can be increased when combined with Hydrocortisone succinate.,increase,no risk
Tasimelteon,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tasimelteon,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tasimelteon.,increase,risk
Tasimelteon,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Hydroxyethyl Starch,Tasimelteon may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tasimelteon,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tasimelteon.,increase,no risk
Tasimelteon,Kanamycin,Tasimelteon may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tasimelteon,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tasimelteon.,increase,risk
Tasimelteon,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tasimelteon.,increase,risk
Tasimelteon,Ketoconazole,The metabolism of Tasimelteon can be decreased when combined with Ketoconazole.,decrease,no risk
Tasimelteon,Ketoprofen,Ketoprofen may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Tasimelteon,Ketorolac,Ketorolac may decrease the excretion rate of Tasimelteon which could result in a higher serum level.,decrease,no risk
Rolofylline,Gabapentin enacarbil,Rolofylline may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gadobenic acid,Rolofylline may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gadodiamide,Rolofylline may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gadofosveset trisodium,Rolofylline may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gadopentetic acid,Rolofylline may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gadoteric acid,Rolofylline may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gadoteridol,Rolofylline may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Ganciclovir,Rolofylline may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gemcitabine,Rolofylline may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gemfibrozil,Rolofylline may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gimeracil,Rolofylline may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Glipizide,Rolofylline may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Gluconic Acid,The risk or severity of dehydration can be increased when Rolofylline is combined with Gluconic Acid.,increase,risk
Rolofylline,Glycerin,The risk or severity of dehydration can be increased when Rolofylline is combined with Glycerin.,increase,risk
Rolofylline,Glycerol phenylbutyrate,Rolofylline may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Golodirsen,Rolofylline may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Goserelin,Rolofylline may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Guanethidine,Rolofylline may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Guanfacine,Rolofylline may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Haloperidol,Rolofylline may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Hydralazine,Rolofylline may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Hydrocodone,The therapeutic efficacy of Rolofylline can be decreased when used in combination with Hydrocodone.,decrease,no risk
Rolofylline,Hydromorphone,Rolofylline may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Hydroxocobalamin,Rolofylline may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Hydroxyethyl Starch,Rolofylline may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Ketamine,Rolofylline may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Ketazolam,Rolofylline may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Ketoprofen,Rolofylline may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Octinoxate,Rolofylline may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oliceridine,The therapeutic efficacy of Rolofylline can be decreased when used in combination with Oliceridine.,decrease,no risk
Rolofylline,Opium,Rolofylline may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oseltamivir,Rolofylline may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oxacillin,Rolofylline may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oxaprozin,Rolofylline may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oxazepam,Rolofylline may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oxybenzone,Rolofylline may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Oxycodone,The therapeutic efficacy of Rolofylline can be decreased when used in combination with Oxycodone.,decrease,no risk
Rolofylline,Oxymorphone,The therapeutic efficacy of Rolofylline can be decreased when used in combination with Oxymorphone.,decrease,no risk
Rolofylline,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Rolofylline is combined with Oxyphenisatin acetate.,increase,risk
Rolofylline,Oxyquinoline,Rolofylline may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Quetiapine,Rolofylline may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Quinidine,Rolofylline may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Vaborbactam,Rolofylline may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Valaciclovir,Rolofylline may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Valbenazine,Rolofylline may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Valganciclovir,Rolofylline may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Vancomycin,Rolofylline may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Varenicline,Rolofylline may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Venlafaxine,Rolofylline may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Verapamil,Rolofylline may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Vilanterol,Rolofylline may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Viloxazine,Rolofylline may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Vortioxetine,Rolofylline may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Warfarin,Rolofylline may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Zaleplon,Rolofylline may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Zanamivir,Rolofylline may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rolofylline,Ziconotide,The risk or severity of CNS depression can be increased when Rolofylline is combined with Ziconotide.,increase,risk
Rolofylline,Zonisamide,Rolofylline may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
SR-123781A,Gemcitabine,The risk or severity of bleeding can be increased when SR-123781A is combined with Gemcitabine.,increase,risk
SR-123781A,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when SR-123781A is combined with Gemtuzumab ozogamicin.,increase,risk
SR-123781A,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with SR-123781A.,increase,risk
SR-123781A,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of SR-123781A.,increase,no risk
SR-123781A,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with SR-123781A.,increase,risk
SR-123781A,Hemin,Hemin may increase the anticoagulant activities of SR-123781A.,increase,no risk
SR-123781A,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with SR-123781A.,increase,risk
SR-123781A,Hydrochlorothiazide,The therapeutic efficacy of SR-123781A can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
SR-123781A,Hydroflumethiazide,The therapeutic efficacy of SR-123781A can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
SR-123781A,Hydroxyprogesterone caproate,The therapeutic efficacy of SR-123781A can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
SR-123781A,Hydroxyurea,The risk or severity of bleeding can be increased when SR-123781A is combined with Hydroxyurea.,increase,risk
SR-123781A,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with SR-123781A.,increase,risk
SR-123781A,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with SR-123781A.,increase,risk
SR-123781A,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when SR-123781A is combined with Obeticholic acid.,increase,risk
SR-123781A,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when SR-123781A is combined with Obinutuzumab.,increase,risk
SR-123781A,Olaparib,The risk or severity of bleeding can be increased when SR-123781A is combined with Olaparib.,increase,risk
SR-123781A,Olive oil,The therapeutic efficacy of SR-123781A can be decreased when used in combination with Olive oil.,decrease,no risk
SR-123781A,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with SR-123781A.,increase,risk
SR-123781A,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when SR-123781A is combined with Omacetaxine mepesuccinate.,increase,risk
SR-123781A,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of SR-123781A.,increase,no risk
SR-123781A,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with SR-123781A.,increase,risk
SR-123781A,Omega-3-carboxylic acids,The therapeutic efficacy of SR-123781A can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
SR-123781A,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with SR-123781A.,increase,risk
SR-123781A,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with SR-123781A.,increase,risk
SR-123781A,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with SR-123781A.,increase,risk
SR-123781A,Quinestrol,Quinestrol may decrease the anticoagulant activities of SR-123781A.,decrease,no risk
SR-123781A,Quinidine,The therapeutic efficacy of SR-123781A can be increased when used in combination with Quinidine.,increase,no risk
SR-123781A,Quinine,The therapeutic efficacy of SR-123781A can be increased when used in combination with Quinine.,increase,no risk
SR-123781A,Ulipristal,The therapeutic efficacy of SR-123781A can be decreased when used in combination with Ulipristal.,decrease,no risk
SR-123781A,Urokinase,Urokinase may increase the anticoagulant activities of SR-123781A.,increase,no risk
SR-123781A,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when SR-123781A is combined with Ursodeoxycholic acid.,increase,risk
SR-123781A,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with SR-123781A.,increase,risk
SR-123781A,Venlafaxine,The risk or severity of bleeding can be increased when SR-123781A is combined with Venlafaxine.,increase,risk
SR-123781A,Vinblastine,The risk or severity of bleeding can be increased when SR-123781A is combined with Vinblastine.,increase,risk
SR-123781A,Vindesine,The risk or severity of bleeding can be increased when SR-123781A is combined with Vindesine.,increase,risk
SR-123781A,Vinorelbine,The risk or severity of bleeding can be increased when SR-123781A is combined with Vinorelbine.,increase,risk
SR-123781A,Vitamin E,Vitamin E may increase the anticoagulant activities of SR-123781A.,increase,no risk
SR-123781A,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with SR-123781A.,decrease,no risk
SR-123781A,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with SR-123781A.,increase,risk
SR-123781A,Vorinostat,The risk or severity of bleeding can be increased when SR-123781A is combined with Vorinostat.,increase,risk
SR-123781A,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with SR-123781A.,increase,risk
SR-123781A,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with SR-123781A.,increase,risk
SR-123781A,Zidovudine,The risk or severity of bleeding can be increased when SR-123781A is combined with Zidovudine.,increase,risk
SR-123781A,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with SR-123781A.,increase,risk
Ulipristal,Gabapentin,The metabolism of Ulipristal can be increased when combined with Gabapentin.,increase,no risk
Ulipristal,Ganaxolone,The metabolism of Ulipristal can be increased when combined with Ganaxolone.,increase,no risk
Ulipristal,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Glofitamab,The serum concentration of Ulipristal can be increased when it is combined with Glofitamab.,increase,no risk
Ulipristal,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Glycerol phenylbutyrate,The metabolism of Ulipristal can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ulipristal,Griseofulvin,The metabolism of Ulipristal can be increased when combined with Griseofulvin.,increase,no risk
Ulipristal,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Hetacillin,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Hetacillin.,decrease,no risk
Ulipristal,Hydrocortamate,The metabolism of Ulipristal can be increased when combined with Hydrocortamate.,increase,no risk
Ulipristal,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Ketoconazole,The metabolism of Ulipristal can be decreased when combined with Ketoconazole.,decrease,no risk
Ulipristal,Olutasidenib,The metabolism of Ulipristal can be increased when combined with Olutasidenib.,increase,no risk
Ulipristal,Omadacycline,The serum concentration of Ulipristal can be decreased when it is combined with Omadacycline.,decrease,no risk
Ulipristal,Omaveloxolone,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Ulipristal,Oritavancin,The metabolism of Ulipristal can be increased when combined with Oritavancin.,increase,no risk
Ulipristal,Oxacillin,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Oxacillin.,decrease,no risk
Ulipristal,Oxcarbazepine,The metabolism of Ulipristal can be increased when combined with Oxcarbazepine.,increase,no risk
Ulipristal,Oxytetracycline,The serum concentration of Ulipristal can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Ulipristal,Quinine,The metabolism of Ulipristal can be increased when combined with Quinine.,increase,no risk
Ulipristal,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Vadadustat,The serum concentration of Ulipristal can be increased when it is combined with Vadadustat.,increase,no risk
Ulipristal,Valproic acid,The metabolism of Ulipristal can be increased when combined with Valproic acid.,increase,no risk
Ulipristal,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Ulipristal.,increase,no risk
Ulipristal,Vemurafenib,The metabolism of Ulipristal can be increased when combined with Vemurafenib.,increase,no risk
Ulipristal,Venetoclax,The metabolism of Ulipristal can be decreased when combined with Venetoclax.,decrease,no risk
Ulipristal,Verapamil,The metabolism of Ulipristal can be decreased when combined with Verapamil.,decrease,no risk
Ulipristal,Vigabatrin,The metabolism of Ulipristal can be increased when combined with Vigabatrin.,increase,no risk
Ulipristal,Viloxazine,The metabolism of Ulipristal can be decreased when combined with Viloxazine.,decrease,no risk
Ulipristal,Vinblastine,The metabolism of Ulipristal can be increased when combined with Vinblastine.,increase,no risk
Ulipristal,Vitamin E,The metabolism of Ulipristal can be increased when combined with Vitamin E.,increase,no risk
Ulipristal,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Voriconazole,The metabolism of Ulipristal can be decreased when combined with Voriconazole.,decrease,no risk
Ulipristal,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ulipristal.,decrease,no risk
Ulipristal,Zaleplon,The metabolism of Ulipristal can be increased when combined with Zaleplon.,increase,no risk
Ulipristal,Zimelidine,The metabolism of Ulipristal can be decreased when combined with Zimelidine.,decrease,no risk
Ulipristal,Ziprasidone,The metabolism of Ulipristal can be decreased when combined with Ziprasidone.,decrease,no risk
Ulipristal,Zonisamide,The metabolism of Ulipristal can be increased when combined with Zonisamide.,increase,no risk
Rindopepimut,Gemcitabine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Gemcitabine.,decrease,no risk
Rindopepimut,Gemtuzumab ozogamicin,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
Rindopepimut,Glatiramer,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Glatiramer.,decrease,no risk
Rindopepimut,Golimumab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Golimumab.,decrease,no risk
Rindopepimut,Guselkumab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Guselkumab.,decrease,no risk
Rindopepimut,Hydrocortisone,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Rindopepimut,Hydrocortisone acetate,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Rindopepimut,Hydrocortisone butyrate,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Rindopepimut,Hydrocortisone succinate,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Rindopepimut,Hydroxychloroquine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Rindopepimut,Hydroxyurea,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Rindopepimut,Obinutuzumab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Rindopepimut,Ocrelizumab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Ocrelizumab.,decrease,no risk
Rindopepimut,Ofatumumab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Ofatumumab.,decrease,no risk
Rindopepimut,Olaparib,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Olaparib.,decrease,no risk
Rindopepimut,Oxaliplatin,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Oxaliplatin.,decrease,no risk
Rindopepimut,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rindopepimut is combined with Oxetacaine.,increase,risk
Rindopepimut,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rindopepimut is combined with Oxybuprocaine.,increase,risk
Rindopepimut,Ozanimod,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Ozanimod.,decrease,no risk
Rindopepimut,Ublituximab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Ublituximab.,decrease,no risk
Rindopepimut,Upadacitinib,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Upadacitinib.,decrease,no risk
Rindopepimut,Vedolizumab,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vedolizumab.,decrease,no risk
Rindopepimut,Vilanterol,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vilanterol.,decrease,no risk
Rindopepimut,Vinblastine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vinblastine.,decrease,no risk
Rindopepimut,Vincristine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vincristine.,decrease,no risk
Rindopepimut,Vindesine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vindesine.,decrease,no risk
Rindopepimut,Vinorelbine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vinorelbine.,decrease,no risk
Rindopepimut,Voclosporin,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Voclosporin.,decrease,no risk
Rindopepimut,Vorinostat,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Vorinostat.,decrease,no risk
Rindopepimut,Zidovudine,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Zidovudine.,decrease,no risk
Rifamycin,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Bromocriptine,The metabolism of Bromocriptine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Brompheniramine,The metabolism of Brompheniramine can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Budesonide,The metabolism of Budesonide can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Bupivacaine.,increase,risk
Rifamycin,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Buspirone,The metabolism of Buspirone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Busulfan,The metabolism of Busulfan can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Butacaine.,increase,risk
Rifamycin,Butamben,The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Butamben.,increase,risk
Rifamycin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Galantamine,The metabolism of Galantamine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Gefitinib,The metabolism of Gefitinib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Gemfibrozil,The metabolism of Gemfibrozil can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Rifamycin.,decrease,no risk
Rifamycin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Gliclazide,The metabolism of Gliclazide can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Glipizide,The metabolism of Glipizide can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Glyburide,The metabolism of Glyburide can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Granisetron,The metabolism of Granisetron can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Grazoprevir,The metabolism of Grazoprevir can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Guanfacine,The metabolism of Guanfacine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Guanidine,The excretion of Guanidine can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Halofantrine,The metabolism of Halofantrine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Halothane,The metabolism of Halothane can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ketamine,The metabolism of Ketamine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ketazolam,The metabolism of Ketazolam can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ketoconazole,The metabolism of Ketoconazole can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Olaparib,The metabolism of Olaparib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Rifamycin.,decrease,no risk
Rifamycin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Rifamycin.,decrease,no risk
Rifamycin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Rifamycin.,decrease,no risk
Rifamycin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Omeprazole,The metabolism of Omeprazole can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ondansetron,The metabolism of Ondansetron can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Opium,The metabolism of Opium can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Orphenadrine,The metabolism of Orphenadrine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Rifamycin.,decrease,no risk
Rifamycin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ospemifene,The metabolism of Ospemifene can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ouabain,The excretion of Ouabain can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Oxetacaine.,increase,risk
Rifamycin,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rifamycin is combined with Oxybuprocaine.,increase,risk
Rifamycin,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Oxycodone,The metabolism of Oxycodone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Quazepam,The metabolism of Quazepam can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Quetiapine,The metabolism of Quetiapine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Quinine,The metabolism of Quinine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Rifamycin.,decrease,no risk
Rifamycin,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Rifamycin.,decrease,no risk
Rifamycin,Udenafil,The metabolism of Udenafil can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Umbralisib,The serum concentration of Rifamycin can be increased when it is combined with Umbralisib.,increase,no risk
Rifamycin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Valbenazine,The serum concentration of Valbenazine can be decreased when it is combined with Rifamycin.,decrease,no risk
Rifamycin,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Valproic acid,The metabolism of Valproic acid can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Valsartan,The metabolism of Valsartan can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Vamorolone,The metabolism of Vamorolone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vemurafenib,The serum concentration of Rifamycin can be increased when it is combined with Vemurafenib.,increase,no risk
Rifamycin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Verapamil,The metabolism of Verapamil can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rifamycin.,decrease,no risk
Rifamycin,Vilanterol,The metabolism of Vilanterol can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vilazodone,The metabolism of Vilazodone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Vincristine,The excretion of Vincristine can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Vindesine,The metabolism of Vindesine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vitamin D,The metabolism of Vitamin D can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vitamin E,The metabolism of Vitamin E can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Voclosporin,The metabolism of Voclosporin can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Rifamycin.,decrease,no risk
Rifamycin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Voriconazole,The metabolism of Voriconazole can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Yohimbine,The metabolism of Yohimbine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Zaleplon,The metabolism of Zaleplon can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Rifamycin.,increase,no risk
Rifamycin,Zidovudine,The metabolism of Zidovudine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zileuton,The metabolism of Zileuton can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zonisamide,The metabolism of Zonisamide can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Rifamycin.,decrease,no risk
Rifamycin,Zotepine,The metabolism of Zotepine can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Rifamycin.,increase,no risk
Rifamycin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Rifamycin.,decrease,no risk
Regramostim,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Oxprenolol,Regramostim may increase the bradycardic activities of Oxprenolol.,increase,no risk
Regramostim,Oxybuprocaine,Regramostim may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Regramostim,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Vamorolone,The therapeutic efficacy of Regramostim can be decreased when used in combination with Vamorolone.,decrease,no risk
Regramostim,Varenicline,The risk or severity of adverse effects can be increased when Regramostim is combined with Varenicline.,increase,risk
Regramostim,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Regramostim.,decrease,no risk
Regramostim,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Regramostim is combined with Vinblastine.,increase,risk
Regramostim,Vincristine,The risk or severity of peripheral neuropathy can be increased when Regramostim is combined with Vincristine.,increase,risk
Regramostim,Vindesine,The risk or severity of peripheral neuropathy can be increased when Regramostim is combined with Vindesine.,increase,risk
Regramostim,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Regramostim is combined with Vinflunine.,increase,risk
Regramostim,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Regramostim is combined with Vinorelbine.,increase,risk
Regramostim,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Regramostim.,decrease,no risk
Perflubutane,Gatifloxacin,Perflubutane can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Gemifloxacin,Perflubutane can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Grepafloxacin,Perflubutane can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Ofloxacin,Perflubutane can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Olanzapine,Olanzapine can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Omadacycline,Omadacycline can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Omeprazole,The absorption of Perflubutane can be decreased when combined with Omeprazole.,decrease,no risk
Perflubutane,Oxytetracycline,Oxytetracycline can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Perflubutane.,decrease,no risk
Perflubutane,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Perflubutane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perflubutane,Zoledronic acid,Perflubutane can cause a decrease in the absorption of Zoledronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Amibegron,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Amibegron.,increase,risk
Amibegron,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Amibegron.,increase,risk
Amibegron,Guanabenz,Amibegron may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Amibegron,Guanadrel,Amibegron may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Amibegron,Guanethidine,Amibegron may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Amibegron,Guanfacine,Amibegron may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Amibegron,Guanoxan,Amibegron may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Amibegron,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Amibegron.,increase,risk
Amibegron,Hexocyclium,The risk or severity of Tachycardia can be increased when Amibegron is combined with Hexocyclium.,increase,risk
Amibegron,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Amibegron.,increase,risk
Amibegron,Hydralazine,Amibegron may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Amibegron,Hydrochlorothiazide,Amibegron may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Amibegron,Hydroflumethiazide,Amibegron may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Amibegron,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Amibegron.,increase,risk
Amibegron,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Amibegron.,increase,risk
Amibegron,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Amibegron.,increase,risk
Amibegron,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Amibegron.,increase,risk
Amibegron,Olanzapine,The therapeutic efficacy of Amibegron can be decreased when used in combination with Olanzapine.,decrease,no risk
Amibegron,Olmesartan,Amibegron may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Amibegron,Olodaterol,The risk or severity of hypertension can be increased when Amibegron is combined with Olodaterol.,increase,risk
Amibegron,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Amibegron.,increase,risk
Amibegron,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Amibegron.,increase,risk
Amibegron,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Amibegron.,increase,risk
Amibegron,Oxprenolol,The therapeutic efficacy of Amibegron can be decreased when used in combination with Oxprenolol.,decrease,no risk
Amibegron,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Amibegron.,increase,risk
Amibegron,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Amibegron.,increase,risk
Amibegron,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Amibegron.,increase,risk
Amibegron,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Amibegron.,increase,risk
Amibegron,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Amibegron.,increase,risk
Amibegron,Quetiapine,The therapeutic efficacy of Amibegron can be decreased when used in combination with Quetiapine.,decrease,no risk
Amibegron,Quinapril,Amibegron may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Amibegron,Quinidine,The therapeutic efficacy of Amibegron can be decreased when used in combination with Quinidine.,decrease,no risk
Amibegron,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Amibegron.,increase,risk
Amibegron,Umeclidinium,The risk or severity of Tachycardia can be increased when Amibegron is combined with Umeclidinium.,increase,risk
Amibegron,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Amibegron.,increase,risk
Amibegron,Valsartan,Amibegron may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Amibegron,Venlafaxine,Venlafaxine may increase the tachycardic activities of Amibegron.,increase,no risk
Amibegron,Verapamil,The therapeutic efficacy of Amibegron can be decreased when used in combination with Verapamil.,decrease,no risk
Amibegron,Vilanterol,The risk or severity of hypertension can be increased when Amibegron is combined with Vilanterol.,increase,risk
Amibegron,Vilazodone,The risk or severity of hypertension can be increased when Amibegron is combined with Vilazodone.,increase,risk
Amibegron,Vortioxetine,The risk or severity of hypertension can be increased when Amibegron is combined with Vortioxetine.,increase,risk
Amibegron,Xamoterol,The risk or severity of hypertension can be increased when Amibegron is combined with Xamoterol.,increase,risk
Amibegron,Xylometazoline,The risk or severity of hypertension can be increased when Amibegron is combined with Xylometazoline.,increase,risk
Amibegron,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Amibegron.,increase,risk
Amibegron,Ziprasidone,The therapeutic efficacy of Amibegron can be decreased when used in combination with Ziprasidone.,decrease,no risk
Amibegron,Zofenopril,Amibegron may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Amibegron,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Amibegron.,increase,risk
Amibegron,Zuclopenthixol,The therapeutic efficacy of Amibegron can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Albinterferon Alfa-2B,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Quinine,The metabolism of Quinine can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Verapamil,The metabolism of Verapamil can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Warfarin,The metabolism of Warfarin can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Zidovudine,The risk or severity of adverse effects can be increased when Albinterferon Alfa-2B is combined with Zidovudine.,increase,risk
Albinterferon Alfa-2B,Zileuton,The metabolism of Zileuton can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
Albinterferon Alfa-2B,Zotepine,The metabolism of Zotepine can be decreased when combined with Albinterferon Alfa-2B.,decrease,no risk
XTL-001,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with XTL-001.,increase,risk
XTL-001,Obinutuzumab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Obinutuzumab.,increase,risk
XTL-001,Ocrelizumab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Ocrelizumab.,increase,risk
XTL-001,Odesivimab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Odesivimab.,increase,risk
XTL-001,Ofatumumab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Ofatumumab.,increase,risk
XTL-001,Olaratumab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Olaratumab.,increase,risk
XTL-001,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with XTL-001.,increase,risk
XTL-001,Quinestrol,Quinestrol may increase the thrombogenic activities of XTL-001.,increase,no risk
XTL-001,Ublituximab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Ublituximab.,increase,risk
XTL-001,Ustekinumab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Ustekinumab.,increase,risk
XTL-001,Vedolizumab,The risk or severity of adverse effects can be increased when XTL-001 is combined with Vedolizumab.,increase,risk
Canertinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Benzocaine.,increase,risk
Canertinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Benzyl alcohol.,increase,risk
Canertinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Bupivacaine.,increase,risk
Canertinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Butacaine.,increase,risk
Canertinib,Butamben,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Butamben.,increase,risk
Canertinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Oxetacaine.,increase,risk
Canertinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Canertinib is combined with Oxybuprocaine.,increase,risk
Canertinib,Voriconazole,The serum concentration of Canertinib can be increased when it is combined with Voriconazole.,increase,no risk
Talactoferrin alfa,Benzocaine,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Benzocaine.,increase,risk
Talactoferrin alfa,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Benzyl alcohol.,increase,risk
Talactoferrin alfa,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Bupivacaine.,increase,risk
Talactoferrin alfa,Butacaine,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Butacaine.,increase,risk
Talactoferrin alfa,Butamben,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Butamben.,increase,risk
Talactoferrin alfa,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Oxetacaine.,increase,risk
Talactoferrin alfa,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Talactoferrin alfa is combined with Oxybuprocaine.,increase,risk
Motexafin gadolinium,Benzocaine,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Benzocaine.,increase,risk
Motexafin gadolinium,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Benzyl alcohol.,increase,risk
Motexafin gadolinium,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Bupivacaine.,increase,risk
Motexafin gadolinium,Butacaine,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Butacaine.,increase,risk
Motexafin gadolinium,Butamben,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Butamben.,increase,risk
Motexafin gadolinium,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Oxetacaine.,increase,risk
Motexafin gadolinium,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Motexafin gadolinium is combined with Oxybuprocaine.,increase,risk
Motexafin gadolinium,Verteporfin,Motexafin gadolinium may increase the photosensitizing activities of Verteporfin.,increase,no risk
Ibalizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ibalizumab.,increase,risk
Ibalizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Odesivimab,The risk or severity of adverse effects can be increased when Ibalizumab is combined with Odesivimab.,increase,risk
Ibalizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ibalizumab.,increase,no risk
Ibalizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Ibalizumab.,increase,risk
Ibalizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Ibalizumab.,decrease,no risk
Ibalizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Ibalizumab.,increase,risk
Ibalizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ibalizumab.,decrease,no risk
Ibalizumab,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Ibalizumab.,decrease,no risk
Acetylcysteine,Belantamab mafodotin,The excretion of Belantamab mafodotin can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Bosentan,The excretion of Bosentan can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Acetylcysteine.,increase,no risk
Acetylcysteine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Hydrogen peroxide,The therapeutic efficacy of Acetylcysteine can be decreased when used in combination with Hydrogen peroxide.,decrease,no risk
Acetylcysteine,Ouabain,The excretion of Ouabain can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Oxytetracycline,The therapeutic efficacy of Acetylcysteine can be decreased when used in combination with Oxytetracycline.,decrease,no risk
Acetylcysteine,Valsartan,The excretion of Valsartan can be decreased when combined with Acetylcysteine.,decrease,no risk
Acetylcysteine,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Acetylcysteine.,decrease,no risk
NAV 1800,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with NAV 1800.,increase,risk
NAV 1800,Obinutuzumab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Obinutuzumab.,increase,risk
NAV 1800,Ocrelizumab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Ocrelizumab.,increase,risk
NAV 1800,Odesivimab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Odesivimab.,increase,risk
NAV 1800,Ofatumumab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Ofatumumab.,increase,risk
NAV 1800,Olaratumab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Olaratumab.,increase,risk
NAV 1800,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with NAV 1800.,increase,risk
NAV 1800,Quinestrol,Quinestrol may increase the thrombogenic activities of NAV 1800.,increase,no risk
NAV 1800,Ublituximab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Ublituximab.,increase,risk
NAV 1800,Ustekinumab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Ustekinumab.,increase,risk
NAV 1800,Vedolizumab,The risk or severity of adverse effects can be increased when NAV 1800 is combined with Vedolizumab.,increase,risk
SRP 299,Gemtuzumab ozogamicin,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
SRP 299,Glatiramer,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Glatiramer.,decrease,no risk
SRP 299,Golimumab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Golimumab.,decrease,no risk
SRP 299,Guselkumab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Guselkumab.,decrease,no risk
SRP 299,Hydrocortisone,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Hydrocortisone.,decrease,no risk
SRP 299,Hydrocortisone acetate,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
SRP 299,Hydrocortisone butyrate,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
SRP 299,Hydrocortisone succinate,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
SRP 299,Hydroxychloroquine,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
SRP 299,Hydroxyurea,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Hydroxyurea.,decrease,no risk
SRP 299,Obinutuzumab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Obinutuzumab.,decrease,no risk
SRP 299,Ocrelizumab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Ocrelizumab.,decrease,no risk
SRP 299,Ofatumumab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Ofatumumab.,decrease,no risk
SRP 299,Olaparib,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Olaparib.,decrease,no risk
SRP 299,Oxaliplatin,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Oxaliplatin.,decrease,no risk
SRP 299,Ozanimod,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Ozanimod.,decrease,no risk
SRP 299,Ublituximab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Ublituximab.,decrease,no risk
SRP 299,Upadacitinib,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Upadacitinib.,decrease,no risk
SRP 299,Vedolizumab,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vedolizumab.,decrease,no risk
SRP 299,Vilanterol,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vilanterol.,decrease,no risk
SRP 299,Vinblastine,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vinblastine.,decrease,no risk
SRP 299,Vincristine,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vincristine.,decrease,no risk
SRP 299,Vindesine,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vindesine.,decrease,no risk
SRP 299,Vinorelbine,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vinorelbine.,decrease,no risk
SRP 299,Voclosporin,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Voclosporin.,decrease,no risk
SRP 299,Vorinostat,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Vorinostat.,decrease,no risk
SRP 299,Zidovudine,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Zidovudine.,decrease,no risk
Briakinumab,Galcanezumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Galcanezumab.,increase,risk
Briakinumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Briakinumab.,increase,risk
Briakinumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Briakinumab.,increase,risk
Briakinumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Briakinumab.,increase,risk
Briakinumab,Glofitamab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Glofitamab.,increase,risk
Briakinumab,Golimumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Golimumab.,increase,risk
Briakinumab,Guselkumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Guselkumab.,increase,risk
Briakinumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Briakinumab.,increase,risk
Briakinumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Briakinumab.,increase,risk
Briakinumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Briakinumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Briakinumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Briakinumab.,increase,risk
Briakinumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Briakinumab is combined with Human Rho(D) immune globulin.,increase,risk
Briakinumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Briakinumab is combined with Human varicella-zoster immune globulin.,increase,risk
Briakinumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Briakinumab is combined with Hydrocortisone acetate.,increase,risk
Briakinumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Briakinumab is combined with Hydrocortisone butyrate.,increase,risk
Briakinumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Briakinumab is combined with Hydrocortisone succinate.,increase,risk
Briakinumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Briakinumab.,increase,risk
Briakinumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Briakinumab.,increase,risk
Briakinumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Briakinumab.,increase,risk
Briakinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Obinutuzumab.,increase,risk
Briakinumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Briakinumab.,increase,no risk
Briakinumab,Odesivimab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Odesivimab.,increase,risk
Briakinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Ofatumumab.,increase,risk
Briakinumab,Olaparib,The risk or severity of adverse effects can be increased when Briakinumab is combined with Olaparib.,increase,risk
Briakinumab,Olaratumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Olaratumab.,increase,risk
Briakinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Briakinumab.,increase,risk
Briakinumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Briakinumab.,increase,risk
Briakinumab,Ozanimod,The risk or severity of adverse effects can be increased when Briakinumab is combined with Ozanimod.,increase,risk
Briakinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Briakinumab.,increase,no risk
Briakinumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Briakinumab.,increase,risk
Briakinumab,Upadacitinib,The risk or severity of adverse effects can be increased when Briakinumab is combined with Upadacitinib.,increase,risk
Briakinumab,Ustekinumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Ustekinumab.,increase,risk
Briakinumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Briakinumab.,increase,risk
Briakinumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Briakinumab is combined with Vedolizumab.,increase,risk
Briakinumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Briakinumab.,decrease,no risk
Briakinumab,Vilanterol,The risk or severity of adverse effects can be increased when Briakinumab is combined with Vilanterol.,increase,risk
Briakinumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Briakinumab.,increase,risk
Briakinumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Briakinumab.,increase,risk
Briakinumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Briakinumab.,increase,risk
Briakinumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Briakinumab.,increase,risk
Briakinumab,Voclosporin,The risk or severity of adverse effects can be increased when Briakinumab is combined with Voclosporin.,increase,risk
Briakinumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Briakinumab.,increase,risk
Briakinumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Briakinumab.,increase,risk
Briakinumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Briakinumab.,increase,risk
Tandutinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Gadobenic acid.,increase,risk
Tandutinib,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tandutinib.,increase,risk
Tandutinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Tandutinib.,increase,risk
Tandutinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Gemifloxacin.,increase,risk
Tandutinib,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Tandutinib.,increase,risk
Tandutinib,Gilteritinib,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Gilteritinib.,increase,risk
Tandutinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Glasdegib.,increase,risk
Tandutinib,Goserelin,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Goserelin.,increase,risk
Tandutinib,Granisetron,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Granisetron.,increase,risk
Tandutinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Grepafloxacin.,increase,risk
Tandutinib,Halofantrine,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Halofantrine.,increase,risk
Tandutinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Haloperidol.,increase,risk
Tandutinib,Histrelin,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Histrelin.,increase,risk
Tandutinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Tandutinib.,increase,risk
Tandutinib,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Tandutinib.,increase,risk
Tandutinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Hydroxyzine.,increase,risk
Tandutinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tandutinib.,increase,risk
Tandutinib,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Tandutinib.,increase,risk
Tandutinib,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Tandutinib.,increase,risk
Tandutinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Ofloxacin.,increase,risk
Tandutinib,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Tandutinib.,increase,risk
Tandutinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Olodaterol.,increase,risk
Tandutinib,Ondansetron,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Ondansetron.,increase,risk
Tandutinib,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Tandutinib.,increase,risk
Tandutinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Tandutinib.,increase,risk
Tandutinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Oxatomide.,increase,risk
Tandutinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Tandutinib.,increase,risk
Tandutinib,Quetiapine,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Quetiapine.,increase,risk
Tandutinib,Quinidine,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Quinidine.,increase,risk
Tandutinib,Quinine,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Quinine.,increase,risk
Tandutinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Quizartinib.,increase,risk
Tandutinib,Valproic acid,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Valproic acid.,increase,risk
Tandutinib,Vandetanib,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Vandetanib.,increase,risk
Tandutinib,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tandutinib.,increase,risk
Tandutinib,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Tandutinib.,increase,risk
Tandutinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Vernakalant.,increase,risk
Tandutinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Tandutinib.,increase,risk
Tandutinib,Voriconazole,The serum concentration of Tandutinib can be increased when it is combined with Voriconazole.,increase,no risk
Tandutinib,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Tandutinib.,increase,risk
Tandutinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Ziprasidone.,increase,risk
Tandutinib,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Tandutinib.,increase,risk
Tandutinib,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Zuclopenthixol.,increase,risk
Palovarotene,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Palovarotene.,decrease,no risk
Palovarotene,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Glofitamab,The serum concentration of Palovarotene can be increased when it is combined with Glofitamab.,increase,no risk
Palovarotene,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Palovarotene.,increase,no risk
Palovarotene,Halothane,The metabolism of Halothane can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Palovarotene.,decrease,no risk
Palovarotene,Ketamine,The metabolism of Ketamine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Ketoconazole,The serum concentration of Palovarotene can be increased when it is combined with Ketoconazole.,increase,no risk
Palovarotene,Olaparib,The metabolism of Olaparib can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Palovarotene.,decrease,no risk
Palovarotene,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Omadacycline is combined with Palovarotene.,increase,risk
Palovarotene,Omaveloxolone,The serum concentration of Palovarotene can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Palovarotene,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Osimertinib,The metabolism of Osimertinib can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Ospemifene,The metabolism of Ospemifene can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Oxytetracycline is combined with Palovarotene.,increase,risk
Palovarotene,Quinidine,The metabolism of Quinidine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Ulipristal,The metabolism of Ulipristal can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vadadustat,The serum concentration of Palovarotene can be increased when it is combined with Vadadustat.,increase,no risk
Palovarotene,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Palovarotene.,increase,no risk
Palovarotene,Vandetanib,The metabolism of Vandetanib can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Venetoclax,The serum concentration of Palovarotene can be increased when it is combined with Venetoclax.,increase,no risk
Palovarotene,Verapamil,The serum concentration of Palovarotene can be increased when it is combined with Verapamil.,increase,no risk
Palovarotene,Viloxazine,The metabolism of Palovarotene can be decreased when combined with Viloxazine.,decrease,no risk
Palovarotene,Vinblastine,The metabolism of Vinblastine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vincristine,The metabolism of Vincristine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vindesine,The metabolism of Vindesine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vinflunine,The metabolism of Vinflunine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Palovarotene.,increase,risk
Palovarotene,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Voriconazole,The serum concentration of Palovarotene can be increased when it is combined with Voriconazole.,increase,no risk
Palovarotene,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Voxelotor,The metabolism of Voxelotor can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Warfarin,The metabolism of Warfarin can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Zimelidine,The serum concentration of Palovarotene can be increased when it is combined with Zimelidine.,increase,no risk
Palovarotene,Ziprasidone,The serum concentration of Palovarotene can be increased when it is combined with Ziprasidone.,increase,no risk
Palovarotene,Zolpidem,The metabolism of Zolpidem can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Palovarotene.,increase,no risk
Palovarotene,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Palovarotene.,decrease,no risk
Human interferon omega-1,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Golimumab,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Golimumab.,increase,risk
Human interferon omega-1,Guselkumab,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Guselkumab.,increase,risk
Human interferon omega-1,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Hydrocortisone acetate.,increase,risk
Human interferon omega-1,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Hydrocortisone butyrate.,increase,risk
Human interferon omega-1,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Hydrocortisone succinate.,increase,risk
Human interferon omega-1,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Obinutuzumab,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Obinutuzumab.,increase,risk
Human interferon omega-1,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Human interferon omega-1.,increase,no risk
Human interferon omega-1,Ofatumumab,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Ofatumumab.,increase,risk
Human interferon omega-1,Olaparib,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Olaparib.,increase,risk
Human interferon omega-1,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Ozanimod,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Ozanimod.,increase,risk
Human interferon omega-1,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Upadacitinib,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Upadacitinib.,increase,risk
Human interferon omega-1,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Vedolizumab,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Vedolizumab.,increase,risk
Human interferon omega-1,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Human interferon omega-1.,decrease,no risk
Human interferon omega-1,Vilanterol,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Vilanterol.,increase,risk
Human interferon omega-1,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Voclosporin,The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Voclosporin.,increase,risk
Human interferon omega-1,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Human interferon omega-1.,increase,risk
Human interferon omega-1,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Human interferon omega-1.,increase,risk
SN-38,Gepirone,The serum concentration of Gepirone can be increased when it is combined with SN-38.,increase,no risk
SN-38,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with 7-ethyl-10-hydroxycamptothecin.,decrease,no risk
SN-38,Glofitamab,The serum concentration of 7-ethyl-10-hydroxycamptothecin can be increased when it is combined with Glofitamab.,increase,no risk
SN-38,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Ketoconazole,The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Ketoconazole.,decrease,no risk
SN-38,Olaparib,The serum concentration of Olaparib can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Omaveloxolone,The serum concentration of 7-ethyl-10-hydroxycamptothecin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
SN-38,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Oxetacaine,The risk or severity of methemoglobinemia can be increased when 7-ethyl-10-hydroxycamptothecin is combined with Oxetacaine.,increase,risk
SN-38,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when 7-ethyl-10-hydroxycamptothecin is combined with Oxybuprocaine.,increase,risk
SN-38,Quinidine,The serum concentration of Quinidine can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vadadustat,The serum concentration of 7-ethyl-10-hydroxycamptothecin can be increased when it is combined with Vadadustat.,increase,no risk
SN-38,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vardenafil,The metabolism of Vardenafil can be decreased when combined with 7-ethyl-10-hydroxycamptothecin.,decrease,no risk
SN-38,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Verapamil,The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Verapamil.,decrease,no risk
SN-38,Viloxazine,The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Viloxazine.,decrease,no risk
SN-38,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vincristine,The serum concentration of Vincristine can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vindesine,The serum concentration of Vindesine can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with 7-ethyl-10-hydroxycamptothecin.,decrease,no risk
SN-38,Voriconazole,The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Voriconazole.,decrease,no risk
SN-38,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Warfarin,The serum concentration of Warfarin can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with 7-ethyl-10-hydroxycamptothecin.,increase,no risk
SN-38,Zimelidine,The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Zimelidine.,decrease,no risk
SN-38,Ziprasidone,The metabolism of 7-ethyl-10-hydroxycamptothecin can be decreased when combined with Ziprasidone.,decrease,no risk
SN-38,Zopiclone,The metabolism of Zopiclone can be decreased when combined with 7-ethyl-10-hydroxycamptothecin.,decrease,no risk
SN-38,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with 7-ethyl-10-hydroxycamptothecin.,decrease,no risk
Plozalizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Plozalizumab.,increase,risk
Plozalizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Plozalizumab.,increase,risk
Plozalizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Plozalizumab.,increase,risk
Plozalizumab,Odesivimab,The risk or severity of adverse effects can be increased when Plozalizumab is combined with Odesivimab.,increase,risk
Plozalizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Plozalizumab.,increase,risk
Plozalizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Plozalizumab.,increase,risk
Plozalizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Plozalizumab.,increase,risk
Plozalizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Plozalizumab.,increase,no risk
Plozalizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Plozalizumab.,increase,risk
Plozalizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Plozalizumab.,increase,risk
Plozalizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Plozalizumab.,increase,risk
Technetium Tc-99m ciprofloxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Gilteritinib.,increase,risk
Technetium Tc-99m ciprofloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Glasdegib.,increase,risk
Technetium Tc-99m ciprofloxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Grepafloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Halofantrine.,increase,risk
Technetium Tc-99m ciprofloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Haloperidol.,increase,risk
Technetium Tc-99m ciprofloxacin,Hetacillin,The serum concentration of Technetium Tc-99m ciprofloxacin can be increased when it is combined with Hetacillin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Hydroxyzine.,increase,risk
Technetium Tc-99m ciprofloxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Oxacillin,The serum concentration of Technetium Tc-99m ciprofloxacin can be increased when it is combined with Oxacillin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Oxatomide.,increase,risk
Technetium Tc-99m ciprofloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Technetium Tc-99m ciprofloxacin is combined with Oxetacaine.,increase,risk
Technetium Tc-99m ciprofloxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Technetium Tc-99m ciprofloxacin is combined with Oxybuprocaine.,increase,risk
Technetium Tc-99m ciprofloxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Quinapril,Quinapril can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Quinidine.,increase,risk
Technetium Tc-99m ciprofloxacin,Quinine,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Quinine.,increase,risk
Technetium Tc-99m ciprofloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Quizartinib.,increase,risk
Technetium Tc-99m ciprofloxacin,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Valproic acid,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Valproic acid.,increase,risk
Technetium Tc-99m ciprofloxacin,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Vandetanib,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Vandetanib.,increase,risk
Technetium Tc-99m ciprofloxacin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Vemurafenib.,increase,risk
Technetium Tc-99m ciprofloxacin,Verapamil,The metabolism of Verapamil can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Technetium Tc-99m ciprofloxacin.,increase,no risk
Technetium Tc-99m ciprofloxacin,Zileuton,The metabolism of Zileuton can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc,Zinc can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Technetium Tc-99m ciprofloxacin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Technetium Tc-99m ciprofloxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Technetium Tc-99m ciprofloxacin is combined with Ziprasidone.,increase,risk
Technetium Tc-99m ciprofloxacin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Technetium Tc-99m ciprofloxacin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Technetium Tc-99m ciprofloxacin.,increase,risk
Technetium Tc-99m ciprofloxacin,Zotepine,The metabolism of Zotepine can be decreased when combined with Technetium Tc-99m ciprofloxacin.,decrease,no risk
Otelixizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Otelixizumab.,increase,risk
Otelixizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Obinutuzumab.,increase,risk
Otelixizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Ocrelizumab.,increase,risk
Otelixizumab,Odesivimab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Odesivimab.,increase,risk
Otelixizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Ofatumumab.,increase,risk
Otelixizumab,Olaratumab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Olaratumab.,increase,risk
Otelixizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Otelixizumab.,increase,risk
Otelixizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Otelixizumab.,increase,no risk
Otelixizumab,Ublituximab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Ublituximab.,increase,risk
Otelixizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Ustekinumab.,increase,risk
Otelixizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Otelixizumab is combined with Vedolizumab.,increase,risk
Lapachone,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Lapachone.,decrease,no risk
Lapachone,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Lapachone.,decrease,no risk
Vosaroxin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Benzocaine.,increase,risk
Vosaroxin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Benzyl alcohol.,increase,risk
Vosaroxin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Bupivacaine.,increase,risk
Vosaroxin,Butacaine,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Butacaine.,increase,risk
Vosaroxin,Butamben,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Butamben.,increase,risk
Vosaroxin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Oxetacaine.,increase,risk
Vosaroxin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vosaroxin is combined with Oxybuprocaine.,increase,risk
Telaprevir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Galantamine,The metabolism of Galantamine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Telaprevir.,decrease,no risk
Telaprevir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Glofitamab,The serum concentration of Telaprevir can be increased when it is combined with Glofitamab.,increase,no risk
Telaprevir,Glyburide,The metabolism of Glyburide can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Golimumab,The metabolism of Telaprevir can be increased when combined with Golimumab.,increase,no risk
Telaprevir,Granisetron,The metabolism of Granisetron can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Telaprevir.,decrease,no risk
Telaprevir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Telaprevir.,decrease,no risk
Telaprevir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Ketamine,The metabolism of Ketamine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Ketoconazole,The serum concentration of Telaprevir can be increased when it is combined with Ketoconazole.,increase,no risk
Telaprevir,Olaparib,The metabolism of Olaparib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Opium,The metabolism of Opium can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Ouabain,The excretion of Ouabain can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Oxcarbazepine,The metabolism of Telaprevir can be increased when combined with Oxcarbazepine.,increase,no risk
Telaprevir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Quazepam,The metabolism of Quazepam can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Quinidine,The metabolism of Quinidine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Quinine,The metabolism of Quinine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Udenafil,The metabolism of Udenafil can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Telaprevir.,decrease,no risk
Telaprevir,Umbralisib,The serum concentration of Telaprevir can be increased when it is combined with Umbralisib.,increase,no risk
Telaprevir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vadadustat,The serum concentration of Telaprevir can be increased when it is combined with Vadadustat.,increase,no risk
Telaprevir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Valsartan,The excretion of Valsartan can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Telaprevir.,decrease,no risk
Telaprevir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vemurafenib,The serum concentration of Telaprevir can be increased when it is combined with Vemurafenib.,increase,no risk
Telaprevir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Verapamil,The metabolism of Verapamil can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Telaprevir.,decrease,no risk
Telaprevir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Viloxazine,The metabolism of Telaprevir can be decreased when combined with Viloxazine.,decrease,no risk
Telaprevir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vincristine,The excretion of Vincristine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vindesine,The metabolism of Vindesine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Voriconazole,The serum concentration of Telaprevir can be increased when it is combined with Voriconazole.,increase,no risk
Telaprevir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Telaprevir.,increase,no risk
Telaprevir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Warfarin,The serum concentration of Warfarin can be decreased when it is combined with Telaprevir.,decrease,no risk
Telaprevir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Telaprevir.,decrease,no risk
Telaprevir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zileuton,The metabolism of Zileuton can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zimelidine,The metabolism of Telaprevir can be decreased when combined with Zimelidine.,decrease,no risk
Telaprevir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zolpidem,The serum concentration of Zolpidem can be decreased when it is combined with Telaprevir.,decrease,no risk
Telaprevir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zotepine,The metabolism of Zotepine can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Telaprevir.,decrease,no risk
Telaprevir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Telaprevir.,increase,no risk
Pelitinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Benzocaine.,increase,risk
Pelitinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Benzyl alcohol.,increase,risk
Pelitinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Bupivacaine.,increase,risk
Pelitinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Butacaine.,increase,risk
Pelitinib,Butamben,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Butamben.,increase,risk
Pelitinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Oxetacaine.,increase,risk
Pelitinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pelitinib is combined with Oxybuprocaine.,increase,risk
Pralatrexate,Bismuth subgallate,Pralatrexate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Bismuth subsalicylate,The serum concentration of Pralatrexate can be increased when it is combined with Bismuth subsalicylate.,increase,no risk
Pralatrexate,Bisoprolol,Bisoprolol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Bisoxatin,Pralatrexate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Pralatrexate,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Pralatrexate.,increase,risk
Pralatrexate,Blinatumomab,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Blinatumomab.,increase,risk
Pralatrexate,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Pralatrexate.",decrease,no risk
Pralatrexate,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Pralatrexate.,increase,risk
Pralatrexate,Bosutinib,The risk or severity of adverse effects can be increased when Bosutinib is combined with Pralatrexate.,increase,risk
Pralatrexate,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Brentuximab vedotin.,increase,risk
Pralatrexate,Brigatinib,Brigatinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Brivaracetam,Brivaracetam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Brodalumab,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Brodalumab.,increase,risk
Pralatrexate,Bromazepam,Bromazepam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Bromotheophylline,Bromotheophylline may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pralatrexate,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Pralatrexate.,increase,risk
Pralatrexate,Bumadizone,Bumadizone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Bumetanide,Bumetanide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pralatrexate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Bupivacaine.,increase,risk
Pralatrexate,Buprenorphine,Buprenorphine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Bupropion,Bupropion may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Buspirone,Buspirone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Pralatrexate.,increase,risk
Pralatrexate,Butabarbital,Butabarbital may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Butacaine,The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Butacaine.,increase,risk
Pralatrexate,Butamben,The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Butamben.,increase,risk
Pralatrexate,Gabapentin enacarbil,Pralatrexate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gadodiamide,Gadodiamide may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gadoteric acid,Pralatrexate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gadoteridol,Gadoteridol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ganciclovir,Ganciclovir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gefitinib,Gefitinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Pralatrexate.,increase,risk
Pralatrexate,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pralatrexate.,increase,risk
Pralatrexate,Gentamicin,Pralatrexate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gilteritinib,Gilteritinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Gimeracil,Pralatrexate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pralatrexate,Givosiran,Givosiran may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Glasdegib,Glasdegib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Pralatrexate.,increase,risk
Pralatrexate,Glecaprevir,Glecaprevir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Glipizide,Glipizide may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Glucarpidase,The serum concentration of the active metabolites of Pralatrexate can be reduced when Pralatrexate is used in combination with Glucarpidase resulting in a loss in efficacy., ,no risk
Pralatrexate,Glycerol phenylbutyrate,Pralatrexate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Glycol salicylate,Glycol salicylate may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Pralatrexate.,increase,risk
Pralatrexate,Golodirsen,Pralatrexate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pralatrexate,Goserelin,Goserelin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Grazoprevir,Grazoprevir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Guanethidine,Guanethidine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Guanfacine,Guanfacine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Guselkumab,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Guselkumab.,increase,risk
Pralatrexate,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Haloperidol,Haloperidol may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Pralatrexate.,increase,risk
Pralatrexate,Hydralazine,Hydralazine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pralatrexate,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Hydrocortisone acetate.,increase,risk
Pralatrexate,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Hydrocortisone butyrate.,increase,risk
Pralatrexate,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Hydrocortisone succinate.,increase,risk
Pralatrexate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pralatrexate,Hydromorphone,Hydromorphone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Pralatrexate.,increase,risk
Pralatrexate,Hydroxyethyl Starch,Pralatrexate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pralatrexate,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Pralatrexate.,increase,risk
Pralatrexate,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Kanamycin,Pralatrexate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ketamine,Ketamine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ketazolam,Ketazolam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ketoprofen,Ketoprofen may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ketorolac,Ketorolac may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Obinutuzumab,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Obinutuzumab.,increase,risk
Pralatrexate,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Pralatrexate.,increase,no risk
Pralatrexate,Octinoxate,Pralatrexate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Pralatrexate.,increase,risk
Pralatrexate,Olaparib,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Olaparib.,increase,risk
Pralatrexate,Olsalazine,The serum concentration of Pralatrexate can be increased when it is combined with Olsalazine.,increase,no risk
Pralatrexate,Opium,Pralatrexate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oseltamivir,Oseltamivir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Osimertinib,Osimertinib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oteseconazole,The serum concentration of Pralatrexate can be increased when it is combined with Oteseconazole.,increase,no risk
Pralatrexate,Oxacillin,Oxacillin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Pralatrexate.,increase,risk
Pralatrexate,Oxaprozin,Oxaprozin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oxazepam,Oxazepam may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Oxetacaine.,increase,risk
Pralatrexate,Oxybenzone,Oxybenzone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pralatrexate is combined with Oxybuprocaine.,increase,risk
Pralatrexate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Oxyquinoline,Pralatrexate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ozanimod,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Ozanimod.,increase,risk
Pralatrexate,Quetiapine,Quetiapine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Quinethazone,Quinethazone may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pralatrexate,Quinidine,Pralatrexate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pralatrexate,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Pralatrexate.,increase,risk
Pralatrexate,Upadacitinib,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Upadacitinib.,increase,risk
Pralatrexate,Vaborbactam,Pralatrexate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pralatrexate,Vadadustat,Vadadustat may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Valaciclovir,Valaciclovir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Valbenazine,Pralatrexate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Pralatrexate,Valdecoxib,Valdecoxib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Valganciclovir,Valganciclovir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Vancomycin,Pralatrexate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pralatrexate,Vandetanib,Vandetanib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Varenicline,Varenicline may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Pralatrexate.,increase,risk
Pralatrexate,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Vedolizumab,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Vedolizumab.,increase,risk
Pralatrexate,Velpatasvir,Velpatasvir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Vemurafenib,Vemurafenib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Venetoclax,Venetoclax may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Venlafaxine,Venlafaxine may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pralatrexate,Verapamil,Verapamil may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Pralatrexate.,decrease,no risk
Pralatrexate,Vilanterol,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Vilanterol.,increase,risk
Pralatrexate,Viloxazine,Pralatrexate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Pralatrexate,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Pralatrexate.,increase,risk
Pralatrexate,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Pralatrexate.,increase,risk
Pralatrexate,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Pralatrexate.,increase,risk
Pralatrexate,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Pralatrexate.,increase,risk
Pralatrexate,Vismodegib,Vismodegib may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Voclosporin,The risk or severity of adverse effects can be increased when Pralatrexate is combined with Voclosporin.,increase,risk
Pralatrexate,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Pralatrexate.,increase,risk
Pralatrexate,Vortioxetine,Pralatrexate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Pralatrexate,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Warfarin,Pralatrexate may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Pralatrexate,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Pralatrexate.,increase,risk
Pralatrexate,Zaleplon,Zaleplon may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Zanamivir,Zanamivir may decrease the excretion rate of Pralatrexate which could result in a higher serum level.,decrease,no risk
Pralatrexate,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Pralatrexate.,increase,risk
Pralatrexate,Zonisamide,Zonisamide may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mipomersen,Omadacycline,Omadacycline may increase the hepatotoxic activities of Mipomersen.,increase,no risk
Mipomersen,Oxytetracycline,Oxytetracycline may increase the hepatotoxic activities of Mipomersen.,increase,no risk
Mipomersen,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Mipomersen.,decrease,no risk
BMS-488043,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with BMS-488043.,decrease,no risk
BMS-488043,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with BMS-488043.,decrease,no risk
Dacetuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Human varicella-zoster immune globulin is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Dacetuzumab is combined with Odesivimab.,increase,risk
Dacetuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dacetuzumab is combined with Oxetacaine.,increase,risk
Dacetuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dacetuzumab is combined with Oxybuprocaine.,increase,risk
Dacetuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Dacetuzumab.,increase,no risk
Dacetuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Dacetuzumab.,increase,risk
Dacetuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Dacetuzumab.,increase,risk
Alanosine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Benzocaine.,increase,risk
Alanosine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Benzyl alcohol.,increase,risk
Alanosine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Bupivacaine.,increase,risk
Alanosine,Butacaine,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Butacaine.,increase,risk
Alanosine,Butamben,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Butamben.,increase,risk
Alanosine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Oxetacaine.,increase,risk
Alanosine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Alanosine is combined with Oxybuprocaine.,increase,risk
Brivaracetam,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Benperidol,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Benperidol.,increase,risk
Brivaracetam,Benserazide,Brivaracetam may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Brivaracetam,Benzatropine,Benzatropine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Benznidazole,Brivaracetam may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Brivaracetam,Benzocaine,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Benzocaine.,increase,risk
Brivaracetam,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Brivaracetam.,increase,risk
Brivaracetam,Benzthiazide,Benzthiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Benzydamine,Benzydamine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Benzyl alcohol.,increase,risk
Brivaracetam,Bepotastine,Bepotastine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Berotralstat,The metabolism of Brivaracetam can be decreased when combined with Berotralstat.,decrease,no risk
Brivaracetam,Betamethasone,The metabolism of Brivaracetam can be increased when combined with Betamethasone.,increase,no risk
Brivaracetam,Bexarotene,The metabolism of Brivaracetam can be decreased when combined with Bexarotene.,decrease,no risk
Brivaracetam,Bicisate,Brivaracetam may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Brivaracetam,Bimekizumab,The metabolism of Brivaracetam can be increased when combined with Bimekizumab.,increase,no risk
Brivaracetam,Bismuth subgallate,Brivaracetam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Brivaracetam,Bisoprolol,Bisoprolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Bisoxatin,Brivaracetam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Brivaracetam,Bleomycin,Bleomycin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Boceprevir,The metabolism of Brivaracetam can be decreased when combined with Boceprevir.,decrease,no risk
Brivaracetam,Borage oil,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Borage oil.,decrease,no risk
Brivaracetam,Bortezomib,The metabolism of Brivaracetam can be decreased when combined with Bortezomib.,decrease,no risk
Brivaracetam,Bosentan,The metabolism of Brivaracetam can be increased when combined with Bosentan.,increase,no risk
Brivaracetam,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Brivaracetam.,increase,risk
Brivaracetam,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Brivaracetam.,increase,risk
Brivaracetam,Brexanolone,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Brexanolone.,increase,risk
Brivaracetam,Brexpiprazole,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Brexpiprazole.,increase,risk
Brivaracetam,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.,increase,no risk
Brivaracetam,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Brivaracetam.,increase,risk
Brivaracetam,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Brivaracetam.,increase,risk
Brivaracetam,Bromotheophylline,Brivaracetam may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Bromperidol,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Bromperidol.,increase,risk
Brivaracetam,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Brivaracetam.,increase,risk
Brivaracetam,Budesonide,Budesonide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Bumadizone,Bumadizone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Bumetanide,Bumetanide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Bupivacaine.,increase,risk
Brivaracetam,Buprenorphine,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Brivaracetam,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Brivaracetam.,increase,risk
Brivaracetam,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Brivaracetam.,increase,risk
Brivaracetam,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Brivaracetam.,increase,risk
Brivaracetam,Butacaine,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Butacaine.,increase,risk
Brivaracetam,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Brivaracetam.,increase,risk
Brivaracetam,Butamben,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Butamben.,increase,risk
Brivaracetam,Butaperazine,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Butaperazine.,increase,risk
Brivaracetam,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Brivaracetam.,increase,risk
Brivaracetam,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Brivaracetam.,increase,risk
Brivaracetam,Butriptyline,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Butriptyline.,increase,risk
Brivaracetam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Brivaracetam.,increase,risk
Brivaracetam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Gabapentin enacarbil.,increase,risk
Brivaracetam,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gadodiamide,Gadodiamide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gadofosveset trisodium,Brivaracetam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gadoteric acid,Brivaracetam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gadoteridol,Gadoteridol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Brivaracetam.,increase,risk
Brivaracetam,Gamolenic acid,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Brivaracetam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Brivaracetam is combined with Ganaxolone.",increase,risk
Brivaracetam,Ganciclovir,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Ganciclovir.,decrease,no risk
Brivaracetam,Gemcitabine,Gemcitabine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gemfibrozil,The metabolism of Brivaracetam can be decreased when combined with Gemfibrozil.,decrease,no risk
Brivaracetam,Gentamicin,Brivaracetam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gepirone,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Gepirone.,increase,risk
Brivaracetam,Gestrinone,The metabolism of Gestrinone can be increased when combined with Brivaracetam.,increase,no risk
Brivaracetam,Gimeracil,Brivaracetam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Brivaracetam,Ginkgo biloba,The metabolism of Brivaracetam can be decreased when combined with Ginkgo biloba.,decrease,no risk
Brivaracetam,Givosiran,Givosiran may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gliclazide,The metabolism of Brivaracetam can be decreased when combined with Gliclazide.,decrease,no risk
Brivaracetam,Glimepiride,The metabolism of Brivaracetam can be decreased when combined with Glimepiride.,decrease,no risk
Brivaracetam,Glipizide,Glipizide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Gliquidone,The metabolism of Brivaracetam can be decreased when combined with Gliquidone.,decrease,no risk
Brivaracetam,Glofitamab,The serum concentration of Brivaracetam can be increased when it is combined with Glofitamab.,increase,no risk
Brivaracetam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Brivaracetam.,increase,risk
Brivaracetam,Glyburide,The metabolism of Brivaracetam can be decreased when combined with Glyburide.,decrease,no risk
Brivaracetam,Glycerol phenylbutyrate,Brivaracetam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Brivaracetam,Golimumab,The metabolism of Brivaracetam can be increased when combined with Golimumab.,increase,no risk
Brivaracetam,Golodirsen,Brivaracetam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Brivaracetam,Goserelin,Goserelin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Brivaracetam.,increase,risk
Brivaracetam,Guanethidine,Guanethidine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Brivaracetam.,increase,risk
Brivaracetam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Brivaracetam.,increase,risk
Brivaracetam,Halofantrine,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Halofantrine.,decrease,no risk
Brivaracetam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Brivaracetam.,increase,risk
Brivaracetam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Brivaracetam.,increase,risk
Brivaracetam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Brivaracetam.,increase,risk
Brivaracetam,Hydralazine,Hydralazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Hydrocodone,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Brivaracetam,Hydrocortisone,The metabolism of Brivaracetam can be increased when combined with Hydrocortisone.,increase,no risk
Brivaracetam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Brivaracetam.,increase,risk
Brivaracetam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Hydroxychloroquine,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Brivaracetam,Hydroxyethyl Starch,Brivaracetam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Brivaracetam,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Brivaracetam.,increase,no risk
Brivaracetam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.,increase,no risk
Brivaracetam,Kanamycin,Brivaracetam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Brivaracetam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Brivaracetam.,increase,risk
Brivaracetam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Brivaracetam.,increase,risk
Brivaracetam,Ketoconazole,The metabolism of Brivaracetam can be decreased when combined with Ketoconazole.,decrease,no risk
Brivaracetam,Ketoprofen,Ketoprofen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Ketorolac,Ketorolac may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Octinoxate,Brivaracetam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Brivaracetam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Brivaracetam.,increase,risk
Brivaracetam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Brivaracetam is combined with Oliceridine.",increase,risk
Brivaracetam,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Brivaracetam.,decrease,no risk
Brivaracetam,Olsalazine,Olsalazine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Omaveloxolone,The serum concentration of Brivaracetam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Brivaracetam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Brivaracetam.,increase,risk
Brivaracetam,Opium,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Opium.,increase,risk
Brivaracetam,Oritavancin,The metabolism of Brivaracetam can be decreased when combined with Oritavancin.,decrease,no risk
Brivaracetam,Orlistat,Orlistat can cause a decrease in the absorption of Brivaracetam resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Brivaracetam,Orphenadrine,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Brivaracetam,Oseltamivir,Oseltamivir may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Brivaracetam.,decrease,no risk
Brivaracetam,Ospemifene,The metabolism of Brivaracetam can be decreased when combined with Ospemifene.,decrease,no risk
Brivaracetam,Oxacillin,Oxacillin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Oxandrolone,The metabolism of Brivaracetam can be decreased when combined with Oxandrolone.,decrease,no risk
Brivaracetam,Oxaprozin,Oxaprozin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Brivaracetam.,increase,risk
Brivaracetam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Brivaracetam.,increase,risk
Brivaracetam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Oxetacaine.,increase,risk
Brivaracetam,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Brivaracetam.,increase,risk
Brivaracetam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Brivaracetam.,increase,risk
Brivaracetam,Oxtriphylline,Brivaracetam may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Oxybenzone,Oxybenzone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Oxybuprocaine.,increase,risk
Brivaracetam,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Brivaracetam.,increase,risk
Brivaracetam,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Brivaracetam.,increase,risk
Brivaracetam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Oxyquinoline,Brivaracetam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Brivaracetam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Brivaracetam.,increase,risk
Brivaracetam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Brivaracetam.,increase,risk
Brivaracetam,Quinethazone,Quinethazone may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Brivaracetam,Quinidine,Brivaracetam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Brivaracetam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Brivaracetam.,increase,risk
Brivaracetam,Quinupramine,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Quinupramine.,increase,risk
Brivaracetam,Ulipristal,The metabolism of Ulipristal can be increased when combined with Brivaracetam.,increase,no risk
Brivaracetam,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Brivaracetam.,increase,risk
Brivaracetam,Vaborbactam,Brivaracetam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Vadadustat,The serum concentration of Brivaracetam can be decreased when it is combined with Vadadustat.,decrease,no risk
Brivaracetam,Valaciclovir,Valaciclovir may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Valbenazine,Brivaracetam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Brivaracetam,Valdecoxib,Valdecoxib may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Valganciclovir,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Valganciclovir.,decrease,no risk
Brivaracetam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Brivaracetam.,increase,risk
Brivaracetam,Valsartan,The metabolism of Brivaracetam can be decreased when combined with Valsartan.,decrease,no risk
Brivaracetam,Vancomycin,Brivaracetam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Brivaracetam,Vardenafil,The metabolism of Brivaracetam can be decreased when combined with Vardenafil.,decrease,no risk
Brivaracetam,Varenicline,Varenicline may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Brivaracetam.,increase,risk
Brivaracetam,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Brivaracetam.,decrease,no risk
Brivaracetam,Vemurafenib,The metabolism of Brivaracetam can be decreased when combined with Vemurafenib.,decrease,no risk
Brivaracetam,Venetoclax,The metabolism of Brivaracetam can be decreased when combined with Venetoclax.,decrease,no risk
Brivaracetam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Brivaracetam.,increase,risk
Brivaracetam,Verapamil,The metabolism of Brivaracetam can be decreased when combined with Verapamil.,decrease,no risk
Brivaracetam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Brivaracetam.,increase,risk
Brivaracetam,Vilanterol,Brivaracetam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Brivaracetam,Vilazodone,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Vilazodone.,increase,risk
Brivaracetam,Viloxazine,The metabolism of Brivaracetam can be decreased when combined with Viloxazine.,decrease,no risk
Brivaracetam,Voriconazole,The metabolism of Brivaracetam can be decreased when combined with Voriconazole.,decrease,no risk
Brivaracetam,Vortioxetine,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Vortioxetine.,increase,risk
Brivaracetam,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Brivaracetam.,decrease,no risk
Brivaracetam,Warfarin,Brivaracetam may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Brivaracetam,Ximelagatran,The metabolism of Brivaracetam can be decreased when combined with Ximelagatran.,decrease,no risk
Brivaracetam,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Brivaracetam.,increase,risk
Brivaracetam,Zafirlukast,The metabolism of Brivaracetam can be decreased when combined with Zafirlukast.,decrease,no risk
Brivaracetam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Brivaracetam.,increase,risk
Brivaracetam,Zanamivir,Zanamivir may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Brivaracetam,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Brivaracetam.,decrease,no risk
Brivaracetam,Ziconotide,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Ziconotide.,increase,risk
Brivaracetam,Zidovudine,The metabolism of Brivaracetam can be decreased when combined with Zidovudine.,decrease,no risk
Brivaracetam,Zileuton,The metabolism of Brivaracetam can be decreased when combined with Zileuton.,decrease,no risk
Brivaracetam,Zimelidine,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Zimelidine.,increase,risk
Brivaracetam,Ziprasidone,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Ziprasidone.,increase,risk
Brivaracetam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Brivaracetam.,increase,risk
Brivaracetam,Zolpidem,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Brivaracetam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Brivaracetam.,increase,risk
Brivaracetam,Zopiclone,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Zopiclone.,increase,risk
Brivaracetam,Zotepine,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Zotepine.,increase,risk
Brivaracetam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Brivaracetam.,increase,risk
Brivaracetam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Brivaracetam.,increase,risk
Naronapride,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Naronapride.,increase,risk
Naronapride,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Naronapride is combined with Gabapentin enacarbil.,increase,risk
Naronapride,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Naronapride.,increase,risk
Naronapride,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Naronapride is combined with Ganaxolone.",increase,risk
Naronapride,Gepirone,The risk or severity of CNS depression can be increased when Naronapride is combined with Gepirone.,increase,risk
Naronapride,Gilteritinib,The therapeutic efficacy of Naronapride can be decreased when used in combination with Gilteritinib.,decrease,no risk
Naronapride,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Naronapride.,increase,risk
Naronapride,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Naronapride.,increase,risk
Naronapride,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Naronapride.,increase,risk
Naronapride,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Naronapride.,increase,risk
Naronapride,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Naronapride.,increase,risk
Naronapride,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Naronapride.,increase,risk
Naronapride,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Naronapride.,increase,risk
Naronapride,Hydrocodone,Naronapride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Naronapride,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Naronapride.,increase,risk
Naronapride,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Naronapride.,increase,no risk
Naronapride,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Naronapride.,increase,risk
Naronapride,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Naronapride.,increase,risk
Naronapride,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Naronapride.,increase,risk
Naronapride,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Naronapride is combined with Oliceridine.",increase,risk
Naronapride,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Naronapride.,increase,risk
Naronapride,Opium,The risk or severity of CNS depression can be increased when Naronapride is combined with Opium.,increase,risk
Naronapride,Orphenadrine,Naronapride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Naronapride,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Naronapride.,increase,risk
Naronapride,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Naronapride.,increase,risk
Naronapride,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Naronapride.,increase,risk
Naronapride,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Naronapride.,increase,risk
Naronapride,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Naronapride.,increase,risk
Naronapride,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Naronapride.,increase,risk
Naronapride,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Naronapride.,increase,risk
Naronapride,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Naronapride.,increase,risk
Naronapride,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Naronapride.,increase,risk
Naronapride,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Naronapride.,increase,risk
Naronapride,Quinupramine,The risk or severity of CNS depression can be increased when Naronapride is combined with Quinupramine.,increase,risk
Naronapride,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Naronapride.,increase,risk
Naronapride,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Naronapride.,increase,risk
Naronapride,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Naronapride.,increase,risk
Naronapride,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Naronapride.,increase,risk
Naronapride,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Naronapride.,increase,risk
Naronapride,Vilazodone,The risk or severity of CNS depression can be increased when Naronapride is combined with Vilazodone.,increase,risk
Naronapride,Viloxazine,The risk or severity of CNS depression can be increased when Naronapride is combined with Viloxazine.,increase,risk
Naronapride,Vortioxetine,The risk or severity of CNS depression can be increased when Naronapride is combined with Vortioxetine.,increase,risk
Naronapride,Warfarin,The risk or severity of adverse effects can be increased when Naronapride is combined with Warfarin.,increase,risk
Naronapride,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Naronapride.,increase,risk
Naronapride,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Naronapride.,increase,risk
Naronapride,Ziconotide,The risk or severity of CNS depression can be increased when Naronapride is combined with Ziconotide.,increase,risk
Naronapride,Zimelidine,The risk or severity of adverse effects can be increased when Naronapride is combined with Zimelidine.,increase,risk
Naronapride,Ziprasidone,The risk or severity of adverse effects can be increased when Naronapride is combined with Ziprasidone.,increase,risk
Naronapride,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Naronapride.,increase,risk
Naronapride,Zolpidem,Naronapride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Naronapride,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Naronapride.,increase,risk
Naronapride,Zopiclone,The risk or severity of adverse effects can be increased when Naronapride is combined with Zopiclone.,increase,risk
Naronapride,Zotepine,The risk or severity of CNS depression can be increased when Naronapride is combined with Zotepine.,increase,risk
Naronapride,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Naronapride.,increase,risk
Naronapride,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Naronapride.,increase,risk
AMG 108,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with AMG 108.,increase,risk
AMG 108,Obinutuzumab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Obinutuzumab.,increase,risk
AMG 108,Ocrelizumab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Ocrelizumab.,increase,risk
AMG 108,Odesivimab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Odesivimab.,increase,risk
AMG 108,Ofatumumab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Ofatumumab.,increase,risk
AMG 108,Olaratumab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Olaratumab.,increase,risk
AMG 108,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with AMG 108.,increase,risk
AMG 108,Quinestrol,Quinestrol may increase the thrombogenic activities of AMG 108.,increase,no risk
AMG 108,Ublituximab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Ublituximab.,increase,risk
AMG 108,Ustekinumab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Ustekinumab.,increase,risk
AMG 108,Vedolizumab,The risk or severity of adverse effects can be increased when AMG 108 is combined with Vedolizumab.,increase,risk
Iratumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Iratumumab.,increase,risk
Iratumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Obinutuzumab.,increase,risk
Iratumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Ocrelizumab.,increase,risk
Iratumumab,Odesivimab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Odesivimab.,increase,risk
Iratumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Ofatumumab.,increase,risk
Iratumumab,Olaratumab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Olaratumab.,increase,risk
Iratumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Iratumumab.,increase,risk
Iratumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Iratumumab.,increase,no risk
Iratumumab,Ublituximab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Ublituximab.,increase,risk
Iratumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Ustekinumab.,increase,risk
Iratumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Iratumumab is combined with Vedolizumab.,increase,risk
Enokizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Enokizumab.,increase,risk
Enokizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Obinutuzumab.,increase,risk
Enokizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Ocrelizumab.,increase,risk
Enokizumab,Odesivimab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Odesivimab.,increase,risk
Enokizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Ofatumumab.,increase,risk
Enokizumab,Olaratumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Olaratumab.,increase,risk
Enokizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Enokizumab.,increase,risk
Enokizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Enokizumab.,increase,no risk
Enokizumab,Ublituximab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Ublituximab.,increase,risk
Enokizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Ustekinumab.,increase,risk
Enokizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Enokizumab is combined with Vedolizumab.,increase,risk
Tralokinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Tralokinumab.,increase,risk
Tralokinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Odesivimab,The risk or severity of adverse effects can be increased when Tralokinumab is combined with Odesivimab.,increase,risk
Tralokinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Tralokinumab.,increase,no risk
Tralokinumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Tralokinumab.,increase,risk
Tralokinumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Tralokinumab.,increase,risk
Tralokinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Tralokinumab.,increase,risk
Naluzotan,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Naluzotan.,increase,risk
Naluzotan,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Naluzotan is combined with Gabapentin enacarbil.,increase,risk
Naluzotan,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Naluzotan.,increase,risk
Naluzotan,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Naluzotan is combined with Ganaxolone.",increase,risk
Naluzotan,Gepirone,The risk or severity of CNS depression can be increased when Naluzotan is combined with Gepirone.,increase,risk
Naluzotan,Gilteritinib,The therapeutic efficacy of Naluzotan can be decreased when used in combination with Gilteritinib.,decrease,no risk
Naluzotan,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Naluzotan.,increase,risk
Naluzotan,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Naluzotan.,increase,risk
Naluzotan,Guanabenz,Naluzotan may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Naluzotan,Guanadrel,Naluzotan may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Naluzotan,Guanethidine,Naluzotan may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Naluzotan,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Naluzotan.,increase,risk
Naluzotan,Guanoxan,Naluzotan may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Naluzotan,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Naluzotan.,increase,risk
Naluzotan,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Naluzotan.,increase,risk
Naluzotan,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Naluzotan.,increase,risk
Naluzotan,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Naluzotan.,increase,risk
Naluzotan,Hydralazine,Naluzotan may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Naluzotan,Hydrochlorothiazide,Naluzotan may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Naluzotan,Hydrocodone,Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Naluzotan,Hydroflumethiazide,Naluzotan may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Naluzotan,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Naluzotan.,increase,risk
Naluzotan,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Naluzotan.,increase,no risk
Naluzotan,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Naluzotan.,increase,risk
Naluzotan,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Naluzotan.,increase,risk
Naluzotan,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Naluzotan.,increase,risk
Naluzotan,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Naluzotan.,increase,risk
Naluzotan,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Naluzotan.,increase,risk
Naluzotan,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Naluzotan is combined with Oliceridine.",increase,risk
Naluzotan,Olmesartan,Naluzotan may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Naluzotan,Olodaterol,The risk or severity of hypertension can be increased when Naluzotan is combined with Olodaterol.,increase,risk
Naluzotan,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Naluzotan.,increase,risk
Naluzotan,Opium,The risk or severity of CNS depression can be increased when Naluzotan is combined with Opium.,increase,risk
Naluzotan,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Naluzotan.,increase,risk
Naluzotan,Orphenadrine,Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Naluzotan,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Naluzotan.,increase,risk
Naluzotan,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Naluzotan.,increase,risk
Naluzotan,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Naluzotan.,increase,risk
Naluzotan,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Naluzotan.,increase,risk
Naluzotan,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Naluzotan.,increase,risk
Naluzotan,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Naluzotan.,increase,risk
Naluzotan,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Naluzotan.,increase,risk
Naluzotan,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Naluzotan.,increase,risk
Naluzotan,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Naluzotan.,increase,risk
Naluzotan,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Naluzotan.,increase,risk
Naluzotan,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Naluzotan.,increase,risk
Naluzotan,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Naluzotan.,increase,risk
Naluzotan,Quinapril,Naluzotan may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Naluzotan,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Naluzotan.,increase,risk
Naluzotan,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Naluzotan.,increase,risk
Naluzotan,Quinupramine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Quinupramine.,increase,risk
Naluzotan,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Naluzotan.,increase,risk
Naluzotan,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Naluzotan.,increase,risk
Naluzotan,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Naluzotan.,increase,risk
Naluzotan,Valsartan,Naluzotan may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Naluzotan,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Naluzotan.,increase,risk
Naluzotan,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Naluzotan.,increase,risk
Naluzotan,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Naluzotan.,increase,risk
Naluzotan,Vilanterol,The risk or severity of hypertension can be increased when Naluzotan is combined with Vilanterol.,increase,risk
Naluzotan,Vilazodone,The risk or severity of CNS depression can be increased when Naluzotan is combined with Vilazodone.,increase,risk
Naluzotan,Viloxazine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Viloxazine.,increase,risk
Naluzotan,Vortioxetine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Vortioxetine.,increase,risk
Naluzotan,Warfarin,The risk or severity of adverse effects can be increased when Naluzotan is combined with Warfarin.,increase,risk
Naluzotan,Xamoterol,The risk or severity of hypertension can be increased when Naluzotan is combined with Xamoterol.,increase,risk
Naluzotan,Xylometazoline,The risk or severity of hypertension can be increased when Naluzotan is combined with Xylometazoline.,increase,risk
Naluzotan,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Naluzotan.,increase,risk
Naluzotan,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Naluzotan.,increase,risk
Naluzotan,Ziconotide,The risk or severity of CNS depression can be increased when Naluzotan is combined with Ziconotide.,increase,risk
Naluzotan,Zimelidine,The risk or severity of adverse effects can be increased when Naluzotan is combined with Zimelidine.,increase,risk
Naluzotan,Ziprasidone,The risk or severity of adverse effects can be increased when Naluzotan is combined with Ziprasidone.,increase,risk
Naluzotan,Zofenopril,Naluzotan may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Naluzotan,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Naluzotan is combined with Zolmitriptan.,increase,risk
Naluzotan,Zolpidem,Naluzotan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Naluzotan,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Naluzotan.,increase,risk
Naluzotan,Zopiclone,The risk or severity of adverse effects can be increased when Naluzotan is combined with Zopiclone.,increase,risk
Naluzotan,Zotepine,The risk or severity of CNS depression can be increased when Naluzotan is combined with Zotepine.,increase,risk
Naluzotan,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Naluzotan.,increase,risk
Naluzotan,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Naluzotan.,increase,risk
Linaclotide,Gallamine triethiodide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Linaclotide,Glycerin,The risk or severity of adverse effects can be increased when Linaclotide is combined with Glycerin.,increase,risk
Linaclotide,Glycopyrronium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Linaclotide,Hexafluronium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hexafluronium.,decrease,no risk
Linaclotide,Hexocyclium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hexocyclium.,decrease,no risk
Linaclotide,Homatropine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Homatropine.,decrease,no risk
Linaclotide,Homatropine methylbromide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Linaclotide,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Linaclotide.,increase,risk
Linaclotide,Hydrocodone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Linaclotide,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Linaclotide.,increase,risk
Linaclotide,Hydromorphone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hydromorphone.,decrease,no risk
Linaclotide,Hyoscyamine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Linaclotide,Olanzapine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Olanzapine.,decrease,no risk
Linaclotide,Oliceridine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oliceridine.,decrease,no risk
Linaclotide,Opium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Opium.,decrease,no risk
Linaclotide,Orphenadrine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Orphenadrine.,decrease,no risk
Linaclotide,Oxybutynin,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxybutynin.,decrease,no risk
Linaclotide,Oxycodone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxycodone.,decrease,no risk
Linaclotide,Oxymorphone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Linaclotide,Oxyphencyclimine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Linaclotide,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Linaclotide is combined with Oxyphenisatin acetate.,increase,risk
Linaclotide,Oxyphenonium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Linaclotide,Quetiapine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quetiapine.,decrease,no risk
Linaclotide,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Linaclotide.,increase,risk
Linaclotide,Quinidine,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quinidine.,decrease,no risk
Linaclotide,Umeclidinium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Umeclidinium.,decrease,no risk
Linaclotide,Vecuronium,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Vecuronium.,decrease,no risk
Linaclotide,Verapamil,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Verapamil.,decrease,no risk
Linaclotide,Xylometazoline,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Xylometazoline.,decrease,no risk
Linaclotide,Ziconotide,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Ziconotide.,decrease,no risk
Linaclotide,Ziprasidone,The therapeutic efficacy of Linaclotide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Linaclotide,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Linaclotide.,increase,risk
Motesanib,Voriconazole,The serum concentration of Motesanib can be increased when it is combined with Voriconazole.,increase,no risk
Ramucirumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Ramucirumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ramucirumab.,increase,risk
Ramucirumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Human Rho(D) immune globulin.,increase,risk
Ramucirumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Human varicella-zoster immune globulin.,increase,risk
Ramucirumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ramucirumab.,increase,risk
Ramucirumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Obinutuzumab.,increase,risk
Ramucirumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ocrelizumab.,increase,risk
Ramucirumab,Odesivimab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Odesivimab.,increase,risk
Ramucirumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ofatumumab.,increase,risk
Ramucirumab,Olaratumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Olaratumab.,increase,risk
Ramucirumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ramucirumab.,increase,risk
Ramucirumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ramucirumab is combined with Oxetacaine.,increase,risk
Ramucirumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ramucirumab is combined with Oxybuprocaine.,increase,risk
Ramucirumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ramucirumab.,increase,no risk
Ramucirumab,Ublituximab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ublituximab.,increase,risk
Ramucirumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Ustekinumab.,increase,risk
Ramucirumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ramucirumab is combined with Vedolizumab.,increase,risk
Ramucirumab,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Ramucirumab is combined with Zoledronic acid.,increase,risk
Teriparatide,Quizartinib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Quizartinib.,decrease,no risk
Teriparatide,Vandetanib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Vandetanib.,decrease,no risk
Teriparatide,Vemurafenib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Vemurafenib.,decrease,no risk
Teriparatide,Zanubrutinib,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Teriparatide,Zimelidine,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Zimelidine.,decrease,no risk
Farletuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Farletuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Farletuzumab.,increase,risk
Farletuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Obinutuzumab.,increase,risk
Farletuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ocrelizumab.,increase,risk
Farletuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Odesivimab.,increase,risk
Farletuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ofatumumab.,increase,risk
Farletuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Olaratumab.,increase,risk
Farletuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Farletuzumab.,increase,risk
Farletuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Farletuzumab is combined with Oxetacaine.,increase,risk
Farletuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Farletuzumab is combined with Oxybuprocaine.,increase,risk
Farletuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Farletuzumab.,increase,no risk
Farletuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ublituximab.,increase,risk
Farletuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Ustekinumab.,increase,risk
Farletuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Farletuzumab is combined with Vedolizumab.,increase,risk
PRX-08066,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with PRX-08066.,increase,risk
PRX-08066,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Gabapentin enacarbil.,increase,risk
PRX-08066,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with PRX-08066.,increase,risk
PRX-08066,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when PRX-08066 is combined with Ganaxolone.",increase,risk
PRX-08066,Gepirone,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Gepirone.,increase,risk
PRX-08066,Gilteritinib,The therapeutic efficacy of PRX-08066 can be decreased when used in combination with Gilteritinib.,decrease,no risk
PRX-08066,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with PRX-08066.,increase,risk
PRX-08066,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with PRX-08066.,increase,risk
PRX-08066,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with PRX-08066.,increase,risk
PRX-08066,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with PRX-08066.,increase,risk
PRX-08066,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with PRX-08066.,increase,risk
PRX-08066,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with PRX-08066.,increase,risk
PRX-08066,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with PRX-08066.,increase,risk
PRX-08066,Hydrocodone,PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
PRX-08066,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with PRX-08066.,increase,risk
PRX-08066,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of PRX-08066.,increase,no risk
PRX-08066,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with PRX-08066.,increase,risk
PRX-08066,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with PRX-08066.,increase,risk
PRX-08066,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with PRX-08066.,increase,risk
PRX-08066,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when PRX-08066 is combined with Oliceridine.",increase,risk
PRX-08066,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with PRX-08066.,increase,risk
PRX-08066,Opium,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Opium.,increase,risk
PRX-08066,Orphenadrine,PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
PRX-08066,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with PRX-08066.,increase,risk
PRX-08066,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with PRX-08066.,increase,risk
PRX-08066,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with PRX-08066.,increase,risk
PRX-08066,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with PRX-08066.,increase,risk
PRX-08066,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with PRX-08066.,increase,risk
PRX-08066,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with PRX-08066.,increase,risk
PRX-08066,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with PRX-08066.,increase,risk
PRX-08066,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with PRX-08066.,increase,risk
PRX-08066,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with PRX-08066.,increase,risk
PRX-08066,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with PRX-08066.,increase,risk
PRX-08066,Quinupramine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Quinupramine.,increase,risk
PRX-08066,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with PRX-08066.,increase,risk
PRX-08066,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with PRX-08066.,increase,risk
PRX-08066,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with PRX-08066.,increase,risk
PRX-08066,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with PRX-08066.,increase,risk
PRX-08066,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with PRX-08066.,increase,risk
PRX-08066,Vilazodone,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Vilazodone.,increase,risk
PRX-08066,Viloxazine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Viloxazine.,increase,risk
PRX-08066,Vortioxetine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Vortioxetine.,increase,risk
PRX-08066,Warfarin,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Warfarin.,increase,risk
PRX-08066,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with PRX-08066.,increase,risk
PRX-08066,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with PRX-08066.,increase,risk
PRX-08066,Ziconotide,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Ziconotide.,increase,risk
PRX-08066,Zimelidine,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Zimelidine.,increase,risk
PRX-08066,Ziprasidone,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Ziprasidone.,increase,risk
PRX-08066,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with PRX-08066.,increase,risk
PRX-08066,Zolpidem,PRX-08066 may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
PRX-08066,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with PRX-08066.,increase,risk
PRX-08066,Zopiclone,The risk or severity of adverse effects can be increased when PRX-08066 is combined with Zopiclone.,increase,risk
PRX-08066,Zotepine,The risk or severity of CNS depression can be increased when PRX-08066 is combined with Zotepine.,increase,risk
PRX-08066,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with PRX-08066.,increase,risk
PRX-08066,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with PRX-08066.,increase,risk
Elvitegravir,Galantamine,The metabolism of Galantamine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Glecaprevir,The metabolism of Elvitegravir can be decreased when combined with Glecaprevir.,decrease,no risk
Elvitegravir,Glofitamab,The serum concentration of Elvitegravir can be increased when it is combined with Glofitamab.,increase,no risk
Elvitegravir,Glyburide,The metabolism of Glyburide can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Granisetron,The metabolism of Granisetron can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Elvitegravir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ketamine,The metabolism of Ketamine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ketoconazole,The serum concentration of Elvitegravir can be increased when it is combined with Ketoconazole.,increase,no risk
Elvitegravir,Olaparib,The metabolism of Olaparib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Ombitasvir,The metabolism of Elvitegravir can be decreased when combined with Ombitasvir.,decrease,no risk
Elvitegravir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Opium,The metabolism of Opium can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quazepam,The metabolism of Quazepam can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Quinidine,The metabolism of Quinidine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quinine,The metabolism of Quinine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Udenafil,The metabolism of Udenafil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vadadustat,The serum concentration of Elvitegravir can be increased when it is combined with Vadadustat.,increase,no risk
Elvitegravir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Valproic acid,The metabolism of Elvitegravir can be decreased when combined with Valproic acid.,decrease,no risk
Elvitegravir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Verapamil,The metabolism of Verapamil can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Viloxazine,The metabolism of Elvitegravir can be decreased when combined with Viloxazine.,decrease,no risk
Elvitegravir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vincristine,The metabolism of Vincristine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vindesine,The metabolism of Vindesine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Voriconazole,The metabolism of Elvitegravir can be decreased when combined with Voriconazole.,decrease,no risk
Elvitegravir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Elvitegravir.,increase,no risk
Elvitegravir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Warfarin,The serum concentration of Warfarin can be decreased when it is combined with Elvitegravir.,decrease,no risk
Elvitegravir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Elvitegravir.,decrease,no risk
Elvitegravir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zileuton,The metabolism of Zileuton can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zimelidine,The metabolism of Elvitegravir can be decreased when combined with Zimelidine.,decrease,no risk
Elvitegravir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zotepine,The metabolism of Zotepine can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Elvitegravir.,decrease,no risk
Elvitegravir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Elvitegravir.,increase,no risk
Mocetinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Mocetinostat.,increase,risk
Mocetinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Mocetinostat.,increase,risk
Mocetinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Mocetinostat.,increase,risk
Mocetinostat,Gilteritinib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Gilteritinib.,increase,risk
Mocetinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Glasdegib.,increase,risk
Mocetinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Mocetinostat.,increase,risk
Mocetinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Mocetinostat.,increase,risk
Mocetinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Grepafloxacin.,increase,risk
Mocetinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Halofantrine.,increase,risk
Mocetinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Haloperidol.,increase,risk
Mocetinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Mocetinostat.,increase,risk
Mocetinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mocetinostat.,increase,risk
Mocetinostat,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Mocetinostat.,increase,risk
Mocetinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Hydroxyzine.,increase,risk
Mocetinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Mocetinostat.,increase,risk
Mocetinostat,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Mocetinostat.,increase,risk
Mocetinostat,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mocetinostat.,increase,risk
Mocetinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Mocetinostat.,increase,risk
Mocetinostat,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Mocetinostat.,increase,risk
Mocetinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Mocetinostat.,increase,risk
Mocetinostat,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Mocetinostat.,increase,risk
Mocetinostat,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Mocetinostat.,increase,risk
Mocetinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mocetinostat.,increase,risk
Mocetinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Oxatomide.,increase,risk
Mocetinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mocetinostat is combined with Oxetacaine.,increase,risk
Mocetinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mocetinostat is combined with Oxybuprocaine.,increase,risk
Mocetinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mocetinostat.,increase,risk
Mocetinostat,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Mocetinostat.,increase,risk
Mocetinostat,Quinidine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Quinidine.,increase,risk
Mocetinostat,Quinine,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Quinine.,increase,risk
Mocetinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Quizartinib.,increase,risk
Mocetinostat,Valproic acid,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Valproic acid.,increase,risk
Mocetinostat,Vandetanib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Vandetanib.,increase,risk
Mocetinostat,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Mocetinostat.,increase,risk
Mocetinostat,Vemurafenib,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Vemurafenib.,increase,risk
Mocetinostat,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Mocetinostat.,increase,risk
Mocetinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mocetinostat.,increase,risk
Mocetinostat,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Mocetinostat.,increase,risk
Mocetinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Mocetinostat is combined with Vorinostat.,increase,risk
Mocetinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Ziprasidone.,increase,risk
Mocetinostat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Mocetinostat.,increase,risk
Mocetinostat,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Zuclopenthixol.,increase,risk
Sagopilone,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sagopilone is combined with Oxetacaine.,increase,risk
Sagopilone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sagopilone is combined with Oxybuprocaine.,increase,risk
Sagopilone,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Quinine,The serum concentration of Quinine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sagopilone.,decrease,no risk
Sagopilone,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Sagopilone.,increase,no risk
Sagopilone,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sagopilone.,decrease,no risk
Sagopilone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Sagopilone.,decrease,no risk
Veltuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Veltuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Veltuzumab.,increase,risk
Veltuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Obinutuzumab.,increase,risk
Veltuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ocrelizumab.,increase,risk
Veltuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Odesivimab.,increase,risk
Veltuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ofatumumab.,increase,risk
Veltuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Olaratumab.,increase,risk
Veltuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Veltuzumab.,increase,risk
Veltuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Veltuzumab is combined with Oxetacaine.,increase,risk
Veltuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Veltuzumab is combined with Oxybuprocaine.,increase,risk
Veltuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Veltuzumab.,increase,no risk
Veltuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ublituximab.,increase,risk
Veltuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Ustekinumab.,increase,risk
Veltuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Veltuzumab is combined with Vedolizumab.,increase,risk
Boceprevir,Galantamine,The metabolism of Galantamine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Glofitamab,The serum concentration of Boceprevir can be increased when it is combined with Glofitamab.,increase,no risk
Boceprevir,Glyburide,The metabolism of Glyburide can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Golimumab,The metabolism of Boceprevir can be increased when combined with Golimumab.,increase,no risk
Boceprevir,Granisetron,The metabolism of Granisetron can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ketamine,The metabolism of Ketamine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ketoconazole,The serum concentration of Boceprevir can be increased when it is combined with Ketoconazole.,increase,no risk
Boceprevir,Olaparib,The metabolism of Olaparib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Opium,The metabolism of Opium can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oxcarbazepine,The metabolism of Boceprevir can be increased when combined with Oxcarbazepine.,increase,no risk
Boceprevir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quazepam,The metabolism of Quazepam can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Quinidine,The metabolism of Quinidine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quinine,The metabolism of Quinine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Udenafil,The metabolism of Udenafil can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vadadustat,The serum concentration of Boceprevir can be increased when it is combined with Vadadustat.,increase,no risk
Boceprevir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Viloxazine,The metabolism of Boceprevir can be decreased when combined with Viloxazine.,decrease,no risk
Boceprevir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vincristine,The metabolism of Vincristine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vindesine,The metabolism of Vindesine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Voriconazole,The metabolism of Boceprevir can be decreased when combined with Voriconazole.,decrease,no risk
Boceprevir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Warfarin,The metabolism of Warfarin can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Boceprevir.,decrease,no risk
Boceprevir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zileuton,The metabolism of Zileuton can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zimelidine,The metabolism of Boceprevir can be decreased when combined with Zimelidine.,decrease,no risk
Boceprevir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Boceprevir.,increase,no risk
Boceprevir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zotepine,The metabolism of Zotepine can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Boceprevir.,decrease,no risk
Boceprevir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Boceprevir.,increase,no risk
Levoketoconazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Glofitamab,The serum concentration of Levoketoconazole can be increased when it is combined with Glofitamab.,increase,no risk
Levoketoconazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Granisetron,The metabolism of Granisetron can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Guanidine,The excretion of Guanidine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Haloperidol,The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Haloperidol.,increase,risk
Levoketoconazole,Halothane,The metabolism of Halothane can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Histamine,The serum concentration of Histamine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Hydroxyzine.,increase,risk
Levoketoconazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ketoconazole,The metabolism of Levoketoconazole can be decreased when combined with Ketoconazole.,decrease,no risk
Levoketoconazole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Olaparib,The metabolism of Olaparib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Omeprazole,Omeprazole can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Opium,The metabolism of Opium can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levoketoconazole.,increase,risk
Levoketoconazole,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quazepam,The metabolism of Quazepam can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Quinidine,The metabolism of Quinidine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quinine,The metabolism of Quinine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Udenafil,The metabolism of Udenafil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vadadustat,The serum concentration of Levoketoconazole can be increased when it is combined with Vadadustat.,increase,no risk
Levoketoconazole,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Varenicline,The excretion of Varenicline can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Verapamil,The metabolism of Verapamil can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Viloxazine,The metabolism of Levoketoconazole can be decreased when combined with Viloxazine.,decrease,no risk
Levoketoconazole,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vincristine,The excretion of Vincristine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vindesine,The metabolism of Vindesine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Levoketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levoketoconazole,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Voriconazole,The metabolism of Levoketoconazole can be decreased when combined with Voriconazole.,decrease,no risk
Levoketoconazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Levoketoconazole.,increase,no risk
Levoketoconazole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Xylometazoline,The therapeutic efficacy of Levoketoconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Levoketoconazole,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Ziconotide,The therapeutic efficacy of Levoketoconazole can be increased when used in combination with Ziconotide.,increase,no risk
Levoketoconazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zimelidine,The metabolism of Levoketoconazole can be decreased when combined with Zimelidine.,decrease,no risk
Levoketoconazole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Levoketoconazole is combined with Ziprasidone.,increase,risk
Levoketoconazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zotepine,The metabolism of Zotepine can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Levoketoconazole.,decrease,no risk
Levoketoconazole,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Levoketoconazole.,increase,no risk
Palifosfamide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Benzocaine.,increase,risk
Palifosfamide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Benzyl alcohol.,increase,risk
Palifosfamide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Bupivacaine.,increase,risk
Palifosfamide,Butacaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Butacaine.,increase,risk
Palifosfamide,Butamben,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Butamben.,increase,risk
Palifosfamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Oxetacaine.,increase,risk
Palifosfamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Palifosfamide is combined with Oxybuprocaine.,increase,risk
Apremilast,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Apremilast.,increase,risk
Apremilast,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Apremilast.,increase,risk
Apremilast,Bacitracin,Bacitracin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Baclofen,Baclofen may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Balsalazide,Balsalazide may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Baricitinib,The risk or severity of adverse effects can be increased when Apremilast is combined with Baricitinib.,increase,risk
Apremilast,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Apremilast.,increase,risk
Apremilast,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Apremilast.,increase,risk
Apremilast,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Apremilast.,increase,risk
Apremilast,Belatacept,The risk or severity of adverse effects can be increased when Apremilast is combined with Belatacept.,increase,risk
Apremilast,Belimumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Belimumab.,increase,risk
Apremilast,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Apremilast.,increase,risk
Apremilast,Belumosudil,The risk or severity of adverse effects can be increased when Apremilast is combined with Belumosudil.,increase,risk
Apremilast,Belzutifan,The metabolism of Belzutifan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bendamustine,The metabolism of Bendamustine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Benorilate,Benorilate may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Benserazide,Apremilast may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Apremilast,Benzatropine,The metabolism of Benzatropine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Benznidazole,Apremilast may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Apremilast,Benzocaine,The metabolism of Benzocaine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Benzthiazide,Benzthiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Benzydamine,Benzydamine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bepotastine,Bepotastine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Bepridil,The metabolism of Bepridil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Berotralstat,The metabolism of Apremilast can be decreased when combined with Berotralstat.,decrease,no risk
Apremilast,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Apremilast.,increase,risk
Apremilast,Betaxolol,The metabolism of Betaxolol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bexarotene,The metabolism of Bexarotene can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bicisate,Apremilast may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Apremilast,Bimekizumab,The metabolism of Apremilast can be increased when combined with Bimekizumab.,increase,no risk
Apremilast,Binimetinib,The metabolism of Binimetinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bismuth subgallate,Apremilast may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Apremilast,Bisoprolol,Bisoprolol may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Bisoxatin,Apremilast may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Apremilast,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Apremilast.,increase,risk
Apremilast,Blinatumomab,The risk or severity of adverse effects can be increased when Apremilast is combined with Blinatumomab.,increase,risk
Apremilast,Boceprevir,The metabolism of Apremilast can be decreased when combined with Boceprevir.,decrease,no risk
Apremilast,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Apremilast.",decrease,no risk
Apremilast,Bortezomib,The metabolism of Bortezomib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bosentan,The metabolism of Bosentan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bosutinib,The metabolism of Bosutinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brigatinib,The metabolism of Brigatinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brodalumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Brodalumab.,increase,risk
Apremilast,Bromazepam,The metabolism of Bromazepam can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Apremilast.,increase,no risk
Apremilast,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Apremilast.,increase,risk
Apremilast,Bumadizone,Bumadizone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Bumetanide,Bumetanide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Bupropion,The metabolism of Bupropion can be increased when combined with Apremilast.,increase,no risk
Apremilast,Buspirone,The metabolism of Buspirone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Busulfan,The metabolism of Busulfan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Butabarbital,Butabarbital may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gabapentin enacarbil,Apremilast may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Apremilast,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gadodiamide,Gadodiamide may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gadofosveset trisodium,Apremilast may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Apremilast,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gadoteric acid,Apremilast may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Apremilast,Gadoteridol,Gadoteridol may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Galantamine,The metabolism of Galantamine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ganciclovir,Ganciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Gatifloxacin,The metabolism of Apremilast can be decreased when combined with Gatifloxacin.,decrease,no risk
Apremilast,Gefitinib,The metabolism of Gefitinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Apremilast.,increase,risk
Apremilast,Gemfibrozil,The metabolism of Apremilast can be decreased when combined with Gemfibrozil.,decrease,no risk
Apremilast,Gemifloxacin,The metabolism of Apremilast can be decreased when combined with Gemifloxacin.,decrease,no risk
Apremilast,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Apremilast.,increase,risk
Apremilast,Gentamicin,Apremilast may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Apremilast,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Gimeracil,Apremilast may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Apremilast,Givosiran,The serum concentration of Apremilast can be increased when it is combined with Givosiran.,increase,no risk
Apremilast,Glasdegib,The metabolism of Glasdegib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Apremilast.,increase,risk
Apremilast,Gliclazide,The metabolism of Gliclazide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glimepiride,The metabolism of Glimepiride can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glipizide,The metabolism of Glipizide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Gliquidone,The metabolism of Gliquidone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glofitamab,The serum concentration of Apremilast can be increased when it is combined with Glofitamab.,increase,no risk
Apremilast,Glyburide,The metabolism of Glyburide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Glycerol phenylbutyrate,Apremilast may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Apremilast,Golimumab,The therapeutic efficacy of Apremilast can be decreased when used in combination with Golimumab.,decrease,no risk
Apremilast,Golodirsen,Apremilast may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Apremilast,Goserelin,Goserelin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Guanabenz,The metabolism of Guanabenz can be increased when combined with Apremilast.,increase,no risk
Apremilast,Guanethidine,Guanethidine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Guanfacine,Guanfacine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Guselkumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Guselkumab.,increase,risk
Apremilast,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Halofantrine,The metabolism of Halofantrine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Apremilast.,increase,no risk
Apremilast,Halothane,The metabolism of Halothane can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Apremilast.,increase,risk
Apremilast,Hydralazine,Hydralazine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Apremilast is combined with Hydrocortisone succinate.,increase,risk
Apremilast,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydroxyethyl Starch,Apremilast may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Apremilast,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Apremilast.,increase,no risk
Apremilast,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Apremilast.,increase,risk
Apremilast,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Kanamycin,Apremilast may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Apremilast,Ketamine,The metabolism of Ketamine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ketazolam,Ketazolam may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Ketoprofen,Ketoprofen may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Ketorolac,The metabolism of Ketorolac can be increased when combined with Apremilast.,increase,no risk
Apremilast,Obeticholic acid,The metabolism of Apremilast can be decreased when combined with Obeticholic acid.,decrease,no risk
Apremilast,Obinutuzumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Obinutuzumab.,increase,risk
Apremilast,Ocrelizumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Ocrelizumab.,increase,risk
Apremilast,Octinoxate,Apremilast may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Apremilast,Ofatumumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Ofatumumab.,increase,risk
Apremilast,Olanzapine,The metabolism of Olanzapine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Olaparib,The metabolism of Olaparib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oliceridine,The metabolism of Oliceridine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Olodaterol,The metabolism of Olodaterol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Olsalazine,Olsalazine may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Omaveloxolone,The serum concentration of Apremilast can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Apremilast,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Apremilast.,increase,no risk
Apremilast,Omeprazole,The metabolism of Omeprazole can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ondansetron,The metabolism of Ondansetron can be increased when combined with Apremilast.,increase,no risk
Apremilast,Opium,The metabolism of Opium can be increased when combined with Apremilast.,increase,no risk
Apremilast,Orphenadrine,The metabolism of Apremilast can be decreased when combined with Orphenadrine.,decrease,no risk
Apremilast,Oseltamivir,Oseltamivir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Apremilast.,increase,no risk
Apremilast,Osimertinib,The serum concentration of Apremilast can be decreased when it is combined with Osimertinib.,decrease,no risk
Apremilast,Ospemifene,The metabolism of Ospemifene can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxacillin,Oxacillin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Apremilast.,increase,risk
Apremilast,Oxaprozin,Oxaprozin may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxazepam,Oxazepam may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxybenzone,Oxybenzone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxycodone,The metabolism of Oxycodone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Oxyquinoline,Apremilast may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Apremilast,Ozanimod,The risk or severity of adverse effects can be increased when Apremilast is combined with Ozanimod.,increase,risk
Apremilast,Quetiapine,The metabolism of Quetiapine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Quinethazone,Quinethazone may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Apremilast,Quinidine,The metabolism of Quinidine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Quinine,The metabolism of Quinine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Quizartinib,The metabolism of Quizartinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Apremilast.,increase,risk
Apremilast,Udenafil,The metabolism of Udenafil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Apremilast.,increase,no risk
Apremilast,Upadacitinib,The risk or severity of adverse effects can be increased when Apremilast is combined with Upadacitinib.,increase,risk
Apremilast,Ustekinumab,The therapeutic efficacy of Apremilast can be decreased when used in combination with Ustekinumab.,decrease,no risk
Apremilast,Vaborbactam,Apremilast may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Apremilast,Vadadustat,The serum concentration of Apremilast can be increased when it is combined with Vadadustat.,increase,no risk
Apremilast,Valaciclovir,Valaciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Valbenazine,The metabolism of Valbenazine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Valganciclovir,Valganciclovir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Valproic acid,The metabolism of Valproic acid can be increased when combined with Apremilast.,increase,no risk
Apremilast,Valsartan,The metabolism of Valsartan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vancomycin,Apremilast may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Apremilast,Vandetanib,The metabolism of Vandetanib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vardenafil,The metabolism of Vardenafil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Varenicline,Varenicline may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Apremilast.,increase,risk
Apremilast,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Vedolizumab,The risk or severity of adverse effects can be increased when Apremilast is combined with Vedolizumab.,increase,risk
Apremilast,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vemurafenib,The serum concentration of Apremilast can be increased when it is combined with Vemurafenib.,increase,no risk
Apremilast,Venetoclax,The metabolism of Venetoclax can be increased when combined with Apremilast.,increase,no risk
Apremilast,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Verapamil,The metabolism of Verapamil can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vernakalant,The metabolism of Vernakalant can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Apremilast.,decrease,no risk
Apremilast,Vilanterol,The risk or severity of adverse effects can be increased when Apremilast is combined with Vilanterol.,increase,risk
Apremilast,Vilazodone,The metabolism of Vilazodone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Viloxazine,The metabolism of Apremilast can be decreased when combined with Viloxazine.,decrease,no risk
Apremilast,Vinblastine,The metabolism of Vinblastine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vincristine,The metabolism of Vincristine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vindesine,The metabolism of Vindesine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vinflunine,The metabolism of Vinflunine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voclosporin,The risk or severity of adverse effects can be increased when Apremilast is combined with Voclosporin.,increase,risk
Apremilast,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voriconazole,The metabolism of Apremilast can be decreased when combined with Voriconazole.,decrease,no risk
Apremilast,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Apremilast.,increase,risk
Apremilast,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voxelotor,The metabolism of Voxelotor can be increased when combined with Apremilast.,increase,no risk
Apremilast,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Apremilast.,increase,no risk
Apremilast,Warfarin,The metabolism of Warfarin can be increased when combined with Apremilast.,increase,no risk
Apremilast,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Apremilast.,increase,no risk
Apremilast,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Apremilast.,increase,risk
Apremilast,Yohimbine,The metabolism of Yohimbine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zaleplon,The metabolism of Zaleplon can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zanamivir,Zanamivir may decrease the excretion rate of Apremilast which could result in a higher serum level.,decrease,no risk
Apremilast,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zidovudine,The metabolism of Zidovudine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zileuton,The metabolism of Zileuton can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zimelidine,The metabolism of Apremilast can be decreased when combined with Zimelidine.,decrease,no risk
Apremilast,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zolpidem,The metabolism of Zolpidem can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zonisamide,The metabolism of Zonisamide can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zopiclone,The metabolism of Zopiclone can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zotepine,The metabolism of Zotepine can be increased when combined with Apremilast.,increase,no risk
Apremilast,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Apremilast.,increase,no risk
Radium Ra 223 dichloride,Benzocaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Benzocaine.,increase,risk
Radium Ra 223 dichloride,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Benzyl alcohol.,increase,risk
Radium Ra 223 dichloride,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Bupivacaine.,increase,risk
Radium Ra 223 dichloride,Butacaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Butacaine.,increase,risk
Radium Ra 223 dichloride,Butamben,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Butamben.,increase,risk
Radium Ra 223 dichloride,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Oxetacaine.,increase,risk
Radium Ra 223 dichloride,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Radium Ra 223 dichloride is combined with Oxybuprocaine.,increase,risk
Ustekinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ustekinumab.,increase,risk
Ustekinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Obinutuzumab.,increase,risk
Ustekinumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ocrelizumab.,increase,risk
Ustekinumab,Odesivimab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Odesivimab.,increase,risk
Ustekinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ofatumumab.,increase,risk
Ustekinumab,Olaratumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Olaratumab.,increase,risk
Ustekinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab.,increase,risk
Ustekinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Ustekinumab,Ublituximab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ublituximab.,increase,risk
Ustekinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Vedolizumab.,increase,risk
BL-1020,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with BL-1020.,increase,risk
BL-1020,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when BL-1020 is combined with Gabapentin enacarbil.,increase,risk
BL-1020,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with BL-1020.,increase,risk
BL-1020,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when BL-1020 is combined with Ganaxolone.",increase,risk
BL-1020,Gepirone,The risk or severity of CNS depression can be increased when BL-1020 is combined with Gepirone.,increase,risk
BL-1020,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with BL-1020.,increase,risk
BL-1020,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with BL-1020.,increase,risk
BL-1020,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with BL-1020.,increase,risk
BL-1020,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with BL-1020.,increase,risk
BL-1020,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with BL-1020.,increase,risk
BL-1020,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with BL-1020.,increase,risk
BL-1020,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with BL-1020.,increase,risk
BL-1020,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with BL-1020.,increase,risk
BL-1020,Hydrocodone,BL-1020 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
BL-1020,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Hydromorphone.,increase,risk
BL-1020,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of BL-1020 resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
BL-1020,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with BL-1020.,increase,risk
BL-1020,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of BL-1020.,increase,no risk
BL-1020,Hyoscyamine,BL-1020 may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
BL-1020,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with BL-1020.,increase,risk
BL-1020,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with BL-1020.,increase,risk
BL-1020,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with BL-1020.,increase,risk
BL-1020,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when BL-1020 is combined with Oliceridine.",increase,risk
BL-1020,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with BL-1020.,increase,risk
BL-1020,Opium,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Opium.,increase,risk
BL-1020,Orphenadrine,BL-1020 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
BL-1020,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with BL-1020.,increase,risk
BL-1020,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with BL-1020.,increase,risk
BL-1020,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with BL-1020.,increase,risk
BL-1020,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with BL-1020.,increase,no risk
BL-1020,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with BL-1020.,increase,risk
BL-1020,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Oxycodone.,increase,risk
BL-1020,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when BL-1020 is combined with Oxymorphone.,increase,risk
BL-1020,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with BL-1020.,increase,risk
BL-1020,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with BL-1020.,increase,risk
BL-1020,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with BL-1020.,decrease,no risk
BL-1020,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with BL-1020.,increase,risk
BL-1020,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with BL-1020.,increase,risk
Vorapaxar,Butalbital,The metabolism of Vorapaxar can be increased when combined with Butalbital.,increase,no risk
Vorapaxar,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Vorapaxar is combined with Gemtuzumab ozogamicin.,increase,risk
Vorapaxar,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Vorapaxar.,increase,risk
Vorapaxar,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Vorapaxar,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Glofitamab,The serum concentration of Vorapaxar can be increased when it is combined with Glofitamab.,increase,no risk
Vorapaxar,Glucosamine,Glucosamine may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vorapaxar,Glyburide,The metabolism of Vorapaxar can be decreased when combined with Glyburide.,decrease,no risk
Vorapaxar,Glycerol phenylbutyrate,The metabolism of Vorapaxar can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Vorapaxar,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Vorapaxar.,increase,risk
Vorapaxar,Golimumab,The metabolism of Vorapaxar can be increased when combined with Golimumab.,increase,no risk
Vorapaxar,Grapefruit,The metabolism of Vorapaxar can be decreased when combined with Grapefruit.,decrease,no risk
Vorapaxar,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Griseofulvin,The metabolism of Vorapaxar can be increased when combined with Griseofulvin.,increase,no risk
Vorapaxar,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Hemin,Hemin may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Vorapaxar,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Heparin.,increase,risk
Vorapaxar,Hydralazine,The metabolism of Vorapaxar can be decreased when combined with Hydralazine.,decrease,no risk
Vorapaxar,Hydrochlorothiazide,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Vorapaxar,Hydrocortamate,The metabolism of Vorapaxar can be increased when combined with Hydrocortamate.,increase,no risk
Vorapaxar,Hydrocortisone,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone.,increase,no risk
Vorapaxar,Hydrocortisone acetate,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone acetate.,increase,no risk
Vorapaxar,Hydrocortisone butyrate,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Vorapaxar,Hydrocortisone succinate,The metabolism of Vorapaxar can be increased when combined with Hydrocortisone succinate.,increase,no risk
Vorapaxar,Hydroflumethiazide,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Vorapaxar,Hydroxyprogesterone caproate,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Vorapaxar,Hydroxyurea,The risk or severity of bleeding can be increased when Vorapaxar is combined with Hydroxyurea.,increase,risk
Vorapaxar,Ketazolam,The metabolism of Vorapaxar can be decreased when combined with Ketazolam.,decrease,no risk
Vorapaxar,Ketoconazole,The metabolism of Vorapaxar can be decreased when combined with Ketoconazole.,decrease,no risk
Vorapaxar,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Vorapaxar.,increase,risk
Vorapaxar,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Vorapaxar.,increase,risk
Vorapaxar,Obeticholic acid,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obeticholic acid.,increase,risk
Vorapaxar,Obinutuzumab,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obinutuzumab.,increase,risk
Vorapaxar,Octreotide,The metabolism of Vorapaxar can be decreased when combined with Octreotide.,decrease,no risk
Vorapaxar,Olaparib,The metabolism of Olaparib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Olive oil,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Olive oil.,decrease,no risk
Vorapaxar,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Vorapaxar.,increase,risk
Vorapaxar,Olutasidenib,The metabolism of Vorapaxar can be increased when combined with Olutasidenib.,increase,no risk
Vorapaxar,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Vorapaxar is combined with Omacetaxine mepesuccinate.,increase,risk
Vorapaxar,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Omaveloxolone,The serum concentration of Vorapaxar can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vorapaxar,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vorapaxar,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Vorapaxar.,increase,risk
Vorapaxar,Omega-3-carboxylic acids,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Vorapaxar,Oritavancin,The metabolism of Vorapaxar can be increased when combined with Oritavancin.,increase,no risk
Vorapaxar,Orphenadrine,The metabolism of Vorapaxar can be decreased when combined with Orphenadrine.,decrease,no risk
Vorapaxar,Osilodrostat,The metabolism of Vorapaxar can be decreased when combined with Osilodrostat.,decrease,no risk
Vorapaxar,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Vorapaxar.,increase,risk
Vorapaxar,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Vorapaxar.,increase,risk
Vorapaxar,Oxcarbazepine,The metabolism of Vorapaxar can be increased when combined with Oxcarbazepine.,increase,no risk
Vorapaxar,Oxybutynin,The metabolism of Vorapaxar can be decreased when combined with Oxybutynin.,decrease,no risk
Vorapaxar,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Vorapaxar.,increase,risk
Vorapaxar,Quinestrol,Quinestrol may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Vorapaxar,Quinidine,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinidine.,increase,no risk
Vorapaxar,Quinine,The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinine.,increase,no risk
Vorapaxar,Quinupristin,The metabolism of Vorapaxar can be decreased when combined with Quinupristin.,decrease,no risk
Vorapaxar,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Ulipristal,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ulipristal.,decrease,no risk
Vorapaxar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Urokinase,Urokinase may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Vorapaxar,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Ursodeoxycholic acid.,increase,risk
Vorapaxar,Vadadustat,The serum concentration of Vorapaxar can be increased when it is combined with Vadadustat.,increase,no risk
Vorapaxar,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Vorapaxar.,increase,risk
Vorapaxar,Valproic acid,The metabolism of Vorapaxar can be decreased when combined with Valproic acid.,decrease,no risk
Vorapaxar,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Venlafaxine,The risk or severity of bleeding can be increased when Vorapaxar is combined with Venlafaxine.,increase,risk
Vorapaxar,Verapamil,The metabolism of Vorapaxar can be decreased when combined with Verapamil.,decrease,no risk
Vorapaxar,Viloxazine,The metabolism of Vorapaxar can be decreased when combined with Viloxazine.,decrease,no risk
Vorapaxar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Vincristine,The excretion of Vincristine can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vindesine,The metabolism of Vindesine can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Vitamin E,Vitamin E may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Vorapaxar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Vorapaxar.,decrease,no risk
Vorapaxar,Voriconazole,The metabolism of Vorapaxar can be decreased when combined with Voriconazole.,decrease,no risk
Vorapaxar,Vorinostat,The risk or severity of bleeding can be increased when Vorapaxar is combined with Vorinostat.,increase,risk
Vorapaxar,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Vorapaxar.,increase,risk
Vorapaxar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Vorapaxar.,increase,no risk
Vorapaxar,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Warfarin.,increase,risk
Vorapaxar,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ximelagatran.,increase,risk
Vorapaxar,Zafirlukast,The metabolism of Vorapaxar can be decreased when combined with Zafirlukast.,decrease,no risk
Vorapaxar,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Vorapaxar.,decrease,no risk
Vorapaxar,Zidovudine,The risk or severity of bleeding can be increased when Vorapaxar is combined with Zidovudine.,increase,risk
Vorapaxar,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Vorapaxar.,increase,risk
Vorapaxar,Ziprasidone,The metabolism of Vorapaxar can be decreased when combined with Ziprasidone.,decrease,no risk
Vorapaxar,Zuclopenthixol,The metabolism of Vorapaxar can be decreased when combined with Zuclopenthixol.,decrease,no risk
Elagolix,Galantamine,The metabolism of Elagolix can be decreased when combined with Galantamine.,decrease,no risk
Elagolix,Gefitinib,The metabolism of Elagolix can be decreased when combined with Gefitinib.,decrease,no risk
Elagolix,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Gemfibrozil,The metabolism of Elagolix can be decreased when combined with Gemfibrozil.,decrease,no risk
Elagolix,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Givosiran,The serum concentration of Elagolix can be increased when it is combined with Givosiran.,increase,no risk
Elagolix,Glasdegib,The serum concentration of Elagolix can be increased when it is combined with Glasdegib.,increase,no risk
Elagolix,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Glycerol phenylbutyrate,The metabolism of Elagolix can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Elagolix,Golimumab,The metabolism of Elagolix can be increased when combined with Golimumab.,increase,no risk
Elagolix,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Halofantrine,The metabolism of Elagolix can be decreased when combined with Halofantrine.,decrease,no risk
Elagolix,Haloperidol,The serum concentration of Elagolix can be increased when it is combined with Haloperidol.,increase,no risk
Elagolix,Hydrocortisone,The metabolism of Elagolix can be increased when combined with Hydrocortisone.,increase,no risk
Elagolix,Hydroxychloroquine,The metabolism of Elagolix can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Elagolix,Hydroxyzine,The metabolism of Elagolix can be decreased when combined with Hydroxyzine.,decrease,no risk
Elagolix,Ketamine,The metabolism of Elagolix can be decreased when combined with Ketamine.,decrease,no risk
Elagolix,Ketoconazole,The metabolism of Elagolix can be decreased when combined with Ketoconazole.,decrease,no risk
Elagolix,Ketoprofen,The metabolism of Elagolix can be decreased when combined with Ketoprofen.,decrease,no risk
Elagolix,Ketorolac,The metabolism of Elagolix can be decreased when combined with Ketorolac.,decrease,no risk
Elagolix,Olanzapine,The metabolism of Elagolix can be decreased when combined with Olanzapine.,decrease,no risk
Elagolix,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Elagolix.,decrease,no risk
Elagolix,Olodaterol,The metabolism of Elagolix can be decreased when combined with Olodaterol.,decrease,no risk
Elagolix,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Omaveloxolone,The serum concentration of Elagolix can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Elagolix,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Ondansetron,The metabolism of Elagolix can be decreased when combined with Ondansetron.,decrease,no risk
Elagolix,Opium,The metabolism of Elagolix can be decreased when combined with Opium.,decrease,no risk
Elagolix,Oritavancin,The metabolism of Elagolix can be decreased when combined with Oritavancin.,decrease,no risk
Elagolix,Orphenadrine,The metabolism of Elagolix can be decreased when combined with Orphenadrine.,decrease,no risk
Elagolix,Osilodrostat,The metabolism of Elagolix can be decreased when combined with Osilodrostat.,decrease,no risk
Elagolix,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Ospemifene,The metabolism of Elagolix can be decreased when combined with Ospemifene.,decrease,no risk
Elagolix,Ouabain,The excretion of Elagolix can be decreased when combined with Ouabain.,decrease,no risk
Elagolix,Oxamniquine,The metabolism of Elagolix can be decreased when combined with Oxamniquine.,decrease,no risk
Elagolix,Oxprenolol,The metabolism of Elagolix can be decreased when combined with Oxprenolol.,decrease,no risk
Elagolix,Oxybutynin,The metabolism of Elagolix can be decreased when combined with Oxybutynin.,decrease,no risk
Elagolix,Oxycodone,The metabolism of Elagolix can be decreased when combined with Oxycodone.,decrease,no risk
Elagolix,Oxymorphone,The metabolism of Elagolix can be decreased when combined with Oxymorphone.,decrease,no risk
Elagolix,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Elagolix.,decrease,no risk
Elagolix,Quetiapine,The metabolism of Elagolix can be decreased when combined with Quetiapine.,decrease,no risk
Elagolix,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Quinine,The metabolism of Elagolix can be decreased when combined with Quinine.,decrease,no risk
Elagolix,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Umbralisib,The serum concentration of Elagolix can be increased when it is combined with Umbralisib.,increase,no risk
Elagolix,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Vadadustat,The serum concentration of Elagolix can be increased when it is combined with Vadadustat.,increase,no risk
Elagolix,Valbenazine,The metabolism of Elagolix can be decreased when combined with Valbenazine.,decrease,no risk
Elagolix,Valproic acid,The metabolism of Elagolix can be decreased when combined with Valproic acid.,decrease,no risk
Elagolix,Valsartan,The excretion of Elagolix can be decreased when combined with Valsartan.,decrease,no risk
Elagolix,Vandetanib,The serum concentration of Elagolix can be increased when it is combined with Vandetanib.,increase,no risk
Elagolix,Vardenafil,The serum concentration of Elagolix can be increased when it is combined with Vardenafil.,increase,no risk
Elagolix,Velpatasvir,The serum concentration of Elagolix can be increased when it is combined with Velpatasvir.,increase,no risk
Elagolix,Vemurafenib,The serum concentration of Elagolix can be increased when it is combined with Vemurafenib.,increase,no risk
Elagolix,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Venlafaxine,The metabolism of Elagolix can be decreased when combined with Venlafaxine.,decrease,no risk
Elagolix,Verapamil,The serum concentration of Elagolix can be increased when it is combined with Verapamil.,increase,no risk
Elagolix,Vernakalant,The metabolism of Elagolix can be decreased when combined with Vernakalant.,decrease,no risk
Elagolix,Vilazodone,The metabolism of Elagolix can be decreased when combined with Vilazodone.,decrease,no risk
Elagolix,Viloxazine,The metabolism of Elagolix can be decreased when combined with Viloxazine.,decrease,no risk
Elagolix,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Vincristine,The excretion of Vincristine can be decreased when combined with Elagolix.,decrease,no risk
Elagolix,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Vinorelbine,The metabolism of Elagolix can be decreased when combined with Vinorelbine.,decrease,no risk
Elagolix,Voclosporin,The serum concentration of Elagolix can be increased when it is combined with Voclosporin.,increase,no risk
Elagolix,Vorapaxar,The serum concentration of Elagolix can be increased when it is combined with Vorapaxar.,increase,no risk
Elagolix,Vortioxetine,The metabolism of Elagolix can be decreased when combined with Vortioxetine.,decrease,no risk
Elagolix,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Elagolix.,increase,no risk
Elagolix,Yohimbine,The metabolism of Elagolix can be decreased when combined with Yohimbine.,decrease,no risk
Elagolix,Zidovudine,The metabolism of Elagolix can be increased when combined with Zidovudine.,increase,no risk
Elagolix,Zolpidem,The metabolism of Elagolix can be decreased when combined with Zolpidem.,decrease,no risk
Elagolix,Zonisamide,The serum concentration of Elagolix can be increased when it is combined with Zonisamide.,increase,no risk
Elagolix,Zopiclone,The metabolism of Elagolix can be decreased when combined with Zopiclone.,decrease,no risk
Elagolix,Zuclopenthixol,The metabolism of Elagolix can be decreased when combined with Zuclopenthixol.,decrease,no risk
Trabedersen,Benzocaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Benzocaine.,increase,risk
Trabedersen,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Benzyl alcohol.,increase,risk
Trabedersen,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Bupivacaine.,increase,risk
Trabedersen,Butacaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Butacaine.,increase,risk
Trabedersen,Butamben,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Butamben.,increase,risk
Trabedersen,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Oxetacaine.,increase,risk
Trabedersen,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trabedersen is combined with Oxybuprocaine.,increase,risk
Vortioxetine,Bacitracin,Bacitracin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Vortioxetine.,increase,risk
Vortioxetine,Baricitinib,Vortioxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Vortioxetine,Beclomethasone dipropionate,The metabolism of Vortioxetine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Vortioxetine,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Benazepril,Vortioxetine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Vortioxetine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Benorilate,The risk or severity of hypertension can be increased when Vortioxetine is combined with Benorilate.,increase,risk
Vortioxetine,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Vortioxetine.,increase,risk
Vortioxetine,Benperidol,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Benperidol.,increase,risk
Vortioxetine,Benserazide,Vortioxetine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Vortioxetine,Benzatropine,Benzatropine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Benznidazole,Vortioxetine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Vortioxetine,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Vortioxetine.,increase,risk
Vortioxetine,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Vortioxetine.,increase,risk
Vortioxetine,Benzthiazide,Benzthiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Benzydamine,The risk or severity of hypertension can be increased when Vortioxetine is combined with Benzydamine.,increase,risk
Vortioxetine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Vortioxetine.,increase,risk
Vortioxetine,Bepotastine,Bepotastine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bepridil,The metabolism of Vortioxetine can be decreased when combined with Bepridil.,decrease,no risk
Vortioxetine,Berotralstat,The metabolism of Vortioxetine can be decreased when combined with Berotralstat.,decrease,no risk
Vortioxetine,Betamethasone,The metabolism of Vortioxetine can be increased when combined with Betamethasone.,increase,no risk
Vortioxetine,Betamethasone phosphate,The metabolism of Vortioxetine can be increased when combined with Betamethasone phosphate.,increase,no risk
Vortioxetine,Betaxolol,Vortioxetine may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Vortioxetine,Bethanidine,Vortioxetine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Vortioxetine,Bexarotene,The metabolism of Vortioxetine can be decreased when combined with Bexarotene.,decrease,no risk
Vortioxetine,Bezafibrate,The metabolism of Vortioxetine can be decreased when combined with Bezafibrate.,decrease,no risk
Vortioxetine,Bicisate,Vortioxetine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bimekizumab,The metabolism of Vortioxetine can be increased when combined with Bimekizumab.,increase,no risk
Vortioxetine,Biperiden,The metabolism of Vortioxetine can be decreased when combined with Biperiden.,decrease,no risk
Vortioxetine,Bismuth subgallate,Vortioxetine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bisoprolol,Vortioxetine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Vortioxetine,Bisoxatin,Vortioxetine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Bleomycin,Bleomycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Boceprevir,The metabolism of Vortioxetine can be decreased when combined with Boceprevir.,decrease,no risk
Vortioxetine,Bortezomib,The metabolism of Vortioxetine can be decreased when combined with Bortezomib.,decrease,no risk
Vortioxetine,Bosentan,The metabolism of Vortioxetine can be increased when combined with Bosentan.,increase,no risk
Vortioxetine,Bosutinib,The metabolism of Vortioxetine can be decreased when combined with Bosutinib.,decrease,no risk
Vortioxetine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Vortioxetine.,increase,risk
Vortioxetine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Vortioxetine.,increase,risk
Vortioxetine,Bretylium,Vortioxetine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Vortioxetine,Brexanolone,The risk or severity of CNS depression can be increased when Vortioxetine is combined with Brexanolone.,increase,risk
Vortioxetine,Brexpiprazole,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Brexpiprazole.,increase,risk
Vortioxetine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Vortioxetine.,increase,risk
Vortioxetine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Vortioxetine.,increase,risk
Vortioxetine,Bromocriptine,Bromocriptine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Vortioxetine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Bromperidol,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Bromperidol.,increase,risk
Vortioxetine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vortioxetine.,increase,risk
Vortioxetine,Budesonide,The metabolism of Vortioxetine can be increased when combined with Budesonide.,increase,no risk
Vortioxetine,Bumadizone,The risk or severity of hypertension can be increased when Vortioxetine is combined with Bumadizone.,increase,risk
Vortioxetine,Bumetanide,Bumetanide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Vortioxetine.,increase,risk
Vortioxetine,Buprenorphine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Vortioxetine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Vortioxetine.,increase,risk
Vortioxetine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Vortioxetine.,increase,risk
Vortioxetine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vortioxetine.,increase,risk
Vortioxetine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Vortioxetine.,increase,risk
Vortioxetine,Butaperazine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Butaperazine.,increase,risk
Vortioxetine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Vortioxetine.,increase,risk
Vortioxetine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Vortioxetine.,increase,risk
Vortioxetine,Butriptyline,The risk or severity of CNS depression can be increased when Butriptyline is combined with Vortioxetine.,increase,risk
Vortioxetine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vortioxetine.,increase,risk
Vortioxetine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Vortioxetine.,increase,risk
Vortioxetine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadodiamide,Gadodiamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadoteric acid,Vortioxetine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gadoteridol,Gadoteridol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Galantamine,The metabolism of Vortioxetine can be decreased when combined with Galantamine.,decrease,no risk
Vortioxetine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Vortioxetine.,increase,risk
Vortioxetine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vortioxetine is combined with Ganaxolone.",increase,risk
Vortioxetine,Ganciclovir,Ganciclovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gefitinib,The metabolism of Vortioxetine can be decreased when combined with Gefitinib.,decrease,no risk
Vortioxetine,Gemcitabine,Gemcitabine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gemfibrozil,The metabolism of Vortioxetine can be decreased when combined with Gemfibrozil.,decrease,no risk
Vortioxetine,Gentamicin,Vortioxetine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Vortioxetine.,increase,risk
Vortioxetine,Gilteritinib,The therapeutic efficacy of Vortioxetine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Vortioxetine,Gimeracil,Vortioxetine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Vortioxetine,Ginkgo biloba,The metabolism of Vortioxetine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vortioxetine,Givosiran,The serum concentration of Vortioxetine can be increased when it is combined with Givosiran.,increase,no risk
Vortioxetine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Gliclazide,The metabolism of Vortioxetine can be decreased when combined with Gliclazide.,decrease,no risk
Vortioxetine,Glimepiride,The metabolism of Vortioxetine can be decreased when combined with Glimepiride.,decrease,no risk
Vortioxetine,Glipizide,Glipizide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Gliquidone,The metabolism of Vortioxetine can be decreased when combined with Gliquidone.,decrease,no risk
Vortioxetine,Glofitamab,The serum concentration of Vortioxetine can be increased when it is combined with Glofitamab.,increase,no risk
Vortioxetine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Vortioxetine.,increase,risk
Vortioxetine,Glyburide,The metabolism of Vortioxetine can be decreased when combined with Glyburide.,decrease,no risk
Vortioxetine,Glycerol phenylbutyrate,The metabolism of Vortioxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Vortioxetine,Golimumab,The metabolism of Vortioxetine can be increased when combined with Golimumab.,increase,no risk
Vortioxetine,Golodirsen,Vortioxetine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Vortioxetine,Goserelin,Goserelin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Vortioxetine.,increase,risk
Vortioxetine,Guanabenz,Vortioxetine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Vortioxetine,Guanadrel,Vortioxetine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Vortioxetine,Guanethidine,Vortioxetine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Vortioxetine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vortioxetine.,increase,risk
Vortioxetine,Guanoxan,Vortioxetine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Vortioxetine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Vortioxetine.,increase,risk
Vortioxetine,Halofantrine,The metabolism of Vortioxetine can be decreased when combined with Halofantrine.,decrease,no risk
Vortioxetine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Vortioxetine.,increase,risk
Vortioxetine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Vortioxetine.,increase,risk
Vortioxetine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vortioxetine.,increase,risk
Vortioxetine,Hydralazine,Vortioxetine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Vortioxetine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Hydrocodone,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Vortioxetine,Hydrocortisone,The metabolism of Vortioxetine can be increased when combined with Hydrocortisone.,increase,no risk
Vortioxetine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Vortioxetine.,decrease,no risk
Vortioxetine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vortioxetine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Vortioxetine.,increase,risk
Vortioxetine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Vortioxetine,Hydroxychloroquine,The metabolism of Vortioxetine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Vortioxetine,Hydroxyethyl Starch,Vortioxetine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Vortioxetine,Hydroxyprogesterone caproate,The metabolism of Vortioxetine can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Vortioxetine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Vortioxetine,Kanamycin,Vortioxetine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Vortioxetine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Vortioxetine.,increase,risk
Vortioxetine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Vortioxetine.,increase,risk
Vortioxetine,Ketoconazole,The metabolism of Vortioxetine can be decreased when combined with Ketoconazole.,decrease,no risk
Vortioxetine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vortioxetine.,increase,risk
Vortioxetine,Ketorolac,The metabolism of Vortioxetine can be decreased when combined with Ketorolac.,decrease,no risk
Mirabegron,Baricitinib,Mirabegron may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Mirabegron,Bedaquiline,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bedaquiline.,increase,risk
Mirabegron,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Belladonna,The risk or severity of urinary retention can be increased when Belladonna is combined with Mirabegron.,increase,risk
Mirabegron,Belumosudil,The serum concentration of Mirabegron can be increased when it is combined with Belumosudil.,increase,no risk
Mirabegron,Benazepril,Mirabegron may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Mirabegron,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Benorilate,The risk or severity of hypertension can be increased when Mirabegron is combined with Benorilate.,increase,risk
Mirabegron,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Mirabegron.,increase,risk
Mirabegron,Benserazide,Mirabegron may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Mirabegron,Benzatropine,The risk or severity of urinary retention can be increased when Benzatropine is combined with Mirabegron.,increase,risk
Mirabegron,Benznidazole,Mirabegron may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Mirabegron,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Benzonatate,The serum concentration of Mirabegron can be increased when it is combined with Benzonatate.,increase,no risk
Mirabegron,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Mirabegron.,increase,risk
Mirabegron,Benzthiazide,Benzthiazide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Benzydamine,The risk or severity of hypertension can be increased when Mirabegron is combined with Benzydamine.,increase,risk
Mirabegron,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Benzylpenicilloyl polylysine,Mirabegron may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Mirabegron,Bepotastine,Bepotastine may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Betaine,Betaine may increase the neuromuscular blocking activities of Mirabegron.,increase,no risk
Mirabegron,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bethanidine,Mirabegron may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Mirabegron,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bicisate,Mirabegron may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Mirabegron,Bilastine,The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Bilastine.,increase,risk
Mirabegron,Bimekizumab,The metabolism of Mirabegron can be increased when combined with Bimekizumab.,increase,no risk
Mirabegron,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Biperiden,The risk or severity of urinary retention can be increased when Biperiden is combined with Mirabegron.,increase,risk
Mirabegron,Bismuth subgallate,Mirabegron may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Mirabegron,Bisoprolol,The therapeutic efficacy of Mirabegron can be decreased when used in combination with Bisoprolol.,decrease,no risk
Mirabegron,Bisoxatin,Mirabegron may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Mirabegron,Bleomycin,Bleomycin may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Boceprevir,The metabolism of Mirabegron can be decreased when combined with Boceprevir.,decrease,no risk
Mirabegron,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bosentan,Mirabegron may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Mirabegron,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bretylium,Mirabegron may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Mirabegron,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Mirabegron.,decrease,no risk
Mirabegron,Brivaracetam,Brivaracetam may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bromazepam,Bromazepam may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Mirabegron.,increase,no risk
Mirabegron,Bromotheophylline,Bromotheophylline may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Brompheniramine,The risk or severity of urinary retention can be increased when Brompheniramine is combined with Mirabegron.,increase,risk
Mirabegron,Buclizine,The risk or severity of urinary retention can be increased when Buclizine is combined with Mirabegron.,increase,risk
Mirabegron,Budesonide,Budesonide may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Bumadizone,The risk or severity of hypertension can be increased when Mirabegron is combined with Bumadizone.,increase,risk
Mirabegron,Bumetanide,Bumetanide may increase the excretion rate of Mirabegron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirabegron,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Bupropion,The metabolism of Mirabegron can be decreased when combined with Bupropion.,decrease,no risk
Mirabegron,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Mirabegron.,increase,risk
Mirabegron,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Mirabegron.,increase,no risk
Mirabegron,Butabarbital,Butabarbital may decrease the excretion rate of Mirabegron which could result in a higher serum level.,decrease,no risk
Mirabegron,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Mirabegron.,increase,risk
Mirabegron,Butylscopolamine,The risk or severity of urinary retention can be increased when Butylscopolamine is combined with Mirabegron.,increase,risk
Isosorbide,Gabapentin enacarbil,Isosorbide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadobenic acid,Isosorbide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadodiamide,Isosorbide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadofosveset trisodium,Isosorbide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadopentetic acid,Isosorbide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadoteric acid,Isosorbide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gadoteridol,Isosorbide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ganciclovir,Isosorbide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gemcitabine,Isosorbide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gemfibrozil,Isosorbide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gimeracil,Isosorbide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Glipizide,Isosorbide may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Gluconic Acid,The risk or severity of dehydration can be increased when Isosorbide is combined with Gluconic Acid.,increase,risk
Isosorbide,Glycerin,The risk or severity of dehydration can be increased when Isosorbide is combined with Glycerin.,increase,risk
Isosorbide,Glycerol phenylbutyrate,Isosorbide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Golodirsen,Isosorbide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Goserelin,Isosorbide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Guanethidine,Isosorbide may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Guanfacine,Isosorbide may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Haloperidol,Isosorbide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydralazine,Isosorbide may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydrocodone,The therapeutic efficacy of Isosorbide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Isosorbide,Hydromorphone,Isosorbide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydroxocobalamin,Isosorbide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Hydroxyethyl Starch,Isosorbide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ketamine,Isosorbide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ketazolam,Isosorbide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Isosorbide,Ketoprofen,Isosorbide may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
GTS-21,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with GTS-21.,increase,risk
GTS-21,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with GTS-21.,increase,risk
GTS-21,Gatifloxacin,The metabolism of GTS-21 can be decreased when combined with Gatifloxacin.,decrease,no risk
GTS-21,Gemfibrozil,The metabolism of GTS-21 can be decreased when combined with Gemfibrozil.,decrease,no risk
GTS-21,Gemifloxacin,The metabolism of GTS-21 can be decreased when combined with Gemifloxacin.,decrease,no risk
GTS-21,Gentamicin,The therapeutic efficacy of GTS-21 can be decreased when used in combination with Gentamicin.,decrease,no risk
GTS-21,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with GTS-21.,increase,risk
GTS-21,Givosiran,The serum concentration of GTS-21 can be increased when it is combined with Givosiran.,increase,no risk
GTS-21,Glofitamab,The serum concentration of GTS-21 can be increased when it is combined with Glofitamab.,increase,no risk
GTS-21,Golimumab,The metabolism of GTS-21 can be increased when combined with Golimumab.,increase,no risk
GTS-21,Grepafloxacin,The metabolism of GTS-21 can be decreased when combined with Grepafloxacin.,decrease,no risk
GTS-21,Guanabenz,The metabolism of GTS-21 can be decreased when combined with Guanabenz.,decrease,no risk
GTS-21,Haloperidol,The metabolism of GTS-21 can be decreased when combined with Haloperidol.,decrease,no risk
GTS-21,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with GTS-21.,increase,risk
GTS-21,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with GTS-21.,increase,risk
GTS-21,Kanamycin,The therapeutic efficacy of GTS-21 can be decreased when used in combination with Kanamycin.,decrease,no risk
GTS-21,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with GTS-21.,increase,risk
GTS-21,Ketoconazole,The metabolism of GTS-21 can be decreased when combined with Ketoconazole.,decrease,no risk
GTS-21,Obeticholic acid,The metabolism of GTS-21 can be decreased when combined with Obeticholic acid.,decrease,no risk
GTS-21,Olanzapine,The metabolism of GTS-21 can be decreased when combined with Olanzapine.,decrease,no risk
GTS-21,Ondansetron,The metabolism of GTS-21 can be decreased when combined with Ondansetron.,decrease,no risk
GTS-21,Orphenadrine,The metabolism of GTS-21 can be decreased when combined with Orphenadrine.,decrease,no risk
GTS-21,Osilodrostat,The metabolism of GTS-21 can be decreased when combined with Osilodrostat.,decrease,no risk
GTS-21,Osimertinib,The serum concentration of GTS-21 can be decreased when it is combined with Osimertinib.,decrease,no risk
GTS-21,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with GTS-21.,increase,risk
GTS-21,Oxtriphylline,The metabolism of GTS-21 can be decreased when combined with Oxtriphylline.,decrease,no risk
GTS-21,Quinidine,The metabolism of GTS-21 can be decreased when combined with Quinidine.,decrease,no risk
GTS-21,Quinine,The metabolism of GTS-21 can be decreased when combined with Quinine.,decrease,no risk
GTS-21,Valproic acid,The metabolism of GTS-21 can be decreased when combined with Valproic acid.,decrease,no risk
GTS-21,Vemurafenib,The serum concentration of GTS-21 can be increased when it is combined with Vemurafenib.,increase,no risk
GTS-21,Verapamil,The metabolism of GTS-21 can be decreased when combined with Verapamil.,decrease,no risk
GTS-21,Viloxazine,The metabolism of GTS-21 can be decreased when combined with Viloxazine.,decrease,no risk
GTS-21,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with GTS-21.,decrease,no risk
GTS-21,Warfarin,The metabolism of GTS-21 can be decreased when combined with Warfarin.,decrease,no risk
GTS-21,Zileuton,The metabolism of GTS-21 can be decreased when combined with Zileuton.,decrease,no risk
GTS-21,Zolmitriptan,The metabolism of GTS-21 can be decreased when combined with Zolmitriptan.,decrease,no risk
GTS-21,Zolpidem,The metabolism of GTS-21 can be decreased when combined with Zolpidem.,decrease,no risk
GTS-21,Zotepine,The metabolism of Zotepine can be decreased when combined with GTS-21.,decrease,no risk
Meclocycline,Benzocaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Benzocaine.,increase,risk
Meclocycline,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Benzyl alcohol.,increase,risk
Meclocycline,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Bupivacaine.,increase,risk
Meclocycline,Butacaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Butacaine.,increase,risk
Meclocycline,Butamben,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Butamben.,increase,risk
Meclocycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Oxetacaine.,increase,risk
Meclocycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Meclocycline is combined with Oxybuprocaine.,increase,risk
Meclocycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Meclocycline.,decrease,no risk
Gantacurium,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Gantacurium.,increase,risk
Gantacurium,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gantacurium is combined with Gabapentin enacarbil.,increase,risk
Gantacurium,Galantamine,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Galantamine.,decrease,no risk
Gantacurium,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Gantacurium.,increase,risk
Gantacurium,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gantacurium is combined with Ganaxolone.",increase,risk
Gantacurium,Gepirone,The risk or severity of CNS depression can be increased when Gantacurium is combined with Gepirone.,increase,risk
Gantacurium,Ginkgo biloba,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Gantacurium,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Gantacurium.,increase,risk
Gantacurium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Gantacurium.,decrease,no risk
Gantacurium,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Gantacurium.,increase,risk
Gantacurium,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Gantacurium.,increase,risk
Gantacurium,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Gantacurium.,increase,risk
Gantacurium,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Gantacurium.,increase,risk
Gantacurium,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Gantacurium.,increase,risk
Gantacurium,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Gantacurium.,increase,risk
Gantacurium,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gantacurium.,increase,risk
Gantacurium,Hexocyclium,The risk or severity of adverse effects can be increased when Gantacurium is combined with Hexocyclium.,increase,risk
Gantacurium,Homatropine,The risk or severity of adverse effects can be increased when Gantacurium is combined with Homatropine.,increase,risk
Gantacurium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Gantacurium.,increase,risk
Gantacurium,Huperzine A,The therapeutic efficacy of Gantacurium can be decreased when used in combination with Huperzine A.,decrease,no risk
Gantacurium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Gantacurium.,increase,no risk
Gantacurium,Hydrocodone,Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Gantacurium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Gantacurium.,increase,no risk
Gantacurium,Hydromorphone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Hydromorphone.,increase,risk
Gantacurium,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gantacurium.,increase,no risk
Gantacurium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Gantacurium.,increase,risk
Gantacurium,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Gantacurium.,increase,risk
Gantacurium,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Gantacurium.,increase,risk
Gantacurium,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gantacurium.,increase,risk
Gantacurium,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Gantacurium is combined with Oliceridine.",increase,risk
Gantacurium,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gantacurium.,increase,risk
Gantacurium,Opium,The risk or severity of adverse effects can be increased when Gantacurium is combined with Opium.,increase,risk
Gantacurium,Orphenadrine,Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Gantacurium,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gantacurium.,increase,risk
Gantacurium,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Gantacurium.,increase,risk
Gantacurium,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Gantacurium.,increase,risk
Gantacurium,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Gantacurium.,increase,risk
Gantacurium,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Gantacurium.,increase,risk
Gantacurium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Gantacurium.,increase,risk
Gantacurium,Oxycodone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Oxycodone.,increase,risk
Gantacurium,Oxymorphone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Oxymorphone.,increase,risk
Gantacurium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Gantacurium.,increase,risk
Gantacurium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Gantacurium.,decrease,no risk
Gantacurium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Gantacurium.,increase,risk
Gantacurium,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Gantacurium.,increase,risk
Gantacurium,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Gantacurium.,increase,risk
Gantacurium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Gantacurium.,increase,no risk
Gantacurium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Gantacurium.,increase,risk
Gantacurium,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Gantacurium.,increase,risk
Gantacurium,Quinupramine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Quinupramine.,increase,risk
Gantacurium,Umeclidinium,The risk or severity of adverse effects can be increased when Gantacurium is combined with Umeclidinium.,increase,risk
Gantacurium,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Gantacurium.,increase,risk
Gantacurium,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gantacurium.,increase,risk
Gantacurium,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Gantacurium.,increase,risk
Gantacurium,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gantacurium.,increase,risk
Gantacurium,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Gantacurium.,increase,risk
Gantacurium,Vilazodone,The risk or severity of CNS depression can be increased when Gantacurium is combined with Vilazodone.,increase,risk
Gantacurium,Viloxazine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Viloxazine.,increase,risk
Gantacurium,Vortioxetine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Vortioxetine.,increase,risk
Gantacurium,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Gantacurium.,increase,risk
Gantacurium,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gantacurium.,increase,risk
Gantacurium,Ziconotide,The risk or severity of CNS depression can be increased when Gantacurium is combined with Ziconotide.,increase,risk
Gantacurium,Zimelidine,The risk or severity of adverse effects can be increased when Gantacurium is combined with Zimelidine.,increase,risk
Gantacurium,Ziprasidone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Ziprasidone.,increase,risk
Gantacurium,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gantacurium.,increase,risk
Gantacurium,Zolpidem,Gantacurium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Gantacurium,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gantacurium.,increase,risk
Gantacurium,Zopiclone,The risk or severity of adverse effects can be increased when Gantacurium is combined with Zopiclone.,increase,risk
Gantacurium,Zotepine,The risk or severity of CNS depression can be increased when Gantacurium is combined with Zotepine.,increase,risk
Gantacurium,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Gantacurium.,increase,risk
Gantacurium,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Gantacurium.,increase,risk
Eliglustat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Eliglustat.,increase,risk
Eliglustat,Galantamine,The metabolism of Galantamine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Eliglustat.,increase,risk
Eliglustat,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Givosiran,The serum concentration of Eliglustat can be increased when it is combined with Givosiran.,increase,no risk
Eliglustat,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Glofitamab,The serum concentration of Eliglustat can be increased when it is combined with Glofitamab.,increase,no risk
Eliglustat,Glyburide,The metabolism of Eliglustat can be decreased when combined with Glyburide.,decrease,no risk
Eliglustat,Glycerol phenylbutyrate,The metabolism of Eliglustat can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Eliglustat,Golimumab,The metabolism of Eliglustat can be increased when combined with Golimumab.,increase,no risk
Eliglustat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Eliglustat.,increase,risk
Eliglustat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Eliglustat.,increase,risk
Eliglustat,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Halofantrine,The metabolism of Eliglustat can be decreased when combined with Halofantrine.,decrease,no risk
Eliglustat,Haloperidol,The metabolism of Eliglustat can be decreased when combined with Haloperidol.,decrease,no risk
Eliglustat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Eliglustat.,increase,risk
Eliglustat,Hydralazine,The metabolism of Eliglustat can be decreased when combined with Hydralazine.,decrease,no risk
Eliglustat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Eliglustat.,increase,risk
Eliglustat,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Hydroxyzine.,increase,risk
Eliglustat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Eliglustat.,increase,risk
Eliglustat,Ketazolam,The metabolism of Eliglustat can be decreased when combined with Ketazolam.,decrease,no risk
Eliglustat,Ketoconazole,The metabolism of Eliglustat can be decreased when combined with Ketoconazole.,decrease,no risk
Eliglustat,Octreotide,The metabolism of Eliglustat can be decreased when combined with Octreotide.,decrease,no risk
Eliglustat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Eliglustat.,increase,risk
Eliglustat,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Olaparib,The metabolism of Eliglustat can be decreased when combined with Olaparib.,decrease,no risk
Eliglustat,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Eliglustat.,increase,risk
Eliglustat,Olutasidenib,The therapeutic efficacy of Eliglustat can be decreased when used in combination with Olutasidenib.,decrease,no risk
Eliglustat,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Omaveloxolone,The serum concentration of Eliglustat can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Eliglustat,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Opium,The metabolism of Opium can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oritavancin,The metabolism of Eliglustat can be decreased when combined with Oritavancin.,decrease,no risk
Eliglustat,Orphenadrine,The metabolism of Eliglustat can be decreased when combined with Orphenadrine.,decrease,no risk
Eliglustat,Osilodrostat,The metabolism of Eliglustat can be decreased when combined with Osilodrostat.,decrease,no risk
Eliglustat,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Ospemifene,The metabolism of Eliglustat can be decreased when combined with Ospemifene.,decrease,no risk
Eliglustat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Eliglustat.,increase,risk
Eliglustat,Oxamniquine,The metabolism of Eliglustat can be decreased when combined with Oxamniquine.,decrease,no risk
Eliglustat,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Eliglustat.,increase,risk
Eliglustat,Oxetacaine,The metabolism of Eliglustat can be decreased when combined with Oxetacaine.,decrease,no risk
Eliglustat,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oxybutynin,The metabolism of Eliglustat can be decreased when combined with Oxybutynin.,decrease,no risk
Eliglustat,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oxymetholone,The metabolism of Eliglustat can be decreased when combined with Oxymetholone.,decrease,no risk
Eliglustat,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Eliglustat.,increase,risk
Eliglustat,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Quinidine,The metabolism of Eliglustat can be decreased when combined with Quinidine.,decrease,no risk
Eliglustat,Quinine,The metabolism of Eliglustat can be decreased when combined with Quinine.,decrease,no risk
Eliglustat,Quinupristin,The metabolism of Eliglustat can be decreased when combined with Quinupristin.,decrease,no risk
Eliglustat,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Vadadustat,The serum concentration of Eliglustat can be increased when it is combined with Vadadustat.,increase,no risk
Eliglustat,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Valproic acid,The metabolism of Eliglustat can be decreased when combined with Valproic acid.,decrease,no risk
Eliglustat,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Eliglustat.,increase,risk
Eliglustat,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Venetoclax,The metabolism of Eliglustat can be decreased when combined with Venetoclax.,decrease,no risk
Eliglustat,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Verapamil,The metabolism of Eliglustat can be decreased when combined with Verapamil.,decrease,no risk
Eliglustat,Vernakalant,The risk or severity of Cardiac Arrhythmia can be increased when Eliglustat is combined with Vernakalant.,increase,risk
Eliglustat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Eliglustat.,increase,risk
Eliglustat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Viloxazine,The metabolism of Eliglustat can be decreased when combined with Viloxazine.,decrease,no risk
Eliglustat,Vinblastine,The metabolism of Eliglustat can be decreased when combined with Vinblastine.,decrease,no risk
Eliglustat,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Vinorelbine,The metabolism of Eliglustat can be decreased when combined with Vinorelbine.,decrease,no risk
Eliglustat,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Voriconazole,The metabolism of Eliglustat can be decreased when combined with Voriconazole.,decrease,no risk
Eliglustat,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Eliglustat.,increase,risk
Eliglustat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Eliglustat.,increase,no risk
Eliglustat,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Zafirlukast,The metabolism of Eliglustat can be decreased when combined with Zafirlukast.,decrease,no risk
Eliglustat,Zimelidine,The metabolism of Eliglustat can be decreased when combined with Zimelidine.,decrease,no risk
Eliglustat,Ziprasidone,The metabolism of Eliglustat can be decreased when combined with Ziprasidone.,decrease,no risk
Eliglustat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Eliglustat.,decrease,no risk
Eliglustat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Eliglustat.,increase,risk
Eliglustat,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Eliglustat.,decrease,no risk
Maxy-G34,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vinblastine.,increase,risk
Maxy-G34,Vincristine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vincristine.,increase,risk
Maxy-G34,Vindesine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vindesine.,increase,risk
Maxy-G34,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vinflunine.,increase,risk
Maxy-G34,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Maxy-G34 is combined with Vinorelbine.,increase,risk
Cixutumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Cixutumumab.,increase,risk
Cixutumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Odesivimab,The risk or severity of adverse effects can be increased when Cixutumumab is combined with Odesivimab.,increase,risk
Cixutumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Cixutumumab.,increase,no risk
Cixutumumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Cixutumumab.,increase,risk
Cixutumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Cixutumumab.,increase,risk
Cixutumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Cixutumumab.,increase,risk
Levosalbutamol,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Bismuth subgallate,Levosalbutamol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bisoprolol,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Levosalbutamol,Bisoxatin,Bisoxatin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bleomycin,Bleomycin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bosentan,Levosalbutamol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Levosalbutamol,Bretylium,Levosalbutamol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Levosalbutamol,Brexpiprazole,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Levosalbutamol,Brivaracetam,Brivaracetam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bromazepam,Bromazepam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Levosalbutamol.,increase,no risk
Levosalbutamol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Levosalbutamol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levosalbutamol,Brompheniramine,The risk or severity of Tachycardia can be increased when Brompheniramine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Bumadizone,The risk or severity of hypertension can be increased when Levosalbutamol is combined with Bumadizone.,increase,risk
Levosalbutamol,Bumetanide,The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Bumetanide.,increase,risk
Levosalbutamol,Bupropion,Bupropion may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Butabarbital,Butabarbital may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Butriptyline,The risk or severity of hypertension can be increased when Butriptyline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Butylscopolamine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadodiamide,Gadodiamide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gadoteridol,Gadoteridol may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Ganciclovir,Ganciclovir may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gemcitabine,Gemcitabine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gemfibrozil,The excretion of Levosalbutamol can be decreased when combined with Gemfibrozil.,decrease,no risk
Levosalbutamol,Gentamicin,Levosalbutamol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Gimeracil,Gimeracil may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Givosiran,Givosiran may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Glecaprevir,The excretion of Levosalbutamol can be decreased when combined with Glecaprevir.,decrease,no risk
Levosalbutamol,Glipizide,Glipizide may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Golodirsen,Levosalbutamol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Goserelin,Goserelin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Guanabenz,Levosalbutamol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Levosalbutamol,Guanadrel,Levosalbutamol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Levosalbutamol,Guanethidine,Levosalbutamol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Levosalbutamol,Guanfacine,Levosalbutamol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Levosalbutamol,Guanoxan,Levosalbutamol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Levosalbutamol,Haloperidol,Haloperidol may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydralazine,Levosalbutamol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Levosalbutamol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Hydrochlorothiazide.,increase,risk
Levosalbutamol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Levosalbutamol is combined with Hydroflumethiazide.,increase,risk
Levosalbutamol,Hydromorphone,Hydromorphone may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Kanamycin,Levosalbutamol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketamine,Ketamine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketazolam,Ketazolam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ketoconazole,The excretion of Levosalbutamol can be decreased when combined with Ketoconazole.,decrease,no risk
Levosalbutamol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Octinoxate,Octinoxate may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Olanzapine,The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Olanzapine.,decrease,no risk
Levosalbutamol,Olmesartan,Levosalbutamol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Levosalbutamol,Olodaterol,The risk or severity of adverse effects can be increased when Olodaterol is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Olsalazine,Olsalazine may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Opium,Opium may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oseltamivir,Oseltamivir may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Ouabain,The excretion of Levosalbutamol can be decreased when combined with Ouabain.,decrease,no risk
Levosalbutamol,Oxacillin,Oxacillin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxazepam,Oxazepam may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Levosalbutamol.,decrease,no risk
Levosalbutamol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxybenzone,Oxybenzone may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.,decrease,no risk
Levosalbutamol,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Levosalbutamol.,increase,risk
Levosalbutamol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Levosalbutamol.,increase,risk
Navitoclax,Benzocaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Benzocaine.,increase,risk
Navitoclax,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Benzyl alcohol.,increase,risk
Navitoclax,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Bupivacaine.,increase,risk
Navitoclax,Butacaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Butacaine.,increase,risk
Navitoclax,Butamben,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Butamben.,increase,risk
Navitoclax,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Oxetacaine.,increase,risk
Navitoclax,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Navitoclax is combined with Oxybuprocaine.,increase,risk
Andrographolide,Gemcitabine,The risk or severity of bleeding can be increased when Andrographolide is combined with Gemcitabine.,increase,risk
Andrographolide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Andrographolide is combined with Gemtuzumab ozogamicin.,increase,risk
Andrographolide,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Glucosamine,Glucosamine may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Andrographolide.,increase,risk
Andrographolide,Heparin,The risk or severity of bleeding can be increased when Andrographolide is combined with Heparin.,increase,risk
Andrographolide,Hydroxyurea,The risk or severity of bleeding can be increased when Andrographolide is combined with Hydroxyurea.,increase,risk
Andrographolide,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Andrographolide.,increase,risk
Andrographolide,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Andrographolide.,increase,risk
Andrographolide,Obeticholic acid,The risk or severity of adverse effects can be increased when Andrographolide is combined with Obeticholic acid.,increase,risk
Andrographolide,Obinutuzumab,The risk or severity of adverse effects can be increased when Andrographolide is combined with Obinutuzumab.,increase,risk
Andrographolide,Olaparib,The risk or severity of bleeding can be increased when Andrographolide is combined with Olaparib.,increase,risk
Andrographolide,Olsalazine,The risk or severity of bleeding can be increased when Andrographolide is combined with Olsalazine.,increase,risk
Andrographolide,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Andrographolide.,increase,risk
Andrographolide,Oxaliplatin,The risk or severity of bleeding can be increased when Andrographolide is combined with Oxaliplatin.,increase,risk
Andrographolide,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Andrographolide.,increase,risk
Andrographolide,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Andrographolide.,increase,risk
Andrographolide,Urokinase,Andrographolide may increase the anticoagulant activities of Urokinase.,increase,no risk
Andrographolide,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Andrographolide is combined with Ursodeoxycholic acid.,increase,risk
Andrographolide,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Andrographolide.,increase,risk
Andrographolide,Venlafaxine,The risk or severity of bleeding can be increased when Andrographolide is combined with Venlafaxine.,increase,risk
Andrographolide,Vinblastine,The risk or severity of bleeding can be increased when Andrographolide is combined with Vinblastine.,increase,risk
Andrographolide,Vindesine,The risk or severity of bleeding can be increased when Andrographolide is combined with Vindesine.,increase,risk
Andrographolide,Vinorelbine,The risk or severity of bleeding can be increased when Andrographolide is combined with Vinorelbine.,increase,risk
Andrographolide,Vitamin E,Vitamin E may increase the antiplatelet activities of Andrographolide.,increase,no risk
Andrographolide,Vorapaxar,The risk or severity of bleeding can be increased when Andrographolide is combined with Vorapaxar.,increase,risk
Andrographolide,Vorinostat,The risk or severity of bleeding can be increased when Andrographolide is combined with Vorinostat.,increase,risk
Andrographolide,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Andrographolide.,increase,risk
Andrographolide,Warfarin,The risk or severity of bleeding can be increased when Andrographolide is combined with Warfarin.,increase,risk
Andrographolide,Ximelagatran,The risk or severity of bleeding can be increased when Andrographolide is combined with Ximelagatran.,increase,risk
Andrographolide,Zidovudine,The risk or severity of bleeding can be increased when Andrographolide is combined with Zidovudine.,increase,risk
Andrographolide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Andrographolide.,increase,risk
Trastuzumab emtansine,Berotralstat,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Berotralstat.,increase,no risk
Trastuzumab emtansine,Besilesomab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Besilesomab.,increase,risk
Trastuzumab emtansine,Betamethasone,The metabolism of Trastuzumab emtansine can be increased when combined with Betamethasone.,increase,no risk
Trastuzumab emtansine,Betamethasone phosphate,The metabolism of Trastuzumab emtansine can be increased when combined with Betamethasone phosphate.,increase,no risk
Trastuzumab emtansine,Betrixaban,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Betrixaban.,increase,no risk
Trastuzumab emtansine,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Bexarotene,The metabolism of Trastuzumab emtansine can be increased when combined with Bexarotene.,increase,no risk
Trastuzumab emtansine,Bezlotoxumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Bezlotoxumab.,increase,risk
Trastuzumab emtansine,Bicalutamide,The metabolism of Trastuzumab emtansine can be decreased when combined with Bicalutamide.,decrease,no risk
Trastuzumab emtansine,Bifonazole,The metabolism of Trastuzumab emtansine can be decreased when combined with Bifonazole.,decrease,no risk
Trastuzumab emtansine,Bimekizumab,The metabolism of Trastuzumab emtansine can be increased when combined with Bimekizumab.,increase,no risk
Trastuzumab emtansine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Trastuzumab emtansine.,increase,no risk
Trastuzumab emtansine,Bisoprolol,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Bisoprolol.,increase,no risk
Trastuzumab emtansine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Blinatumomab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Blinatumomab.,increase,risk
Trastuzumab emtansine,Boceprevir,The metabolism of Trastuzumab emtansine can be decreased when combined with Boceprevir.,decrease,no risk
Trastuzumab emtansine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Trastuzumab emtansine.",decrease,no risk
Trastuzumab emtansine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Bosentan,The metabolism of Trastuzumab emtansine can be increased when combined with Bosentan.,increase,no risk
Trastuzumab emtansine,Bosutinib,The metabolism of Trastuzumab emtansine can be decreased when combined with Bosutinib.,decrease,no risk
Trastuzumab emtansine,Brentuximab vedotin,The serum concentration of Trastuzumab emtansine can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Trastuzumab emtansine,Brodalumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Brodalumab.,increase,risk
Trastuzumab emtansine,Brolucizumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Brolucizumab.,increase,risk
Trastuzumab emtansine,Budesonide,The metabolism of Trastuzumab emtansine can be increased when combined with Budesonide.,increase,no risk
Trastuzumab emtansine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Bupivacaine.,increase,risk
Trastuzumab emtansine,Buprenorphine,The metabolism of Trastuzumab emtansine can be decreased when combined with Buprenorphine.,decrease,no risk
Trastuzumab emtansine,Burosumab,The risk or severity of adverse effects can be increased when Trastuzumab emtansine is combined with Burosumab.,increase,risk
Trastuzumab emtansine,Buspirone,The metabolism of Trastuzumab emtansine can be decreased when combined with Buspirone.,decrease,no risk
Trastuzumab emtansine,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Trastuzumab emtansine.,increase,risk
Trastuzumab emtansine,Butacaine,The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Butacaine.,increase,risk
Trastuzumab emtansine,Butalbital,The metabolism of Trastuzumab emtansine can be increased when combined with Butalbital.,increase,no risk
Trastuzumab emtansine,Butamben,The risk or severity of methemoglobinemia can be increased when Trastuzumab emtansine is combined with Butamben.,increase,risk
Necitumumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Necitumumab is combined with Human varicella-zoster immune globulin.,increase,risk
Necitumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Necitumumab.,increase,risk
Necitumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Necitumumab.,increase,risk
Necitumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Ocrelizumab.,increase,risk
Necitumumab,Odesivimab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Odesivimab.,increase,risk
Necitumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Necitumumab.,increase,risk
Necitumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Necitumumab.,increase,risk
Necitumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Necitumumab.,increase,risk
Necitumumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Oxetacaine.,increase,risk
Necitumumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Necitumumab is combined with Oxybuprocaine.,increase,risk
Necitumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Necitumumab.,increase,no risk
Necitumumab,Ublituximab,The risk or severity of adverse effects can be increased when Necitumumab is combined with Ublituximab.,increase,risk
Necitumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Necitumumab.,increase,risk
Necitumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Necitumumab.,increase,risk
Oglufanide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Benzocaine.,increase,risk
Oglufanide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Benzyl alcohol.,increase,risk
Oglufanide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Bupivacaine.,increase,risk
Oglufanide,Butacaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Butacaine.,increase,risk
Oglufanide,Butamben,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Butamben.,increase,risk
Oglufanide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Oxetacaine.,increase,risk
Oglufanide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oglufanide is combined with Oxybuprocaine.,increase,risk
Irofulven,Benzocaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Benzocaine.,increase,risk
Irofulven,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Benzyl alcohol.,increase,risk
Irofulven,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Bupivacaine.,increase,risk
Irofulven,Butacaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Butacaine.,increase,risk
Irofulven,Butamben,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Butamben.,increase,risk
Irofulven,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Oxetacaine.,increase,risk
Irofulven,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Irofulven is combined with Oxybuprocaine.,increase,risk
PRO-542,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with PRO-542.,increase,risk
PRO-542,Obinutuzumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Obinutuzumab.,increase,risk
PRO-542,Ocrelizumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Ocrelizumab.,increase,risk
PRO-542,Odesivimab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Odesivimab.,increase,risk
PRO-542,Ofatumumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Ofatumumab.,increase,risk
PRO-542,Olaratumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Olaratumab.,increase,risk
PRO-542,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with PRO-542.,increase,risk
PRO-542,Quinestrol,Quinestrol may increase the thrombogenic activities of PRO-542.,increase,no risk
PRO-542,Ublituximab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Ublituximab.,increase,risk
PRO-542,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with PRO-542.,increase,risk
PRO-542,Vedolizumab,The risk or severity of adverse effects can be increased when PRO-542 is combined with Vedolizumab.,increase,risk
Solriamfetol,Betaxolol,Solriamfetol may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Solriamfetol,Bethanidine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Bethanidine.,increase,risk
Solriamfetol,Bicisate,Bicisate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bictegravir,The excretion of Solriamfetol can be decreased when combined with Bictegravir.,decrease,no risk
Solriamfetol,Biperiden,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Biperiden.,increase,risk
Solriamfetol,Bismuth subgallate,Bismuth subgallate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bisoprolol,Solriamfetol may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Solriamfetol,Bisoxatin,Bisoxatin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bleomycin,Bleomycin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bosentan,Solriamfetol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Solriamfetol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Solriamfetol.,increase,risk
Solriamfetol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Solriamfetol.,increase,risk
Solriamfetol,Bretylium,Solriamfetol may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Solriamfetol,Brexanolone,The risk or severity of CNS depression can be increased when Brexanolone is combined with Solriamfetol.,increase,risk
Solriamfetol,Brexpiprazole,The risk or severity of hypertension can be increased when Solriamfetol is combined with Brexpiprazole.,increase,risk
Solriamfetol,Brigatinib,The excretion of Solriamfetol can be decreased when combined with Brigatinib.,decrease,no risk
Solriamfetol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Solriamfetol.,increase,no risk
Solriamfetol,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Solriamfetol.,increase,risk
Solriamfetol,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Bromocriptine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Bromocriptine.,increase,risk
Solriamfetol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Bromperidol,The risk or severity of CNS depression can be increased when Bromperidol is combined with Solriamfetol.,increase,risk
Solriamfetol,Brompheniramine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Brompheniramine.,increase,risk
Solriamfetol,Buclizine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Buclizine.,increase,risk
Solriamfetol,Budesonide,Budesonide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Bumadizone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Bumadizone.,increase,risk
Solriamfetol,Bumetanide,Bumetanide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Solriamfetol.,increase,risk
Solriamfetol,Buprenorphine,Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Solriamfetol,Bupropion,The excretion of Solriamfetol can be decreased when combined with Bupropion.,decrease,no risk
Solriamfetol,Buspirone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Buspirone.,increase,risk
Solriamfetol,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Solriamfetol.,increase,risk
Solriamfetol,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Solriamfetol.,increase,risk
Solriamfetol,Butaperazine,The risk or severity of CNS depression can be increased when Butaperazine is combined with Solriamfetol.,increase,risk
Solriamfetol,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Solriamfetol.,increase,risk
Solriamfetol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Solriamfetol.,increase,risk
Solriamfetol,Butriptyline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Butriptyline.,increase,risk
Solriamfetol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Butylscopolamine.,increase,risk
Solriamfetol,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Solriamfetol.,increase,risk
Solriamfetol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Solriamfetol.,increase,risk
Solriamfetol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadodiamide,Gadodiamide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gadoteridol,Gadoteridol may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Gallamine triethiodide.,increase,risk
Solriamfetol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Solriamfetol is combined with Ganaxolone.",increase,risk
Solriamfetol,Ganciclovir,Ganciclovir may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gemcitabine,Gemcitabine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gentamicin,Solriamfetol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Gepirone,The risk or severity of CNS depression can be increased when Gepirone is combined with Solriamfetol.,increase,risk
Solriamfetol,Gilteritinib,The excretion of Solriamfetol can be decreased when combined with Gilteritinib.,decrease,no risk
Solriamfetol,Gimeracil,Gimeracil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Givosiran,Givosiran may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Glasdegib,The excretion of Solriamfetol can be decreased when combined with Glasdegib.,decrease,no risk
Solriamfetol,Glipizide,Glipizide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Solriamfetol.,increase,risk
Solriamfetol,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Glycopyrronium.,increase,risk
Solriamfetol,Golodirsen,Solriamfetol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Solriamfetol,Goserelin,Goserelin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Solriamfetol.,increase,risk
Solriamfetol,Grepafloxacin,The serum concentration of Solriamfetol can be increased when it is combined with Grepafloxacin.,increase,no risk
Solriamfetol,Guanabenz,The risk or severity of hypertension can be increased when Solriamfetol is combined with Guanabenz.,increase,risk
Solriamfetol,Guanadrel,Solriamfetol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Solriamfetol,Guanethidine,Solriamfetol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Solriamfetol,Guanfacine,The risk or severity of hypertension can be increased when Solriamfetol is combined with Guanfacine.,increase,risk
Solriamfetol,Guanidine,The serum concentration of Solriamfetol can be increased when it is combined with Guanidine.,increase,no risk
Solriamfetol,Guanoxan,Solriamfetol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Solriamfetol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Solriamfetol.,increase,risk
Solriamfetol,Halothane,The risk or severity of hypertension can be increased when Solriamfetol is combined with Halothane.,increase,risk
Solriamfetol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Solriamfetol.,increase,risk
Solriamfetol,Hexocyclium,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Hexocyclium.,increase,risk
Solriamfetol,Histamine,The serum concentration of Solriamfetol can be increased when it is combined with Histamine.,increase,no risk
Solriamfetol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Homatropine methylbromide.,increase,risk
Solriamfetol,Hydralazine,Solriamfetol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Solriamfetol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Hydrocodone,Solriamfetol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Solriamfetol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solriamfetol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Solriamfetol.,increase,risk
Solriamfetol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Solriamfetol.,increase,no risk
Solriamfetol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Hyoscyamine.,increase,risk
Solriamfetol,Kanamycin,Solriamfetol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Solriamfetol,Ketamine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Ketamine.,increase,risk
Solriamfetol,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Solriamfetol.,increase,risk
Solriamfetol,Ketoprofen,The risk or severity of hypertension can be increased when Solriamfetol is combined with Ketoprofen.,increase,risk
Solriamfetol,Ketorolac,The risk or severity of hypertension can be increased when Solriamfetol is combined with Ketorolac.,increase,risk
Solriamfetol,Octinoxate,Octinoxate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Olanzapine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Olanzapine.,increase,risk
Solriamfetol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Solriamfetol is combined with Oliceridine.",increase,risk
Solriamfetol,Olmesartan,Solriamfetol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Solriamfetol,Olodaterol,The risk or severity of hypertension can be increased when Solriamfetol is combined with Olodaterol.,increase,risk
Solriamfetol,Olsalazine,Olsalazine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Solriamfetol.,increase,risk
Solriamfetol,Opium,The risk or severity of CNS depression can be increased when Opium is combined with Solriamfetol.,increase,risk
Solriamfetol,Orciprenaline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Orciprenaline.,increase,risk
Solriamfetol,Orphenadrine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Orphenadrine.,increase,risk
Solriamfetol,Oseltamivir,Oseltamivir may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Oxacillin,Oxacillin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Oxaprozin,The risk or severity of hypertension can be increased when Solriamfetol is combined with Oxaprozin.,increase,risk
Solriamfetol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxybenzone,Oxybenzone may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
Solriamfetol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxybutynin,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxybutynin.,increase,risk
Solriamfetol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxymetazoline,The risk or severity of hypertension can be increased when Solriamfetol is combined with Oxymetazoline.,increase,risk
Solriamfetol,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Solriamfetol.,increase,risk
Solriamfetol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Solriamfetol is combined with Oxyphenbutazone.,increase,risk
Solriamfetol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxyphencyclimine.,increase,risk
Solriamfetol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Oxyphenonium.,increase,risk
Solriamfetol,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Solriamfetol which could result in a higher serum level.,decrease,no risk
TNX-901,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with TNX-901.,increase,risk
TNX-901,Obinutuzumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Obinutuzumab.,increase,risk
TNX-901,Ocrelizumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Ocrelizumab.,increase,risk
TNX-901,Odesivimab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Odesivimab.,increase,risk
TNX-901,Ofatumumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Ofatumumab.,increase,risk
TNX-901,Olaratumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Olaratumab.,increase,risk
TNX-901,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with TNX-901.,increase,risk
TNX-901,Quinestrol,Quinestrol may increase the thrombogenic activities of TNX-901.,increase,no risk
TNX-901,Ublituximab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Ublituximab.,increase,risk
TNX-901,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with TNX-901.,increase,risk
TNX-901,Vedolizumab,The risk or severity of adverse effects can be increased when TNX-901 is combined with Vedolizumab.,increase,risk
Vedolizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Galcanezumab.,increase,risk
Vedolizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vedolizumab.,increase,risk
Vedolizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vedolizumab.,increase,risk
Vedolizumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Vedolizumab.,increase,risk
Vedolizumab,Glofitamab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Glofitamab.,increase,risk
Vedolizumab,Golimumab,The risk or severity of infection can be increased when Golimumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Guselkumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Guselkumab.,increase,risk
Vedolizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Vedolizumab.,increase,risk
Vedolizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Vedolizumab.,increase,risk
Vedolizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Vedolizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vedolizumab.,increase,risk
Vedolizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Human Rho(D) immune globulin.,increase,risk
Vedolizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Vedolizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone acetate.,increase,risk
Vedolizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone butyrate.,increase,risk
Vedolizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Hydrocortisone succinate.,increase,risk
Vedolizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Vedolizumab.,increase,risk
Vedolizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vedolizumab.,increase,risk
Vedolizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Vedolizumab.,increase,risk
Vedolizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Vedolizumab.,increase,no risk
Vedolizumab,Odesivimab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Odesivimab.,increase,risk
Vedolizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Olaparib,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Olaparib.,increase,risk
Vedolizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Vedolizumab.,increase,risk
Vedolizumab,Ozanimod,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Ozanimod.,increase,risk
Vedolizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Vedolizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Vedolizumab.,increase,risk
Vedolizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Upadacitinib.,increase,risk
Vedolizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Vedolizumab.,increase,risk
Vedolizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Vedolizumab.,increase,risk
Vedolizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vedolizumab,Vilanterol,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Vilanterol.,increase,risk
Vedolizumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Vedolizumab.,increase,risk
Vedolizumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Vedolizumab.,increase,risk
Vedolizumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Vedolizumab.,increase,risk
Vedolizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Vedolizumab.,increase,risk
Vedolizumab,Voclosporin,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Voclosporin.,increase,risk
Vedolizumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Vedolizumab.,increase,risk
Vedolizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Vedolizumab.,increase,risk
Vedolizumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Vedolizumab.,increase,risk
Prasterone sulfate,Glimepiride,Glimepiride may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Glipizide,Glipizide may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Glyburide,Glyburide may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Glycyrrhizic acid,Prasterone sulfate may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Golimumab,The metabolism of Prasterone sulfate can be increased when combined with Golimumab.,increase,no risk
Prasterone sulfate,Haloperidol,The metabolism of Prasterone sulfate can be decreased when combined with Haloperidol.,decrease,no risk
Prasterone sulfate,Hydrocortisone,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone.,increase,risk
Prasterone sulfate,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone acetate.,increase,risk
Prasterone sulfate,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone butyrate.,increase,risk
Prasterone sulfate,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone cypionate.,increase,risk
Prasterone sulfate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Prasterone sulfate.,decrease,no risk
Prasterone sulfate,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Hydrocortisone succinate.,increase,risk
Prasterone sulfate,Ketoconazole,The metabolism of Prasterone sulfate can be decreased when combined with Ketoconazole.,decrease,no risk
Prasterone sulfate,Ofloxacin,Ofloxacin may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Olmesartan,Olmesartan may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Ondansetron,The metabolism of Prasterone sulfate can be decreased when combined with Ondansetron.,decrease,no risk
Prasterone sulfate,Quetiapine,The metabolism of Prasterone sulfate can be decreased when combined with Quetiapine.,decrease,no risk
Prasterone sulfate,Quinidine,The metabolism of Quinidine can be decreased when combined with Prasterone sulfate.,decrease,no risk
Prasterone sulfate,Quinine,The metabolism of Prasterone sulfate can be decreased when combined with Quinine.,decrease,no risk
Prasterone sulfate,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Vamorolone,The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Vamorolone.,increase,risk
Prasterone sulfate,Vinblastine,Vinblastine may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.,decrease,no risk
Prasterone sulfate,Vincristine,The metabolism of Vincristine can be decreased when combined with Prasterone sulfate.,decrease,no risk
Prasterone sulfate,Voriconazole,The metabolism of Prasterone sulfate can be decreased when combined with Voriconazole.,decrease,no risk
Prasterone sulfate,Zaleplon,The metabolism of Prasterone sulfate can be decreased when combined with Zaleplon.,decrease,no risk
Abiraterone,Galantamine,The metabolism of Galantamine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Glofitamab,The serum concentration of Abiraterone can be increased when it is combined with Glofitamab.,increase,no risk
Abiraterone,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Guanabenz,The serum concentration of Guanabenz can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ketamine,The metabolism of Ketamine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ketoconazole,The metabolism of Abiraterone can be decreased when combined with Ketoconazole.,decrease,no risk
Abiraterone,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Omaveloxolone,The serum concentration of Abiraterone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Abiraterone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Opium,The metabolism of Opium can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Oxetacaine.,increase,risk
Abiraterone,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Abiraterone is combined with Oxybuprocaine.,increase,risk
Abiraterone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Quinine,The serum concentration of Quinine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Vadadustat,The serum concentration of Abiraterone can be increased when it is combined with Vadadustat.,increase,no risk
Abiraterone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Venetoclax,The metabolism of Abiraterone can be decreased when combined with Venetoclax.,decrease,no risk
Abiraterone,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Viloxazine,The metabolism of Abiraterone can be decreased when combined with Viloxazine.,decrease,no risk
Abiraterone,Voriconazole,The metabolism of Abiraterone can be decreased when combined with Voriconazole.,decrease,no risk
Abiraterone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zimelidine,The metabolism of Abiraterone can be decreased when combined with Zimelidine.,decrease,no risk
Abiraterone,Ziprasidone,The metabolism of Abiraterone can be decreased when combined with Ziprasidone.,decrease,no risk
Abiraterone,Zolmitriptan,The serum concentration of Zolmitriptan can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Abiraterone.,decrease,no risk
Abiraterone,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Abiraterone.,increase,no risk
Abiraterone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Abiraterone.,decrease,no risk
GPI-1485,Olaparib,The serum concentration of Olaparib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Quinidine,The serum concentration of Quinidine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vardenafil,The metabolism of Vardenafil can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vincristine,The serum concentration of Vincristine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vindesine,The serum concentration of Vindesine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Warfarin,The serum concentration of Warfarin can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with GPI-1485.,increase,no risk
GPI-1485,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Zopiclone,The metabolism of Zopiclone can be decreased when combined with GPI-1485.,decrease,no risk
GPI-1485,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with GPI-1485.,decrease,no risk
Apomorphine,Bosentan,Apomorphine may increase the hypotensive activities of Bosentan.,increase,no risk
Apomorphine,Bosutinib,The metabolism of Apomorphine can be decreased when combined with Bosutinib.,decrease,no risk
Apomorphine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Apomorphine.,increase,risk
Apomorphine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Apomorphine.,increase,risk
Apomorphine,Bretylium,The risk or severity of adverse effects can be increased when Apomorphine is combined with Bretylium.,increase,risk
Apomorphine,Brexanolone,The risk or severity of CNS depression can be increased when Apomorphine is combined with Brexanolone.,increase,risk
Apomorphine,Brexpiprazole,The risk or severity of adverse effects can be decreased when Apomorphine is combined with Brexpiprazole.,decrease,risk
Apomorphine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Apomorphine.,increase,no risk
Apomorphine,Brivaracetam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Brivaracetam.,increase,risk
Apomorphine,Bromazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Bromazepam.,increase,risk
Apomorphine,Bromocriptine,The risk or severity of adverse effects can be decreased when Apomorphine is combined with Bromocriptine.,decrease,risk
Apomorphine,Bromperidol,The risk or severity of CNS depression can be increased when Apomorphine is combined with Bromperidol.,increase,risk
Apomorphine,Brompheniramine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Brompheniramine.,increase,risk
Apomorphine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Apomorphine.,increase,risk
Apomorphine,Budesonide,The metabolism of Apomorphine can be increased when combined with Budesonide.,increase,no risk
Apomorphine,Bumetanide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Bumetanide.,increase,risk
Apomorphine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Apomorphine.,increase,risk
Apomorphine,Buprenorphine,Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Apomorphine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Apomorphine.,increase,risk
Apomorphine,Buserelin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Buserelin.,increase,risk
Apomorphine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Apomorphine.,increase,risk
Apomorphine,Butabarbital,Butabarbital may increase the hypotensive activities of Apomorphine.,increase,no risk
Apomorphine,Butalbital,Butalbital may increase the hypotensive activities of Apomorphine.,increase,no risk
Apomorphine,Butaperazine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Butaperazine.,increase,risk
Apomorphine,Butobarbital,The risk or severity of CNS depression can be increased when Apomorphine is combined with Butobarbital.,increase,risk
Apomorphine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Apomorphine.,increase,risk
Apomorphine,Butriptyline,The risk or severity of CNS depression can be increased when Apomorphine is combined with Butriptyline.,increase,risk
Apomorphine,Gabapentin,The risk or severity of CNS depression can be increased when Apomorphine is combined with Gabapentin.,increase,risk
Apomorphine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Apomorphine is combined with Gabapentin enacarbil.,increase,risk
Apomorphine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gadobenic acid.,increase,risk
Apomorphine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Apomorphine.,increase,risk
Apomorphine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Apomorphine.,increase,risk
Apomorphine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Apomorphine is combined with Ganaxolone.",increase,risk
Apomorphine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gatifloxacin.,increase,risk
Apomorphine,Gefitinib,The metabolism of Apomorphine can be decreased when combined with Gefitinib.,decrease,no risk
Apomorphine,Gemfibrozil,The metabolism of Apomorphine can be decreased when combined with Gemfibrozil.,decrease,no risk
Apomorphine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Gemifloxacin.,increase,risk
Apomorphine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Apomorphine.,increase,risk
Apomorphine,Gilteritinib,The therapeutic efficacy of Apomorphine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Apomorphine,Glasdegib,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Glasdegib.,increase,risk
Apomorphine,Glutethimide,The risk or severity of CNS depression can be increased when Apomorphine is combined with Glutethimide.,increase,risk
Apomorphine,Glyburide,The metabolism of Glyburide can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Golimumab,The metabolism of Apomorphine can be increased when combined with Golimumab.,increase,no risk
Apomorphine,Goserelin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Goserelin.,increase,risk
Apomorphine,Granisetron,The risk or severity of hypotension can be increased when Granisetron is combined with Apomorphine.,increase,risk
Apomorphine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Grepafloxacin.,increase,risk
Apomorphine,Guanabenz,Apomorphine may increase the hypotensive activities of Guanabenz.,increase,no risk
Apomorphine,Guanadrel,Apomorphine may increase the hypotensive activities of Guanadrel.,increase,no risk
Apomorphine,Guanethidine,Apomorphine may increase the hypotensive activities of Guanethidine.,increase,no risk
Apomorphine,Guanfacine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Guanfacine.,increase,risk
Apomorphine,Guanoxan,Apomorphine may increase the hypotensive activities of Guanoxan.,increase,no risk
Apomorphine,Halazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Halazepam.,increase,risk
Apomorphine,Halofantrine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Halofantrine.,increase,risk
Apomorphine,Haloperidol,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Haloperidol.,increase,risk
Apomorphine,Halothane,The risk or severity of CNS depression can be increased when Apomorphine is combined with Halothane.,increase,risk
Apomorphine,Hexafluronium,The risk or severity of CNS depression can be increased when Apomorphine is combined with Hexafluronium.,increase,risk
Apomorphine,Histrelin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Histrelin.,increase,risk
Apomorphine,Hydralazine,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydralazine.,increase,risk
Apomorphine,Hydrochlorothiazide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydrochlorothiazide.,increase,risk
Apomorphine,Hydrocodone,Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Apomorphine,Hydrocortisone,The metabolism of Apomorphine can be increased when combined with Hydrocortisone.,increase,no risk
Apomorphine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Apomorphine is combined with Hydroflumethiazide.,increase,risk
Apomorphine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Apomorphine.,increase,risk
Apomorphine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Hydroxyzine.,increase,risk
Apomorphine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Apomorphine.,increase,risk
Apomorphine,Ketamine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Ketamine.,increase,risk
Apomorphine,Ketazolam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Ketazolam.,increase,risk
Apomorphine,Ketoconazole,The metabolism of Apomorphine can be decreased when combined with Ketoconazole.,decrease,no risk
Apomorphine,Ketoprofen,The metabolism of Apomorphine can be decreased when combined with Ketoprofen.,decrease,no risk
Apomorphine,Ketorolac,The metabolism of Apomorphine can be decreased when combined with Ketorolac.,decrease,no risk
Apomorphine,Obinutuzumab,The risk or severity of adverse effects can be increased when Apomorphine is combined with Obinutuzumab.,increase,risk
Apomorphine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Apomorphine.,increase,risk
Apomorphine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Ofloxacin.,increase,risk
Apomorphine,Olanzapine,The therapeutic efficacy of Apomorphine can be decreased when used in combination with Olanzapine.,decrease,no risk
Apomorphine,Olaparib,The metabolism of Olaparib can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Apomorphine is combined with Oliceridine.",increase,risk
Apomorphine,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Apomorphine.,increase,risk
Apomorphine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Omaveloxolone,The serum concentration of Apomorphine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Apomorphine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Apomorphine.,increase,risk
Apomorphine,Opicapone,The metabolism of Apomorphine can be decreased when combined with Opicapone.,decrease,no risk
Apomorphine,Opium,The risk or severity of CNS depression can be increased when Apomorphine is combined with Opium.,increase,risk
Apomorphine,Orphenadrine,Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Apomorphine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Apomorphine.,increase,risk
Apomorphine,Oxatomide,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Oxatomide.,increase,risk
Apomorphine,Oxazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxazepam.,increase,risk
Apomorphine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxcarbazepine.,increase,risk
Apomorphine,Oxitriptan,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxitriptan.,increase,risk
Apomorphine,Oxprenolol,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxprenolol.,increase,risk
Apomorphine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxybuprocaine.,increase,risk
Apomorphine,Oxybutynin,The metabolism of Apomorphine can be decreased when combined with Oxybutynin.,decrease,no risk
Apomorphine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Apomorphine.,increase,risk
Apomorphine,Oxymorphone,The risk or severity of CNS depression can be increased when Apomorphine is combined with Oxymorphone.,increase,risk
Apomorphine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Apomorphine.,increase,risk
Apomorphine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Apomorphine.,decrease,no risk
Apomorphine,Quazepam,The risk or severity of CNS depression can be increased when Apomorphine is combined with Quazepam.,increase,risk
Apomorphine,Quetiapine,The therapeutic efficacy of Apomorphine can be decreased when used in combination with Quetiapine.,decrease,no risk
Apomorphine,Quinagolide,The risk or severity of adverse effects can be decreased when Apomorphine is combined with Quinagolide.,decrease,risk
Apomorphine,Quinapril,The risk or severity of adverse effects can be increased when Apomorphine is combined with Quinapril.,increase,risk
Apomorphine,Quinidine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quinidine.,increase,risk
Apomorphine,Quinine,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quinine.,increase,risk
Apomorphine,Quinupramine,The risk or severity of CNS depression can be increased when Apomorphine is combined with Quinupramine.,increase,risk
Apomorphine,Quizartinib,The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Quizartinib.,increase,risk
Nitroaspirin,Benzydamine,The risk or severity of adverse effects can be increased when Benzydamine is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Bepotastine,Nitroaspirin may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Betaxolol,Nitroaspirin may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Nitroaspirin,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Betulinic Acid,The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Betulinic Acid.,increase,risk
Nitroaspirin,Bexagliflozin,Nitroaspirin may increase the hypoglycemic activities of Bexagliflozin.,increase,no risk
Nitroaspirin,Bexarotene,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bexarotene.,increase,risk
Nitroaspirin,Bicisate,Nitroaspirin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Bismuth subgallate,Nitroaspirin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bismuth subsalicylate,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Bismuth subsalicylate is combined with Nitroaspirin.",increase,risk
Nitroaspirin,Bisoprolol,Nitroaspirin may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Nitroaspirin,Bisoxatin,Nitroaspirin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Nitroaspirin is combined with Bivalirudin.,increase,risk
Nitroaspirin,Bleomycin,Nitroaspirin may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Blinatumomab,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Blinatumomab.,increase,risk
Nitroaspirin,Bortezomib,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bortezomib.,increase,risk
Nitroaspirin,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Bosutinib,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Bosutinib.,increase,risk
Nitroaspirin,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Brexpiprazole,The risk or severity of hypertension can be increased when Brexpiprazole is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Brinzolamide,The risk or severity of electrolyte abnormality can be increased when Brinzolamide is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Brivaracetam,Nitroaspirin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bromazepam,Nitroaspirin may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Bromfenac,The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Bromfenac.,decrease,no risk
Nitroaspirin,Bromocriptine,Nitroaspirin may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Nitroaspirin,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Bufexamac,The therapeutic efficacy of Nitroaspirin can be decreased when used in combination with Bufexamac.,decrease,no risk
Nitroaspirin,Bumadizone,The risk or severity of adverse effects can be increased when Nitroaspirin is combined with Bumadizone.,increase,risk
Nitroaspirin,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Bupropion,Nitroaspirin may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Busulfan,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Busulfan.,increase,risk
Nitroaspirin,Butabarbital,Nitroaspirin may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Gabapentin enacarbil,Nitroaspirin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadobenic acid,Nitroaspirin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadodiamide,Nitroaspirin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadofosveset trisodium,Nitroaspirin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadopentetic acid,Nitroaspirin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadoteric acid,Nitroaspirin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gadoteridol,Nitroaspirin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ganciclovir,Nitroaspirin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gatifloxacin,Nitroaspirin may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Nitroaspirin,Gemcitabine,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Gemcitabine.,increase,risk
Nitroaspirin,Gemfibrozil,Nitroaspirin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gemifloxacin,Nitroaspirin may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Nitroaspirin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Gemtuzumab ozogamicin.,increase,risk
Nitroaspirin,Gentamicin,Nitroaspirin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Gimeracil,Nitroaspirin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ginkgo biloba,The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Givosiran,The risk or severity of nephrotoxicity can be increased when Nitroaspirin is combined with Givosiran.,increase,risk
Nitroaspirin,Gliclazide,Nitroaspirin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Nitroaspirin,Glimepiride,Nitroaspirin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Nitroaspirin,Glipizide,Nitroaspirin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Nitroaspirin,Gliquidone,Nitroaspirin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Nitroaspirin,Glucosamine,Glucosamine may increase the antiplatelet activities of Nitroaspirin.,increase,no risk
Nitroaspirin,Glyburide,Nitroaspirin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Nitroaspirin,Glycerol phenylbutyrate,Nitroaspirin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Glycol salicylate,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Glymidine,Nitroaspirin may increase the hypoglycemic activities of Glymidine.,increase,no risk
Nitroaspirin,Golodirsen,Nitroaspirin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Goserelin,Nitroaspirin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Grepafloxacin,Nitroaspirin may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Nitroaspirin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Nitroaspirin.,increase,no risk
Nitroaspirin,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Nitroaspirin is combined with Heparin.,increase,risk
Nitroaspirin,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydralazine,Nitroaspirin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Nitroaspirin,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Nitroaspirin.,decrease,no risk
Nitroaspirin,Hydromorphone,Nitroaspirin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Hydroxocobalamin,Nitroaspirin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Hydroxyethyl Starch,Nitroaspirin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Hydroxyurea,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Hydroxyurea.,increase,risk
Nitroaspirin,Kanamycin,Nitroaspirin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketamine,Nitroaspirin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketazolam,Nitroaspirin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nitroaspirin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Nitroaspirin.,increase,risk
Nitroaspirin,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Nitroaspirin is combined with Ketoprofen.,increase,risk
Nitroaspirin,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Nitroaspirin.,increase,risk
Parathyroid hormone,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Parathyroid hormone.,increase,risk
Parathyroid hormone,Osimertinib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Osimertinib.,decrease,no risk
Parathyroid hormone,Ouabain,The risk or severity of adverse effects can be increased when Parathyroid hormone is combined with Ouabain.,increase,risk
Parathyroid hormone,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Parathyroid hormone.,increase,risk
Parathyroid hormone,Quizartinib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Quizartinib.,decrease,no risk
Parathyroid hormone,Vandetanib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vandetanib.,decrease,no risk
Parathyroid hormone,Vemurafenib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Vemurafenib.,decrease,no risk
Parathyroid hormone,Zanubrutinib,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Parathyroid hormone,Zimelidine,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zimelidine.,decrease,no risk
Parathyroid hormone,Zoledronic acid,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Zoledronic acid.,decrease,no risk
Trestolone,Gabapentin,The metabolism of Trestolone can be increased when combined with Gabapentin.,increase,no risk
Trestolone,Ganaxolone,The metabolism of Trestolone can be increased when combined with Ganaxolone.,increase,no risk
Trestolone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Glycerol phenylbutyrate,The metabolism of Trestolone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Trestolone,Griseofulvin,The metabolism of Trestolone can be increased when combined with Griseofulvin.,increase,no risk
Trestolone,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Hetacillin,The therapeutic efficacy of Trestolone can be decreased when used in combination with Hetacillin.,decrease,no risk
Trestolone,Hydrocortamate,The metabolism of Trestolone can be increased when combined with Hydrocortamate.,increase,no risk
Trestolone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Olutasidenib,The metabolism of Trestolone can be increased when combined with Olutasidenib.,increase,no risk
Trestolone,Omadacycline,The serum concentration of Trestolone can be decreased when it is combined with Omadacycline.,decrease,no risk
Trestolone,Omaveloxolone,The therapeutic efficacy of Trestolone can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Trestolone,Oritavancin,The metabolism of Trestolone can be increased when combined with Oritavancin.,increase,no risk
Trestolone,Oxacillin,The therapeutic efficacy of Trestolone can be decreased when used in combination with Oxacillin.,decrease,no risk
Trestolone,Oxcarbazepine,The metabolism of Trestolone can be increased when combined with Oxcarbazepine.,increase,no risk
Trestolone,Oxytetracycline,The serum concentration of Trestolone can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Trestolone,Quinine,The metabolism of Trestolone can be increased when combined with Quinine.,increase,no risk
Trestolone,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Valproic acid,The metabolism of Trestolone can be increased when combined with Valproic acid.,increase,no risk
Trestolone,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Trestolone.,increase,no risk
Trestolone,Vemurafenib,The metabolism of Trestolone can be increased when combined with Vemurafenib.,increase,no risk
Trestolone,Vigabatrin,The metabolism of Trestolone can be increased when combined with Vigabatrin.,increase,no risk
Trestolone,Vinblastine,The metabolism of Trestolone can be increased when combined with Vinblastine.,increase,no risk
Trestolone,Vitamin E,The metabolism of Trestolone can be increased when combined with Vitamin E.,increase,no risk
Trestolone,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Trestolone.,decrease,no risk
Trestolone,Zaleplon,The metabolism of Trestolone can be increased when combined with Zaleplon.,increase,no risk
Trestolone,Zonisamide,The metabolism of Trestolone can be increased when combined with Zonisamide.,increase,no risk
Besifloxacin,Bedaquiline,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Bedaquiline.,increase,risk
Besifloxacin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Benzocaine.,increase,risk
Besifloxacin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Benzyl alcohol.,increase,risk
Besifloxacin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Bupivacaine.,increase,risk
Besifloxacin,Butacaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Butacaine.,increase,risk
Besifloxacin,Butamben,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Butamben.,increase,risk
Besifloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Besifloxacin.,increase,risk
Besifloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Glasdegib.,increase,risk
Besifloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Haloperidol.,increase,risk
Besifloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Hydroxyzine.,increase,risk
Besifloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Besifloxacin.,increase,risk
Besifloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Oxetacaine.,increase,risk
Besifloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Oxybuprocaine.,increase,risk
Besifloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Quizartinib.,increase,risk
Besifloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Besifloxacin.,decrease,no risk
Besifloxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Besifloxacin.,increase,risk
Besifloxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Ziprasidone.,increase,risk
UC-781,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with UC-781.,decrease,no risk
UC-781,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with UC-781.,decrease,no risk
Raxibacumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Raxibacumab.,increase,risk
Raxibacumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Obinutuzumab.,increase,risk
Raxibacumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Ocrelizumab.,increase,risk
Raxibacumab,Odesivimab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Odesivimab.,increase,risk
Raxibacumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Raxibacumab.,increase,no risk
